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Abstract 
Mesoporous silica materials have attracted much interest in the past decades due to their 
potential in numerous fields including adsorption, sensing, catalysis and biomedical 
applications. Especially mesoporous silica nanoparticles (MSNs) have been widely studied as 
delivery vehicles and bioimaging devices on the nanoscale allowing for successful cell 
internalization due to their small sizes. These silica-based nanoparticles feature a well-defined 
and controllable porosity, high surface areas and the possibility to introduce a large variety of 
functionalities for controlled host-guest interactions, fluorescent labeling and cell-surface 
recognition. Different methods for the facile introduction of organo-moieties to the silica 
surface have been established in the past years, including post-synthesis grafting, delayed co-
condensation approaches and functionalization with metal-organic reagents. The porous 
structure of the nano-carriers allows for the shielded transport of fragile and expensive cargos 
such as chemotherapeutics. A major challenge in modern nano-medicine is the development 
and engineering of nanostructures for the efficient encapsulation of drug molecules avoiding 
premature release before the target site is reached; temporally- and spatially-controlled release 
properties of the nano-carriers are highly favored. Furthermore, the adsorption of different 
therapeutics at high concentrations, the targeted delivery into tumor or inflammatory tissues 
and the controllable release at the target site are key prerequisites in the field of advanced drug 
delivery and will be addressed in this work. Various gatekeepers for successful pore sealing 
have been developed in the past years, ranging from inorganic nanoparticles and polymeric 
shells to enzyme caps and highly biocompatible supported lipid bilayers. To enable a stimuli-
responsive release of the cargo molecules, redox- or light-driven opening pathways have been 
widely studied. Additionally, endosomal entrapment after successful internalization into the 
targeted cell, a major bottleneck in delivery of membrane impermeable drugs, has to be 
overcome. Different opening strategies have been developed recently, ranging from 
photosensitizers for light-induced disruption of the endosomal membrane to proton-
sponge-effect-driven release mechanisms, based on the internal acidification of the endosome. 
Yet, the development of multifunctional stimuli-responsive release on-demand systems 
combining all prerequisites for successful drug delivery systems is still a major goal of current 
research. 
In addition to the above-mentioned issues, MSNs with ultra-large pores (LP_MSNs, exhibiting 
pore sizes up to 20 nm) and distinct small particle sizes have become a main focus of 
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MSN-based research as they should allow the incorporation of high molecular weight cargos 
and thus the successful delivery of oligonucleotides to cancer cells and in vivo systems. Tailor-
made oligonucleotides together with polyplexes and liposomes as carrier vehicles are already 
widely used in gene-therapy for effective gene-silencing. Despite the existence of such nano-
vehicles, encapsulation of the siRNA in the mesoporous framework of LP_MSNs is highly 
desirable since unspecific RNA degradation could be overcome as the pores are not accessible 
for RNA-cleaving enzymes (RNAses). An important prerequisite of such nanocarriers for 
successful adsorption and delivery of oligonucleotides is the possibility to modify the silica 
surface with functional groups enabling control of host-guest interactions with the cargo 
molecules. Additionally, fine-tuning of the outer shell of the LP_MSNs should allow for 
efficient capping of the mesopores, preventing premature release of the cargo molecules. Yet, 
to the best of our knowledge, the reported nano-agents with large pores (over 5 nm) lack the 
possibility for in situ organo-functionalization of the drug delivery vehicle and typically require 
an additional grafting process. 
The further development and improvement of structurally stable mesoporous silica 
nanoparticles with different pore sizes, exhibiting distinct recognition and trigger functions for 
successful cellular uptake are part of recent research and will be addressed in detail in this work. 
In a first project in collaboration with the group of Prof. J. Rädler (LMU München, Department 
of Physics), we designed a fluorimetric reporter system based on supported lipid bilayer coated 
mesoporous silica nanoparticles (SLB@MSN) to obtain time distributions of endosomal escape 
events, which enables us to evaluate the efficiency of drug and gene delivery vectors. The 
developed system is equipped with a blue-light sensitive on-board photosensitizer 
(protoporphyrin IX, PpIX) on the outer surface enabling endosomal escape upon singlet oxygen 
generation and subsequent membrane rupture. The core of the silica nanoparticles is modified 
with a redox-labile dye/quencher system, allowing an estimation of the number of particles per 
endosome as well as the timescales at which endosomal lysis takes place. Furthermore, the 
varying uptake behavior of our lipid-coated drug delivery system in different cell-lines (Renca 
LacZ, 3T3 and HuH7) was successfully investigated in this study. 
Multifunctional mesoporous silica nanoparticles (MSNs) exhibit excellent cellular 
internalization behavior via endocytosis due to their small size (diameter of 80 nm) but it has 
to be noted that endosomal entrapment is the major bottleneck of drug delivery nano-carriers 
and hinders efficient cargo release. Therefore, in collaboration with the group of Prof. Bräuchle 
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we developed a release on-demand system based on highly biocompatible SLB-capped MSNs 
and a light-responsive external stimulus. A novel core-shell MSN-system with pore diameter 
of 5 nm (a 25% higher value compared to common MSNs) was developed and post-
synthetically modified with a covalently bound red-light sensitive photosensitizer (AlPcS2a) 
excitable near the therapeutic window. Two differently sized targeting ligands (folate and 
epidermal growth factor) were successfully incorporated into the SLB via diffusion. 
Fluorescence live-cell imaging allowed us to evaluate the functionality of the targeting ligands 
on two different cell lines (KB and HuH7). The successful release of different fluorescent model 
drugs (calcein and a rhodamine derivative) upon singlet oxygen generation and subsequent 
membrane rupture was monitored with in vial and in vitro methods. We have developed a highly 
efficient custom-made release on-demand nano-carrier system for efficient cell targeting and 
cargo release, which provides high potential for in vivo applications. 
A second approach for successful targeted drug delivery and stimuli-responsive release was 
based on the covalent attachment of a pH-responsive polymer to the outer surface of our MSNs. 
The use of the bi-functional, pH-sensitive polymer poly-(2-vinylpyridine) [PVP] permits the 
sequential attachment of polyethylene glycol (PEG), enhancing the dispersibility of the nano-
carriers and the subsequent modification with a photosensitizer (AlPcS2a) and targeting ligands 
(folate). The long-term stability of the multifunctional drug delivery vehicles in cell media was 
studied at different pH values, yielding important information on the behavior of the 
nano-carrier in biological fluids. The efficient targeting ability of the drug delivery system was 
proven by competition experiments with free folic acid in vitro and fluorescence live-cell 
imaging in co-operation with the group of Prof. Bräuchle. Endosomal acidification was used as 
internal trigger for the subsequent release of cargo molecules from the mesopores: membrane 
permeable cargos (colchicine and DAPI) could be delivered without applying an external 
stimulus to the system, whereas a photosensitizer was employed to release non-membrane 
permeable cargos (fluorescein) from the endosome. Thus, a modular toolbox based on a 
pH-responsive system with long term stability suitable for in vitro and in vivo applications was 
designed. 
A major interest of the present work was the development of organo-modified mesoporous 
silica nanoparticles with ultra-large pores and defined small particle sizes (LP_MSNs) allowing 
for the adsorption of high molecular weight cargos (e.g. enzymes and oligonucleotides). In 
chapter 8, we demonstrate the successful optimization of the pore diameter and the molecular 
functionalization of the mesopores in order to permit the facile diffusion and attachment of 
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guest molecules into the host. An increase in pore diameter to values of 7 – 15 nm was achieved 
with high molecular weight surfactants (Pluronic F127) and novel fluorinated co-surfactants 
(FC-4), special low temperature synthesis protocols and the employment of organic micellar 
expanders. For the first time the successful synthesis of organo-functionalized LP_MSNs 
(LP_MSN-SH, LP_MSN-NH2/Ph and LP_MSN-N3) via a co-condensation approach is 
reported, making these nanoparticles highly promising candidates for various biomedical 
applications. 
Enzyme immobilization for catalytic processes is a key application of mesoporous silica 
materials, as the pores can protect the fragile cargo from external influences such as 
degradation. The covalent attachment of active, functional biomolecules at the large internal 
surface of the newly developed organo-functionalized LP_MSNs (pore diameter of 13 nm) was 
investigated. For this purpose, a facile synthesis of azide-modified LP_MSNs based on a co-
condensation approach was successfully developed, which permits a mild and bioorthogonal 
click chemistry reaction within the porous network. Two acetylene-functionalized enzymes of 
different sizes (cytochrome C and trypsin) were immobilized in the pores of LP_MSN-N3 and 
their catalytic activity was investigated with fluorogenic reactions. It was demonstrated that 
both enzymes provide an extraordinary increase in activity in their immobilized state compared 
to previous studies and free enzymes; a 2.9 times higher activity was observed for LP_MSN-
CytC compared to the free enzyme. 
In addition to the immobilization of biocatalysts, mesoporous silica nanoparticles with ultra-
large pores (LP_MSNs) are promising candidates for the in vivo delivery of oligonucleotides, 
as the porous network meets the molecular dimensions of the bioactive molecules. We designed 
a stimuli-responsive nano-carrier system based on LP_MSNs with amino-functionality 
modified with a red-light sensitive phthalocyanine photosensitizer (AlPcS2a). In a joint project 
with Prof. Bräuchle and coworkers, the successful cellular uptake behavior of supported lipid 
bilayer capped LP_MSNs was studied with fluorescence live-cell imaging. This system 
provides an on-demand release mechanism based on photoactivation and subsequent singlet 
oxygen production. The successful membrane rupture was proven by in vial and in vitro cargo 
release experiments with model drugs of different sizes (calcein, propidium iodide, 
fluorescently-labeled dextran 10 kD). 
Another aim of this work was the organo-functionalization of MCM-41 with aromatic systems, 
introduced into the mesoporous framework via metal-organic reagents. 13C MAS ssNMR 
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studies revealed that the choice of the lithiation agent is of key importance; the lithiation of 
4-bromo arenes with tert-butyllithium is highly favorable compared to the lithiation with 
n-butyllithium since no unwanted side-reactions can occur. With this newly generated approach 
it was possible to introduce multiple aromatic compounds into the mesopores of MCM-41 
without destruction of the mesoporous framework. Since all introduced organo-functionalities 
are suitable for post-synthesis modification with functionalities such as catalysts, this approach 
offers a versatile toolbox for the highly efficient post-synthesis modification of mesoporous 
materials. 
In summary, we have established different multifunctional mesoporous silica nanoparticle 
systems that allow successful release of different cargo molecules via external (photoactivation) 
and internal (pH-responsive polymer) stimuli after targeted cellular internalization. It could be 
shown in different projects that due to their unique properties, mesoporous silica nanoparticles 
are highly promising candidates for advanced biomedical applications. Furthermore, different 
MSNs with ultra-large pores (7 – 15 nm average pore size) and organo-functionalization were 
developed during this work and successfully employed for enzyme immobilization and in vitro 
release experiments. The future aim is to combine the different approaches to achieve targeted 
delivery of chemotherapeutics and oligonucleotides for effective gene-silencing in tumors in 
vivo, thus achieving the ultimate spatio-temporal control of the nanoparticle agents. 
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1 Introduction 
1.1 Mesoporous silica materials 
To date a large variety of differently shaped mesoporous silica materials is known, ranging 
from films1, 2 to micrometer-sized particles3, 4, rod-like silica structures5, 6 and nanometer-sized 
mesoporous silica nanoparticles (MSNs)7-9. The most widely studied family of nanostructured 
mesoporous materials, the M41S-family and its relatives, was discovered in the early 1990s by 
researchers from Mobil Research and Development Corporation and others.10-12 These 
mesoporous silica materials were synthesized via silica condensation under basic conditions 
employing organic surfactants including cetyltrimethylammonium bromide/chloride 
(CTAB/CTAC) as templates.13 Depending on the surfactant concentration, the formed material 
exhibits three main subgroups, namely MCM-41 (Mobile Composition of Matter), MCM-48 
and MCM-50 together with a variety of less ordered phases.11, 12 MCM-41 forms hexagonally 
packed micelle structures whereas MCM-48 features a cubic and MCM-50 a lamellar 
arrangement of the mesopores (Figure 1.1).11, 12, 14, 15 
 
Figure 1.1: M41S structure types. A) hexagonal, B) cubic bi-continuous and, C) lamellar.14 
Further research in the following years led to a rapid development in the area of ordered 
mesoporous silica materials due to their unique properties, which provide a variety of 
nanotechnological applications in the fields of separation, catalysis, adsorption, and sensing.16-
20 Another well-established representative of mesoporous silica materials is the Santa Barbara 
Amorphous 15 (SBA-15), exhibiting a 2D hexagonal mesostructure.3, 4 SBA-15 has been 
extensively studied for various applications, ranging from enzyme immobilization21-23, 
catalysis24-27 to single molecule studies with oligonucleotides28, 29 due to its well-ordered pore 
1.1 Mesoporous silica materials 
 
2 
 
structures with uniform, tuneable mesopores (9 – 30 nm) and large specific surface areas. Kruk 
and co-workers showed that a substitution of the micellar expander 1,3,5-trimethylbenzene 
(TMB) by 1,3,5-triisopropylbenzene (TiPB) leads to an increase in pore size of SBA-15 
particles.30, 31 The application of SBA-15 materials in drug delivery, however, is limited due to 
their typically large particle sizes in the micrometer-range, which hinders efficient cell uptake.32 
Spherical and rod-like SBA-15 in the sub-micrometer range have been synthesized, yet particle 
sizes below 200 nm could not be obtained with these methods to date.22, 23 
1.1.1 Mesoporous silica nanoparticles (2 – 5 nm pores)  
The application field of conventional mesoporous materials (SBA-15 and MCM-41) in drug 
delivery, a main focus of today’s mesoporous silica research, is limited due to their large particle 
diameters (≥ 500 nm). Different studies have evaluated the size-dependent cellular uptake of 
nano-carriers via endocytosis.32, 33 Thus, considerable effort has been extended towards the 
design of novel silica materials exhibiting small and controllable particle sizes, suitable for 
endocytosis. Since the first report of MCM-41 type mesoporous silica nanoparticles (MSNs) 
with defined small sizes as drug delivery system in 2000, interest in these nanomaterials has 
dramatically increased.34 Brinker and co-workers developed an aerosol-based synthesis 
procedure for the formation of MSNs with different pore geometries, depending on the 
employed structure directing agent (CTAB, Brij-58 and Pluronic P123; Figure 1.2).7 The 
method relies on an evaporation induced self-assembly (EISA) process of the silica precursor 
in the aerosol droplets. 
 
Figure 1.2: A) Template-free particles with cubic mesostructure (Brij-58 as surfactant), and B) calcined 
particles with a vesicular mesophase (Pluronic P123 as surfactant).7 
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The research groups of Grün35, Cai36, Mann37, and Ostafin38 developed MSNs of 
sub-micrometer sizes based on a modified Stöber39 procedure by adding different cationic 
surfactants to the reaction mixture. These approaches paved the way for the success of 
mesoporous silica nanoparticles, because the synthesis is straightforward compared to the 
aerosol method, which requires special equipment. Since then, considerable effort has been 
extended regarding the synthesis of MSNs with a focus on mesostructural diversity, 
compositional flexibility and morphological control.9, 40-45 Lin and co-workers have synthesized 
thiol-functionalized MSNs with a mean diameter of 200 nm and pore sizes of 2.9 nm and 
showed successful capping of the mesopores with CdS nanoparticles to prevent cargo leakage 
(Figure 1.3A).8 A standard synthesis approach for the generation of MCM-41-like silica 
nanoparticles follows a condensation procedure of the silica precursors (TEOS and 
organotrialkoxy silanes) at highly basic conditions (pH 12.5) and is widely used for the 
development of multifunctional nanoparticles.46-49 Another strategy for highly homogeneous 
MSNs meeting the prerequisites for drug delivery applications was developed in our group.9  
Instead of sodium hydroxide, triethanolamine is used as base and complexing ligand for the 
silica precursor. This CTAC-mediated pathway allows for the facile synthesis of uniform MSNs 
with 4 nm pores (worm-like pore structure, suggesting a seed-growth mechanism) and 
spherically shaped particles with sizes of about 80 nm (Figure 1.3B).9, 40, 50 Recently, this 
synthesis approach was refined by adding the micellar expander TiPB. This modification of the 
synthesis approach led to an pore size enlargement of 25% (5 nm) compared to the previously 
described MSNs.41 Additionally, small amounts of ammonium fluoride were added to the 
reaction mixture resulting in perfectly spherically shaped nanoparticles that seem to exhibit a 
radial growth mechanism (Figure 1.3C). The multifunctional MSNs developed by Bein and co-
workers were already successfully examined as promising drug delivery vehicles in cells, 
exhibiting stimuli-responsive release properties..41, 51, 52 Gai et al. were able to synthesize MSNs 
with fibrous morphology by a urea assisted synthesis. These nanoparticles have been shown to 
efficiently adsorb the anti-cancer therapeutic doxorubicin (Dox).53 The particle size of MSNs 
could be easily varied by a change of the TEOS:CTAB-ratio.  
1.1 Mesoporous silica materials 
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Figure 1.3: TEM micrographs of different, template-free mesoporous silica nanoparticles. A) Organo-
modified MCM-41-like silica nano-spheres,8 B) core-shell MSNs with 4 nm pore size exhibiting a 
worm-like mesoporous framework,40 C) core-shell MSNs with 5 nm pores,41 and D) MSNs with fibrous 
morphology.53 
In addition to the above-mentioned systems, other types such as the Singapore Institute of 
Bioengineering and Nanotechnology (IBN)42, 54 and FDU-n (Fudan University) series55 show 
great potential in various biomedical applications. In general, multifunctional MSNs have been 
widely studied as promising nano-carriers for anti-cancer drugs such as doxorubicin56, 57 or 
paclitaxel58, 59 both in vitro as well as in vivo.60, 61 
1.1.2 Functionalization of mesoporous silica materials 
The selective functionalization of mesoporous silica materials is of key importance to allow the 
attachment of shielding polymers (poly(ethylene glycol), PEG), targeting ligands and stimuli-
responsive trigger systems, among others. These requirements for successful drug delivery 
vehicles will be explored in the following chapters. Different functionalization methods to 
modify mesoporous silica materials are known: post-synthesis grafting with organo-silanes, 
co-condensation methods, synthesis of periodic mesoporous organosilicas (PMO) and 
modification with metal-organic reagents.62-67 Post-synthetic grafting with organo-silanes is the 
most common method to introduce organo-moieties to the silica surface. However, the grafting 
procedure shows several disadvantages. For instance, no distinct control over the location of 
the functionalization is possible and is not always evenly distributed over the pore walls and 
external particle surface. Furthermore, the amount of introduced functionality can vary from 
one reaction to another, which requires a detailed analysis and calculation of the grafted 
material prior to subsequent reactions.  
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Another promising approach is the so-called co-condensation method, which enables a direct 
incorporation of organo-silanes into the mesoporous framework during the synthesis procedure. 
It has to be noted that certain organo-silanes, especially with amino-functionality (e.g., 
3-aminopropyl triethoxysilane (APTES)), are able to disrupt the mesostructure formation due 
to a change of the pH value during the synthesis. In particular, Lebold et al. showed that amino-
functionalized SBA-15 can only be synthesized by a co-condensation approach when a distinct 
amount of stabilizing phenyl-silane is added to the synthesis.68 Similar results were obtained 
for large pore mesoporous silica nanoparticles (cf. chapter 7). Another elegant way to establish 
organo-functionalities is their introduction via a site-selective delayed co-condensation 
approach, which allows for a facile synthesis of core-shell functionalized MSNs (Figure 1.4).40 
The onion-like structure provides a selective successive decoration of the nanoparticle interior 
with fluorescent dyes or the fine-tuning of host-guest interactions. Moreover, the outer surface 
can be selectively modified with biocompatible polyethylene glycol (PEG) linkers or stimuli-
responsive gatekeepers without affecting the core of the MSNs, and thus the pores remain 
accessible for the efficient uptake and release of cargo molecules.51, 69 
 
 
Figure 1.4: Facile synthesis of core-shell MSNs via a delayed co-condensation approach. In a first step 
the silica core with organo-functionalization is synthesized (R1TES, green), followed by a thin pure 
silica layer (blue) that shields the core from the differently modified shell of the MSN (R2TES, red). 
Several studies of our group in the past years have already shown the great potential of the 
delayed co-condensation approach for the synthesis of advanced drug delivery 
nano-carriers.70-74 It can be concluded that surface modification with organic-moieties permits 
the introduction of a large variety of functionalities to control host-guest interactions, diffusion 
and release, fluorescent labeling, and cell-surface recognition, amongst others. This will be 
addressed in the following chapters. 
1.1 Mesoporous silica materials 
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1.1.3 Large-pore mesoporous silica nanoparticles 
Although a wide application of MSNs as versatile vehicles for advanced drug delivery purposes 
was observed in the past twenty years,13, 51, 75-78 limits arise when large cargos should be 
immobilized.  The relatively small pore sizes of conventional MSNs limit their application as 
host system for macromolecules such as enzymes and cell-active oligonucleotides. Great efforts 
have been made to optimize the pore diameter with regard to the adsorption of large 
biomolecules. Furthermore, an optimization of the molecular functionalization of the 
mesopores will provide a facile diffusion and attachment of guest molecules into the host 
material.28, 29 In particular, the adsorption of small interfering RNA (siRNA) into large pore 
MSNs (LP_MSNs) is of great current interest. Artificially generated siRNA is a promising 
therapeutic in gene therapy since it can be specifically designed to knock down messenger RNA 
(mRNA). Subsequently, it inhibits the translation of a target protein that is known to cause a 
certain disease.79-81 Hom et al. attached siRNA to the external surface of PEI-modified 
mesoporous silica nanoparticles and observed an effective gene silencing of enhanced green 
fluorescent protein (EGFP).81 It is highly desirable to incorporate the fragile and expensive 
molecules within the mesoporous channels of the drug delivery vehicles to prevent premature 
degradation and leakage before the targeted compartment is reached. Proof that the 
oligonucleotides are actually adsorbed in the mesopores of the LP_MSNs and not only 
complexed at the outer surface remains vague in both above-mentioned reports. A 
well-established representative of mesoporous silica materials with large pores is the µm-sized 
SBA-15, which was introduced by Stucky and co-workers in 1998, exhibiting a high 
hydrothermal stability and large, tuneable pore sizes (4.9 – 30 nm).3, 4 However, it has to be 
noted that in addition to large pore sizes, a distinctly small particle size (within a size range of 
50 – 300 nm) of the nano-carrier is of key importance for cell experiments and in vivo 
applications.13 Recently, several strategies for the synthesis of LP_MSNs with a particle 
diameter of 70 – 300 nm and very large pores (up to 17 nm) using a novel fluorocarbon 
surfactant (FC-4) and triblock copolymers (Pluronic F127, P123 and P65) have been published 
by different groups.42, 54 Han et al. studied the impact of different non-ionic triblock copolymers 
(Pluronic P65, P123 and F127) and FC-4 (cf. Table 1.1). FC-4 which acts as co-surfactant was 
found to limit the particle growth at moderate temperatures.42 Different Singapore Institute of 
Bioengineering and Nanotechnology (IBN) mesoporous silica materials were synthesized with 
this approach, exhibiting distinctive pore sizes depending on the employed surfactant and 
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reaction temperatures. 3D cubic, 2D hexagonal as well as foam-like and disordered pore 
structures with varying pore sizes were synthesized (Table 1.1). 
Table 1.1: LP_MSNs obtained with a fluorocarbon-mediated synthesis.42 
Sample Mesostructure 
 
Template 
BET surface area 
[m²/g] 
Pore volume 
[cm3/g] 
Pore sizeb  
[nm] 
IBN-1 3D cubic (Im3m) F127 779 0.73 5.8 
IBN-2 3D cubic (Fm3m) F127 + TMB 804 0.65 9.5 
IBN-3 Mesocellular foam P65 + TMB 821 0.72 19.5 
IBN-4 2D hexagonal (p6m) P123 709 0.88 6.4 
IBN-5 disordered F108 575 0.54 5.2 
 
The use of FC-4 during the syntheses proved to be necessary as very large and irregular 
mesoporous particles were obtained without the co-surfactant. Additionally, the reported 
syntheses were carried out under mildly acidic conditions and moderate reaction temperatures 
(25 – 30 °C). Higher acidity and temperatures are known to promote a rapid and uncontrolled 
hydrolysis of the silica precursors, hindering the formation of well-defined nanoparticles.42 Gao 
et al. developed a facile strategy for the generation of LP_MSNs based on the work of Ying 
and co-workers.54 A dual surfactant system consisting of the triblock copolymer Pluronic F127 
together with FC-4 and TMB as micellar expander was studied in detail at different low 
temperatures (5 – 10 °C). Different studies report that low synthesis temperatures favor the 
diffusion of the micellar expander into the hydrophobic core of the micelles during the particle 
formation and therefore help to enlarge the pore size.42, 54, 55, 82 Additionally, the post-synthesis 
hydrothermal treatment was varied by Gao et al. in comparison to the original publication.54 
Spherical, unfunctionalized LP_MSNs with ultra-large pores were obtained with this modified 
procedure (Figure 1.5C). 
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Figure 1.5: Transmission electron micrographs of LP_MSNs generated with a fluorocarbon-assisted 
synthesis. A) HRTEM image of 3D cubic LP_MSNs taken along the [111] direction (inset: 
corresponding FT patterns),42 B) HRTEM image of calcined LP_MSNs (mesocellular foam) synthesized 
with Pluronic P65 and TMB,42 and C) LP_MSNs obtained at a synthesis temperature of 15 °C with a 
hydrothermal treatment at 135 °C. The inset shows the view from the [110] direction and the local 
arrangement.54 
 
Besides the fluorocarbon surfactant mediated syntheses, several other possibilities for the 
generation of LP_MSNs are known: Shi and co-workers developed core-shell structured 
mesoporous silica spheres (Figure 1.6A and B) via an amphiphilic block copolymer 
(polystyrene-b-poly (acrylic acid), PS-b-PAA) route in combination with CTAB as template. 
Several different core-shell nanoparticles were generated by this procedure.83 Ryoo and 
co-workers obtained mesoporous silica nanoparticles with an average pore diameter of 23 nm 
via a post-synthesis pore expansion procedure with TMB under static conditions 
(Figure 1.6C).43 
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Figure 1.6: A) and B) TEM images of core-shell structured dual-mesoporous silica spheres (DMSS-
PS100) synthesized with an amphiphilic block copolymer (polystyrene-b-poly (acrylic acid), PS-b-
PAA) and cetyltrimethyl ammonium bromide (CTAB) acting as co-templates.83 C) MSN23 after 
hydrothermal treatment.43 
 
Importantly, the above-mentioned LP_MSNs synthesis protocols lack the possibility of a direct 
incorporation of organo-functionalities into the silica framework and employ post-synthesis 
grafting for surface modification. However, a controlled distribution of the functionality is a 
key prerequisite for the attachment of external triggers such as targeting ligands and/or 
stimuli-responsive capping mechanisms. Different strategies for an efficient delivery of 
modified LP_MSNs to cells have been reported previously, but it has to be noted that all 
approaches were based on post-synthesis grafting methods.43, 54 Gao et al. modified the silica 
surface with amino-moieties for efficient plasmid DNA (pDNA) adsorption.54 In contrast, 
Hartono et al. described the post-synthesis attachment of poly-L-lysine (PLL) to the outer 
surface of LP_MSNs for efficient siRNA delivery to osteosarcoma cancer cells.84 However, 
cationic polymers such as PLL are widely used for the generation of polyplexes for efficient 
gene delivery due to their interaction with the negative backbone of the oligonucleotides and 
no evidence of a direct incorporation of the siRNA in the mesopores is given. Another class of 
promising large pore mesoporous silica materials which was recently discovered and 
extensively studied for various applications are so-called hollow spheres and rattle-type 
(yolk-shell) materials.13, 85, 86 These MSNs exhibit low densities, high specific surface areas and 
loading capacities that make them promising candidates for various biomedical applications.13 
Different synthesis routes are available for the generation of hollow spheres, namely (1) a 
soft-templating approach, (2) a selective etching strategy and (3) a self-templating method. We 
refrain from discussing possibilities (2) and (3) in this chapter. Yeh et al. reported in 2006 a 
facile synthesis of hollow sphere mesoporous silica materials with a ternary surfactant system 
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consisting of Pluronic P123, CTAB and sodium dodecyl sulfate (SDS)87, an approach which 
was later modified by Lu et al..88 Mou and co-workers generated hollow spheres with a 
water-in-oil (w/o) microemulsion technique, employing cyclohexane, Triton X-100 and 
water.89 Aminopropyl trimethoxysilane (APTMES) combined with TEOS was used as silica 
source in this approach (Figure 1.7A and B). The APTMES amount is crucial to control the 
particle size of the hollow spheres. Lu et al. synthesized yolk-shell MSNs of tuneable wall 
thickness by employing Pluronic F127 together with FC-4 and a distinct amount of ammonium 
nitrate.88, 90 The core of the yolk-shell MSNs was composed of Fe3O4 nanoparticles, allowing 
their application in catalysis. Besides the soft-templating approaches, numerous yolk-shell 
MSNs were obtained by etching methods, enabling the facile synthesis of large amounts (up to 
10 g) in a convenient one-pot synthesis (Figure 1.7 C and D).13, 91-94 Additionally, the particle 
size can be effectively tuned from sub-100 nm nanoparticles to micrometer-sized rattle-
spheres.13 It can be concluded that nowadays several different methods are available for a 
precise formation of hollow sphere silica nanoparticles and yolk-shell nano-rattles. 
 
Figure 1.7: A) and B) TEM micrographs of hollow sphere silica nanoparticles89, and C) and D) of 
yolk-shell nano-rattles.94 
Many of the above-mentioned materials are promising candidates for advanced drug delivery 
with flexible and tuneable nano-carriers. This topic will be addressed in the following chapters. 
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1.2 Targeted drug delivery for cancer treatment with nano-carriers 
1.2.1 Nano-material based cancer therapy  
Cancer is one of the most devastating diseases worldwide with more than 14 million new cases 
per year, with an increasing tendency.95 Modern cancer treatments utilize surgical intervention, 
radiation and chemotherapeutic drugs (such as doxorubicin, paclitaxel and cis-platin) that cause 
severe side-effects.96 Doxorubicin (DOX) is the most commonly used anti-cancer therapeutic 
causing an efficient induction of apoptosis in cancer cells but also showing a high 
cardiotoxicity.13 The fluorescence of this drug allows for the direct observation with 
fluorescence microscopy.97 In the context of reducing the side-effects and the required amount 
of drug, nanomaterials have attracted an increasing interest in cancer treatment due to their 
securely and shielded delivery of the therapeutics to the desired targeting sites without affecting 
healthy tissues.96, 98-102 Potential nano-carriers should fulfill several prerequisites for successful 
applications in drug delivery, namely (1) a high loading capacity with regard to the drug, (2) a 
site-specific delivery mechanism (targeting) exclusively to cancer cells, (3) no premature 
release before the target site is reached, (4) high level of cellular internalization, (5) a 
stimuli-responsive release mechanism that enables a selective drug release at the target site, and 
(6) a composition of biocompatible /biodegradable/bioexcretable materials.101 The most widely 
studied nano-vehicle systems are based on ‘soft’, organic carriers due to their high 
biocompatibility and possibility for functionalization, most commonly the decoration with 
polyethylene glycol (PEG). The most prominent representatives are liposomes that complex the 
cytostatic agents and form so-called active lipoplexes. The liposomal drug complexes Doxil 
(for doxorubicin) and Daunoxome (for daunorubicine) were the first to find their use in the 
clinic and are successfully used in cancer treatment, limiting the side-effects of the free 
drugs.101, 103 To date, a total of six drugs with liposomal carrier systems have been approved for 
cancer treatments100 and about additional 20 liposomal drugs are in clinical trials.99, 102 
However, it has to be noted that liposomal systems show several disadvantages ranging from 
instability under physiological conditions and the lack of temporal control over the drug release 
rate, showing sustained release.104 Additionally, Doxil shows side-effects, namely skin toxicity, 
which is not present upon administration of the free drug.105 Another class of organic carriers 
that has been widely studied in the past years are so called polyplexes consisting of polymers 
that enable complexation of the drugs.98, 106-108 The most prominent application of such 
polyplexes is the successful delivery of oligonucleotides, mainly small interfering RNA 
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(siRNA) and single-stranded oligonucleotides for artificially induced gene silencing (gene 
knock-down).109 For instance, 21-23 base pair (bp) long double-stranded siRNA110, 111 is 
delivered to the cytosol where the antisense strand is integrated into the RNA-induced silencing 
complex (RISC).107 This complex binds and cleaves the complementary messenger RNA 
(mRNA) with high precision, leading to a knock-down of the expressed gene. The most widely 
used polymers for gene delivery are cationic polymers that bind nucleic acids via electrostatic 
interactions with the negatively charged backbone of the oligonucleotides. The cationic 
polymers used for this purpose include linear or branched poly(ethyleneimine) (PEI), 
poly(amidoamine) (PAMAM) dendrimers and poly-L-lysine (PLL).112-115 The major drawback 
of these nano-carriers is a possible premature unpacking of the polyplexes by serum proteins 
and extracellular matrix components before the target site is reached.116 PEI-siRNA-polyplexes 
were found to dissociate in full human serum immediately after their administration.117, 118 To 
solve this so-called ‘polyplex-dilemma’ (of polyplexes being too labile in extracellular medium 
and too stable for intracellular dissociation)107 attention is likely to be focused on bio-responsive 
polymers that respond to internal stimuli.119-121 By 2014, two therapeutic drugs based on nucleic 
acids, namely Vitravene (Fomivirsen) and Kynamro (Mipomersen)122, have been approved by 
the FDA, and several other antisense therapeutics have reached advanced stages of clinical 
trials.123, 124 Despite the above-mentioned achievements in nano-medicine, novel drug delivery 
systems are of key importance, allowing to overcome certain disadvantages (low drug loading, 
high costs, low synthesis yields) and facilitating cost-effective alternatives.13 Inorganic nano-
carriers such as mesoporous silica nanoparticles provide a multiplicity of advantages for drug 
delivery applications including selective size and shape control, tuneable pore sizes, and large 
pore volume and surface area for high loading capacities. Additionally, they are more robust 
than many organic supports and comparably cheap.34, 101 Selective post-synthesis 
functionalization of the silica surface permits the circumvention of undesired biological 
interactions (e.g., cargo degradation prior to reaching the target), and facilitates bioavailability 
and effective cellular uptake.41, 69, 77, 125, 126 The ultimate goal of modern nano-medicine is to 
enable efficient and patient-friendly treatments by a reduction of the systemic drug 
concentration and dosing frequency and  by offering easier administration and improved 
safety.127  
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1.2.2 Mesoporous silica nanoparticles as drug delivery vehiclesi  
Mesoporous silica nanoparticles (MSNs) with sizes up to 500 nm have attracted much interest 
for their potential as drug delivery vehicles to control various cell functions by the stimuli-
responsive delivery of bioactive cargos.13, 78, 128-133 For further reading on this topic, see full 
review article of Argyo et al..133  The first application of MSNs as potential drug delivery 
systems was reported by Vallet-Regí and co-workers in 2000.34 Ibuprofen was successfully 
adsorbed into the mesopores of MCM-41 type MSNs, yielding high loading capacities and 
subsequent drug release. Ever since, an exponential increase in MSN-based drug delivery 
research could be observed, as the MSNs feature well-defined and controllable porosity at the 
nanometer scale.13 Furthermore, the host-guest interactions can be selectively modified for 
increased cargo adsorption, which results in higher yields of drug loading. Efficient uptake of 
the MSNs via endocytosis into different types of cells was observed.76, 134, 135 However, Mou 
and co-workers reported a size-dependent endosomal uptake in HeLa cells, favoring a size-
range of 50 – 120 nm.33 Particles with a size of 190 nm already showed significant cytotoxicity 
at concentrations higher than 25 mg/mL. An ideal drug delivery vehicle based on MSNs may 
be composed of a multifunctional silica core to be able to specifically control the interaction 
with diverse active cargo components. The cargo molecules (e.g. fluorescent dyes or 
pharmaceutically active drugs) are adsorbed in the mesopores of the nanoparticle, yielding a 
sufficient shielding from external degradation in biological fluids.69, 136 Efficient pore closure, 
and consequently a prevention of premature release, is achieved via stimuli-responsive bulky 
gatekeepers (e.g. gold nanoparticles, polymers, rotaxanes, enzymes, oligonucleotides) that 
efficiently block the pore entrances. These gatekeepers can respond to external or internal 
cellular stimuli for a specifically controlled cargo release.137-142 To enable high cellular uptake 
of the multifunctional MSNs, targeting ligands can be covalently attached to the outer surface 
of the particles via a flexible PEG-linker that additionally shields the particle from external 
influences. It is known that many receptors are overexpressed on the extracellular surface of 
cancer cells and can be specifically targeted with corresponding ligands. The mechanism 
follows a key-lock principle and is highly selective towards receptor-mediated endocytosis. The 
most commonly used receptor target is the folic acid receptor (FAR) and the epidermal growth 
                                                 
 
i) This part of the introduction was inspired by the perspective article of C. Argyo et al., Chem. Mater. 2013, 26, 
435–451.   
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factor (EGF). Since endosomal escape is a major bottle-neck for successful drug delivery, a 
trigger that helps the nano-carrier to escape its entrapment and to release its cargo into the 
cytosol is highly desirable. Different approaches based on internal (acidification of the 
endosome, membrane fusion) as well as external triggers (light-induced membrane rupture) are 
reported in the literature (Figure 1.8).133  
 
Figure 1.8: Schematic illustration of a multifunctional mesoporous silica nanoparticle (MSN) based on 
the core-shell MSNs developed by Bein and co-workers,40 exhibiting the key features for stimuli-
responsive drug release from the endosomal compartment of a targeted cancer cell. Ideally, the vehicle 
consists of a fluorescent tracking marker, a stimuli-responsive gatekeeper, a targeting ligand on the outer 
surface enabling receptor-mediated endocytosis and an endosomal escape trigger. (SPION: 
superparamagnetic iron oxide nanoparticle, QD: quantum dot, PEG: poly(ethylene glycol), Au-NP: gold 
nanoparticle, RGD: Arg-Gly-Asp amino acid sequence, EGF: epidermal growth factor, PEI: 
poly(ethylene imine), H5WYG: endosomolytic peptide).133 
Various model drugs and pharmaceutically active cargos such as ibuprofen34, 
doxorubicin48, 53, 56, 143, cis-platin144-146 and paclitaxel58 have been successfully delivered by 
MSNs until today. In addition to their application as promising nano-carriers for the treatment 
of chronic inflammation diseases and cancer, the MSNs have also been widely studied in the 
field of bone tissue engineering147 and treatment of diabetes.148 
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1.2.3 Cellular uptake in cancer cells and receptor-targeting 
A major limitation of common cytostatic drugs used for chemotherapy is the insufficient target 
selectivity that can lead to nonspecific toxicity and severe side-effects as well as a reduction of 
therapeutic efficacy, requiring higher applied drug doses. This “vicious circle” in anticancer 
treatment can be overcome by specially designed drug delivery vehicles for targeted cell 
internalization. Cellular uptake of nanoparticles within a distinct size range (< 200 nm) usually 
occurs via endocytosis where the nano-carriers are engulfed by the cell membrane and delivered 
to the intracellular matrix in membrane bound vesicles.134, 135, 149, 150 Mou and co-workers 
investigated the influence of the particle size on the cellular internalization by HeLa cells.33 It 
was shown that the cellular uptake is highly size-dependent in the order 50 nm > 30 nm > 
110 nm > 280 nm > 170 nm. Shi and co-workers examined the in vivo biodistribution and 
urinary excretion of spherical MSNs of different sizes (80, 120, 200, and 360 nm) by 
intravenous administration of the nano-carrier.151 Smaller sizes of the PEGylated MSNs proved 
to have a slower biodegradability and correspondingly lower degradation products in the urine. 
Site-specific targeting can be classified into two different types, namely passive and active 
targeting. Passive targeting is based on the so-called enhanced permeability and retention (EPR) 
effect which is commonly observed in solid tumors; the tumor tissues grow extraordinary 
quickly in comparison to healthy cells, leading to leaky microvasculatures and impaired 
lymphatic function. Thus, nanoparticles in the suitable size-range present in the tumor-
surrounding blood vessels tend to accumulate in the tumor tissue.152 In contrast, active targeting 
is based on a ligand-receptor interaction following a lock-key-principle which requires the 
modification of the drug delivery vehicles with a targeting ligand (TL), enabling increased cell 
uptake.153 In general, receptors are membrane-bound proteins of different sizes being 
commonly overexpressed on the extracellular membrane of various cancer cell types. The main 
challenge of targeted drug delivery with nano-vehicles is to selectively design stable, 
non-immunogenic carriers that are able to achieve a high targeting specificity but avoid 
non-specific binding to the cell membranes. TLs range from small molecules (folic acid) to 
different macromolecules (e.g. epidermal growth factor), which all enable an efficient uptake 
of the drug delivery vehicles via a receptor-mediated endocytosis. An overview of the major 
receptors together with their overexpression in cancer cell types is given in Table 1.2.152 FA is 
one of the most frequently used targeting ligands in current research as the folate receptor is 
highly up-regulated in many human cancers.154-157 Additionally, folate is highly stable, 
non-toxic, comparably cheap and easily modified to meet the requirements of successful 
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attachment onto the nano-carrier. A broad variety of FA modified lipids and PEG-chains is 
actually commercially available, which enables the facile modification of the vehicles. Lee et al. 
showed that a flexible PEG-spacer between FA and the lipid is mandatory to successfully target 
liposomes158, a strategy that was recently employed by our group to deliver supported lipid 
bilayer capped MSNs (SLB@MSN) to cancer cells.41 Mamaeva et al. demonstrated active 
targeting by covalent conjugation of folate to MSNs and the successful delivery of γ-secretase 
inhibitors (GSIs) down-regulating the notch signaling pathway.159 Two other widely studied 
receptors for the targeting of nano-carriers are the epidermal growth factor receptor 
(EGFR)160-162 and the integrin receptor.163-165 Additionally, nano-sized drug delivery vehicles 
modified with so called dual-receptor targeting have gained high attention in recent years since 
these systems enable the addressing of two different cells which are related to a certain disease 
process with a single nano-carrier. Xu et al. designed a branched copolymer with cyclicRGDfK 
and transferrin on the outer surface for successful delivery of paclitaxel.166 These systems are 
highly attractive for the treatment of glioma as the blood brain barrier restricts the diffusion of 
larger molecules such as common chemotherapeutics and nano-carriers.167, 168 Recently, 
aptamers have attracted great attention as receptor targeting ligands for cancer cells.169 The 
custom-made aptamers consist of single-stranded deoxyribonucleic acid (DNA) or ribonucleic 
acid (RNA) oligonucleotides selectively designed for the interaction with a target receptor.170 
For instance, the human transferrin receptor CD71 (TfR), which is overexpressed in a number 
of cancer cell lines and the blood brain barrier, can be targeted by DNA aptamers.171 Wilner 
and co-workers synthesized specific aptamers that are stabilized against serum via a modified 
selection protocol to target stable nucleic acid lipid particles (SNALPs). A minimized aptamer 
(c2.min) was reported to be specific for the human receptor, allowing a successful 
internalization into various cancer cell lines.171 
 
 
 
 
 
 
 17 
 
Table 1.2: Summary of overexpressed cell membrane receptors on cancer cells widely used for selective 
drug delivery using receptor–ligand pairs in preclinical models of cancer.152 
Major Receptor Type 
 
Specific receptor 
 
Overexpression in cancer cell types 
 
G protein coupled receptors 
(GPCRs) 
Bombesin receptor (BnR) 
 
 
 
 
 
Somatostatin receptors (SSTRs) 
 
 
 
 
Endothelin receptors (ETRs) 
 
 
 
Lung, prostate, breast, pancreatic, head/neck, 
colon, uterine, ovarian, renal cell, 
glioblastomas, neuroblastomas, 
gastrointestinal carcinoids, intestinal 
carcinoids, and bronchial carcinoids. 
 
Small cell lung, neuroendocrine tumor, 
prostate cancer, breast cancer, colorectal 
carcinoma, gastric cancer, hepatocellular 
carcinoma. 
 
Melanoma tissues 
 
 
 
 
 
 
 
Integrins ανβ3 is of particular interest in 
selective drug targeting 
 
Activated endothelial cells and tumor cells 
(such as U87MG glioblastoma cells), ovarian 
cancer cells 
Folate receptors (FRs) FRα, FRβ and FRγ; FRα, a cell 
surface glycosyl 
phosphatidylinositol-anchored 
glycoprotein most commonly 
studied 
 
 
Most tissues including breast cancer cells. 
 
 
 
Transferrin receptors 
(TfRs) 
 
TfR1 & TfR2 
Breast, ovary, and brain cancers such as 
glioma and glioblastomas 
Epidermal growth factor 
receptor (EGFR) 
EGFR (or ErbB1, HER1) 
ErbB2 (HER2, in rodents) 
ErbB3 (HER3) 
ErbB4 (HER4) 
 
 
 
Lung, breast, bladder, and ovarian cancers. 
Fibroblast growth factors 
(FGFRs) So called ‘acid box’ Breast, prostate, bladder, and gastric cancer 
Sigma receptors (SRs) 
S1R and S2R 
Non-small cell lung carcinoma, prostate 
cancer, melanoma, and breast cancer 
cancer. Others Follicle stimulating hormone 
receptors (FSHRs) 
 
Biotin receptors (BRs) 
 
C-type lectin receptors (CLRs) 
 
Asialoglycoprotein receptor 
(ASGPR) 
 
NRP-1 
Ovarian surface epithelium 
 
 
Leukemia 
 
Hepatocytes, dendritic cells, macrophages 
 
 
 
 
Human vascular cells 
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It has to be noted that although the main research interest lies on active targeting in recent years, 
passive targeting of nano-carriers via the EPR effect is already successfully being employed for 
several systems (e.g. Doxil) in the clinic.152  
 
1.2.4 Endosomal escape 
Drug delivery vehicles based on nanomaterials show good cellular internalization via the 
endocytosis pathway, but endosomal entrapment is a major challenge for successful drug 
delivery, especially for membrane-impermeable cargos and those exhibiting a low solubility. 
The typical fate of nanoparticles internalized by endocytosis includes intracellular trafficking 
of early endosomes to late endosomes or endolysosomes. A drastic acidification of the vesicle 
occurs by proton pumps (ATPases) and results in a change of internal pH-value (from 7.4 to 
5.5).172 In addition to the decrease in pH, the transition leads to an increase of the enzymatic 
concentration (including e. g. proteases, reductases) within the compartment which can be 
harmful to many therapeutic molecules and can finally lead to the degradation of the drugs.173 
Therefore, major efforts have been made to develop mechanisms that allow the nano-carriers 
to escape the endosome. Endosomal escape is of high importance and several possibilities to 
overcome this have been studied in the past years. To date, various different methods are known 
for a successful endosomal membrane rupture and subsequent cargo release, based on external 
(light irradiation, ultrasonic radiation, change in temperature) and internal (change of the 
pH-value within the endosome) stimuli. The most intensively studied endosomal escape 
pathway relies on pH-buffering effects (so called ‘proton sponge’)174, 175 and on the 
photochemical activation of photosensitizers that generate singlet oxygen leading to a 
disintegration of the endosomal membrane.41, 51, 176 Brinker and co-workers developed a 
multifunctional drug delivery system based on MSNs with a supported lipid bilayer for cargo 
encapsulation, which is equipped with an endosomolytic peptide (H5WYG) on the outer surface 
of the nano-carrier (Figure 1.9).75 The peptide sequence derives from the active subunit of the 
glycoprotein hemagglutinin of the influenza virus A and undergoes a conformational change 
upon protonation, facilitating endosomal escape. In addition, the attached targeting ligand 
(SP94) enables efficient receptor-mediated uptake of the “protocells” into cells via endocytosis. 
Due to neutral pH-values in early endosomes, the endosomolytic peptide remains inactive but 
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undergoes a conformational change during the subsequent endosomal acidification into its 
active state, leading to membrane rupture. Thus, the cargo molecules such as 5-fluoruracil, 
siRNA and cis-platin were released into the cytosol and found to accumulate on their target site 
(Figure 1.9-4). It has to be noted that, although these H5WYG-peptides are commonly used 
together with nano-vehicles, experimental evidence and proof for the exact mechanism is not 
yet available.177-179 
 
Figure 1.9: Scheme of efficient internalization of multifunctional, lipid-coated “protocells” (MSNs) and 
subsequent drug release upon endosomal acidification. 1) DOPC-coated protocells with a targeting 
peptide (SP94) and a fusogenic peptide on the outer surface are internalized via receptor-mediated 
endocytosis, 2) uptake of the protocell is followed by subsequent acidification of the cellular 
compartment, 3) upon acidification a conformational change of the fusogenic peptide takes place (blue) 
leading to endosomal membrane rupture and subsequent cargo release into the cytosol, and 4) cargo 
modified with a nuclear localization sequence (NLS) accumulates in the nucleus.75 
Another widely studied endosomal escape mechanism based on the internal stimulus of 
compartment acidification is the so called ‘proton sponge effect’. This mechanism is based on 
an intrinsic osmotic swelling caused by the buffering capacity of specially designed 
nano-vehicles which finally leads to endosomal membrane rupture.172 Several cationic, 
amino-modified lipids and polymers such as PEI and PAMAM dendrimer structures were 
examined as potential proton sponges as they exhibit a substantial buffering capacity below the 
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physiological pH.175, 180, 181 PAMAM dendrimers have been originally introduced by 
Tomalia et al.182 in 1985 and have already gained high attention for various applications.183 Lin 
and co-workers developed a gene-transfection drug delivery system based on MSNs with 
covalently attached PAMAM dendrimer (second generation, G2)184, whereas Nel and 
co-workers used non-covalently attached PEI on the surface of MSNs for the successful 
delivery of DNA and siRNA to cells.59  
An alternative mechanism for endosomal escape relies on external stimuli such as light-
activation of photosensitizers (PS), which leads to subsequent membrane rupture by singlet 
oxygen.76, 176 In comparison to internal triggers, the endosomal escape events can be precisely 
controlled with such systems, facilitating a spatial and temporal controlled cargo release. In 
contrast to photodynamic therapy (PDT), the photosensitizer (PS) does not act as actual “drug” 
in these systems, but as tool for endosomal escape of the nano-carriers by the generation of 
reactive oxygen species (ROS) upon photoactivation. Recently, different approaches with on-
board photosensitizers excitable with visible light have been developed by our group, providing 
control of the endosomal escape events and thus, the release of the drug into the cytosol of 
cancer cells. The utilization of photosensitizers is not only a reliable method for the 
disintegration of the supported lipid bilayer which encloses the MSNs, but also a powerful tool 
to overcome nanoparticle and cargo entrapment by the endosomal membrane.51 Schlossbauer 
et al. developed an on-board system with a blue light excitable photosensitizer based on 
protoporphyrin IX for a successful chromobody delivery51, which was investigated in more 
detail by Dobay et al..74 Due to the low penetration depth of short wavelength light in tissues, 
a recent study by Bräuchle and co-workers employs a  phthalocyanine-based photosensitizer 
where successful targeting of MSNs and subsequent endosomal escape was shown 
(cf. chapter 4).41 Importantly, the activation of the PS with red light instead of blue light reduces 
the phototoxicity and significantly increases the depth of tissue penetration185 which will be 
crucial when activation in vivo is required as shown by Kataoka and co-workers.186 Novel 
approaches to overcome endosomal entrapment by light responsive opening mechanisms are 
based on two-photon excitation or near infrared photosensitizers.187-190 
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1.2.5 Controlled, stimuli-responsive cargo release 
The precise spatial and temporal control of nano-vehicles allowing an on-demand cargo release 
in cell compartments can be described as the holy grail of advanced drug delivery research, 
since premature cargo release is highly undesirable. A broad variety of different triggered-
release capping systems were presented in the past years, based on external stimuli such as 
light51, 191, 192, heat71, 193-195 or magnetic fields,57 or triggered by intracellular events including a 
change in pH196-198, redox reactions8, 199 or the presence of enzymes.200 
Exogenous stimuli-responsive systems. The most widely studied stimuli-responsive capping 
systems are based on external triggers that allow control and activation of the internalized 
nano-carriers on demand and without invasive methods. Light-triggered release has attracted 
great interest since the development of photo-responsive azobenzene ligands by Brinker and 
co-workers in 2003 that enable the switching of molecular valves by cis-trans isomerization.192 
Matsukata and co-workers developed a UV-light responsive capping system for MCM-41 based 
on the 2+2 photodimerization of coumarin at distinct wavelengths.191 The photodimerziation-
cleavage cycle of thymine was successfully employed by He et al. for the gating of MSNs.201 
Zhao and co-workers developed a photothermal-responsive system based on rotaxane-modified 
MSNs (Figure 1.10 A).202 The movement of the α-cyclodextrin ring (green) can be controlled 
by cis-trans isomerization of azobenzene linkers, which allows for efficient cargo loading (at 
365 nm) and subsequent curcumin release upon irradiation with visible light. Another 
possibility for light-triggered release is the employment of singlet oxygen responsive lipids 
(e.g. DOPC) to generate a supported lipid bilayer (SLB) around photosensitizer-functionalized 
MSNs.41, 51, 76 The highly biocompatible SLB enables successful uptake into different cells, and 
efficient cargo encapsulation in the mesoporous framework of MSNs. The photo-induced 
release mechanism is based on a two-step cascaded membrane rupture by singlet oxygen; the 
SLB around the MSN is disintegrated in a first step, followed by subsequent rupture of the 
endosomal membrane, and consequently cargo release into the cytosol can be achieved. 
Therefore, light-responsive mechanisms relying on two photon excitation and photosensitizers 
excitable in the NIR-range are promising possibilities for tumor treatment in deeper 
tissues.203-205 Another possibility for a non-invasive and stimuli-responsive, controlled drug 
delivery approach for cancer therapy is the design of nano-carriers sensitive to applied magnetic 
fields. Several multifunctional core-shell nanosystems based on a superparamagnetic iron oxide 
core (Fe3O4) and a silica or polymer shell have been designed recently
206, 207 and tested both in 
vitro and in vivo for targeted cell uptake and cargo release upon magnetization.208, 209 Lee and 
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co-workers used polymer-coated zinc-doped iron oxide nanoparticles for the successful in vivo 
delivery of doxorubicin.210 Zink and co-workers developed an iron oxide/MSN core-shell 
system which was modified with a pseudorotaxane on the outer surface of the nano-carrier, 
serving as efficient capping system (Figure 1.10 B).57 The dye-loaded MSNs were successfully 
internalized in cancer cells with no premature release observable prior to the application of the 
external magnet field. In addition to the previously described studies, magnetically guided 
nano-carriers based on cationic polymers, iron oxide nanoparticles and oligonucleotides are 
also used for the successful delivery of nucleic acids to cancer cells. The so-called 
magnetofection has led to an increased effectiveness of siRNA directed against breast211 and 
prostate cancers.212 Moreover, in addition to the triggered drug release, with these particles it is 
possible to perform magnetic resonance imaging (MRI), which facilitates the combination of 
diagnostics with therapy in a single nano-carrier system (so called theranostic approach).213 
Current research is based on an enhancement of the magnetic strength of the iron oxide core by 
doping with Mn2+ and Zn2+ ions.214, 215 Among the opening mechanisms based on exogenous 
stimuli, thermo-responsiveness is the most widely studied approach in nano-medicine, and 
thermoresponsive liposomes (TSLs) with encapsulated doxorubicin (ThermoDox) reacting to 
mild hypothermia have already reached phase III of clinical trials for unresectable 
hepatocellular carcinoma.173 Nevertheless, due to the known disadvantages of liposomal 
carriers, the development of novel drug delivery vehicles reacting to heat is a major topic of 
current research. Al-Ahmady et al. developed an alternative approach for thermosensitive 
liposomes by incorporating a thermoresponsive peptide, a so-called leucine-zipper into the 
liposomes.216 Upon an increase in temperature (43 °C) the peptide undergoes a conformational 
change leading to membrane rupture and subsequent cargo release. A completely different 
approach for thermosensitive pore opening was developed by Bein and co-workers.71 
Multifunctional MSNs were modified with a thermo-labile DNA-valve system 
(Figure 1.10C-1). This release on-demand system employs double-stranded DNA of different 
length and biotin-avidin coupling for effective pore closure. Depending on the length of the 
DNA-linker, different opening temperatures of the gates were observed, enabling a fine-tuning 
of the stimuli-responsive release system.  
A different strategy is based on thermoresponsive polymers, with poly(N-isopropyl acrylamide) 
(PNIPAM) the most commonly used among them.173 A temperature-sensitive inorganic-
organic hybrid system was developed by You and co-workers; MSNs were coated with 
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PNIPAM to achieve efficient pore closure and successful encapsulation of fluorescein (Figure 
1.10C-2) at 38 °C.217 The model drug is released upon a decrease to ambient temperature. It has 
to be noted that an opposite closure-opening mechanism (closure at ambient temperature, 
release at mild hypothermia conditions) would be highly favorable for a successful application 
of silica-polymer systems in drug delivery applications and is part of current research. 
Endogenous stimuli-responsive systems. In comparison to the aforementioned triggered-release 
mechanisms based on exogenous stimuli that require external triggers for successful drug 
release, internal stimuli based on enzyme activity, cell compartment acidification and redox-
sensitive triggers have also gained much interest in recent years. Specific enzymes 
(e.g. proteases, phospholipases and glycosidases) were found to be overexpressed under the 
pathologic conditions of inflammation and cancer and can therefore be exploited as potential 
biological target. Especially so-called matrix metalloproteinases (MMPs), zinc-dependent 
endopeptides, are overexpressed during advanced stages of several cancers, as the 
MMP-mediated matrix degradation increases the metastatic potential of tumor cells whereas 
healthy cells show almost no expression of MMPs.218 Zhu et al. described the use of short 
peptide sequences that are exclusively cleavable by MMP-2.219 They were used as linkers 
between PEG and TAT-functionalized liposomes with encapsulated siRNA (Figure 1.10D), 
masking the bioactive compounds. After successful cleavage in the tumor, the active ligands 
are exposed showing increased intracellular penetration and thus, high amounts of gene 
silencing in vivo (70%). A similar approach was applied by Singh et al. to obtain bioresponsive 
MSNs for successful in vivo application.220 A different strategy for bioresponsive MSNs is 
based on pore closure/opening with enzymes. Schlossbauer et al. developed a protease-
responsive capping system based on biotin-avidin interaction and showed successful cargo 
release in the presence of the protease trypsin.70 In addition to the previously described methods 
of enzyme-responsive release systems, an exploitation of the increased enzyme concentration 
in lysosomes has become a major focus of research.221, 222 Another intrinsic stimulus is based 
on the reductive milieu of certain cell compartments: the concentrations of glutathione vary 
between extracellular (~2–10 μM) and intracellular compartments (~2–10 mM) and can 
therefore be used for selective cleavage of redox-labile bonds, most commonly disulfide 
bridges.173 Lin and co-workers attached organo-modified quantum dots via a disulfide bridge 
to the outer surface of MSNs and achieved successful capping of the mesopores with this 
method, showing no premature release of the adsorbed cargo. Upon the addition of 
dithiothreitol the disulfide bridge was cleaved and a successful release of ATP and vancomycin 
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was observed (Figure 1.9E - schematic).8 Additionally, redox-sensitive systems have been 
studied for dendrimer-drug conjugates223, liposomes with conjugates224, MSNs with snap-top 
caps140 and reducible cationic polymers together with nucleic acids.225, 226 It has to be mentioned 
that the strength of the reductive milieu varies strongly within different cell lines and endosomal 
entrapment might be a bottle-neck for redox-driven release in some cases.76  
Cargo release can also be triggered by an intrinsic change of the pH value within cellular 
compartments. As described above, an acidification of the endosomal compartments takes place 
when the endosomes change from early to late endosomes (pH 7.4 to 5.5). Additionally, it is 
known that cancer tissues exhibit a slightly lower pH (6.5–7.2) than healthy tissues, which has 
led to an increase in research interest on pH-responsive systems.173 A promising approach that 
takes advantage of this internal trigger involves pH-responsive linkers based on acetals. 
Schlossbauer et al. attached the bee venom melittin with a pH-responsive acetal-linker to SBA-
15 mesoporous silica and showed successful release upon acidification whereas no release was 
observed for a non-cleavable linker (Figure 1.10F-1).198 Another commonly used strategy is the 
design of pH-responsive ligands for the attachment of gatekeepers for efficient pore capping of 
MSNs. Especially, cyclodextrin rings have been widely studied as capping systems for MSNs, 
preventing premature release of the cargo molecules under physiological conditions. Zink and 
co-workers have developed several pH-responsive MSN systems based on cyclodextrin rings 
and rotaxanes that allow triggered release of encapsulated cargo molecules.56, 227 Zhu et al. have 
developed an entirely different strategy for intrinsic, pH-triggered cargo release.143 Zinc oxide 
nanoparticles, matching the pore size of the mesoporous material were covalently attached to 
the outer surface after adsorption of doxorubicin, preventing premature release of the 
chemotherapeutic before the nano-lids were dissolved upon internal acidification 
(Figure 1.10F-2). 
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Figure 1.10: Exogenous and endogenous stimuli-responsive release mechanisms. A) Light-responsive 
cargo release based on cis-trans isomerization of the organic linker.202 B) Cargo release based on an 
external magnetic field.57 C-1) Temperature-responsive DNA-valve.71 C-2) Pore closure and opening 
with PNIPAM.217 D) Enzyme-responsive liposome system based on matrix metalloproteases.219 E) 
Redox-labile disulfide capping system.133 F-1) Delivery of melittin from SBA-15 by cleaving of a 
pH-responsive acetal-linker.198 F-2) Pore-capping with pH-responsive ZnO nano-lids.143
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Until now, only drug delivery vehicles reacting to exogenous stimuli are successfully being 
tested in clinical trials, namely thermosensitive liposomes (ThermoDox, Phase I – III, 
depending on the target cancer) and magneto-responsive nano-carriers (iron-oxide magnetite, 
Phase I for prostate and pancreatic carcinoma).173 The major challenge with endogenous 
triggers is the probability of variation from one patient to another and between different cancer 
types. 
1.3 Enzyme immobilization in mesoporous silica hosts 
Enzymes exhibit outstanding properties as catalysts in terms of environmental safety, high 
efficiency, high chemo-, regio- and stereo selectivity, and they enable shorter synthetic routes 
compared to conventional catalysts.228 Especially the enantioselective conversion of organic 
molecules is of great importance and a main focus of current research, especially in the 
production of pharmaceuticals.229 Despite all the above advantages, the industrial use of 
enzymes is limited by difficulties in recovery of the biocatalyst, as well as by low operational 
stability.230 The main goals of the immobilization of enzymes onto various solid supports are 
an enhancement of stability and the simplification of enzyme recovery. Therefore, many 
immobilization techniques on various solid support materials such as organo silica231-235, metal 
oxides236, metals237, carbons238 and polymers239 have been investigated in the past years. 
Among the inorganic host systems, organo-functionalized nanostructured mesoporous silica 
materials have attracted great attention since they offer outstanding properties for the 
encapsulation of various catalytically active biomolecules.21, 229, 240, 241  The broad variety of 
available mesoporous silica materials enables the adjustment and fine-tuning of the pore- and 
particle size, matching the requirements of the enzyme. Additionally, structural arrangements 
and surface properties for optimized loading capacities can be modified matching the targeted 
biocatalyst.242 It is of high importance that the physiochemical properties of the protein and the 
support are matching, and this has to be taken into account upon selection of the solid support. 
Especially the hydrodynamic radius of the enzymes has to be considered; Diaz and co-workers 
showed that horse-radish peroxidase with a mean diameter of 4.6 nm cannot be immobilized 
into the comparably small pores of MCM-41 (average 2.8 nm).243 Yiu et al. investigated the 
immobilization of trypsin in different mesoporous materials, namely MCM-41, MCM-48 and 
SBA-15; it was shown that the amount of adsorbed enzyme was directly correlated to the pore 
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size of the support material.244 Studies on standard silica materials (e.g. SBA-15) revealed that 
enzyme confinement within different supports can increase its stability and reduce denaturation 
by protein unfolding, one major drawback in the industrial application of biocatalysis.232 
However, it was reported by Takahashi et al. for horse-radish peroxidase that an enhanced 
enzyme activity in organic solvents and an increased hydrothermal stability requires similar 
diameters of the porous network and the guest molecules.245, 246 These results were supported 
by several other studies of different research groups.247-249 Besides the optimal choice of the 
support material, a sufficient immobilization technique must be employed. The most prominent 
techniques are (1) physical adsorption via van der Waals forces, hydrophobic interactions and 
hydrogen bonding, (2) covalent attachment of the biocatalyst, and (3) cross-linking of enzymes 
in the mesoporous framework of the support material.228 It has to be noted that each 
immobilization route has certain advantages as well as disadvantages (e.g. leakage, 
conformational change of the enzyme).228 However, in this work, we will mainly focus on the 
covalent attachment of enzymes within the mesopores of silica supports. Hartmann and 
co-workers and Lee et al. and have reviewed different methods of covalent enzyme 
immobilization onto mesoporous silica supports.228, 250 The most prominent approach for 
covalent immobilization is the linkage via an amino-moiety on the silica surface, which 
facilitates the attachment of the enzyme via a glutaraldehyde linker (Figure 1.11A). This 
approach significantly improves the stability and reduces leakage, leading to increased 
reusability of the material. Several different enzymes have been immobilized with this 
approach, namely glucose oxidase251, lipase252 and invertase.253 Additionally, glutaric 
anhydride (Figure 1.11B) and succinimido-3-maleimidopropionate are commonly used as 
linkers. Mou and co-workers covalently immobilized cytochrome C (CytC) with the above 
mentioned linkers onto the solid support and studied the catalytic activity of the obtained hybrid 
materials.254 It was revealed that the orientation of the enzyme, and therefore the catalytic 
activity, is controlled by the specific binding of CytC. Another study investigating the influence 
of different attachment mechanisms was carried out by Jung and co-workers. Chloroperoxidase 
and glucose oxidase were immobilized on amine- and epoxy-modified SBA-15 supports, 
revealing that the epoxy-pathway diminishes the activity of chloroperoxidase, whereas 
glucooxidase was not affected; no change of activity could be observed for the amino-
functionalized supports.255 The immobilization of biocatalysts via a click chemistry approach 
has gained much interest in recent years as the reaction is highly efficient and shows 
extraordinary bioorthogonality (Figure 1.11D).21, 256 This approach was successfully employed 
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by Bein and co-workers to immobilize trypsin into the pores of SBA-1521 and by Fried et al. to 
covalently attach glycopyranose.257  
 
Figure 1.11: Different routes for the immobilization of enzymes on mesoporous silica by covalent 
attachment. A) Enzyme immobilization via a glutaraldehyde linker, B) enzyme immobilization using 
glutar anhydride, C) enzyme immobilization using succinimido-3-maleimidopropionate, and D) enzyme 
immobilization via an azide-alkyne cycloaddition.228  
Biocatalysis is the most prominent field of applications for immobilized enzymes, yet it can be 
noted that several additional applications have been studied recently, e.g. drug delivery and 
immunosensing. Chen and co-workers showed the successful delivery of superoxide dismutase, 
an antioxidant enzyme that detoxifies intracellular reactive oxygen species, to HeLa cells, 
employing mesoporous silica nanoparticles as inorganic carrier vehicle.258 
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2 Characterization 
Mesoporous silica materials can be characterized by various different techniques with regard to 
their structural and morphological parameters. X-ray diffraction, nitrogen physisorption, 
scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were used 
to investigate the porous structure and the morphology of the nano-materials. Additionally, 
dynamic light scattering was employed to investigate mesoporous silica nanoparticles (MSNs) 
regarding their size and agglomeration behavior. Furthermore, zeta potential measurements 
were used to investigate the surface properties of the MSNs. Vibrational spectroscopy (IR- and 
Raman spectroscopy) in combination with magic angle solid state nuclear magnetic resonance 
spectroscopy (MAS ssNMR) gives detailed information about the chemical bonding of the 
nano-structured materials and was frequently used in this work. Additionally, 
thermogravimetric analysis (TGA) was used to evaluate the amount of organo-functionalities 
introduced to the mesoporous materials. Time-based fluorescence spectroscopy with 
fluorescent model drugs (calcein, propidium iodide, and fluorescein) was performed in order to 
obtain information about the capping behavior of different gatekeepers attached to the silica 
surface. Additionally, quenching experiments were carried out with fluorescence spectroscopy. 
UV-VIS spectroscopy was used for enzyme-catalyzed colorimetric reactions. 
 
2.1 Dynamic Light Scattering 
Dynamic light scattering (DLS) measurements are a valuable tool to determine the size of 
particles and molecules in solution as well as to investigate solution dynamics.1,2 DLS is also 
referred to as photon correlation spectroscopy (PCS) or quasi-elastic light scattering (QELS).3 
Typically, a DLS instrument is composed of a laser source, a sample cell, a photodetector and 
a computer containing an autocorrelator (Figure 2.1).4 
2.1. Dynamic Light Scattering 
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Figure 2.1: Schematic arrangement of a conventional DLS instrument.4 
This technique is highly valuable for the analysis of nanometer-sized particles, typically with 
diameters between 1 – 1000 nm. The Brownian motion, which is a random movement of the 
particles in a liquid caused by constant collisions, is highly correlated to the particle size. 
Therefore, the particles in solution are in constant, random movement and the interparticle 
distance changes constantly, and so do the conditions for constructive and destructive 
interference of scattered light. This results in a time-dependent intensity fluctuation of the 
scattered light. Since the diffusion of large particles is slower than that of smaller particles, the 
intensity of the scattered light will change more slowly for larger particles and aggregates. 
During DLS measurements, these changes in intensity are recorded over a distinct time and can 
be evaluated afterwards. DLS measures the hydrodynamic diameter d(H) which is a value that 
is related to the diffusion properties of a particle in a liquid. The translational diffusion 
coefficient D depends on diverse parameters, including the ionic strength of the suspension, the 
texture of the particle surface, and the shape of the particles. Correlation analysis is used to 
calculate the diffusion coefficient, which is associated with the hydrodynamic diameter of 
colloidal spherical particles via the Stokes-Einstein equation: 
𝑑(𝐻) =  
𝑘𝑇
3𝜋𝜂𝐷
 
(2.1) 
 
Stokes-Einstein equation: d(H) is the hydrodynamic diameter, D is the translational diffusion 
coefficient, k is the Boltzmann’s constant, T is the temperature, η is the viscosity. 
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2.2 Zeta Potential Measurements 
Particles in suspension feature a zeta potential, which is the electrokinetic potential difference 
between a so-called stationary layer of ions in a solvent attached to the dispersed particle and 
the liquid medium in the surroundings. The zeta potential is also a force that mediates particle 
interactions.5 Generally, particles dispersed in an aqueous solution possess a surface charge 
which results either from adsorption of charged species or from ionization of their surface 
groups. Both surface modifications lead to a surface charge that changes the distribution of the 
surrounding ions. As a consequence a layer different to the bulk solution with tightly bound 
ions (Stern layer) and loosely bound ions (slipping plane) is generated around the particle. 
Being a part of the particle, the interfacial double layer moves if the particle drifts due to 
Brownian motion within the solution. The potential at the point in this layer where it moves 
past the bulk solution is referred to as zeta potential (Figure 2.2). At this plane the charge is 
highly sensitive to the type of ions in solution as well as to their concentration.6 
 
Figure 2.2: Schematic representation of the electric double layer around a negatively charged particle 
and location of the zeta potential.7 
In order to measure the zeta potential of a sample, an electric field is applied across the 
dispersion and the electrophoretic mobility is observed. Particles inside the dispersion that 
possess a zeta potential will migrate towards the electrode of opposite charge whereby the 
2.3. Nitrogen Physisorption 
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migration velocity is proportional to the magnitude of the zeta potential. Using the technique 
of laser Doppler anemometry, this velocity within the dispersion is measured. An incident laser 
beam striking one of the moving particles causes a frequency or phase shift that is recorded as 
the particle mobility. This mobility is transformed into zeta potential with the application of an 
appropriate theory together with the input of the dispersant’s viscosity. The Henry equation 
(2.2) describes the relation between the electrophoretic mobility and the zeta potential. 
𝑈𝐸 =
2𝜀𝜁𝑓(𝑎)
3
     (2.2) 
Henry equation: UE is the electrophoretic mobility, ε is the dielectric constant of the sample, ζ is the 
zeta potential, f(ka) is the Henry function, and η is the viscosity. 
Specifically, to obtain the electrophoretic mobility, the velocity of the particles is determined 
by Laser Doppler Velocimetry (LDV).8 The LDV applies an electrical field of known strength 
across the capillary cell which contains the colloidal particle solution. A shift in frequency is 
observed when the laser light (633 nm) passes the sample, determined by the velocity of the 
particles. Henry´s function is commonly set to f(Ka)=1.5, according to Smoluchowski´s 
approximation which is frequently used for particles larger than 200 nm and when the electric 
double layer is very thin compared to the particle diameter. Hückel’s approximation uses 
f(Ka) = 1.0, this is frequently used for small particles in organic solvents.  
 
2.3 Nitrogen Physisorption 
Sorption measurements are an appropriate and commonly used technique to determine pore 
characteristics like pore size distribution, pore volume and pore width, as well as the surface 
area of various porous materials.9 The nitrogen sorption process can be classified as 
physisorption, since only weak interactions including van-der-Waals forces occur during the 
sorption process. For nitrogen physisorption measurements, the obtained amount of the 
adsorbed nitrogen gas at different pressures and constant temperature (77 K) can be used to 
generate sorption isotherms (Figure 2.3). 
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Figure 2.3: IUPAC classification of six different sorption isotherms.10  
Six different types of sorption isotherms were classified by IUPAC.11 The different types (I-VI) 
distinguish porous materials with respect to pore structure and size, and the interactions of the 
adsorbed gas molecules with the adsorbent. 
Table 2.1: Types of sorption isotherms classified by IUPAC and the corresponding materials.11 
Isotherm Type Corresponding Material 
I Microporous material with restricted micropore volume; 
Adsorbed amount of nitrogen reaches a constant value after pore filling 
II Macroporous or non-porous material; monolayer adsorption followed by 
unrestricted multilayer condensation 
III Fairly weak interactions between adsorbent and adsorbate 
IV Mesoporous material; hysteresis loop appearing due to capillary condensation 
inside the mesopores 
V Fairly weak interactions between adsorbent and adsorbate, but in contrast to 
Type III occurrence of a hysteresis loop 
VI Non-porous material; stepwise multilayer adsorption 
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Mesoporous silica nanoparticles typically show type IV shaped isotherms. The arising 
hysteresis loop is assigned to high pressure hysteresis in the range of multilayer adsorption.12 
Due to resulting van der Waals forces more energy has to be applied to remove the adsorbed 
gas molecules from the solid when the external pressure p is reduced during the desorption 
process. Hence, adsorption and desorption curves do not coincide.13 Generally, a wide variety 
of shapes for hysteresis loops is known. The most common ones are presented in Figure 2.4. 
 
Figure 2.4: Different types of hysteresis loops.11 
Several different methods exist to describe an isotherm. The simplest one was set up by 
Langmuir, but based on several approximations this approach oversimplifies the processes 
taking place in the experiment.13 An enhancement of the Langmuir theory is represented by the 
Brunauer-Emmett-Teller (BET) approach, which is much more suitable to characterize an 
isotherm, as it takes processes such as multilayer condensation into account.14 
2.3.1 Specific surface area 
In mesopores, which have a pore size range of 2 – 50 nm, van-der-Waals forces between 
adsorbate molecules as well as attractions between adsorbate and bulk surface cause capillary 
pore condensation. Gas forms a condensed phase at a pressure lower than the saturation 
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pressure psat. Depending on the shape of the pore and the surface tension, a meniscus is formed 
at the liquid-vapor interface in the pore. If the pore is not of ideal cylindrical shape, the pore 
opening can exhibit a smaller radius than the bottom of the pore. Considering the Kelvin 
equation (2.3) a lower partial pressure is required during the desorption process, leading to 
diverse isotherms.5  
𝑅𝑇 ∙ 𝑙𝑛
𝑃0
𝐾
𝑃0
=  − 
2𝛾𝑉𝑚
𝑟𝑐
 
(2.3) 
Kelvin equation. R: gas constant, T: temperature, P0
K: equilibrium pressure, P0: saturation 
vapor pressure, γ: surface tension, Vm: molar volume, rc: reduced radius 
 
Isotherm IV shows the resulting hysteresis, which reflects the different adsorption and 
desorption pathways (Figure 2.3). The obtained curves can be interpreted to obtain information 
on the porous features of the investigated sample. 
There are different models to describe isotherms. The most common models are named after 
their developers, Langmuir (Langmuir isotherms) and Brunauer, Emmett and Teller (BET 
isotherms).13,14 The Langmuir interpretation is the simplest characterization method and is 
based on the approximations that (i) the adsorption is leading at most to monolayer formation, 
(ii) the surface is uniform and (iii) all binding sites are equal. Furthermore, the ability of a 
molecule to bind at a specific surface site is independent of the occupancy of neighboring 
binding sites (no interactions between adsorbed molecules). The Langmuir equation is shown 
below (2.4). 
𝑛
𝑛𝑚
=  
𝐾 ∙ 𝑝
1 + 𝐾 ∙ 𝑝
 
(2.4) 
Langmuir equation. n: amount of adsorbate, nm: capacity of one monolayer, p: pressure, 
K = kad/kdes 
 
If the initial adsorbate-layer acts as substrate for additional adsorption processes 
(physisorption), then the isotherms should not show a saturation value but continue to increase. 
This multilayer adsorption is described by Brunauer, Emmett and Teller (BET).14,15  
The BET equation can be expressed as follows (2.5). 
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𝑛
𝑛𝑚
=  
𝐶 ∙
𝑝
𝑝0
(1 −
𝑝
𝑝0
)(1 + 𝐶 −
𝑝
𝑝0
)
 
(2.5) 
BET equation. n: amount of adsorbate, nm: capacity of one monolayer, C: BET constant, p: 
equilibrium pressure, p0: saturation vapor pressure of adsorbate 
 
To calculate the specific surface area of a material, the linear part of the BET isotherm (at small 
p/p0-values) can be used, as this part corresponds to monolayer formation. 
2.3.2 Pore size calculation 
Sorption data are further applicable to determine the pore volume and the pore size distribution 
of an analyzed sample. This method is based on the change of physical properties of gas 
molecules when being adsorbed in a porous material. The pore size distribution function is a 
very important characteristic of porous materials. The thermodynamic relation between the 
reduced pore radius rk and the relative vapor pressure p/p0 is described by Kelvin’s equation 
(2.3) 
Kelvin’s equation frequently leads to inexact results as it tends to underestimate the pore size. 
An enhancement by Barrett-Joyner-Halenda (BJH) corrects the Kelvin radius rk by including 
the thickness t of the monolayer which is already adsorbed to the sample surface.16 This method 
however is limited, as it disregards the impact of surface curvature on the formation of the film, 
it is only derived for cylindrical pores, it assumes formation of homogenous films and it does 
not explicitly account for surface forces between the film and the surface. Due to these 
limitations the BJH method is known to underestimate the pore size, especially for small pores. 
An approach that combines density functional theory (DFT) with the grand canonical Monte 
Carlo (GCMC) simulation method is frequently applied and usually gives the most exact results. 
In order to obtain the equilibrium density profile via DFT, the corresponding grand potential is 
minimized for a pore system in equilibrium with a bulk phase. The function contains terms 
describing attractive as well as repulsive solid-fluid and fluid-fluid interactions. Hypothetically, 
two different DFT methods exist, but in contrast to the applied non-local density functional 
theory (NLDFT) the local density functional theory (LDFT) is not applicable for narrow pores. 
The reason is that it cannot characterize short-range correlations inside the pores.9 NLDFT in 
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combination with Monte Carlo simulations quite reliably describes the local fluid structure near 
curved solid walls. As the solid walls of mesoporous silica have an influence on the number 
density, NLDFT is used for calculating the pore size distribution in this work. 
 
2.4 Infrared and Raman Spectroscopy 
Infrared (IR) and Raman spectroscopy can be used to obtain information about functional 
groups present within the sample and offers the potential to study the properties of the chemical 
bonds in a molecule by exciting vibrational transitions.17-19 Radiation in the mid-infrared 
(200 – 4000 cm-1) region is predominantly used for IR spectroscopy. Today, usually Fourier 
transform (FT) IR spectroscopy is used for the analysis in which polychromatic IR light passes 
through a Michelson interferometer and subsequently through the sample. The spectra are 
background-corrected and the spectrum is calculated by FT from the interferogram.  
The IR light interacts with the sample and the intensity of the scattered or transmitted light is 
measured; the energy of the IR absorption bands is often characteristic for a certain chemical 
bond and offers therefore the possibility of detailed analysis. It is important that the vibration 
itself is IR-active (the vibrational transition is allowed); a dipole moment that changes during 
the measurement is a prerequisite.   
Compared to infrared spectroscopy, different selection rules apply for Raman spectroscopy, so 
that data from Raman spectra often complement data obtained with IR spectroscopy. The 
difference in the selection rules is based on the fact that the Raman process relies on scattering 
rather than a direct transition between two vibrational states as it is the case for IR. For Raman 
spectroscopy monochromatic light, usually generated by a laser, is used to characterize the 
sample. Through interaction with the electron shells in the sample, the sample is excited into a 
virtual energy level.3 The two types of Raman scattering (Stokes and Anti-Stokes) and 
additional Rayleigh scattering are depicted in Figure 2.5. 
2.5. UV-VIS Spectroscopy 
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Figure 2.5:  Energy states and scattering processes (Stokes-, Rayleigh-, and anti-Stokes scattering, 
respectively) occurring in a Raman experiment.20  
Rayleigh scattering displays no change in frequency. As most molecules are located in the 
ground state at room temperature, Stokes shifts occur with higher intensity and are therefore 
commonly used for Raman measurements. The intensity of Raman signals is inversely 
proportional to the fourth power of the excitation wavelength, and Raman scattering comprises 
only a very small fraction of the scattered light.3, 19  
2.5 UV-VIS Spectroscopy 
In UV-Vis spectroscopy, the sample is irradiated with electromagnetic waves in the ultraviolet 
(10 – 400 nm) and visible range (400 – 750 nm). The UV-range can be divided in UV-A 
(400 – 320 nm), UV-B (320 – 280 nm) and UV-C (280 – 210 nm). Absorption of light leads to 
the excitation of valence electrons from the ground state (S0) to an excited state (S1), typically 
at higher vibrational states.  
Accordingly, molecules with the same HOMO-LUMO energy difference can have different 
excitation energies. By spontaneous emission or stimulated emission (by a light ray), the excited 
electron can relax into the ground state, depending on the transition probability. For all 
electronic transitions selection rules have to be fulfilled. The spin selection rule implies that the 
total spin S or the multiplicity (M = 2S+1) cannot change during the transition. This implies 
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that singlet states cannot pass into triplet states. In centrosymmetric molecules, the inversion 
can be symmetric (even) or asymmetric (uneven). According to the Laporte rule, electronic 
transitions that conserve parity, either symmetric or asymmetric, are forbidden. However, due 
to atomic movements the symmetry can be degraded, which allows the transition to occur, albeit 
with low intensity.19  
In UV-Vis spectroscopy the incoming light hits a homogeneous medium with a defined 
thickness d. The weakening of the light intensity by absorption (besides reflection and scattering 
losses) is given by the Beer-Lambert law (2.6). 
 
𝐴 = log
𝐼𝑜
𝐼
=  𝜀 ∙ 𝑐 ∙ 𝑑 
(2.6) 
A: absorption, I0: intensity of incident beam, I: intensity of emergent beam,  
ε: molar absorption coefficient, c: concentration of diluted solution, d: sample thickness 
 
The law is attributed to Bouguer (1728), Lambert (1760) and Beer (1852) and applies for 
monochromatic light and dilute solutions. In UV-Vis spectra, the absorbance is plotted against 
the wavelength of the incident light. Due to the energy width of the electronic levels (vibronic 
states), the observed spectrum is typically a band spectrum, which can be characterized by the 
position, intensity, shape and structure of the different bands.19 This allows for the quantitative 
determination of different analytes, like transition metal ions, highly conjugated organic 
compounds or biological macromolecules. 
 
2.6 Fluorescence Spectroscopy 
Photoluminescence can be divided into phosphorescence and fluorescence, depending on the 
internal excitation mechanism and the resulting lifetimes of the excited states. According to the 
Franck-Condon rule, absorption of light results in a vertical electronic excitation. Typically, the 
excited molecule loses energy upon collisions with the environment until the vibrational ground 
state of the excited electronic state is reached. A schematic Jablonski diagram is depicted in 
Figure 2.5, which gives information about the three-stage process of fluorescence.  
2.6. Fluorescence Spectroscopy 
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Figure 2.6: Jablonski diagram illustrating the three-stage process of fluorescence. 1) Excitation of 
electron by external photon hex, 2) non-radiative relaxation, and 3) emission of photon hem.21 
Excitation: In a first step, a photon of certain energy (hex) generated by an external source 
(incandescent lamp or laser light) is absorbed by the fluorophore, resulting in an excitation of 
the electon from the ground state (S0) to the excited state (S1’). This process is very fast, taking 
place within femtoseconds. 
Non-radiative relaxation: The non-radiative transition of the electron from the excited state 
(S1’) to the relaxed excited state (S1) is caused by vibrational relaxation of the fluorophores and 
usually takes 1 – 10 ns.  
Fluorescence emission: In the third and last step, the excited electron falls back to the ground 
state (S0) by emitting photons (hem) of a lower wavelength. Therefore, fluorescence features a 
red-shift of the emitted wavelength in comparison with the incident photons emitted by the 
external source. This bathochromic shift of the emission maximum compared to absorption is 
called Stokes shift. 15, 22 
In addition to fluorescence other processes can occur that cause a return of the excited molecules 
to the ground state, namely quenching, fluorescence energy transfer (FRET) and intersystem 
crossing (leading to phosphorescence). 
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2.7 Thermogravimetric Analysis 
Thermogravimetric analysis (TGA) can be performed to determine the composition of a 
material that contains volatile or combustible components.23, 24 TGA investigates the mass loss 
of a material with increasing temperature and yields information about the temperature stability 
of the sample. Typically, samples are placed into an adjustable oven and are heated to 
temperatures up to 900 °C.  A controlled temperature program with a constant heating rate in 
inert gas atmosphere or synthetic air is applied to the sample, resulting in either desorption of 
adsorbed molecules or decomposition of the material, while its weight loss is measured as 
function of temperature. A sensitive thermobalance is connected to the specimen holder to 
detect small changes in mass (0.1 µg) during the heating process or while the sample is held at 
the required temperature.  
 
2.8 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) is a technique using a focused beam of electrons that is 
raster-scanned over the surface of a solid sample. The highly energetic electrons focused onto 
the specimen interact with the surface atoms producing various signals that hold information 
about the shape, topography and composition of the material.25 Compared to optical microscopy 
which uses visible light with a wavelength of about 400 – 800 nm, the resolution that can be 
achieved with an electron microscope is roughly four orders of magnitude higher. It is a 
versatile method for the analysis and examination of solid materials since it allows high 
resolution down to the nanometer range. Additionally, this method provides a large depth of 
field that is partly responsible for the three-dimensional appearance of the image.  
 
2.8. Scanning Electron Microscopy 
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Figure 2.7: Scheme of a scanning electron microscope.26 
In a scanning electron microscope primary electrons are accelerated by an anode and then 
focused by several coils on the specimen, scanning the latter line by line.25 The electrons are 
generated from a tungsten filament inside the electron gun by thermionic emission or by field 
emission. Then they are accelerated by an anode. Through acceleration voltages in the range of 
2 – 40 kV within the SEM chamber, a beam of energetic electrons is generated. After focusing 
this electron beam onto the sample with the help of a condenser and objective lens, the so-called 
primary electrons (PE) interact with the specimen’s surface producing secondary electrons 
(SE), back scattered electrons (BSE), X-rays, Auger electrons and cathodoluminescence. The 
condenser lens displays the image of the source on the condenser aperture. Subsequently, the 
collimated beam is focused by an objective lens and swept in a raster across the specimen 
employing scanning coils. These are controlled by varying the applied voltage on the scan coils 
generating a magnetic field which leads to a controlled deflection of the electron beam.25 
Depending on the nature of the sample and the energy of the primary electrons, different 
processes can occur when the electron beam hits the surface of the specimen. Importantly, 
electrostatic charging of the surface has to be avoided, as it leads to unstable secondary 
emission, which destroys the resolution and the image stability. Two possibilities to avoid 
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electrostatic charging are known, (1) using a low beam voltage, and (2) coating the sample with 
a thin layer of an electrically conducting film (Au, C).  
 
2.9 Transmission Electron Microscopy 
Transmission electron microscopy (TEM) is a powerful imaging technique for nanometer-sized 
materials offering a spatial resolution down to about 0.1 nm. Resolution of common light 
microscopes is limited by the wavelength of the used light and can reach values of 0.2 µm. 
Providing spatial resolution down to the range of Angstrom, TEM micrographs provide 
information about the elemental composition, the particle size distribution, the crystallography 
as well as the morphology of a sample. These (up to) atomic-resolution-images in combination 
with chemical and electronic properties make TEM a valuable instrument for the 
characterization of nanomaterials.27 
In a conventional TEM, the electron beam is generated via heating a pin-shaped tungsten 
filament (cathode) that possesses a negative potential.  Due to the strong interactions of 
electrons with matter the method requires ultrahigh vacuum, and limiting factors for high 
resolution are spherical aberrations, chromatic aberrations, and astigmatism. The emitted 
electrons are accelerated towards the positive anode and hence towards the sample by applying 
large voltages typically between 100 and 500 kV. Subsequently, the beam is tightly focused 
through the electromagnetic lens system whereby condenser lenses focus the beam to a small 
cylinder while the condenser aperture is used to remove electrons that are scattered at large 
angles. Having reached the specimen, the electron beam is scattered whereas a certain 
percentage of electrons is transmitted through the sample. Additionally, various processes occur 
upon electron irradiation of a material generating X-rays and a large variety of resulting 
electrons, namely secondary, backscattered, and so-called Auger electrons, which can be 
detected and are utilized for different techniques in electron microscopy including selected area 
electron diffraction (SAED), energy dispersive X-ray (EDX) analysis, and electron energy loss 
spectroscopy (EELS). Only electrons emitted at the bottom side of the sample are refocused by 
an objective lens. In TEM the transmitted electrons are detected by a fluorescent screen or by a 
CCD camera. This technique offers the investigation of the internal structure of the specimen.  
2.10. Nuclear Magnetic Resonance 
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Another possibility of imaging with a TEM is connected to electron beam scanning. This 
so-called scanning transmission electron microscopy (STEM) possesses the advantage of high 
contrast and absence of imaging artefacts.27, 28 
 
 
 
Figure 2.8: Schematic representation of a transmission electron microscope. The pathway of the 
electron beam is presented in yellow.29  
TEM and STEM were used to investigate and characterize the morphology of mesoporous silica 
nanoparticles, especially their structure, wall thickness and pore dimensions. 
 
2.10 Nuclear Magnetic Resonance 
Nuclear magnetic resonance (NMR) spectroscopy can be applied to investigate the chemical 
environment of certain nuclear isotopes by applying a static magnetic field.19 The analysis of 
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NMR data provides information about the structural properties and bonds of nuclear isotopes. 
Importantly, the investigated elements need to have a non-zero nuclear spin, which is present 
in, e.g., 1H, 13C, 19F, 29Si and 31P. By applying electromagnetic waves in the radio frequency 
region, transitions between different energetic states can be induced when the resonance 
condition is met. The measured difference between the strength of the local magnetic field and 
the applied external field gives insights about the electronic and chemical environment of the 
nuclei. The transition between these quantum states is induced by radiofrequency energy, 
typically ranging from a few kHz to several hundred MHz, in case of resonance conditions 
(2.7). 
ω = γ(B0 + B𝑖𝑛𝑡)     (2.7) 
ω is the frequency of electromagnetic radiation at resonance conditions, γ is the gyromagnetic ratio, B0 
is the applied external magnetic field, and Bint is the internal field arising from the electronic 
environment and surrounding magnetic moments. 
Nuclear magnetic resonance spectroscopy of liquids typically gives sharp spectra at high 
resolution, since the mobility of the nuclei in liquid samples creates an averaging process that 
leads to an intrinsic elimination of the line broadening related to dipole-dipole interactions. In 
comparison, the characterization of solid materials with solid state NMR (ssNMR) requires 
special methods to give comparable structural information.30 The dipole-dipole interactions 
between the magnetic moments of nearby nuclei lead to line broadening in the spectra. 
Chemical shifts and spin-spin-coupling can no longer be observed. To solve this problem, the 
dipolar interaction has to be suppressed. In general, there are three methods available to solve 
this problem. 
 
1) If the specimen is dissolved, the thermal motion is much greater than in a solid. 
This so-called Brownian motion is even faster than the precession movement of 
the nuclear spins. As a result, the coupling is averaged out.  
2) Magic angle spinning (MAS).31 At a certain angle (“magic angle”, equation 2.9) 
that is between the interproton vector and the magnetic field H0 the dipole-dipole 
interaction vanishes. Solid specimens can be rotated at this angle, and at typical 
rotation frequencies in the range of 10 kHz this averaging effect is observed. 
𝑐𝑜𝑠2(𝜃𝑚𝑎𝑔𝑖𝑐) =  
1
3
             (2.8) 
2.11. X-Ray Diffraction 
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3) Multi pulse sequence. The Carr-Purcell-Maiboom-Gill-sequence consists of a 
90° pulse followed by a series of 180° pulses. Consequently, a number of spin-
echoes can be detected with decreasing amplitudes with respect to time.  
 
The “magic angle spinning” (MAS) technique provides a method to eliminate this anisotropic 
effect and to sharpen the obtained broad peaks in solid state NMR by rotating the sample at 
high velocity at an angle of 54.74 ° to the applied magnetic field. In this work, only magic angle 
spinning was used.  
2.11 X-Ray Diffraction 
X-ray diffraction measurements can be performed to characterize nanostructures and to gain 
information about the crystallinity of the investigated material. Additionally, the size of the 
nanomaterials, information about the pore structure, pore width and pore wall thickness can be 
obtained.32 X-ray diffraction peaks for mesoporous silica materials appear in the low-angle 
range as the pore diameter is rather large in comparison to interatomic distances; therefore small 
angle X-ray scattering (SAXS)  ranging from 2θ = 0.1 – 10 ° was used in this work. X-ray 
radiation is emitted from a metal source, typically copper, with a characteristic wavelength (Cu-
Kα is 1.54182 Å).
33 In order to obtain monochromatic X-ray radiation for X-ray diffraction 
(XRD) measurements, monochromators or blocking filters are used.34 The wavelength of the 
monochromatic X-rays is in the Ångstrøm range, which is the same order of magnitude as 
interatomic distances in solids. Therefore, their diffraction on crystalline solid materials can be 
used to obtain structural information. The diffraction of X-rays on diffraction centers of the 
lattice leads to their reflection at sequential lattice planes. When X-rays hit the crystal with an 
incident angle of θ, constructive interference occurs at the same exit angle if the Bragg equation 
is fulfilled (2.10). 
sin 𝜃 =
𝑛𝜆
2𝑑
     (2.9) 
Bragg’s relation: θ is the angle of incidence, d is the lattice plane distance, λ is the wavelength, and n 
is the order of interference. 
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3 Cell Type Determines the Light-Induced Endosomal Escape Kinetics of 
Multifunctional Mesoporous Silica Nanoparticles 
This chapter is based on the following publication: 
Maria Pamela Dobay, Alexandra Schmidt, Eduardo Mendoza, Thomas Bein, Joachim O. 
Rädler, Nano Letters 2013, 3, 1047. 
 
Abstract 
We investigated uptake and individual endosome lysis events in fibroblast, normal and 
carcinoma cell lines using a colloidal mesoporous silica nanoparticle (MSN)-based reporter 
system with a covalently attached photosensitizer. Endosome lysis was induced through the 
activation of protoporphyrin IX (PpIX). Surprisingly, this release on-demand system resulted 
in more broadly-distributed lysis times than expected, particularly for Renca, a renal carcinoma 
cell line. An analysis of the nanoparticle (NP) load per endosome, endosome size and uptake 
characteristics indicate that Renca cells not only take up a lower amount of NPs in comparison 
with the fibroblast cells, but also have larger endosomes, and a lower NP load per endosome. 
We then extended an existing stochastic pi calculus model of gold NP intracellular distribution 
to understand how much factors that cannot be directly measured, such as variations in the PpIX 
load per NP, affect the distributions. Model results indicate that the lysis time distribution is 
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primarily determined by the minimum of PpIX required to burst an endosome, a factor 
influenced by the NP load per endosome, as well as the endosome size. 
 
3.1 Introduction 
Endosomal escape has been identified as one of the main bottlenecks in gene and drug 
delivery.1, 2 To date, however, there are few papers that investigate single endosome lysis in 
real time because of low signal-to-noise ratios3. Previous studies have recorded the intracellular 
trafficking of individual nanoparticles and various delivery vectors4-6, measured endosome or 
cellular contents ex vivo7, 8, or tracked individual viruses as they move across the cell.9 In these 
protocols, individual components of the virus or the vector, as well as cellular components, are 
labeled.10 In all studies involving delivery vector tracking4-6, confocal laser scanning 
microscopy was used, since dye localization on a single plane is insufficient to definitely 
establish particle internalization;11 it was reported in Akita et al. that at least 20 z-slice images 
were required for their method, and that at least 30 cells were needed to be imaged in this 
manner to obtain statistically meaningful results.4 If this method were translated into a 30-hour 
observation period, as in employed by Schwake and co-workers11, this would entail the capture, 
consolidation and analysis of 216.000 images. Due to such limitations, most of the studies have 
concentrated on the spatial distribution of the material,6, 12 or on the trafficking mechanisms 
used instead.4, 9 Endosome escape efficiency is inferred from a minimal amount of sampling 
points.4 Uptake events are likewise rarely recorded in real time, again due to the low signal-to-
noise ratio; real time recording frequently requires confocal or total internal reflection 
microscopy.9 It is more common for endosomal escape rates to be estimated from data fits.8 
Combining direct analysis of uptake and endosomal escape will not only yield time distributions 
of the escape events, but also information on the vector load per endosome, and the influence 
of endosome size on escape. Availability of such information for vectors tested on different cell 
lines would be important in evaluating their performance. To obtain real-time information on 
individual lysis events, it would be highly desirable to have a reporter system that could be 
co-delivered with, or be used itself as a delivery vector. An ideal detector system should have 
distinct signals for each target compartment, and the signals produced should not immediately 
diffuse into the cytosolic milieu. Given these considerations, we chose to modify a recently 
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designed colloidal mesoporous silica nanoparticle (MSN) system to create a fluorometric 
detector.  
MSNs are non-toxic and biocompatible,14, 15 possess a controllable and well-defined uniform 
porosity, offer large surface areas, pore volumes, multifunctionality and are small in size, a 
critical feature for endosomal uptake.16-19 The surface of these nanoparticles (NPs) can be 
modified by inorganic and organic functionalization to give multifunctional hybrid 
materials.20-22 MSNs can be functionalized with polymers such as polyethylene glycol 
(PEG)23, 24 and polyethyleneimine (PEI)25, which increase colloidal stability by preventing non-
specific protein adsorption.23, 26-29 In addition, controlled release from MSNs can be 
implemented using various stimuli-responses to these cap systems.30-33 The opening stimulus 
can be a change in pH34, UV irradiation35, or redox-activity.36 MSNs can also be enclosed in 
supported lipid bilayers (SLB@MSN)37, created by a solvent exchange induced self-assembly 
of lipids around the MSNs.38 NP-supported lipid bilayers exhibit a narrower size distribution 
and enhanced stability compared to liposomes.39-41 Combining SLB@MSNs with 
photochemical internalization (PCI)42, 43  and photosensitizers (PS) leads to a highly potent drug 
delivery system.39 PS generate reactive oxygen species (ROS) upon light-activation, leading to 
membrane rupture.44 Recently, multifunctional MSNs have been equipped with an on-board 
photosensitizer, namely amino-modified protoporphyrin IX (PpIX-NH2). This system has 
already been tested in different cell lines.43 Here we combine PCI with a covalently bound blue-
light sensitive photosensitizer and the redox-labile disulfide-bridge approach to create highly 
potent, multifunctional MSNs acting as fluorimetric reporter vectors in different cell lines 
(Figure 3.1).  
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Figure 3.1: MSN-based endosome lysis detector system (A). MSNs to which inactive 
protoporphyrin IX (PpIX) and the quenched dye Atto633 are covalently attached (CMS core), are 
encapsulated in a lipid bilayer. Cells are incubated with NPs for at least 6 hours prior to a lysis 
experiment together with a fluid-phase marker, AlexaFluor Dextran 488. Endosome lysis is induced by 
activating PpIX with 405 nm light. (B) The reactive oxygen species (ROS) produced by this reaction 
oxidize double bonds in the lipid tails in both the SLB surrounding the NPs, as well as of the endosome. 
Following membrane disruption, the reductive intracellular milieu cleaves the bonds between the 
quencher and Atto633, leading to localized fluorescence at the site of lysis. 
Apart from the construction of a reporter system, it is useful to construct a model that can be 
used to understand variations in the lysis time distributions, especially the contributions of 
factors that could not be directly quantified, such as the PpIX load per NP. We have previously 
created a stochastic pi calculus model for describing the intracellular distribution of NPs and 
NP aggregates.45 Here, we extended the model to include the PpIX-mediated endosome lysis 
reaction. The model is executed using SPiM (http://research.microsoft.com/en-
us/projects/spim/), developed by Andrew Philips and Luca Cardelli, at Microsoft Research, 
Cambridge.45, 46 SPiM uses the Gillespie algorithm to describe the time evolution of the system 
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by selecting the reaction that will occur, as well as its duration, with a probability proportional 
to the base rate of reaction and reactant availability.47 Model results indicate that for a 
PpIX-dependent NP system, the lysis time distribution depends heavily on cell specific uptake 
parameters, rather than any inter-NP variability in PpIX load, provided that the PpIX load is 
not too low. In this paper, we demonstrate that the use of this reporter system for generating 
time distributions of lysis events, coupled with an appropriate stochastic model, is a powerful 
method for evaluating and analyzing the efficiency of delivery vectors. 
3.2 Results and Discussion 
Multifunctional mesoporous core-shell silica nanoparticles 
The multifunctional core-shell MSNs were synthesized following a previously reported 
procedure.16, 17 We use a so-called delayed co-condensation approach to selectively introduce 
different functionalities on the inner and outer particle surface. This synthesis employs 
tetraethyl orthosilicate (TEOS) as silica source, 3-aminopropyl triethoxysilane (APTES) and 
3-mercaptopropyl triethoxysilane as functionalized silica precursors and 
cetyltrimethylammonium chloride (CTAC) as structure directing agent. The polyalcohol 
triethanolamine (TEA) slows down the condensation rate of TEOS and leads to a small size 
distribution and radial growth of MSNs. Functionalized MSNs with 3-mercaptopropyl moieties 
in the shells of the particles and 3-aminopropyl groups in the core were synthesized according 
to this procedure giving the sample multifunctional MSNs (sample CMS_NH2in_SHout) after 
template removal (cf. experimental section), offering the possibility for post-synthesis 
modification due to the reactive nature of the groups. The MSNs were characterized in detail 
before further post-synthesis functionalization was carried out. The nitrogen sorption data 
revealed a type IV isotherm for the sample CMS_NH2core_SHshell typical for mesoporous 
materials (Figure 3.2A). A high Brunauer-Emmett-Teller (BET) surface area of 1160 m2g-1 was 
derived from the data. Additionally, the pore size of the MSNs was calculated from the nitrogen 
physisorption data (Figure 3.2B). The pore size distribution derived from non-local density 
functional theory shows a narrow pore size distribution of 3.7 nm. Additionally, transmission 
electron microscopy was employed for further characterization, revealing spherically shaped 
nanoparticles of about 70 nm with a homogenous mesoporsity (cf. appendix 3.12).  
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Figure 3.2: Nitrogen sorption data of template-free multifunctional MSNs (sample 
CMS_NH2core-SHshell). A) Nitrogen sorption isotherms and B) pore size distribution. 
 
MSN based detector system. Figure 3.2-A shows the post-synthesis functionalization of the 
outer surface of the MSNs. In a first reaction step the thiol-moieties on the outer shell of the 
MSNs were reacted with a short, bi-functional polyethyleneglycol linker 
(maleimide-dPEG8-COOH, (1-maleimido-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahen-
triacontan-31-oic acid), which increases the monodispersity of the sample in water and avoids 
pore blocking by the relatively large photosensitizer. The thiol moiety forms a stable bond with 
the maleimide functionalization of the PEG-linker in a Michael addition whereas the carboxy-
functionality remains accessible for further modification. The amino-modified photosensitizer 
protoporphyrin-IX (PpIX-NH2) was synthesized according to a modified literature procedure 
to allow covalent attachment to the carboxy-terminated PEG-linker on the outer surface of the 
MSNs.48 This precursor was covalently attached to the carboxy-functions at the particle surface 
via an N-(3-dimethylaminopropyl-)N’-ethylcarbodiimide (EDC) assisted amidation to give the 
photosensitizer-modified MSN sample (CMS_NH2in_PEG-PpIXout). 
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Figure 3.3: Reactions of MSNs. A) Shell reaction: 1) PEGylation 2) PpIX-NH2 attachment via EDC-
amidation. B) Core reactions: 1) Atto633-CYS attachment via EDC-amidation 2) The 
2,2’-dithiopyridine attachment to the SH-group of Atto633Cys is followed by the bonding of QSY21Cys 
via a redox-labile disulfide bridge. 
The core of the silica nanoparticles was modified according to Figure 3.3-B. We designed a 
redox-sensitive fluorimetric dye-quencher system for the MSN core. In the first step the highly 
reactive ATTO633-NHS ester was covalently attached to the amino group of cysteine 
(CysATTO633). Subsequently, CysATTO633 was reacted with the aminopropyl-functionality 
in an EDC assisted amidation to give the sample CMS_CysATTO633in_PEG-PpIXout. The thiol 
group of cysteine was activated with 2,2’-dithiopyridine, and cysteine-modified QSY21 
(CysQSY21) was added. This resulted in a disulfide bridged dye-quencher system in the particle 
core and yielded the final sample CMS_CysATTO633-CysQSY21in_PEG-PpIXout.  
The multi-step shell functionalization of the MSNs was monitored with dynamic light scattering 
(DLS) measurements, revealing homogeneous nanoparticles with a narrow size distribution 
(Figure 3.4). The modification with PEG leads to a slightly smaller particle sizes in water, 
whereas the attachment of PpIX leads to a broader size distribution; this can be explained by 
the hydrophobic nature of the photosensitizer. 
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Figure 3.4: Dynamic light scattering (DLS) measurement of samples CMS_NH2in_SHout (black curve), 
CMS_NH2in_PEGout (blue curve) and CMS_NH2in_PEG-PpIXout (red curve). For clarity reasons curves 
for CMS_NH2in_PEGout  (blue) and CMS_NH2in_PEG-PpIXout (red) were shifted along the y-axis by a 
value of 25 each.  
 
To demonstrate the efficiency of our disulfide bridged dye/quencher system in the sample 
CMS_CysATTO633-QSY21Cysin-_PEG-PpIXout the NPs were investigated with fluorescence 
spectroscopy (Figure 3.5). The disulfide bridge between the two cysteine moieties is cleaved 
upon the addition of 10 mM L-glutathione (GSH) which corresponds to the strength of the 
reductive milieu. As a result, the covalently attached quencher CysQSY21 can diffuse out of 
the pores, resulting in a fluorescence of ATTO633.  
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Figure 3.5: Fluorescence emission spectra of the sample CMS_CysATTO633-QSY21Cysin_PEG-
PpIXout (black curve) and 60 seconds after the addition of 10 mM L-glutathione (red curve), allowing 
the quencher to diffuse out of the mesopores.  
 
Lipids. 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-Dioleoyl-sn-glycero-3-
phospho-ethanolamine (DOPE), were chosen for the study. Both lipids bear a sufficiently high 
number of double bonds with which the singlet oxygen produced upon PpIX activation can 
react to destabilize the membrane structure.49 Additionally, both lipids have been previously 
reported to form stable, fluid bilayers on the MSN core in their pure form.50, 51 DOPE is known 
to possess fusogenic properties because of its ability to adopt an inverted hexagonal phase52, 
influencing the curvature and structural integrity of a lipid bilayer53, and can fuse with cell 
membranes better than DOPC.52-54 The multifunctional MSNs were covered with SLBs 
comprised of either pure DOPC (DOPC@MSN) or pure DOPE (DOPE@MSN) lipid 
membranes labelled with 1 mol% Texas Red 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt (TR-DHPE). The quality of the membrane was 
previously assessed using confocal microscopy and correlation spectroscopy, and was shown 
to prevent cargo release before it reaches the delivery target55, or before controlled release is 
initiated. Additionally, the tight closure of the system was studied with time-based fluorescence 
release experiments (cf. appendix 3.13). Here, we provide further characterization of the system 
using single-cell uptake experiments and single-endosome lysis experiments. 
Supported lipid bilayer (SLB) deposition on MSNs through solvent exchange. SLBs were 
deposited on MSNs particles as previously described50. Briefly, post-synthesis modified MSNs 
in solution are centrifuged at 13000 rpm for five minutes. The supernatant is discarded and the 
3.2. Results and Discussion  
 
72 
 
particles are re-dispersed in a 2.5 mg/mL lipid solution in 40 vol% ethanol : 60  vol% water; 
this solution was subsequently titrated with water until a 95% vol water content is reached. The 
solution is allowed to equilibrate for 15 minutes, in the process forming the SLB on individual 
particles56; the NPs are separated from excess lipid by centrifugation, and subsequently 
re-suspended in a smaller volume comprised of 50 vol% complete cell culture medium: 50 %vol 
water solution. In this alcohol-free environment, the SLB is fully stabilized. The aggregation of 
NPs in this solution is minimized by brief sonication followed by filtration. 
Uptake experiments. DOPC@MSN were tested on non-phagocytic cell lines whose 
interactions with NPs were of interest: Beas2B, a human normal bronchial epithelium cell line; 
Huh7, a human hepatocarcinoma cell line; Renca-LacZ, a transformed murine renal carcinoma 
cell line; and 3T3, a mouse embryonic fibroblast cell line.  Cells were plated to a density of 
0.75 x 104 cells/cm2 on 8-well ibiTreat-coated Ibidi chambers 3 - 4 days before the start of the 
experiment. Cells were subsequently incubated with 50 μg/cm2 DOPC@MSN over two-hour 
intervals up to eight hours and washed with PBS five times post-incubation. External 
fluorescence was additionally quenched with a wash using 0.4 % w/w trypan blue.57, 58 Cells 
were then fixed with 2% formaldehyde in Leibovitz medium, reported to reduce cellular 
fluorescence59, supplemented with 10% FCS for a total of two hours. Internalized NPs were 
visualized using fluorescence microscopy at 40x magnification, and recorded at an exposure 
time of 1 s and a density power of 0.12 W/cm2. For each setup, eight random viewfields were 
chosen. Experiments were performed in triplicate. The relative number of particles taken up by 
each cell was approximated by taking the mean gray values across the area occupied by the cell. 
Analysis was done semi-automatically in ImageJ using an in-house program.60 Control 
experiments were performed using 30 nm, fluorescein labeled Latex NPs (Sigma Aldrich). 
Lysis experiments. For in vitro lysis experiments, cells were incubated for 12 hours with 
DOPC@MSN or DOPE@MSNs functionalized with PpIX and ATTO633-QSY21 to ensure 
completion of uptake. Lysis experiments were performed on 3T3 and Renca-LacZ cells, which 
appear to exhibit the highest and lowest uptake characteristics for DOPC@MSN particles. 
AlexaFluor Dextran 488 (MW=10 kDa) was used as a fluid-phase marker for endocytosis. 
Following incubation, cells were washed with PBS five times post-incubation, or until most of 
the fluorescence from the AlexaFluor Dextran was removed; washing with 0.4% w/w trypan 
blue was performed to quench any remaining external fluorescence. PpIX was activated by a 
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one or two minute exposure to a 405 nm laser prior to imaging. Fluorescence images were taken 
every second with an exposure time of 200 ms over a period of two minutes per view field. NP 
and endosome fluorescence were monitored using the following excitation/emission filter sets: 
488 nm/525 nm (AlexaFluor dextran); 560 nm/645 nm (Texas Red); and 640 nm/690 nm 
(ATTO633) (Chroma Technology). A negative control composed of DOPC@MSNs or 
DOPE@MSN functionalized with ATTO633-QSY21, but not PpIX, was used in parallel with 
all setups. Single endosome lysis events were detected using the same ImageJ plugin described 
previously. Briefly, images are segmented based on the fluid-phase marker channel 
(Figure 3.6). Discontinuities that occur in both the red and green channels were recorded as an 
endosome lysis event, and the time distribution of these events was collected for the different 
experimental setups. Apart from lysis times, the endosome area and NP colocalization intensity, 
based on the mean gray values in the red channel, are recorded.   
 
Figure 3.6: Single-endosome lysis time evaluation. Individual endosomes (A) are identified using 
automatic segmentation59 performed on the green channel, which is able to identify three out of four 
endosomes; the arrow indicates an endosome that was not properly segmented, and that had to be 
manually added. Colors represent automatically-defined ROIs, and not RGB channels (B) ATTO633 
fluorescence is artificially colored blue. For each endosome, the lysis time is determined through the 
occurrence of discontinuities in the time course in the red and green channels, as well as an increase in 
fluorescence in the long red channel (C). 
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Modelling. To systematically evaluate the factors that influence lysis time distributions, we 
extended the generic stochastic pi calculus model that we have created for gold NP uptake and 
intracellular movement.61 Specifically, we included PpIX and activated PpIX (Act_PpIX) 
counts as attributes of each NP process; an activation reaction, coupled with preconditions for 
lysis in the form of a minimum amount of Act_PpIX per endosome, also replaces the simple 
endosome lysis rate. We also redefine the aggregate size restrictions for 100 nm MSNs, instead 
of 4 nm gold NPs. Finally, we made uptake rates variable to represent cell specific responses. 
Each simulation was carried out with a starting value of 10000 NPs per cell; the PpIX load 
assigned to each NP was taken from a normal distribution with a mean of 50 PpIX per NP, and 
a width of 5. Sensitivity analysis was performed to identify the critical parameters of the model. 
We used code for SPiM v.0.05, which is run automatically using a Perl script that also permits 
parameter alteration. We omit the events downstream of endosomal escape, which we do not 
consider in this study. 
 
Statistics from single-endosome PpIX-mediated lysis with different lipids, cell types, and 
PpIX activation times. We investigated the time distribution of endosome lysis as a function 
of PpIX activation time, lipid coat, and cell type. Our results generally show that DOPE@MSN 
exhibit marginally earlier lysis times than DOPC@MSN. An interesting observation is that the 
activation time appears to play a more prominent role in Renca-LacZ than in 3T3, as evinced 
by the bigger shift in the distribution when the activation time is decreased (Figure 3.7A-D, 
Table 3.1). Furthermore, the distribution of lysis times after a two-minute PpIX activation is 
considerably more spread than in 3T3, which could be an indication of cell-specific dependence 
of endosome lysis.  
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Figure 3.7: A and B) Time distributions of endosome lysis events after PpIX-activation in 3T3 and 
C and D) Renca-LacZ cells. PpIX-functionalized DOPC@MSN and DOPE@MSN were incubated 
overnight, then activated for either one or two minutes. Results generally show marginally earlier lysis 
times for DOPE@MSN. It is interesting to note that lysis appears to be more concentrated towards 
earlier times for 3T3 cells than for Renca-LacZ; furthermore, the shift in the lysis times when activation 
is shorter is less prominent in 3T3. 
Table 3.1. Selected gauss fit parameters of endosomal escape data for DOPC@MSN and DOPE@MSN 
in 3T3 and Renca-LacZ cultures. 
Sample Activation time (min) Mean Width 
DOPC@MSN, 3T3  2 17.4 + 0.9 17.0 + 1.5 
DOPC@MSN, 3T3  1 23.7  + 1.8 17.2 + 2.9 
DOPE@MSN, 3T3  2 5.3 + 0.3 5.2 + 0.4 
DOPE@MSN, 3T3 1 15.4 + 1.6 24.0 + 2.7 
DOPC@MSN, Renca-LacZ 2 25.9 +7.3 39.3 + 15.6 
DOPC@MSN, Renca-LacZ  1 77.6 + 1.9 13.6 + 3.0 
DOPE@MSN, Renca-LacZ 2 31.1 + 5.3 28.0 + 10.1 
DOPE@MSN, Renca-LacZ 1 49.8 + 5.0 35.0 + 15.2 
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In order to check if there were cell-specific differences that may have influenced the lysis 
events, we analyzed the size distribution of endosomes, demarcated by the AlexaFluor Dextran 
488. We also obtained the red channel intensity within the area occupied by the endosome as a 
rough approximation of the endosome load. Although the colocalization intensity distribution 
appears to have a similar range (Figure 3.8B), the disparities in the endosome area are relatively 
marked (Figure 3.8A), with Renca-LacZ cells displaying more size variation, and tending 
towards larger endosomes. When a correlation is made between individual endosomes and 
corresponding mean gray values (Figure 3.8C), it becomes evident that 3T3 cells have a higher 
NP load per endosome on average.  
A possible reason for this is the higher expression and/or a longer lifetime of Rab5 in 
Renca-LacZ, a protein that controls endosome fusion, and consequently endosome size 
distribution.62 Expression profiles of 3T3 cells and differentiated counterparts show an increase 
in Rab5 expression in differentiated cells; Rab5 has also been reported to be overexpressed in 
several carcinoma cell lines, including lung adenocarcinoma63 and HeLa.64 One way of 
clarifying the results would be to use a Rab5 tag to have an approximation of both its expression 
and lifetime in the cell types tested. 
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Figure 3.8: Endosome size and colocalization intensity data for 3T3 and Renca-LacZ cells. Endosomes 
appear to have more varied sizes in Renca-LacZ cells than in 3T3 cells (A), as well as a lower MSN 
reporter load (B). The variation in endosome size may be a result of differences in Rab5 expression. 
Cell-type dependence of NP uptake. Another interesting observation was that Renca-LacZ 
cells generally took up a smaller amount of MSNs than 3T3 (Figure 3.9). To confirm this, we 
conducted time-course uptake experiments using 3T3 and Renca cells, as well as two additional 
cell lines. From these experiments, we gathered information for between 500 and 1000 cells for 
each time point and each cell line. We ran a parallel experiment using 30 nm fluorescently-
labeled Latex NPs as a form of control. Our results confirm that 3T3 cells take up more 
DOPC@MSN than Renca-LacZ on average (Figure 3.10, Table 3.2). Additionally, the 
cell-to-cell uptake variation in Renca-LacZ cells appears to be at least twice of what could be 
expected from 3T3. Table 3.2 summarizes selected parameters from Gaussian fits of the uptake 
data eight hours post-incubation. The cell-specific uptake features can also be observed with 
Latex NPs, with Renca-LacZ cells being able to take up the highest amount, followed by 3T3 
and Huh7.  
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Figure 3.9: Uptake of MSNs in 3T3 cells A) appears to be higher than in Renca-LacZ B) after 12 hours 
of incubation with DOPC@MSN. Note that individual cells of the same type appear to take up a widely 
variable numbers of NPs. NPs (red) were incubated together with Alexa-Fluor Dextran 488 (green). NPs 
inside endosomes appear as yellow spots. Images are taken at 40x. 
 
Figure 3.10: Cell type differences in reporter system uptake. Uptake of DOPC@MSN A) in 3T3, 
Renca-LacZ, Huh7 and Beas2B cells. The numbers of NPs taken up were approximated using the mean 
fluorescence intensity across a cell. A parallel experiment was performed using commercially available 
30 nm latex nanoparticles B) for 3T3, Renca-LacZ and Huh7 cells. 
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Table 3.2: Selected Gauss fit parameters of cell-type specific NP uptake profiles at eight hours 
post-incubation. 
Sample Activation time (min) Mean 
DOPC@MSN, 3T3 675.7 + 0.3 17.2 + 0.2 
DOPC@MSN, Renca-LacZ 644.5 + 1.7 41.7 + 2.4 
DOPC@MSN, Huh7 673.9 + 1.2 20.9 + 1.1 
DOPC@MSN, Beas2B 726.9 + 9.4 132.5 + 14.3 
Latex, 3T3 1314.1 + 29.9 227.8 + 43.3 
Latex, Renca-LacZ 1603.54 + 19.3 1065.7 + 31.6 
Latex, Huh7 613.4 + 69.4 1314.5 + 102.0 
 
It is not the first time that cell type uptake dependence for non-functionalized NPs was reported. 
Non-functionalized silver NPs, for instance, are taken up better by peripheral monocytes, but 
not by T-cell populations.64 A recent paper also indicates that apart from uptake differences 
resulting from cell surface properties, there are also cell-type specific cytoplasmic and nuclear 
pore penetration constraints.65 Our results, together with other recent reports on cell-type 
dependent uptake specificity, indicate the need to investigate this phenomenon more closely, 
and to take results as a consideration in NP design and dosage. 
Stochastic pi calculus model of endosomal escape. We extended the gold NP model to be 
able to systematically study the factors that influence endosomal escape. For a release 
on-demand system such as PpIX, we expected a very narrow distribution of endosome lysis 
times. Considering the time window, which is two minutes post-PpIX activation, the spread is 
of course insignificant compared to non-release on-demand systems. However, what was 
striking is the disparity of the distributions in 3T3 and Renca cells. In order to check how much 
of the spread is caused by noise inherent to the reporter system, we added PpIX and Act_PpIX 
parameters to each NP, through which we can vary the PpIX load distribution per NP. As 
indicated in the methods section, we made the initial assumption that the NPs had a normally 
distributed PpIX load with a mean of 50, and a width of 5, which we changed in the course of 
the sensitivity analysis. For the first run, we also made the assumption that the binding and 
aggregation rates are the same as those used for gold NPs. Other parameters were also subjected 
to sensitivity analysis, results of which are summarized in Figure 3.11. Interestingly, the model 
is most sensitive to the minimum number of PpIX required to burst an endosome. Although the 
current version of SPiM does not permit us to dynamically create endosomes that are assigned 
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an unfixed size parameter (taken from a distribution as in Figure 3.11), this result is logical in 
that this minimum number is intimately linked with the NP load per endosome, as well as 
endosome size, which we have shown experimentally to be the main difference between the 
two cells. 
 
Figure 3.11: Fits of representative 3T3 and Renca data (DOPC-coated, 2-min PpIX activation) 
presented as a cumulative sum (A) and sensitivity analysis of the different model parameters (B) indicate 
that the cell associated parameter, klysis, causes most of the data spread, followed by the NP load per 
endosome. klysis was assumed to decrease by a factor proportional to the endosome size, represented in 
arbitrary units (a.u.). 
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3.3 Conclusion 
A reporter system based on colloidal mesoporous silica nanoparticles (MSNs) was developed. 
The MSNs were covalently modified with a blue-light sensitive photosensitizer, 
protoporphyrin IX (PpIX) and capped with a supported DOPC lipid bilayer (SLB). In this study, 
photochemical internalization (PCI) with an on-board photosensitizer and the redox-labile 
disulfide-bridge approach (of a corresponding dye-quencher system) was combined to create 
highly potent multifunctional MSNs as fluorimetric reporter vector. The photosensitizer allows 
to overcome endosomal entrapment through the formation of highly reactive singlet oxygen 
which is followed by the subsequent disintegration of both membranes in a cascaded manner. 
Endosomal uptake of the SLB-capped MSNs and individual endosome lysis events were studied 
in three different cell lines (a fibroblast, normal and carcinoma cell line). The release on-
demand system resulted in more broadly distributed lysis times than expected, particularly for 
Renca, a renal carcinoma cell line. An analysis of the nanoparticle load per endosome, 
endosome size and uptake characteristics indicate that Renca cells not only take up a lower 
amount of NPs in comparison with the fibroblast cells, but also have larger endosomes, and a 
lower NP load per endosome. An existing stochastic pi calculus model of the gold nanoparticle 
intracellular distribution was extended to our reporter-system, enabling to understand how 
different factors (e.g. PpIX load per NP) affect the distributions. Model results indicate that the 
lysis time distribution is primarily determined by the minimum net PpIX required to burst an 
endosome, a factor influenced by the NP load per endosome, as well as the endosome size. 
 
3.4 Experimental 
Chemicals. Tetraethyl orthosilicate (TEOS, Fluka, >99%), (3-mercaptopropyl)-triethoxysilane 
(MPTES, Gelest, 95%), (3-aminopropyl)-triethoxysilane (APTES, Sigma, 98%), 
cetyltrimethylammonium chloride (CTAC, Fluka, 25wt% in H2O), phenyltriethoxysilane 
(PhTES, Sigma, 98%), triethanolamine (TEA, Aldrich, 98%), Atto633-NHS ester (Atto-Tec), 
QSY21 succinimidyl ester (Invitrogen), tetrahydrofuran (THF, Acros, 99.8%), protoporphyrin 
IX (Sigma, >95%), p-phenylenediamine (Sigma, 95%), triethylamine (Sigma, 99%), ethyl 
chloroformate (Fluka, >98%), ammonium nitrate (Sigma, 99%), conc. hydrochloric acid 
(Aldrich, >95%, 37wt%) 1-maleinimido-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-
azahentriacontan-31-oic acid (mal-dPEG(8)-COOH, Iris Biotech), sulfo-N-
hydroxysuccinimide (sulfo-NHS, Aldrich, 98%), N-(3-dimethylaminopropyl)-N′-
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ethylcarbodiimide (EDC, Sigma, 97%), toluene (Aldrich, 99.8 %), ethanol (EtOH, Aldrich, 
>99.5%), fluorescein disodium salt dihydrate (Acros, >95%), L-glutathione (Aldrich, >98%), 
2,2‘-dithiopyridine (DTP, Sigma, >99%), L-cysteine (Cys, Sigma, >97%), anhydrous N,N-
dimethylformamide (DMF, Sigma, >99.8%). All chemicals were used as received without 
further purification. Doubly distilled water from a Millipore system (Milli-Q Academic A10) 
was used for all synthesis and purification steps. The lipids 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) and 1,2-Dioleoyl-sn-glycero-3-phospho-ethanolamine (DOPE) were 
purchased from Avanti polar lipids. 
 
Synthesis procedures 
Synthesis of core-shell CMS_NH2in_SHout. Bi-functional core-shell colloidal mesoporous 
silica was synthesized following the previously published method.66 A mixture of TEOS 
(1.63 g, 9.22 mmol), PhTES (57 mg, 0.24 mmol), APTES (53.1 mg, 0.24 mmol) and TEA 
(14.3 g, 95.6 mmol) was heated at 90 °C for 20 min under static conditions in a polypropylene 
reactor. Then a solution of CTAC (25 % in water, 2.41 mL, 1.83 mmol) in water (21.7 g, 
1.21 mol) was preheated to 60 °C and added quickly. The reaction mixture was stirred at room 
temperature for 20 minutes. TEOS (138.2 mg, 0.92 mmol) was added in four equal increments 
every three minutes. This step was followed by 30 minutes of stirring at room temperature. For 
the shell functionalization a mixture of TEOS (19.3 mg, 92.5 μmol) and MPTES (22 mg, 
92.5 μmol) was added to the reaction. The resulting mixture was then allowed to stir at room 
temperature for 12 hours. After the addition of 100 mL ethanol, the MSNs were collected by 
centrifugation, re-dispersed in 100 mL of ethanol and extracted according to the procedure 
described below. 
Extraction of CMS_NH2in_SHout. Extraction of the surfactant from the MSNs was performed 
by heating 250 mg for 45 minutes under reflux at 90 °C in a solution containing 2 g ammonium 
nitrate in 100 mL ethanol, followed by 45 minutes under reflux in a mixture of 4 g conc. 
hydrochloric acid (37 wt%) in 100 mL ethanol. The CMS nanoparticles were separated by 
centrifugation and washed with ethanol after each extraction step. MSN materials were obtained 
as colloidal suspensions. 
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PEGylation of CMS_NH2in_SHout with bi-functional Mal-PEG(8)-COOH to the sample 
CMS_NH2in_PEGout. An ethanolic suspension containing 1 mg of CMS_NH2_SHout was 
centrifuged and re-dispersed in 1 mL of water. This washing step was repeated twice. Next, the 
MSNs were suspended in 500 µL of water and 100 μL of a solution of Mal-dPEG(8)-COOH 
(10 mg/mL) was added under stirring. The reaction mixture was stirred for 48 hours at room 
temperature. In order to remove the excess of Mal-dPEG(8)-COOH, the particles were washed 
five times with 1 mL of water to remove unbound PEG. All washings steps were followed by 
centrifugation. Finally, the sample CMS_NH2in_PEGout was re-dispersed in 500 μL ethanol. 
Synthesis of protoporphyrin-IX-bis(phenyleneaminoamide) (PpIX-NH2). Protoporphyrin-
IX-bis(phenyleneaminoamide) was prepared according to a modified literature procedure.43, 48 
In a dry and darkened 100 mL three-neck flask, protoporphyrin-IX (100 mg, 0.178 mmol, 1 eq.) 
was dissolved in 20 mL anhydrous tetrahydrofuran and cooled to 0 °C under nitrogen 
atmosphere. Triethylamine (2.45 mL, 17.7 mmol, 100 eq.) was added with a syringe to the 
solution. Ethyl chloroformate (1.7 mL, 17.9 mmol, 100 eq.) was subsequently added over a 
time of 30 minutes via a dropping funnel. The resulting mixture 1 was stirred for 2 hours at 
0 °C. In a second flask, finely powdered p-phenylene diamine (1.95 g, 17.9 mmol, 100 eq.) was 
dissolved in 10 mL anhydrous THF under nitrogen atmosphere. Mixture 1 was slowly added 
with a syringe. The resulting reaction mixture was stirred for 24 hours at room temperature in 
the dark. The solvent was removed in vacuo, the resulting precipitate suspended in 15 mL of 
ice-cold water. The precipitate was filtered off and washed three times with 15 mL of ice-cold 
water each. PpIX-NH2 was obtained as a brown precipitate (85 mg, 0.114 mmol, 64%). 
Attachment of PpIX-NH2 to CMS_NH2in_PEGout  to the sample CMS_NH2in_PEG-
PpIXout. 1 mg of CMS_NH2in_PEGout was re-suspended in 1 mL THF before PpIX-NH2 (2 mg, 
2.7 µmol) was added. The mixture was stirred for 5 minutes. Subsequently, EDC (3.5 µL, 
20 µmol) and sulfo-NHS (4.3 mg, 20 µmol) were added and the reaction was stirred for 14 hours 
in the dark. The sample was washed five times with 1 mL of THF to remove unbound PpIX-NH2 
and three times with a total amount of 3 mL water. 
Fluorescence labeling procedure for the amino group of L-cysteine (CysAtto633). 
L-Cysteine (Cys, 1 mg, 8.25 μmol) was dissolved in 100 μL of freshly prepared 0.1 M sodium 
bicarbonate buffer (pH 8.3). Then, 10 μL (26.7 nmol) of a solution of Atto633-NHS (1 mg 
dissolved in 500 μL anhydrous DMF) was added. The large excess of Cys is intended to 
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minimize the amount of remaining free dye, since no purification of the product was performed. 
The resulting mixture was stirred for 2 hours in the dark to give CysAtto633. 
Attachment of Cys-Atto633 to the core of CMS_NH2in_PEG-PpIXout. A solution of 1 mg 
Cys-Atto633 in water was added to a colloidal suspension of 1 mg CMS_NH2in_PEG-PpIXout 
in water. The reaction mixture was stirred for 5 minutes in the dark before EDC (3.5 µL, 
20 µmol) and sulfo-NHS (4.3 mg, 20 µmol) were added. The reaction was stirred for 14 hours 
in the dark. The sample was washed two times with 1 mL water and then five times with 1 mL 
ethanol each to remove unbound dye. 
Quencher QSY21 labeling procedure for the amino group of L-cysteine (CysQSY21). 
L-Cysteine (Cys, 1 mg, 8.25 μmol) was dissolved in 100 μL of freshly prepared 0.1 M sodium 
bicarbonate buffer (pH 8.3). Then, 21.8 μL (26.7 nmol) of a solution of QSY21-NHS (1 mg/mL 
in anhydrous DMF) was added. The large excess of Cys is intended to minimize the amount of 
remaining free quencher, since no purification of the product was performed. The resulting 
mixture was stirred for 2 hours in the dark to give CysQSY21. 
Attachment of Cys-QSY21 via a disulfide bond to the Cys-Atto633 moiety in the core of 
CMS_NH2in_PEG-PpIXout. 150 µL of an ethanolic suspension of the sample 
CMS_NH2in_PEG-PpIXout containing 1 mg particles was adjusted to the total volume of 1 mL 
by adding 850 µL absolut ethanol. Then, 2,2'-dithiopyridine (DTP, 1 mg, 4.5 µmol) was added. 
The sample was stirred for 15 minutes in the dark. Three washing steps with 1 mL ethanol each 
were followed by subsequent centrifugation.  The DTP-activated MSNs were re-suspended in 
500 µL water and a solution containing 1 mg CysQSY21 in 100 µL water was added. The 
reaction mixture was stirred 14 hours in the dark. Unbound CysQSY21 was removed by five 
washing steps with 1 mL ethanol each.  
Fluorescence spectroscopy of the sample CMS_CysAtto633-QSY21Cysin-_PEG-PpIXout 
Fluorescence spectroscopy was performed on a PTI spectrofluorometer with a photomultiplier 
detection system (model 810/814). The sample included 0.5 mg of the sample 
CMS_CysAtto633-QSY21Cysin-_PEG-PpIXout suspended in 2 mL of water. GSH (2 mg, 
6.51 µmol) was added under continuous stirring. The obtained spectra derived from excitation 
at 633 nm can be found in Figure 3.5. 
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Characterization. Centrifugation was performed using a Sorvall Evolution RC equipped with 
a SS-34 rotor or an Eppendorf centrifuge 5418 for small volumes (1.5 mL maximum). Dynamic 
light scattering (DLS) were performed on a Malvern Zetasizer-Nano instrument equipped with 
a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. DLS measurements were directly 
recorded on ethanolic colloidal suspension at a constant concentration. Transmission electron 
microscopy (TEM) and Scanning TEM were performed on a FEI Titan 80-300 kV microscope 
operating at 300 kV. Nitrogen sorption measurements were performed on a Quantachrome 
Instruments NOVA 4000e. All three samples (15 mg each) were heated to 393 K for 12 h in 
vacuo to outgas the samples before nitrogen sorption was measured at 77 K. For calculations 
of pore sizes and volumes a non-local density functional theory (NLDFT) equilibrium model 
of nitrogen on silica was used. The Brunauer-Emmett-Teller (BET) model was applied to 
evaluate the surface areas. Fluorescence time-based release experiments were recorded on a 
PTI fluorescence system featuring a PTI 814 photomultiplier detector and a PTI A1010B Xenon 
arclamp driven by a PTI LPS-220B lamp power supply. For temperature settings, a Quantum 
Northwest TC 125 sample holder was used. Our previously described custom-made release 
cuvette system was employed for all experiments. All samples were measured at a temperature 
of 37 °C with slits of 1-1.2-1-1-1. 
 
3.5. Appendix  
 
86 
 
3.5 Appendix 
 
Figure 3.12: Transmission electron micrograph of the multifunctional MSNs (sample 
CMS_NH2in_SHout). 
 
Figure 3.13: Time-based fluorescence release curves with fluorescein as cargo for the MSN samples 
CMS_NH2in_PEG-PpIXout (blue), laser activated DOPC@CMS_NH2in_SHout (red) and tightly capped, 
non-activated DOPC@CMS_NH2in_SHout (black). 
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2484-2492. 
55. Liu, J.; Stace-Naughton, A.; Jiang, X.; Brinker, C. J. J. Am. Chem. Soc. 2009, 131, 1354-
1355. 
56. Hed, J.; Hallden, G.; Johansson, S.; Larsson, P. J. Immunol. Methods 1987, 101, 119-
125. 
57. Xiao, J., Handbook of Single-Molecule Biophysics. Springer: New York, 2009. 
58. Youssef, S.; Gude, S.; Rädler, J. O. Integr. Biol. 2011, 3, 1095-1101. 
59. Dobay, M. P.; Dobay, A.; Bantang, J.; Mendoza, E. Molecular bioSystems 2011, 7, 
2741-2749. 
3.6. References  
 
90 
 
60. Li, G.; Qian, H. Traffic 2002, 3, 249-255. 
61. Li, Y.; Meng, X.; Feng, H.; Zhang, G.; Liu, C.; Li, P. Chin. Med. Sci. J. 1999, 14, 96-
101. 
62. Duclos, S.; Diez, R.; Garin, J.; Papadopoulou, B.; Descoteaux, A.; Stenmark, H.; 
Desjardins, M. J. Cell Science 2000, 113, 3531 - 3541. 
63. Greulich, C.; Diendorf, J.; Geßmann, J.; Simon, T.; Habijan, T.; Eggeler, G.; 
Schildhauer, T. A.; Epple, M.; Köller, M. Acta Biomater. 2011, 7, 3505-3514. 
64. Williams, Y.; Sukhanova, A.; Nowostawska, M. G.; Davies, A. M.; Mitchell, S.; 
Oleinikov, V.; Gun'ko, Y.; Nabiev, I.; Kelleher, D.; Volkov, Y. Small 2009, 5, 2581-
2588. 
65. Cauda, V.; Schlossbauer, A.; Kecht, J.; Zürner, A.; Bein, T. J. Am. Chem. Soc. 2009, 
131, 11361-11370. 
 
 
91 
 
4 Targeted Drug Delivery in Cancer Cells with Red Light Photoactivated 
Mesoporous Silica Nanoparticles 
This chapter is based on the following publication: 
Stephan A. Mackowiak, Alexandra Schmidt, Veronika Weiss, Christian Argyo, Constantin von 
Schirnding, Thomas Bein and Christoph Bräuchle, Nano Letters 2013, 6, 2576. 
 
Abstract 
The development of mesoporous nanoparticles for drug delivery has made significant progress, 
but improvements are still necessary regarding targeting efficiency and endosomal release. We 
present a system based on colloidal mesoporous silica nanoparticles with targeting ligands and 
a covalently attached red-light photosensitizer. This nanoparticle system provides spatial and 
temporal control of the release of the model drug into the cytosol of cancer cells. The system 
can be loaded with different cargos within a certain size range and adapted for multiple cancer 
cell types in regard to their overexpressed receptors. 
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4.1 Introduction 
The delivery of large amounts of cancer therapeutics specifically into the cytosol of cancer cells 
still faces significant challenges. Promising approaches in the field of drug delivery encompass 
the utilization of various types of nanoparticles such as polyplexes,1-3 dendrimers,4-6 gold 
nanoparticles,7 and colloidal mesoporous silica (CMS, also named mesoporous silica 
nanoparticles, MSNs).8-11 Each of these systems has its inherent advantages and disadvantages. 
Usually, they are either optimized for specific uptake by cancer cells, amount of cargo 
delivered, release of cargo into the cytosol or ease of synthesis of the system itself. However, 
often they do not perform well in all of these required areas. Notably, release of the drug from 
the endosome poses a significant hurdle on the way towards drug delivery with high efficacy. 
In this paper, we will present a system that provides solutions for all of these aspects. In 
particular, a photoactivatable drug delivery system, based on core-shell colloidal mesoporous 
silica nanoparticles (MSNs) will be employed, which allows exact spatial and temporal control 
of the release of the cargo from both the MSN and the endosome.12-14 Core-shell MSNs are 
more suitable than regular MSNs for this task because they can have different functionalization 
in the core and the shell. This allows to optimize the core functionalization, e.g. for cargo uptake 
or covalent binding of the cargo to the core by disulfide bridges.15 Moreover, the surface 
functionalization can be chosen to implement various gating mechanisms, such as surrounding 
the MSNs with a lipid bilayer to enclose the cargo in it.13, 16 Previously, our groups published a 
photoactivatable drug delivery system performing most of the above-mentioned tasks well.16 
The current system is improved in 3 key areas. The used photosensitizer (PS) is activated by 
red light instead of blue light, the synthesis is significantly simplified and targeting ligands have 
now been added to the system. The function of the photosensitizer is to solve the problem of 
endosomal entrapment. Other approaches addressing this issue such as taking advantage of the 
proton sponge effect,17-19 employing fusogenic or endosomolytic peptides20-23 and others have 
been used.24 There, the endosomal escape occurs at a less defined time point and for all particles 
regardless of their location in healthy or cancerous cells. In contrast, the photoactivation 
approach offers a solution for both of these shortcomings by initiating the cargo release through 
an external stimulus in form of a laser beam. The laser beam can be directed into the cancer 
tissue and activated at the right time point. The activation of the photosensitizer with red light 
instead of blue light reduces the phototoxicity and significantly increases the depth of tissue 
penetration,25 which will be crucial when activation in vivo is required as shown by the Kataoka 
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group.26 In comparison to regular photochemical internalization and other photoactivatable 
systems our system exhibits specific uptake by cancer cells due to the presence of targeting 
ligands. Schlossbauer et al.16 presented MSNs with photosensitizers that allowed free choice 
and controlled release of the cargo. However, the issue of the targeting capability of the system 
was not addressed. Febvay et al.27 used MSNs with photosensitizers in their studies as well, but 
the cargo had the role of the photosensitizer, i.e. the cargo selection was very limited. Moreover, 
the photosensitizer, i.e. cargo, was covalently bound to the MSN core and hence a suitable 
release mechanism was not present. In the current approach, we covalently link the 
photosensitizer molecule (PS) to the MSN surface and encapsulate the MSN with a supported 
lipid bilayer (SLB) to retain the drug. This allows for choosing a drug different from the PS and 
implementing a gating mechanism as well. Furthermore, the targeting mechanism presented by 
Febvay et al. was based on a streptavidin coated nanoparticle and a cell surface that was stained 
with the antibody P-gp.27 While this demonstrates the targeting effect in principle, this specific 
targeting system is rather rare for cancer cells. Here we introduce the choice between two 
targeting ligands to our MSNs namely folic acid (FA) and epidermal growth factor (EGF), 
where both are relevant for cancer cells. For this purpose, targeting ligands (TL) are inserted 
into the SLB by diffusion to achieve specific uptake of the drug delivery vehicle by cancer cells. 
In the following, we will first discuss the synthesis and characteristics of our drug delivery 
system. Subsequently, live cell microscopy studies will be presented to evaluate the 
functionality of the employed targeting ligands and the release of the cargo from the MSNs by 
photoactivation. 
4.2 Results and Discussion 
Synthesis and characterization of the drug delivery vehicle.  
The core-shell MSN were synthesized via a modified sol-gel method using tetraethyl 
orthosilicate (TEOS) as silica source and CTAC as pore template.14 Kruk and co-workers 
showed the positive effect of ammonium fluoride on the particle morphology and pore size 
enlargement by employing 1,3,5-triisopropylbenzene (TiPB) as micellar expander for  the 
synthesis of SBA-15.28, 29 A distinct amount of both components was introduced into the core-
shell MSN synthesis (cf. experimental). The MSN core was functionalized with thiol groups 
and the surface with cyano groups, allowing for various post-synthesis modifications.   
4.2. Results and Discussion  
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Figure 4.1: Synthesis pathway of core (green) shell (red) MSN with covalently linked AlPcS2a (red star) 
via PEG linker (black chain), and surrounded by DOPC/DOTAP supported lipid bilayer with targeting 
ligand (green star, TL). Before the formation of the SLB, the MSN core is loaded with a cargo (yellow), 
in our case calcein or a rhodamine derivative. Drawing is not to scale. 
In the first reaction step, the surface cyano-groups of the MSN (I) are hydrolyzed to carboxyl 
groups (II), and subsequently the PEG linker is attached to the MSN surface via EDC amidation 
(III). To promote endosomal escape and subsequent delivery of the cargo into the cytosol, we 
employ a photoactivation approach. Therefore, a red-light sensitive photosensitizer, aluminum 
phthalocyanine disulfonate (AlPcS2a), is covalently linked to the surface of the MSN via an 
octamer PEG linker. The PEG linker is functionalized with amino groups on both ends.  
 
Figure 4.2: Shell reactions of MSN_SHin_COOHout nanoparticles. 1) PEGylation reaction and 2) 
covalent attachment of photosensitizer AlPcS2a. 
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The transmission electron microscope (TEM) image of the MSNs (species I in Figure 4.1) 
shows spherical particles with a mean diameter of 70 nm (Figure. 4.3a and cf. appendix 4.12). 
The mesoporous channel structure radiating from the particle center is apparent in the 
micrograph. It was proven that the conversion of the cyano-moieties to carboxy-groups and the 
subsequent PEGylation does not lead to a destruction of the mesostructure (cf. appendix 4.13). 
From dynamic light scattering (DLS) a mean particle size of 69 nm was obtained. In particular, 
it appears that the presence of carboxyl- or sulfonyl groups, either directly on the MSN surface 
or on the AlPcS2a, results in an increase of the effective particle size (red circles and blue inverse 
triangles in Figure 4.3b, respectively). In contrast, the presence of PEG molecules on the MSN 
surface as well as the presence of the SLB results in a decrease of the effective particle size 
(green triangles and cyan diamonds in Figure 4.3b). In both cases, the origin of the size decrease 
can be attributed to the weaker interactions between the particles caused by steric or 
electrostatic stabilization.  
 
Figure 4.3: a) The TEM image shows bare MSN (I). The scale bar is 20 nm. b) Particle sizes of species 
I – VI in Figure 4.1 obtained by DLS measurements. All curves, except of MSN_SHin_CNout, are shifted 
by a value of 22 along the y-axis for clarity reasons. c) Pore size distributions of species I – IV. The 
exact values of the maxima are given in Table 4.1. Data are shifted by a value of 0.3 along the y-axis 
for clarity reasons. 
The nitrogen sorption isotherms of the samples MSN_SHin_CNout (I, black squares), 
MSN_SHin_COOHout (II, red circles), MSN_SHin_PEGd8NH2out (III, green up triangles), and 
MSN_SHin_PEGd8-AlPcS2aout (IV, blue inverted triangles) can be seen in Figure 4.4, exhibiting 
typical type IV isotherms for mesoporous materials. The Brunauer-Emmett-Teller (BET) 
surface areas for each sample are calculated from the corresponding nitrogen sorption isotherm 
in the range p/p0 = 0.05 – 0.2 and are summarized in Table 4.1. All samples feature a high 
specific surface area typical for our MSN.  We assume that the reduced BET surface area in the 
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sample MSN_SHin_COOHout (II) in comparison with MSN_SHin_CNout (I) comes from the 
more condensed silica network and pore shrinkage resulting from the hydrolysis of the 
cyano-moiety in hydrochloric acid. The decrease of the specific surface area in the sample 
MSN_SHin_PEGd8NH2out (III) can be explained by the addition of non-porous PEG and the 
blocking of some pores by frozen PEG-linker in the surface layer of the MSN. This effect is 
relatively small due to the short length of the flexible spacer. In contrast, the BET surface area 
of the sample MSN_SHin_PEGd8-AlPcS2aout is with 918 m
2/g significantly higher than the BET 
surface area for MSN_SHin_COOHout (II) and MSN_SHin_PEGd8NH2out (III). We suppose that 
this effect comes from interstitial pore volume occurring upon attachment of AlPcS2a onto the 
particle shell. Considering phthalocyanines are large, sterically hindered molecules that lack 
the flexibility of a PEG-linker, a covalent attachment of them to the MSN surface will result in 
voids at liquid nitrogen temperatures. The mean pore size of MSN_SHin_CNout was calculated 
to 5.2 nm, indicating the successful employment of the micellar expander (black squares in 
Figure 4.3c). This value is an enlargement of 25% compared to our standard MSNs. The pore 
size distributions for the post-synthesis functionalized samples derived from NLDFT 
calculations are given in Figure 4.3c and the values are summarized in Table 4.1. The pore size 
changes little upon PEGylation and photosensitizer attachment, indicating that the mesopores 
are still accessible for guest molecules. Furthermore, it proves the selective functionalization of 
the particle shell. 
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Figure 4.4: Nitrogen sorption isotherms for the samples MSN_SHin_CNout (black squares), 
MSN_SHin_COOHout (red circles), MSN_SHin_PEGd8NH2out (green up triangles) and 
MSN_SHin_PEGd8-AlPcS2aout (blue down triangles). For clarity reasons curves for 
MSN_SHin_COOHout, MSN_SHin_PEGd8NH2out, and MSN_SHin_PEGd8-AlPcS2aout are shifted along 
the y-axis by a value of 500 each. 
The 13C solid state NMR (ssNMR) shows the successful implementation of these three steps 
(Figure 4.5a). The resonance of the carboxyl group appears at 180 ppm upon hydrolysis of the 
cyano-groups (red trace in Figure 4.5a). Following EDC amidation, the carboxyl group 
disappears and the C-O and CH2 resonances, both from the PEG linker, appear at 70 and 
42 ppm, respectively (green trace in Figure 4.5a). The other resonances originate from the 
functionalized silanes of the MSNs. The different surface functionalization, including the 
attachment of the PEG linker, are apparent in the final relative mass levels of the 
thermogravimetric analysis (TGA) curves as well (Figure 4.5b and Table 4.1). Species III with 
the PEG linker has a significantly greater mass loss than species I and II. The slightly lower 
mass loss of species II in comparison to species I, originates from a more stable silica network 
that is formed during the 3 h heating in HCl, where the cyano is converted to carboxylic acid 
groups. The more stable silica network is apparent from the reduced BET surface area, as 
measured by N2 sorption experiments, as well (isotherms shown in Figure 4.4).  Subsequently, 
AlPcS2a is attached to the free remaining amino group of the PEG linker by linking the 
PEG-NH2 group with one of the two sulfonate groups of AlPcS2a (IV). The PEG linker is 
required here because direct attachment of the AlPcS2a to the MSN surfaces results in a 
significantly reduced pore accessibility and particle aggregation. The successful attachment of 
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AlPcS2a is inferred from the IR spectrum (Figure 4.7) and the TGA (blue curve in Figure 4.5b). 
The mass loss for species IV is comparably large due to the high molecular mass of AlPcS2a. 
In particular, the ratio of the mass loss going from species III to IV and from species II to III 
is 2.  This can be related to the molecular mass ratio of the PS and the PEG, which is 2 as well.  
To utilize the above multifunctional nanoparticles as drug delivery vehicles, a cargo was loaded 
into the MSN pores and the entire nanoparticle was enclosed by a supported lipid bilayer to 
prevent premature release of the cargo from the MSN core. The cargo was loaded into the MSN 
by incubating them in a concentrated solution of the cargo overnight. Afterwards, the SLB was 
formed around the nanoparticle via the solvent exchange method as published by Cauda et al.13 
The SLB consists of a lipid mixture of 70 v% of 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) and 30 v% of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP). We note that the 
length of the PEG linker, as described above, should not be too long because otherwise the 
formation of the SLB around the nanoparticle can be difficult. The DLS data (Figure 4.2b) show 
that the modifications of the MSN surface, the attachment of the PEG linker, the linking of the 
photosensitizer, and the formation of the 70 v% DOPC / 30 v% DOTAP shell (SLB) result in 
colloidal systems with slightly varying hydrodynamic particle sizes (Figure 4.3b and Table 4.1). 
We note that the hydrodynamic sizes can also reflect a weak agglomeration behavior.  
 
Figure 4.5: a) Solid state 13C NMR spectra of species I – III. It shows the successful conversion of the 
surface cyano-groups to carboxyl groups and the subsequent linkage of the PEG8 linker to the MSN 
shell. Spectra for MSN_SHin_COOHout (red) and MSN_SHin_PEGd8NH2out (green) are shifted by a 
value of 2·106 each for clarity reasons. b) Thermogravimetric analysis of species I – IV. The relative 
mass losses are given in Table 4.1. 
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The cyanopropyl-groups of the sample MSN_SHin_CNout (I, black squares) are uncharged at 
high or low pH values, resulting in a zeta potential curve that is similar to the one of 
unfunctionalized MSN (Figure 4.6). The successful attachment of NH2-PEGd8-NH2 to the 
sample MSN_SHin_COOHout results in a higher zeta potential value due to protonation of the 
amino groups at low pH values (green). The sample MSN_SHin_PEGd8_AlPcS2aout (IV) 
couldn’t be measured because the laser wavelength of 633 nm leads to an excitation of the 
photosensitizer, resulting in oxygen production with bubble formation on the electrode. Shorter 
measurement times did not lead to sufficient results. 
 
Figure 4.6: Zeta potential measurements of the samples MSN_SHin_CNout (black squares), 
MSN_SHin_COOHout (red circles), MSN_SHin_PEGd8NH2out (green up triangles). 
In order to prove the functionality of our designed MSN carrier system, IR spectroscopy was 
carried out (Figure 4.7). The CH2 stretching vibrations of the organic functionality 
(mercaptopropyl- and cyanopropyl) are visible between 2800 cm-1 and 2850 cm-1. Furthermore, 
several peaks at 2900 cm-1 (C-H stretching vibrations) and at 1400 cm-1 (C-H bending 
vibrations) are visible. The intensity of these vibrations decreases after the carboxylation of the 
cyanide groups. Further condensation of the silica framework was achieved through the 
hydrolysis of the cyano-moiety and therefore the content of ethoxygroups was reduced. The 
cyanide vibration at 2253 cm-1 for the species I disappears completely after hydrolysis while 
the new -COOH vibration at 1707 cm-1 (MSN_SHin_COOHout) arises. After PEGylation by 
EDC amidation the C=O stretching vibration mode is moved to higher vibrational energies 
(1616 cm-1) resulting from the newly formed amide bond. Also the N-H bending vibrations 
appear at 1530 cm-1. The band between 1300 cm-1 and 900 cm-1 can be attributed to silica 
framework vibrations and is visible in all spectra.  The peak at 1332 cm-1 represents the 
4.2. Results and Discussion  
 
100 
 
asymmetric stretching of the -SO2 group in AlPcS2a. The peak arising at 904 cm
-1 in the spectra 
of MSN_SHin_PEGd8-AlPcS2aout can be assigned to the stretching vibration of the newly 
formed N-S bond between the terminal amino-group of the PEG-linker and AlPcS2a. The two 
peaks at 743 cm-1 and 720 cm-1 correspond to the non-planar deformation vibrations of the C-H 
bonds of benzene rings. 
 
Figure 4.7: IR spectra of MSN_SHin_CNout (black), MSN_SHin_COOHout (red curve), 
MSN_SHin_PEGd8NH2out (green curve) and MSN_SHin_PEGd8-AlPcS2aout (blue curve). For clarity 
reasons curves for MSN_SHin_COOHout (red curve), MSN_SHin_PEGd8NH2out (green curve) and 
MSN_SHin_PEGd8-AlPcS2aout (blue) were shifted along the y-axis by a value of 0.8 each for clarity 
reasons. 
The accessible pore size as obtained by nitrogen sorption measurements is barely affected by 
the various surface modifications, as expected for particles that feature true core-shell spatially 
distributed functionalities (Figure 4.2c). 
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Table 4.1: Particle size, specific BET surface area, pore size and relative mass loss derived from 
dynamic light scattering, nitrogen physisorption and thermogravimetric analysis. 
Sample 
Particle sizea 
[nm] 
BET surface 
area [m²/g] 
Pore sizeb 
[nm] 
Relative mass lossc 
[%] 
MSN_SHin_CNout 69 934 5.2 17 
MSN_SHin_COOHout 125 746 5.1 12 
MSN_SHin_PEGd8NH2out 98 615 5.6 18 
MSN_SHin_PEGd8-AlPcS2aout 294 918 5.5 31 
DOPC/DOTAP_SLB@MSN 160 n.a. n.a n.a 
aParticle size refers to the peak value derived from DLS bDFT pore size refers to the peak value of the pore size 
distribution. cRelative mass loss obtained by TGA; all curves are normalized to 130 °C. 
The permeability of the SLB and the opening of the SLB by photoactivation were examined in 
situ with a cuvette, containing a semipermeable membrane (cf. experimental section).30 Figure 
4.8 shows the release of cargo, either calcein (blue triangles) or a rhodamine derivative (RD) 
(black squares), from the MSN–PS–SLB (VI).  
 
Figure 4.8: Release kinetics of calcein (solid blue triangle) and a rhodamine derivative (RD, solid black 
squares) before and after photoactivation at 3 h with light of λ = 639 nm and 0.55 mW/mm2 for 1 min. 
of MSN-PS-SLB measured in situ. Analogous, the SLB can be open by addition of triton to the MSN 
solution after a 3 h time period. For both calcein (open blue triangles) and the RD (open black squares) 
the release by triton is slower as compared to the opening of the SLB by photoactivation. 
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The amount of released cargo over a 3 h time period before opening the SLB is minimal, 
demonstrating the integrity of the SLB. After 3 h in the cuvette the SLB was opened either by 
photoactivation or triton addition. To open the SLB through photoactivation the MSN-PS-SLB 
particles were exposed to 639 nm light with a power density of 0.55 mW / mm2 for 1 min., 
resulting in an activation of the photosensitizer and singlet oxygen production. The singlet 
oxygen reacts with the double bonds of the DOPC and opens the SLB. This is apparent from 
the strong increase of fluorescence starting after 3 h, originating from the release of the cargo 
from the MSN core (solid symbols in Figure 4.8). Alternatively, the SLB can be opened by 
triton addition (open symbols in Figure 4.8). A strong increase of fluorescence for calcein (open 
blue triangles) and RD (open black squares) is apparent. However, the SLB opening via 
photoactivation seems to be more efficient, judging from the release rate of the cargos after 
induced SLB opening. Besides the prevention of premature release of the cargo from the MSN 
core, the SLB offers the opportunity to add various targeting ligands to our nanoparticle system. 
In the following section, we will discuss how our MSN-PS-SLB system can be modified with 
two different targeting ligands, namely folic acid (FA) and epidermal growth factor (EGF). The 
efficient modification of our drug delivery system with various targeting ligands as the final 
step in the synthesis allows for tuning of our multifunctional nanoparticles for a wide range of 
cancer types without constructing a completely new system for each type of cancer.  
Targeting.  Most cancer cells have specific receptors overexpressed on their surface. These 
receptors are only present in small concentrations or not at all on the surface of healthy cells. 
Ideally, a drug delivery system can be easily modified to make it specific for multiple cancer 
cell types. The system presented above offers this opportunity because the MSN-PS-SLB (VI) 
is only modified at the very end of the synthesis with a specific targeting ligand (TL). The basic 
building block for adding the targeting ligand to the MSN-PS-SLB (VI) is a DSPE-PEG2000-TL 
conjugate molecule. This building block is inserted into the SLB by incubating the 
MSN-PS-SLB (VI) with DSPE-PEG2000-TL at 37 °C for 3 h (FA) and 12 h (EGF), respectively 
(final step in Figure 4.1). In the studies presented here, we chose FA and EGF as targeting 
ligands because their receptors are commonly overexpressed on a wide range of cancer 
cells.31, 32 FA receptors are overexpressed on various cell lines such as HeLa cells and KB 
cells,31 and the EGF receptor is abundant on HuH7 cells, for example.33 The functionality of 
the targeting ligands on our nanoparticle system was evaluated by performing competition 
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experiments and by evaluating the MSN-PS-SLB-TL (VII) uptake with live cell confocal 
fluorescence microscopy.  
 
Figure 4.9: Unspecific and receptor-mediated endocytosis of MSN-PS-SLB particles with folic acid 
ligand (MSN-PS-SLB-FA) by KB cells, and MSN-PS-SLB particles with EGF ligand (MSN-PS-SLB-
EGF) by HuH7 cells with GFP tagged tubulins (HuH7tub), respectively. a) Incubation of MSN-PS-
SLB-FA particles with FA pre-incubated KB cells for 3 h at 37 °C. b) Incubation of MSN-PS-SLB-FA 
particles with KB cells, not FA pre-incubated, for 3 h at 37 °C. c) Internalization of MSN-PS-SLB-EGF 
particles by HuH7tub with EGF pre-incubated, and d) non-pre-incubated HuH7tub cells. The KB cell 
membrane is shown in green and the particles in red. For HuH7tub the GFP tagged tubulins are shown 
in green and the particles in red. Images were taken with live KB cells and HuH7tub cells. The scale bar 
is 10 µm.  
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In a competition experiment the MSN-PS-SLB-TL (VII) are incubated with cells that were 
either previously incubated with free targeting ligand or not. Pre-incubation of cells with free 
targeting ligand will block the specific receptors on the cell surface. Consequently, uptake of 
the MSN-PS-SLB-TL (VII) should only happen unspecific and therefore is expected to take 
much longer than receptor-mediated endocytosis. To evaluate the functionality of the FA 
ligand, KB cells were used. In the experiments shown in Figure 4.9a the cells were 
pre-incubated with FA for 2 h at 37 °C before the MSN-PS-SLB-FA (VII) particles were added 
to the cells and incubated for 3 h at 37 °C. Recording z-stacks of the cells with a spinning disk 
confocal fluorescence microscope allows us to indicate MSNs inside or outside the cell. A 
typical cut through the cell is shown in Figure 4.9. It shows that in KB cells only a few 
individual particles are present inside the cell (Figure 4.9a), whereas full stacks emphasize the 
quasi absence of nanoparticles inside the cell, independent of the chosen focal plane. In contrast, 
incubation of MSN-PS-SLB-FA (VII) with KB cells that were not pre-incubated with FA 
before resulted in significant uptake of particles (Figure 4.9b). The nanoparticles appear in the 
single representative z-slice as well as in the full stack, through the entire height of the cell. 
This clearly demonstrates that the particles are taken up by receptor-mediated endocytosis and 
that unspecific uptake of the particles by KB cells is small after 3 h incubation time 
(cf. appendix 4.19).  
In the case of the EGF ligand, we synthesized the DSPE-PEG2000-EGF conjugate as described 
in Figure 4.14 (cf. appendix). Similar to the FA experiments, we performed competition 
experiments with the EGF ligand. Experiments were performed with HuH7 cells, which are 
known to overexpress the EGF receptor.33 Figure 4.9c shows that in the case of pre-incubation 
of HuH7 cells with EGF almost no MSN-PS-SLB-EGF (VII) particles are endocytosed by the 
HuH7 cells after 3 h. In contrast, a significant number of the particles is present inside the cells 
when the cells were not pre-incubated with EGF (Figure 4.9d). Again typical slices of the 
z-stacks are shown in Figure 4.9c and d (cf. appendix 4.20). The above results demonstrate that 
our MSN-PS-SLB nanoparticles can be modified efficiently to meet the specific requirements 
of various cancer types and to ensure a specific receptor-mediated uptake. In addition, in the 
two cell types discussed here the unspecific uptake of the NPs is very small after 3 h. Both are 
important factors for successful drug delivery vehicles in order to prevent damage of healthy 
cells by cancer therapeutics. Furthermore, the targeting ligand is introduced after the completion 
of the synthesis of the actual nanoparticle system. This offers more flexibility to separately 
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synthesize both the nanoparticle system and the DSPE-PEG2000-TL because possible 
incompatible reaction conditions can be avoided. This allows for selecting the synthesis 
strategies for both components more freely, which is considered a significant advantage for the 
incorporation of fragile peptides into these systems. Besides the specific uptake of the drug 
delivery vehicle by cancer cells, it is of key importance for efficient drug delivery to release the 
drug into the cytosol, and ideally to do so with spatial and temporal control. In the following, 
we will show that our system provides the means to achieve this. 
Cargo Release by Photoactivation. One of the main challenges for drug delivery with high 
efficacy is to overcome the endosomal entrapment in order to release the drug into the cytosol. 
In combination with MSNs, three strategies have been pursued so far to solve this issue, namely 
employing cationic lipids,10 fusion or endosomolytic proteins19-21 or photosensitizers.16, 26, 27 In 
the case of MSNs coated with a cationic lipid, targeting capabilities were shown but release of 
cargo was not and no gating mechanism, to keep the drug enclosed, was presented.10 The fusion 
or endosomolytic protein approach is a rather complicated and costly strategy, but it works well 
as has been demonstrated.19-21 However, for both methods an external control of the exact 
location and time of the cargo release is not possible. A photoactivation approach provides both 
of these capabilities. In the studies where MSNs and photosensitizers were used, the 
photosensitizer was either loaded as a cargo into MSNs27 or covalently attached to them. 15 The 
covalent attachment of the photosensitizer is advantageous compared to loading it into the MSN 
pores. The ratio of MSN to photosensitizer is more easily controlled, the loading capacity of 
the MSNs can be completely used for the drug, and a spatial separation between drug and 
photosensitizer exists. This could be important considering that the singlet oxygen, produced 
by photoactivation of the photosensitizer, will most likely damage the drug when not spatially 
separated from it. In previous work from our group,16 the photosensitizer had to be excited by 
blue light, which cannot penetrate the tissue very deeply.25 Moreover, the attachment of the 
used photosensitizer to the MSN surface was synthetically more involved. Here we have 
improved both of these aspects by using a different photosensitizer, namely AlPcS2a. First, it is 
photoactivatable with red light and thereby the phototoxicity caused by light activation with 
blue light is reduced. Additionally, the potential depth of tissue penetration of the activation 
laser is increased by a factor of about 5. The latter feature will become important if this drug 
delivery system is tested in vivo. Nishiyama et al. demonstrated this by using AlPcS2a for a 
transfection of the conjunctival tissue in rat eyes. 25  Finally, AlPcS2a can be more easily attached 
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to the MSN surface than the previously used photosensitizer because a sulfonate group can be 
directly linked to an amino group.  
To verify that the drug delivery mechanism works in vitro, we incubated MSN-Calcein-PS-
SLB-FA nanoparticles for 3 h with HeLa cells. In comparison to the incubation with free 
calcein, the incubation of the nanoparticles containing calcein as a cargo produces a 
significantly higher calcein concentration inside the cell (Figure 4.10a). The uptake of free 
calcein by KB cells is negligible (cf. appendix 4.17). This demonstrates that our drug delivery 
system can be used to efficiently transport membrane impermeable cargos into the cell. Before 
photoactivation, the calcein and the photosensitizer are co-localized (yellow color in 
Figure 4.10c) and exhibit a dot-like pattern, indicating that the calcein and the 
MSN-PS-SLB-FA particles are still inside the endosomes (Figure 4.10a - c). This demonstrates 
that the escape from the endosome does not happen automatically and that a mechanism is 
required to overcome this key challenge in the field of drug delivery.  
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Figure 4.10: Fluorescence microscopy of MSN-PS-SLB-FA nanoparticles loaded with calcein inside 
HeLa cells, after an incubation time of 16 h. a – c) Calcein (green) and AlPcS2a (red) are co-localized 
(yellow) prior to photoactivation. d) Intensity profile along the white line in the merged image for both. 
e – h)  1 min after photoactivation, i – l) 5 min and m – p) 10 min. after photoactivation. The scale bar 
is 10 µm. 
To induce endosomal escape, we activated the integrated photosensitizer AlPcS2a with 
1.2 W / mm2 of 639 nm light for 1 min., at similar conditions as those used for the in situ 
experiment in Figure 4.8. As a result, 1 min. after activation an increase of the green 
fluorescence caused by calcein through the entire cell and in particular in the nucleus can be 
observed (Figure 4.10 e and h). In contrast, no change of the red fluorescence originating from 
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the photosensitizer is observed. This trend continues over time as is apparent from the images 
taken at 5 min. (Figure 4.10 i – k) and at 10 min. (Figure 4.10 m – o) after photoactivation. In 
the merged image after 1, 5, and 10 min. (Figure 4.10g, k and o), the presence of the green 
signal becomes dominant, indicative of a lower colocalization between calcein and 
photosensitizer due to the spreading of the calcein in the cell. The green fluorescence is 
observed in particular inside the cell nucleus. This time-series of images shows that 
photoactivation can open the SLB and the endosome via an activation cascade, resulting in the 
release of the calcein into the cytosol. While the green fluorescence from calcein is present 
through the entire cytosol after photoactivation (Figure 4.10 e, i and m), the dot-like pattern of 
the red fluorescence, caused by the PS on the MSN, does not change (Figure 4.10 f, j and h). 
This shows that in contrast to calcein, the MSN does not escape from the endosomes. The reason 
for this behavior is unknown, but has been observed before.27 However, we note that free PS in 
endosomes does spread after photoactivation (cf. appendix 4.18).  
In addition to calcein, our multifunctional system can be loaded with various cargos. For 
example, we loaded the MSN core (IV) with a rhodamine derivative (RD). Subsequently, the 
loaded MSN core (V) was surrounded by an SLB and FA was inserted into the SLB, resulting 
in MSN-RD-PS-SLB-FA (VII).  
 
Figure 4.11: MSN-PS-SLB-FA nanoparticles loaded with RD (green) inside KB cells. a) Before and b) 
10 min after photoactivation. c) Intensity profile along the white line in a and b. Post-photoactivation 
(red line) a significantly higher fluorescence signal is apparent in the positions 10 – 20 µm in comparison 
to pre-photoactivation (black line). The scale bar is 10 µm.    
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The nanoparticles were incubated on KB cells for 22 h at 37 °C under a 5% CO2 humidity 
atmosphere. Similar to calcein, the fluorescence from RD-loaded particles in the cells exhibits 
a dot-like pattern before photoactivation (Figure 4.11a). 10 min after the photoactivation an 
evenly spread fluorescence in addition to the dot-like pattern is observed (Figure 4.11b).  The 
increase of the evenly spread fluorescence is apparent when measuring the intensity profile in 
a region that had low fluorescence before photoactivation. Figure 4.11c shows the fluorescence 
intensity along the white line in Figure 4.11a and b. After photoactivation, a strong increase of 
the fluorescence is observed. Thus, we conclude that 10 min after photoactivation some of the 
RD has been released from the MSN core and from the endosome as well and subsequently has 
spread through the cytosol. For both types of cargo the release into the cytosol occurs shortly 
after photoactivation, emphasizing the precise temporal control that is provided by the 
photoactivation approach. In addition, before photoactivation no spreading of the cargo is 
observed, i.e. photoactivation is required for release of cargo into the cytosol. As a result, our 
system provides means to spatially control the release of cargo by applying laser light at specific 
areas, in particular the cancer tissue. This spatial control is available in addition to the ligand-
based targeting ability of our particles and should further reduce unintentional exposure of 
healthy cells to cancer therapeutics. Therefore, the selectivity of drug release should be 
enhanced in comparison to the cases where only the proton sponge effect or 
fusogenic/endosomolytic peptides are used.  
 
4.3 Conclusion 
We have developed a drug delivery system based on mesoporous silica nanoparticles that 
addresses some of the key issues in the field of drug delivery involving high selectivity and 
drug delivery with high efficacy. The combination of the high loading capacity of MSN, the 
supported lipid bilayer for controlled release, the addition of targeting ligands, and overcoming 
of endosomal entrapment by photoactivation makes this system a potent drug delivery vehicle. 
Employing fluorescence microscopy, we were able to demonstrate the selective uptake of our 
nanoparticles by various cancer cell lines and the release of different cargos in vitro. 
Furthermore, we have demonstrated that the red light-based photoactivation approach has many 
advantages compared to other approaches used in the field. In particular, by covalently linking 
the PS to the MSN surface and using a PS that can be excited by red light, negative side-effects 
of the PS can be minimized and activation of the PS in vivo is feasible. Moreover, 
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photoactivation for cargo release enhances the spatial selectivity of where the drug is released 
as compared to using targeting ligands only. We anticipate that the integration of all these 
strategies into one multifunctional drug delivery vehicle as well as the efficient synthesis and 
modification of the nanoparticles for multiple cancer cell types will hold promise for wide-
ranging applications in cancer therapy.   
 
4.4 Experimental 
Materials. Tetraethyl orthosilicate (TEOS, Fluka, >99%), (3-mercaptopropyl)-triethoxysilane 
(MPTES, Gelest, 95%), (3-cyanopropyl)-triethoxysilane (CN-TES, ABCR, 98%), 
cetyltrimethylammonium chloride (CTAC, Fluka, 25wt% in H2O), triethanolamine (TEA, 
Aldrich, 98%), ammonium fluoride (NH4F, Sigma, >98%), α,ω-bis-amino octa (ethylene 
glycol) (NH2-PEGd8-NH2, Iris Biotech), Al(III) phthalocyanine chloride disulfonic acid 
(AlPcS2a, Frontier Scientific), ammonium nitrate (Sigma, 99%), conc. hydrochloric acid 
(Aldrich, >95%, 37 wt%),  1,3,5-triisopropylbenzene (TiPB, Fluka, 96%), sulfo-N-
hydroxysuccinimide (sulfo-NHS, Aldrich, 98%), N-(3-dimethylaminopropyl)-N′-
ethylcarbodiimide (EDC, Sigma, 97%), calcein (CAL, Sigma), dimethyl sulfoxide (DMSO, 
Sigma, >99.5%), ethanol (EtOH, Aldrich, >99.5%),  1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC, Avanti Polar Lipids), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[folate(polyethylene glycol)-2000] (ammonium salt) (DSPE-PEG2000-FA, Avanti Polar Lipids), 
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] 
(ammonium salt) (DSPE-PEG2000-maleimide, Avanti Polar Lipids), 2-Iminothiolane 
hydrochloride (Traut’s reagent, Sigma-Aldrich), 5(6)-Carboxy-X-rhodamine (RD, Sigma), 
Wheat germ agglutinin (WGA) Alexa Fluor 488 conjugate (Invitrogen), epidermal growth 
factor (EGF, PeproTech, >98%), Folic acid (FA, Sigma, >97%). 
All chemicals were used as received without further purification. Doubly distilled water from a 
Millipore system (Milli-Q Academic A10) was used for all synthesis and purification steps.  
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Synthesis of core-shell MSN_SHin_CNout. Bi-functional core-shell colloidal mesoporous 
silica nanoparticles were synthesized according to a slightly modified published method.12 A 
mixture of TEOS (1.63 g, 9.22 mmol), MPTES (112 mg, 0.48 mmol) and TEA (14.3 g, 
95.6 mmol) was heated under static conditions at 90 °C for 20 min in a polypropylene reactor. 
Then a solution of CTAC (25 wt% in water, 2.41 mL, 1.83 mmol), NH4F (100 mg, 2.70 mmol) 
and TiPB (2.54 g, 12.4 mmol) in water (21.7 g, 1.21 mol) was preheated to 60 °C and added 
quickly. The reaction mixture was stirred vigorously (1000 rpm) at room temperature for 
20 minutes. Subsequently TEOS (138.2 mg, 0.922 mmol) was added in four equal increments 
every three minutes. This step was followed by 30 minutes of stirring at room temperature. For 
the shell functionalization a mixture of TEOS (19.3 mg, 92.5 μmol) and CN-TES (21.4 mg, 
92.5 μmol) was added to the reaction. The resulting mixture was then allowed to stir at room 
temperature for 12 h. After the addition of 100 mL ethanol, the MSNs were collected by 
centrifugation (15 min, 20500 rpm, 50228 rcf), re-dispersed in 100 mL of ethanol and extracted 
according to the procedure described below. 
Extraction of MSN_SHin_CNout. Extraction of the surfactant was performed by heating 
250 mg of MSN for 45 minutes under reflux at 90 °C in a solution containing 2 g ammonium 
nitrate in 100 mL ethanol. This extraction step was performed twice. The template-free MSN 
were separated by centrifugation (15 min, 20500 rpm, 50228 rcf) and washed with ethanol after 
each extraction step. MSN_SHin_CNout were obtained as colloidal suspension in EtOH. 
Conversion of MSN_SHin_CNout to MSN_SHin_COOHout. 250 mg of MSN_SHin_CNout in 
EtOH were collected by centrifugation and washed with H2O once. The particles were 
re-dispersed in 10 mL H2O and 30 mL hydrochloric acid (37 wt%) was added carefully. The 
reaction mixture was heated to reflux for 3 h. After cooling down, 20 mL H2O were added and 
the synthesis was stirred at room temperature overnight. The resulting colloidal suspension of 
MSN_SHin_COOHout was diluted further with 100 mL H2O, collected by centrifugation 
(15 min, 20500 rpm, 50228 rcf), and re-dispersed in 100 mL of water. This washing step was 
repeated twice with both water and ethanol. MSN_SHin_COOHout were obtained as an ethanolic 
suspension. 
PEGylation of MSN_SHin_COOHout with bi-functional NH2-PEGd8-NH2 to the sample 
MSN_SHin_PEGd8NH2out. An ethanolic suspension containing 20 mg of 
MSN_SHin_COOHout was centrifuged (15 min, 20500 rpm, 50228 rcf) and re-dispersed in 
60 mL of water. This washing step was repeated twice. EDC (0.85 µL, 4.6 µmol, 1.2 eq) was 
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added at room temperature to a diluted suspension of MSN_SHin_COOHout in 40 mL of water. 
The reaction mixture was stirred for 5 min before sulfo-NHS (1 mg, 4.6 µmol, 1.2 eq) was 
added. A second solution, containing bi-functional NH2-PEGd8-NH2 (7.05 mg, 19.2 µmol, 
5 eq.) dissolved in 2 mL water was prepared. The EDC-activated MSN_SHin_COOHout were 
added dropwise to the PEG-containing solution. Afterwards, the pH was adjusted with two 
drops of hydrochloric acid (37 wt%) to a value pH < 7 and the reaction mixture was stirred for 
12 h at ambient temperature. In order to remove the excess of the PEG-linker, the reaction 
mixture was washed five times with 30 mL of water to remove unbound PEG. All washing 
steps were followed by centrifugation (15 min, 20500 rpm, 50228 rcf). Finally, the sample 
MSN_SHin_PEGd8NH2out was re-dispersed in 10 mL ethanol. 
Attachment of the photosensitizer AlPcS2a to MSN_SHin_PEGd8NH2out yielding the 
sample MSN_SHin_PEGd8-AlPcS2aout. 1 mg of MSN_SHin_PEGd8NH2out in ethanolic 
solution was centrifuged and re-suspended in a 500 µL water/DMSO mixture (2:1). 
Subsequently, 40 µL of an AlPCS2a stock solution (2 mg in 1 mL DMSO) were added to the 
MSN. The reaction mixture was stirred in the dark at room temperature for 72 h. The resulting 
MSN_SHin_PEGd8-AlPcS2aout were extensively washed by centrifugation (4 min, 14000 rpm, 
16873 rcf) with water/DMSO (1:1) in order to remove excess photosensitizer. All supernatants 
were investigated with a Nanodrop UV-VIS in order to monitor the content of free 
photosensitizer. In order to remove DMSO from the mesopores the sample was washed three 
times with water after no free PS could be detected (cf. appendix 4.15 and 4.16). The colloidal 
solution of sample MSN_SHin_PEGd8-AlPcS2aout was used for further experiments 
immediately.   
Adsorption of the the dyes calcein and a rhodamine derivative (RD) into the mesopores of 
MSN_SHin_PEGd8-AlPcS2aout. 0.5 mg of the sample MSN_SHin_PEGd8-AlPcS2aout in 
ethanol were centrifuged (4 min, 14000 rpm, 16873 rcf) and re-dispersed in 1 mL water. This 
washing step was repeated twice. Then, the suspension was centrifuged again and re-dispersed 
in 500 µL calcein in water (1 mM stock solution in water) or RD (1 mM stock solution in water), 
respectively. The mixture was stirred over night in the dark yielding the sample 
MSN_CARGOin_PEGd8-AlPcS2aout. 
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Supported DOPC/DOTAP lipid bilayer (SLB) around MSN_CARGOin_PEGd8-
AlPcS2aout. 0.5 mg of MSN_CARGOin_PEGd8-AlPcS2aout in 1 mL dye solution were 
centrifuged (4 min, 14000 rpm, 16873 rcf) and the supernatant discarded. Afterwards, a mixture 
of 70 µL DOPC and 30 µL DOTAP (each 2.5 mg/mL in 60:40 H2O : EtOH) were added to the 
resulting pellet, mixed extensively, and sonicated for 10 s. To form the supported lipid bilayer 
around the MSN via solvent exchange method, 700 µL of water were added. The resulting 
suspension was mixed and sonicated for 10 s, yielding 
DOPC/DOTAP@MSN_Cargoin_PEGd8-AlPcS2aout. 
Diffusion of the targeting ligand (TL) construct, DSPE-PEG2000-TL, into the SLB of 
DOPC/DOTAP@MSN_CARGOin_PEGd8-AlPcS2aout.  
0.5 mg of DOPC/DOTAP@MSN_CARGOin_PEGd8-AlPcS2aout in 800 µL water were 
incubated with 6 µL of DSPE-PEG2000-TL for 3 h (for DSPE-PEG2000-Folate) or 12 h 
respectively (for DSPE-PEG2000-EGF) at 37 °C. The resulting sample 
DOPC/DOTAP@MSN_CARGOin_PEGd8-AlPcS2aout-TL was used without further 
purification for confocal microscopy studies. 
Time-based fluorescence release experiments of the sample DOPC/DOTAP@ 
MSN_CARGOin_PEGd8-AlPcS2aout. Fluorescence time-based release experiments were 
recorded on a PTI fluorescence system featuring a PTI 814 photomultiplier detector and a PTI 
A1010B Xenon arclamp driven by a PTI LPS-220B lamp power supply. For temperature 
settings, a Quantum Northwest TC 125 sample holder was used. Our previously described 
custom-made release cuvette system was used for all experiments.30 All samples were measured 
at a temperature of 37 °C with slits of 2/2.2/2/2.  For RD an excitation wavelength of 575 nm 
was used (emission maximum at 597 nm), whereas calcein was excited with 495 nm and with 
an emission maximum at 516 nm. Results are given in Figure 4.8. 
For all experiments, 0.5 mg of DOPC/DOTAP@MSN_Cargoin_PEGd8-AlPcS2aout were used. 
200 µL of the particle suspension was filled into the reservoir cap sealed with a dialysis 
membrane (Molecular weight cut-off 14000 g/mol) allowing released dye molecules to pass 
into the fluorescence cuvette. In order to monitor the release of adsorbed dyes upon membrane 
rupture with singlet oxygen, the sample was excited with 0,56 W/mm2 of 633 nm light for 
1 minute prior the measurement.  For triton-mediated release, 5 µL of a 1 mM stock solution of 
TritonX100 was added to the particle solution.  
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Characterization. Centrifugation was performed using a Sorvall Evolution RC equipped with 
a SS-34 rotor or an Eppendorf centrifuge 5418 for small volumes. All samples were investigated 
with a FEI Titan 80-300 operating at 300 kV with a high-angle annular dark field detector. A 
droplet of the diluted MSN solution in ethanol absolute was dried on a carbon-coated copper 
grid. Nitrogen sorption measurements were performed on a Quantachrome Instruments NOVA 
4000e. All four samples (15 mg each) were heated to 393 K for 12 h in vacuum (10 mTorr) to 
outgas the samples before nitrogen sorption was measured at 77 K. For calculations of pore 
sizes and volumes a non-local density functional theory (NLDFT) equilibrium model of 
nitrogen on silica was used. Dynamic light scattering (DLS) measurements were performed on 
a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser (633 nm) and an 
avalanche photodiode. The hydrodynamic radius of the particles was determined by dynamic 
light scattering in ethanolic suspension. For this purpose, 100 µL of an ethanolic suspension of 
MSN particles (ca. 10 mg/mL) was diluted with 3 mL of ethanol prior to the measurement. Zeta 
potential measurements of the samples were performed on a Malvern Zetasizer-Nano 
instrument equipped with a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. For 
determination of the zeta potential curves, two drops of the ethanolic MSN suspension 
(~ 3 %wt.) was mixed with 1 mL commercial Hydrion Buffer solution of the appropriate pH 
prior to measurement. IR measurements were performed on a Bruker Equinox 55 FTIR/FTNIR 
Spectrometer in absorbance mode (spectra were background substracted). Thermogravimetric 
analysis of the bulk samples MSN_SHin_CNout, MSN_SHin_COOHout, 
MSN_SHin_PEGd8NH2out and MSN_SHin_PEGd8-AlPcS2aout was performed on a Netzsch STA 
440 C TG/DSC with a heating rate of 10 K / min in a stream of synthetic air of about 25 mL/min. 
The mass was normalized to 100% at 133.8 °C for all samples and the resulting data is presented 
in Figure 4.5b. Cross-polarized 13C solid-state NMR (ssNMR) measurements were performed 
on a Bruker DSX Avance500 FT spectrometer in a 4 mm ZrO2 rotor. The spinning rate was 
10 kHz and a total number of up to 8000 scans were recorded. UV-VIS spectra were recorded 
with a NanoDrop ND 1000 spectrometer. Usually, 2 µL of sample were used and all presented 
spectra are background corrected for water absorption.  
Cell Culture. KB cells were grown in folic acid deficient Roswell Park Memorial Institute 
1640 medium (RPMI 1640, Invitrogen) supplemented with 10% FCS at 37 °C in a 5% CO2 
humidified atmosphere. The cells were seeded on ibidiTreat µ-Slide (IBIDI). HuH7 cells were 
grown in Dulbecco’s modified Eagle’s medium (DMEM):F12 (1:1) (Invitrogen) medium 
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supplemented with 10% fetal bovineserum (FBS) at 37 °C in a 5% CO2 humidified atmosphere. 
To reduce autofluorescence of the cells, the medium was changed to DMEM:F12(Invitrogen) 
supplemented with 10% B-27 two days before seeding. The cells were seeded on collagen A-
coated LabTek chambered cover glass (Nunc). HeLa cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM):F12 (1:1) (Invitrogen) with Glutamax I medium supplemented with 
10% fetal bovineserum (FBS) at 37 °C in a 5% CO2 humidified atmosphere. The cells were 
seeded on collagen A-coated LabTek chambered cover glass (Nunc). For live cell imaging the 
cells were seeded 24 or 48 h before measuring, at a cell density of 2x104 or 1x104 cells/cm2. 
Uptake studies. To evaluate the functionality of the folic acid ligand, KB cells were incubated 
with nanoparticles for 3 h at 37 °C under a 5% CO2 humidified atmosphere. In the case of live 
cell imaging the cell membrane was stained afterwards by adding 4 µL of 1 mg/mL wheat germ 
agglutinin Alexa Fluor 488 or 633 conjugate (WGA488, WGA633, Invitrogen) to 400 µL of 
cell medium. After 1 min, the cell medium was removed, the cells were washed twice with cell 
medium, and imaged immediately. In the case of fixed cells the cells were washed three times 
after the 3 h incubation time with PBS (Invitrogen). Afterwards 200 μL of 4% 
paraformaldehyde (PFA, Science Service) were added for 15 minutes. After removing PFA the 
cells were washed three times with PBS and stained by adding 4 µL of 1 mg/mL WGA 488 to 
400 μL of PBS. After 1 min the cell medium was removed, the cells were washed twice with 
PBS and imaged. In control experiments, the FA receptors on the KB surface were blocked by 
pre-incubation of the cells with 3 mM folic acid (Sigma) for 2 h at 37 °C under a 5% CO2 
humidified atmosphere, before particle were added. In the case of EGF, HuH7 cells with GFP 
tagged tubulin were used in addition to staining the cell membrane. In the case of HuH7 tubulin 
the cell medium was exchanged with CO2-independent medium (Invitrogen) and imaged 
immediately after incubation with cells. After incubation with nanoparticles, the cell medium 
was exchanged with CO2-independent medium (Invitrogen) and imaged immediately. The 
wildtype HuH7 cells were treated equivalent to the live cell imaging of the KB cells. For the 
control experiments, EGF receptors on the HuH7 surface were saturated by pre-incubating the 
cells with 0.2 µM EGF (PeproTech, >98%) for 2 h at 37 °C under a 5% CO2 humidified 
atmosphere, before particle addition. 
Cargo Release Experiments. Cells were incubated 16 – 22 h prior to the measurements at 
37 °C under a 5% CO2 humidified atmosphere. Shortly before imaging, the medium was 
replaced by CO2-independent medium (Invitrogen). During the measurements all cells were 
kept on a heated microscope stage at 37 °C. The photosensitizer AlPcS2a was activated by 
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1.2 W/mm2 of 639 nm light for 1 min. The subsequent imaging was performed as described in 
the Spinning disk confocal microscopy section. 
Spinning disc confocal microscopy. Confocal microscopy for live-cell imaging was 
performed on a setup based on the Zeiss Cell Observer SD utilizing a Yokogawa spinning disk 
unit CSU-X1. The system was equipped with a 1.40 NA 100x Plan apochromat oil immersion 
objective from Zeiss. For all experiments the exposure time was 0.1 s and the frame rate varied 
between 3 frames/s and 1 frame/30s, depending on the specific requirements of the experiment. 
Calcein and WGA488 were imaged with approximately 0.4 W/mm2 of 488 nm excitation light. 
The rhodamine derivative (RD) was excited with 1.2 W/mm2 of 561 nm light. AlPcS2a was 
excited with 0.12 W/mm2 of 639 nm for imaging and for photoactivation with 1.2 W/mm2. In 
the excitation path a quad-edge dichroic beamsplitter (FF410/504/582/669-Di01-25x36, 
Semrock) was used. For two color detection of calcein and AlPcS2a and accordingly WGA 488 
and AlPcS2a, a dichroic mirror (660 nm, Semrock) and band-pass filters 525/50 and 690/60 
(both Semrock) were used in the detection path. In case of RD a band-pass filter 629/60 
(Semrock) was used. Separate images for each fluorescence channel were acquired using two 
separate electron multiplier charge coupled devices (EMCCD) cameras 
(PhotometricsEvolveTM). 
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Figure 4.12: TEM images of the template-extracted core-shell MSN_SHin_CNout.   
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Figure 4.13: TEM micrographs at different of the sample MSN_SHin_PEGd8NH2out. 
The homogeneity of the sample and the mesostructure of the MSN are preserved during the 
hydrolysis of the cyano-groups and the PEGylation step. The size of around 70 nm is in good 
agreement with the results from the dynamic light scattering experiments. In comparison to 
Figure 4.12, the mesoporous structure of the nanoparticles is hardly detectable due to the 
additional organic layer attached to the MSN shell. The mild white-greyish halo is a focus 
artifact caused by electron beam exposure and ultrahigh vacuum.  
 
 
Figure 4.14: Chemical modification of the EGF targeting ligand via the Traut’s reagent 
(2-iminothiolane) to achieve thiolation of the N-termius of EGF. In a second step the lipid 
DSPE-PEG2000-maleimide covalently binds to the modified EGF. 
To utilize EGF as another targeting ligand beside folic acid, we synthesized a lipid-EGF 
construct, where the EGF (50 µg) is covalently attached to the lipid DSPE-PEG2000-maleimide 
(Figure 4.14). In a first step, the N-terminus of the targeting peptide was modified via the 
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Traut’s reagent (2-Iminothiolane, 2 equiv., 16 nmol) in an aqueous solution by stirring for 1 h 
at room temperature. This resulted in a terminal thiol group which can be used for further 
functionalization. Subsequently, the modified EGF was covalently attached to the lipid 
DSPE-PEG2000-maleimide (3.5 µL of a 10 mg/mL 60/40 H2O/EtOH v%). The final 
DSPE-PEG2000-EGF construct can be further utilized to use as targeting ligand on the 
nanoparticle as described below. 
 
Figure 4.15: Supernatants of the washing procedure of the sample MSN_SHin_PEGd8-AlPcS2aout. 
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Figure 4.16: UV-VIS data obtained from the supernatants of the washing procedure of the sample 
MSN_SHin_PEGd8-AlPcS2aout. No free photosensitizer could be detected in supernatants 8 – 10. 
4.5. Appendix  
 
120 
 
Uptake of free calcein and MSN loaded with calcein by KB cells 
 
Figure 4.17: a) Uptake of free calcein (green) and free AlPcS2a (red) by KB cells after 20 h incubation 
at 37 °C under 5% CO2 humidified atmosphere.  b) Uptake of MSN loaded with calcein (green), covalent 
attached AlPcS2a (red) and SLB after 20 h incubation at 37 °C under 5% CO2 humidified atmosphere.  
Intensity scale is the same in both images. The fluorescence of calcein and AlPcS2a is slightly shifted 
against each other to show the colocalization clearer. Calcein is only transported into the cell in 
significant amounts when it is loaded into the MSN. Scale bar: 10 µm. 
Uptake of free AlPcS2a by HeLa cells and spreading after photoactivation 
 
Figure 4.18: Uptake of free AlPcS2a by HeLa cells after 20 h incubation at 37 °C under 5% CO2 
humidified atmosphere. a) Before photoactivation b) 60s after photoactivation with 1.2 W / mm2 of 639 
nm light c) 100 s after photoactivation. The spreading of the AlPcS2a is apparent. d) Intensity trace of 
one endosome marked by white circle in a – c. Scale bar: 10 µm. 
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Uptake of MSN-PS-SLB-FA particles with folic acid ligand by KB cells, imaging after 
fixation of cells 
 
Figure 4.19: Unspecific and receptor mediated endocytosis of MSN-PS-SLB-FA particles with folic 
acid ligand by KB cells. Cells are fixed with paraformaldehyde after an incubation of 3h and the cell 
membrane is stained with a cell membrane stain (WGA 488). a) Incubation of MSN-PS-SLB-FA 
particles with FA pre-incubated KB cells for 3 h at 37 °C. b) Incubation of MSN-PS-SLB-FA particles 
with KB cells, not FA pre-incubated, 3 h at 37 °C. For both a) and b) the orthogonal view in xz and yz 
plane is shown on the bottom and right side of the main image. The KB cell membrane is shown in green 
and the particles in red. The particles are imaged over the photosensitizer, and even after fixation one 
can see the particles in a dot-like structure which indicates that the photosensitizer is not separated from 
the particles. The scale bar is 10 μm.  
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Uptake of MSN-PS-SLB-EGF particles with folic acid ligand by HuH7 cells 
 
Figure 4.20: Unspecific and receptor mediated endocytosis of MSN-PS-SLB-EGF particles with EGF 
ligand by HuH7 cells. Cells are incubated for 3 h and the cell membrane is stained with a cell membrane 
stain (WGA 633). a) Incubation of MSN-PS-SLB-EGF particles with EGF pre-incubated HuH7 cells 
for 3 h at 37 °C. b) Incubation of MSN-PS-SLB-EGF particles with EGF cells, not EGF pre-incubated, 
3 h at 37 °C. For both a) and b) the orthogonal view in xz and yz plane is shown on the bottom and right 
side of the main image. The HuH7 cell membrane is shown in green and the particles in red. The scale 
bar is 10 μm. 
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5 Multifunctional Polymer-Capped Mesoporous Silica Nanoparticles for 
pH-Responsive Targeted Drug Delivery 
This chapter is based on the following publication: 
Stefan Niedermayer, Veronika Weiss, Annika Herrmann, Alexandra Schmidt,  Stefan Datz,  
Ernst Wagner, Christoph Bräuchle,  and Thomas Bein, to be submitted to Advandced Healthcare 
Materials 2014. 
 
 
Abstract 
A highly stable modular platform, based on the sequential covalent attachment of different 
functionalities to the surface of core-shell mesoporous silica nanoparticles (MSNs) for targeted 
drug delivery is presented. As drug release mechanism poly(2-vinylpyridine) (PVP) was used 
as a pH-responsive cap system. Our platform offers (i) tuneable interactions and release kinetics 
with the cargo drug in the mesopores based on chemically orthogonal core-shell design, (ii) an 
extremely robust and reversible closure and release mechanism based on endosomal 
acidification of the covalently attached PVP polymer block, (iii) high colloidal stability due to 
a covalently coupled PEG shell, and (iv) the ability to covalently attach a wide variety of dyes, 
targeting ligands and other functionalities at the outer periphery of the PEG shell.  
The functionality of the system was demonstrated in several cell studies, showing pH-triggered 
release in the endosome, light-triggered endosomal escape with an on-board photosensitizer, 
and efficient folic acid-based cell targeting.  
5.1. Introduction  
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5.1 Introduction 
Polymers can be attractive for biological applications due to their biocompatibility, tuneable 
properties and production from sustainable sources.1, 2 Therefore, polymers are widely used as 
responsive coatings of surfaces for selective ion-permeability,3 surface patterning4, 5 and drug 
delivery with polyplexes,1, 6 hybrid dendrimers,7, 8 and other drug-polymer conjugates.9, 10 
Regarding drug-polymer conjugates, which offer relatively small particle sizes and good 
biocompatibility, possible issues may arise from low loading capacities and potentially poor 
stability, depending on the strength of the drug-polymer interactions.11 The drug-polymer 
interactions need to be optimized for different kinds of drugs to ensure stable drug-polymer 
conjugates. Aimed at creating a more general delivery platform, much effort has been made 
towards the development of inorganic nanoparticles such as mesoporous silica nanoparticles 
(MSNs) for the delivery of bioactive compounds to cells and tumors.12-16  MSNs have a high 
loading capacity and can be functionalized internally and on the external surface.17 To prevent 
premature release from these mesoporous systems, different strategies including covalent 
attachment of the cargo inside the mesopores18, 19  or complete capping of the whole particle20-23 
have been developed. The release mechanisms include changes in reduction potential,24 pH,18, 20 
temperature,25 and irradiation with light.14, 19, 26  
Combining the high loading capacity and stability of mesoporous nanoparticles with the 
biocompatibility and tuneable properties of polymers offers the possibility to create stimuli-
responsive and reversible delivery systems. For instance, You et al. showed the release behavior 
of poly(N-isopropylacrylamide) coated mesoporous silica at different temperatures.27 Drug 
delivery vehicles based on nanoparticles in a size range of around 100 nm are likely to be taken 
up by cells via endocytosis.28 During this process, the endosome is acidified by the action of 
proton pumps.29, 30 Therefore, pH-responsive polymer coatings around mesoporous silica 
nanoparticles offer the possibility to use the changes in pH during endocytosis as trigger for 
controlled release. For instance, attachment of poly(acrylic acid)31 or 
poly(2-(diethylamino)ethyl methacrylate)32 showed the ability of pH-responsive functional 
polymer coatings around mesoporous silica nanoparticles for release applications. Liu et al. 
reported on different release kinetics from mesoporous silica by the use of 
poly(4-vinylpyridine) as pH-responsive shell created by multipoint anchoring.20 
Poly(2-vinylpyridine) (PVP) has also been used for the pH-sensitive functionalization of 
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surfaces, due to the pronounced transition between hydrophilicity and hydrophobicity upon 
protonation and deprotonation.4 Here, we describe a multifunctional drug delivery vehicle that 
combines the high loading capacity of a mesoporous silica core with the ‘intelligence’ towards 
internal stimuli of a pH-responsive polymer. 
As shown in Figure 5.1, at low pH, the protonated polymer is in a hydrophilic state and 
therefore, cargo molecules are able to diffuse into and out of the mesoporous silica nanoparticle. 
At pH values around 5.5 or higher, the polymer is deprotonated, leading to a hydrophobic state 
which is subsequently followed by a collapse of the polymer onto the silica surface, thus 
preventing premature release of the cargo. The pH-responsive switching behavior of the 
polymer introduces a site-specific release mechanism to the delivery vehicle. After endosomal 
uptake of the particles by a cell, the endosomes are acidified by proton pumps present in the 
endosomal membrane.29 The change in pH leads automatically to a switch of the particle into 
its open state, and therefore triggers the release of cargo into the endosomal compartment. A 
major advantage of this delivery vehicle is offered by the reversibility of the cap system. Once 
the particles have been exocytosed by the cell before having released all of their cargo, the cap 
system will return into the closed state due to the environment (pH > 7) outside of the cell.29 To 
maintain colloidal dispersibility, even in the hydrophobic closed state, poly(ethylene glycol) 
blocks were attached to the ends of the PVP cap system. In this context, the use of α-ω-bis-
functionalized polymers offers the possibility for anchoring any functionality of interest 
(photosensitizers, targeting ligands) step by step (Figure 5.1). 
 
5.2. Results and Discussion  
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Figure 5.1: Concept of the MSN-based pH-responsive drug delivery system. The pores can be reversibly 
opened and closed through changes in the hydrophilicity of the polymer. 
5.2 Results and Discussion 
Colloidal core-shell mesoporous silica nanoparticles (MSNs) with amino-moieties on the shell 
were synthesized via a delayed co-condensation approach according to a published synthesis 
procedure with CTAB as structure directing agent and TEOS as silica source.17 The outer 
surface of the template-free MSNs were subsequently modified with bi-functional 
poly(2-vinylpyridine) (PVP) via an EDC-assisted amidation reaction (cf. appendix 5.8). The 
bi-functionality of the polymer allows the subsequent attachment of PEG, fluorescent dyes and 
targeting ligands. As proved by transmission electron microscopy (TEM), the shell 
functionalized mesoporous silica nanoparticles show an average particle diameter of 90 nm 
with a wormlike pore structure (cf. figure 5.3A). The stepwise functionalization of the MSNs 
with poly(2-vinylpyridine) and PEG was monitored with several methods (dynamic light 
scattering, nitrogen adsorption and zeta potential, Figure 5.2A-C; further characterization: 
cf. appendix 5.9, 5.10 and 5.11) and is discussed in the following section. Dynamic light 
scattering (DLS) measurements revealed the need for PEG as stabilizing agent; the 
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hydrodynamic diameter of amino shell-functionalized MSNs in aqueous media reveals an 
average particle size of 160 nm (Figure 5.2A, black curve), whereas the polymer-modified 
sample MSN-PVP-NH2 (red curve) shows strong aggregation in water due to the 
hydrophobicity at pH 7, indicated by an apparent size increase to 550 nm. However, subsequent 
PEGylation of PVP recovers the colloidal nature of the system, which is indicated by a decrease 
of the average particle size (blue curve). Additionally, the covalent functionalization of the 
mesoporous silica nanoparticles was monitored with thermogravimetric analysis (TGA, 
Figure 5.2B). While the shell functionalized nanoparticles (MSN-NH2) show a relative mass 
loss of 14.6% (2.97 mmol per gram silica), the relative mass loss of 61.6% for MSN-PVP-NH2 
corresponds to 0.14 mmol PVP per gram silica. From these data, it can be concluded that only 
4.7% of the amino-groups present at the MSN-surface have reacted with the polymer. Based on 
the mass loss of 80.4% in the sample MSN-PVP-PEG, the amount of 1.3 mmol PEG per gram 
silica could be determined. This result indicates, that additional attachment of PEG to the shell 
of the MSNs must have occurred besides the attachment to the end of the polymer cap system. 
Additionally, zeta potential titration experiments of the samples MSN-NH2 and MSN-PVP-NH2 
were carried out to prove the functionalization of the synthesized inorganic-organic hybrid 
material (cf. appendix 5.9). The high zeta potential (+50 mV) of MSN-PVP-NH2 at low pH 
reflects the polymer cap system in its fully protonated and thus open state. At pH = 5.5, close 
to the pka value of protonated pyridine, deprotonation of the polymer cap system occurs, leading 
to a significant drop in zeta potential with increasing pH. Together with the zeta potential, DLS 
measurements were performed simultaneously at the same pH values. For MSN-PVP-NH2 the 
particles showed good colloidal dispersability as long as the polymer remained in its protonated 
state. Upon deprotonation, the polymer collapses at the particle surface, forming a hydrophobic 
shell around the particles, which is revealed in the increase in size due to agglomeration. In 
contrast, attachment of PEG to the PVP-functionalized particles led to the suppression of 
aggregation, as no changes in size were observed over the whole pH-range for MSN-PVP-PEG. 
Infrared spectroscopy was carried out to prove the functionality of the designed MSN carrier 
system and to monitor the subsequent reaction steps on the outer shell of the MSNs 
(cf. appendix 5.10). The signals between 2850 cm-1 and 2800 cm-1 can be attributed to the CH2 
stretching vibrations arising from the organic functionality (aminopropyl-moieties) and are 
present in each sample. Furthermore, several peaks at 2900 cm-1 (C-H stretching vibrations) 
and at 1400 cm-1 (C-H bending vibrations) are visible. The peaks at 1590 cm-1  and 1570 cm-1 
correspond to the C=C stretch vibrations of the aromatic pyridine ring and are present in each 
spectra after the attachment of PVP to the surface of MSN-NH2. Additionally, peaks at 
5.2. Results and Discussion  
 
130 
 
1474 cm-1 and 1430 cm-1 are present after covalent attachment of the boc-protected polymer to 
the shell of the MSNs and can be assigned to the C=N stretch vibrations of the aromatic pyridine 
ring. In order to successfully enable additional covalent attachment of functionalities (e.g. PEG 
or targeting ligands), the boc-protection group at the polymer end was subsequently removed 
(cf. appendix 5.8). After deprotection of MSN-PVP-NH2-Boc and conversion of the amino 
group into a carboxy-functionality with oxalic acid, a peak at 1677 cm-1 arises which can be 
attributed to the asymmetric C=O stretching vibration of MSN-PVP-COOH. This band shifts 
after PEGylation, implying a successful attachment of PEG. In order to show the ability of 
poly(2-vinylpyridine) to act as a pH responsive cap system, nitrogen sorption measurements 
were performed (Figure 5.2C). To observe the open form (MSN-PVPopen), the particles where 
dried from a 0.01 M HCl dispersion at 60 °C; this was expected to keep the protonated PVP 
functionalized MSN in an open state. The closed state could be measured after drying from a 
dispersion in millipore water (pH 7). In the open state, the mesopores are highly accessible, 
whereas the polymer completely blocks the pores in the closed state, even for very small 
molecules like nitrogen. The BET surface area of 51 m2/g in the closed state is in very good 
accordance with an estimated external BET surface area of 45 m2/g of dense spheres with 
similar density and diameter. The BET surface area of 51 m2/g for MSN-PVPclosed corresponds 
to a reduction in surface area of 95% compared with MSNs without polymer cap system 
(MSN-NH2), indicating that the surface of the pore walls after blocking is not even accessible 
for nitrogen. The key features of the different MSNs are summarized in Table 5.1. 
 
Table 5.1: Nitrogen physisorption data of MSN-NH2 and MSN-PVP. 
Sample 
BET surface area 
[m²/g] 
Pore sizea  
[nm] 
Pore volumeb 
[cm3/g] 
MSN-NH2 1097 3.8 0.79 
MSN-PVPopen 617 3.4 0.36 
MSN-PVPclosed 51 - - 
aDFT pore size refers to the peak value of the pore size distribution. bPore volume is calculated up to a pore size 
of 8 nm to remove the contribution of interparticle porosity. 
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The decrease of the specific surface area in the sample MSN_PVPopen can be explained by the 
addition of non-porous PVP and the blocking of some pores by frozen polymer on the surface 
layer of the MSNs. This effect is comparably large due to the length of the PVP. 
 
Figure 5.2: Characterization of the MSN system A) Dynamic light scattering data of MSN-NH2 (black), 
MSN-PVP-NH2 (red) and MSN-PVP-PEG-NH2 (blue) B) Thermogravimetric analysis of MSN-NH2 
(black), MSN-PVP-NH2 (red) and MSN-PVP-PEG-NH2 (blue). The curves are normalized at 150 °C, 
C) Nitrogen physisorption measurements of MSN-NH2 (black), MSN-PVP in the open state of the 
polymer (red) and MSN-PVP-closed (blue). D) Time-based fluorescence release experiment of 
MSN-PVP-NH2 (blue) and MSN-PVP-PEG-NH2 (red) with fluorescein as cargo. 
In vial fluorescence release experiments. The pH-responsive opening of the polymer cap 
system was demonstrated by time-based fluorescence release experiments with our 
custom-made release set-up.33 Therefore, a distinct amount of fluorescein-loaded 
MSN-PVP-NH2 (Figure 5.2D, blue curve, or MSN-PVP-PEG-NH2 (red), respectively) were 
measured in the closed state of the polymer for 2 h before the sample was acidified, allowing a 
subsequent opening of the pores and the diffusion of cargo molecules. All intensity values are 
normalized to the highest obtained fluorescence counts of the respective sample. Therefore, the 
5.2. Results and Discussion  
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highest amount released is set to 100% relative release. The pH-dependent release curves show 
the striking capping effect of the poly(2-vinylpyridine) cap system. At pH 7, the polymer is in 
its hydrophobic state and thus successfully blocks the pores of the MSNs until the release is 
triggered by decreasing the pH. In acidic media, the polymer changes into its water soluble 
hydrophilic state through protonation, which allows the cargo to diffuse out of the pores. No 
significant changes in release kinetics are observed by further attachment of PEG compared 
with sample MSN-PVP (Figure 5.2D). Long-term release experiments showed that even after 
16 h, the premature release is less than 4% in the closed state of the polymer (cf. appendix 5.13). 
 
Stability tests of the nanoparticles 
Previous studies on the effect of functionalizations of MSNs on the bio-degradation 
demonstrated the fast degradation of unfunctionalized MSNs in simulated body fluids. The 
attachment of poly(ethylene glycol) increased the stability drastically up to days, whereas the 
un- or organo-silane functionalized MSNs lost their porosity in the first hours of incubation. 
During the partial hydrolysis and dissolution of the silica material, hydroxyapatite layers 
precipitated on the surface of the silica by adsorption of Ca2+ ions in the porous system and via 
hydrogen bonding of PO4
3- ions.10, 34 The functionalization with PEG already exhibited a very 
good improvement of the MSN stability, but the PEG-layer does not close the pores of the 
MSNs. Therefore, the protection of the pores relies on a shielding mechanism, whereas in the 
case of PVP the particles are completely protected from the environment as long as they stay in 
neutral or basic milieu. The stability of the MSNs was tested i) in bio-fluids and ii) for storage 
purposes in order to estimate shelf life. Biostability assays were performed to test whether the 
polymer cap system will prevent the mesoporous silica nanoparticles from degradation. This 
was done using Dulbecco's Modified Eagle's Medium (DMEM) at 37 °C at two different pH 
values (5 and 7). As a widely used basal medium for growing many mammalian cells, DMEM 
contains various amino acids, vitamins and inorganic salts, among other ingredients and is used 
to simulate a biological environment. A certain amount of sample was removed after specific 
times (2 h, 4 h and 24 h), washed thoroughly and dried. The nanoparticles were then 
characterized with transmission electron microscopy and nitrogen sorption. TEM images show 
significant degradation of the nanoparticle structure for unfunctionalized MSNs after 24 h 
immersion at pH 7 (Figure 5.3B), which is in good accordance with results of similar 
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experiments reported earlier.10 In contrast, nanoparticles functionalized with PVP offer very 
good stability in DMEM at pH 7 (Figure 5.3C). At this pH, the polymer cap system forms a 
tight, hydrophobic, and therefore impermeable shield against water, proteins and salts around 
the MSNs. Additionally, the polymer shell also improves the stability of the MSNs in DMEM 
at pH 5, where the cap system is in its open state (Figure 5.3D). In comparison with uncoated 
nanoparticles, MSN-PVP-PEG particles show less degradation, which was also confirmed by 
nitrogen sorption experiments (Figure 5.4). In both cases, in the open and the closed state of the 
cap system, no changes in the pore size distribution were observed, indicating that the pores are 
not affected by the medium and no degradation of the mesoporous framework did occur.  
 
 
Figure 5.3: TEM micrographs of A) template-free, untreated MSN-NH2, B) MSN-NH2 after 24 h 
incubation in DMEM, C) MSN-PVP-PEG at pH 7 (closed state) after 24 h in DMEM and D) 
MSN-PVP-PEG incubated in DMEM at pH 5 (open state) after 24 h. 
5.2. Results and Discussion  
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Figure 5.4: Nitrogen physisorption data of MSN-PVP-PEG after immersion in DMEM at different pH 
values after 2 h (black), 4 h (blue) and 24 h (red). A) Nitrogen sorption isotherms of MSN-PVP-PEG at 
pH 7, B) nitrogen sorption isotherms after immersion in DMEM at pH 5, C) pore size distributions of 
MSNs for different immersion times in DMEM at pH 7 and D) at pH 5 after distinct times. 
In order to test the stability of the MSNs under storage conditions, the functionality of 4-week-
old particles (stored at 4 °C) could be verified with in vitro release experiments 
(cf. appendix 5.13). After storage in water (and therefore in a closed state of the PVP) the 
particles retain the same calcein release behavior in cells (cf. appendix 5.15). Additionally, 
drying and re-dispersion of MSN-PVP-PEG-NH2 in water exhibits no significant 
agglomeration of the particles or any other visible change of their solution behaviour (DLS 
cf. appendix 5.16). This remarkable behavior is exceptional for mesoporous silica 
nanoparticles; the common response to drying is serious agglomeration that cannot even be 
broken with ultrasound. Based on the re-dispersibility of the nanoparticles after drying, a long 
shelf life of the nanoparticles is expected. 
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Targeting. To design an effective drug delivery system, a targeting system is highly desirable. 
Generally one can distinguish between passive and active targeting. Modifications such as 
attaching PEG at the surface of the delivery system provide shielding against undesired 
interactions, and therefore favor the enhanced permeability and retention effect (passive 
targeting). Active targeting, on the other hand, takes advantage of the overexpression of certain 
receptors on diseased cells by attachment of the corresponding targeting ligand to the delivery 
vehicle.35 Accordingly, active targeting was shown in vitro using the example of folic acid (FA) 
receptor targeting on KB cells.  
 
In vitro cellular model. The attachment of active targeting ligands is important for creating a 
functional drug delivery system.35 Folic acid was chosen as targeting ligand because it is an 
ideal model system for targeting with a small molecule and is also believed to be a promising 
candidate for clinical applications.36 Furthermore, the covalent binding of folic acid to the 
particles can be achieved with an EDC-mediated coupling and could be easily substituted by 
other targeting ligands without changing the coupling chemistry. To demonstrate the 
functionality of the particles, they were incubated with KB cells, which are known to 
overexpress FA-receptors.36 In a competition experiment, with either free folic acid to block 
the FA-receptors or with uninhibited FA-receptors, the uptake of MSN-PVP-PEG-NH2-FA 
particles and hence the targeting abilities were monitored. For the visualization of nanoparticle-
uptake, z-stacks of the cells were recorded with a spinning disk confocal fluorescence 
microscope, which allowed to detect MSNs inside or outside the cells after staining the cell 
membrane. 
 
 
 
5.2. Results and Discussion  
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Figure 5.5: Unspecific and receptor-mediated uptake of MSN-PVP-PEG-NH2-FA particles by KB cells. 
A) Incubation of MSN-PVP-PEG-NH2-FA particles with FA pre-incubated KB cells for 2 h at 37 °C. 
B) Incubation of MSN-PVP-PEG-NH2-FA particles with KB cells, no free FA in cell culture medium, 
for 2 h at 37 °C. The KB cell membrane is shown in green (dye WGA 488) and the particles in red (dye 
Atto-633). Orthogonal views are given to illustrate the uptake more clearly. The scale bars represent 
10 µm. 
In Figure 5.5, typical confocal cuts through the cells together with the orthogonal projection are 
shown. In the case of pre-incubation with free folic acid, only a few individual particles are 
present inside the cells (Figure 5.5A), and also in the full stacks the quasi-absence of 
nanoparticles is noted, independent of the chosen focal plane. In contrast, incubation of 
MSN-PVP-PEG-NH2-FA on KB cells without pre-incubation of FA resulted in significant 
uptake of particles (Figure 5.5B). The particles appear in the representative z-slice as well as in 
the entire height of the cell as shown in the orthogonal views. In the case of blocked receptors, 
only unspecific uptake is expected to occur, therefore the results demonstrate the specific 
folate-receptor mediated endocytosis within two hours with only a minor rate of unspecific 
uptake. 
 
Release experiments. To verify the release properties of the particle-system, several 
experiments were performed. First, as already described above, the pH dependency was tested 
in vial with time-based fluorescence spectroscopy at pH 7 and pH 5 (Figure 5.2D). In a second 
approach, the multifunctional MSNs were tested in vitro. For these experiments, 
membrane-permeable (DAPI) and impermeable (calcein) dyes were adsorbed in the mesopores 
of the MSNs and the dye-loaded nanoparticles were incubated with cells to prove the 
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functionality of the system on a cellular level. Membrane-impermeable cargos can’t escape the 
endosomal compartments, therefore a photosensitizer (AlPcS2a) was covalently attached to the 
outer surface of the sample MSN-PVP-PEG.14  
In vitro. The controlled release of cargo inside the desired tissue is one of the greatest challenges 
in drug delivery. Many systems have been developed and characterized, including fusion, 
redox-sensitive systems and photoactivation.30 Some of these systems already exhibit a good 
temporal and spatial control of the cargo release. But once they are activated, the release of the 
cargo is continuous, even if the particles leave the tissue of interest. One advantage of our newly 
developed system is the reversibility of the pore opening. If the pH of the environment turns 
neutral again, it is assumed that PVP will seal the pores again and the delivery system can 
circulate safely inside the blood system.   
 
By photoactivation. In the first experiments, MSN-PVP-PEG particles loaded with calcein 
were incubated on HeLa cells for 20 h. The incubation time is long enough to allow the 
endosomal acidification.37 However, the fluorescence colocalization of the membrane-
impermeable cargo calcein and the covalently bound dye Atto-633 remained 
(cf. appendix 5.19). Calcein is a membrane impermeable cargo and therefore is not able to exit 
intact endosomal compartments without external trigger, but it should be released inside the 
endosomal compartment. For membrane-impermeable cargos the system had to be further 
enhanced to induce endosomal escape. Thus the photosensitizer AlPcS2a (PS) was covalently 
linked to the PEG-chains, in addition to the pH-sensitive polymer on the particle surface. 
Endosomal escape was expected to occur after acidification of the endosomes and activation of 
the photosensitizer with red laser light. After activation with red laser light (639 nm, 
1.2 W/mm2) singlet oxygen is produced, which can destroy the endosomal membrane. We 
emphasize that the lifetime of the singlet oxygen is very short (around 2 x 10-7 s)38, thus its 
diffusion range is limited and therefore the cargo and also the cell membrane should stay intact, 
due to the spatial separation of cargo, cell membrane and PS. Moreover, the red light used for 
activation of the photosensitizer is in a useful region for medical applications and is already 
used in photodynamic therapy.39 For the photoactivated release experiment, 
MSN-PVP-PEG-AlPcS2a/FA particles were incubated on HeLa cells for 18 h. Calcein and PS 
are perfectly co-localized (yellow spots, Figure 5.6C) after endocytosis of the MSNs. Directly 
after 1 min photoactivation with 1.2 W/mm2 of 639 nm light, calcein-spreading over the whole 
cell can be observed, and the calcein-fluorescence gets brighter over time due to de-quenching 
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of the dye upon escape from the MSN host (Figure 5.6C, I, M). In comparison to the emission 
from calcein, the fluorescence of the photosensitizer stays localized in the same dot-like pattern 
as prior to the photoactivation, only the intensity is reduced because of photobleaching effects 
after the activation (Figure 5.6F, J, N). The intensity profile along the white line, indicated in 
the merged pictures, depicts the fluorescence increase due to calcein more clearly (Figure 
5.6D, H, L, P). The cargo release can also be visualized with a constant PS-activation and 
simultaneous observation of calcein fluorescence (over a period of 8 min; cf. appendix 5.18). 
Strikingly, a significant part of the cargo appears to be released inside the cell already within 
two minutes. 
 
Figure 5.6: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA nanoparticles loaded with calcein 
after 18 h incubation on a HeLa cell. A-C) Calcein (green) and AlPcS2a (red) are co-localized (yellow) 
prior to photoactivation. D) Intensity profile along the white line in the merged image. The red line 
indicates photoactivation with 1.2 W/mm2 of red light (639 nm). E-H) after 1 min photoactivation, I-L) 
5 min after photoactivation, M-P) 10 min after photoactivation. The scale bar represents 10 µm. 
  
 
 139 
 
The above results were compared to those of incubation experiments of cells with a solution of 
free calcein and PS. We also observe that the free PS is spreading over the whole cell. If the PS 
is not covalently bound to the nanoparticles, the molecules can diffuse inside the entire cell and 
can cause much more damage to the cell membrane and other organelles due to their greater 
proximity. 
 
By pH-sensitivity with membrane-permeable cargos. To safely deliver membrane-
permeable cargos like DAPI40 or colchicine41 inside cells with our newly developed system, the 
implementation of additional endosomal escape mechanisms is not necessary. It is anticipated 
that the particles will be taken up in endosomal compartments, and in the following the 
endosomes get acidified. This drop in pH from around 7 to approximately 5 results in the 
solvation of poly(2-vinyl pyridine) and thus in release of the cargo from the pores into the 
endosome, and consequently into the cytosol if it diffuses through the endosomal membrane. 
On the other hand, if the particles get exocytosed the pH will increase and poly(2-vinyl 
pyridine) will turn insoluble again. In this case the cargo will stay inside the particles and the 
latter can circulate again and possibly find a new target cell. DAPI and colchicine were used as 
model systems to examine the delivery of membrane permeable cargo. DAPI preferentially 
stains dsDNA and thereby produces a fluorescence enhancement of around 20-fold.42  
Figure 5.7 shows the staining of the nucleus after several time intervals. Shortly after incubation 
only a weak staining of the nucleus can be seen, after 15 h the nucleus is clearly visible and 
after 46 h even the region of the endoplasmic reticulum gets stained. Because of the slowly 
increasing and very strong DAPI-fluorescence signal after several hours of incubation, it could 
be excluded that the staining is due to free DAPI in the particle solution. In the case of free 
DAPI in the solution, the staining would be expected to be detectable shortly after addition, as 
the typical incubation time for nucleus staining with free DAPI in solution is only between 
1 - 5 minutes.  
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Figure 5.7: Fluorescence microscopy of HeLa cells incubated with DAPI-loaded MSN-PVP-PEG. 
MSN-PVP-PEG loaded with DAPI (blue) and labeled with Atto 633 (red) after A) 15 min B) 15 h and 
C) 46 h incubation with the cells. The nucleus region is indicated with dashed white lines. The scale bar 
represents 10 µm. 
5.3 Conclusion 
In this work, we have developed a multifunctional drug delivery vehicle based on polymer-
functionalized mesoporous silica nanoparticles. This system combines attractive features such 
as the high loading capacity of MSNs with the tuneable functionality of a polymer. The use of 
bi-functionalized polymer blocks allowed us to covalently attach step-by-step many 
functionalities of interest.  We demonstrate that covalently bound poly(2-vinylpyridine) in 
combination with a PEG-block acts as a pH-responsive cap system for MSNs. With this system, 
we show the successful delivery of different cargos into cells. Membrane permeable cargos 
were delivered without any external trigger, because such cargos can penetrate the endosomal 
membrane. Covalent attachment of a red-light-photosensitizer offered the possibility to open 
the endosome through irradiation with laser light, and to deliver membrane-impermeable 
cargos. Effective targeting of folic acid receptor expressing cells was enabled by the covalent 
attachment of folic acid. Stability tests revealed the effectiveness of poly(2-vinylpyridine) not 
only as cap system, but also as a highly effective protecting agent for MSNs against aggressive 
body fluids. Strikingly, the polymer-coated nanoparticles can even be dried and then 
re-dispersed in water without agglomeration. This extraordinary feature bodes well for a long 
shelf life of the dried particles. Biodistribution experiments in vivo revealed no particle 
agglomeration and showed preferred liver accumulation. The modified and unmodified MSN 
particles were well tolerated in mice without causing side-effects. With this new system we 
have developed a multifunctional toolbox based on MSNs that is able to open and close its cap 
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system depending on the environment. One major advantage of our system derives from the 
covalent attachment of all components, which allows the system to operate for several cycles. 
We anticipate that the possible integration of almost any functionality of interest as well as the 
efficient synthesis make this system promising for wide-ranging biological and medical 
applications, especially in cancer therapy. 
 
5.4 Experimental 
Chemicals 
All reagents were purchased from commercial suppliers: tetraethyl orthosilicate (TEOS, Fluka, 
>98%), cetyltrimethylammonium bromide (CTAB, Aldrich, 95%), (3-aminopropyl) 
triethoxysilane (APTES, Fluka, 95%), (3-mercaptopropyl)triethoxysilane (ABCR), N-(3-
dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC, Fluka, 97%), α-amino-ω-
carboxy terminated poly(2-vinylpyridine) (NH2-PVP-COOH, Polymer source, Mn = 10000, 
PDI = 1.08), α,ω-polyethyleneglycolbisamine (NH2-PEG-NH2, Aldrich, Mn = 2000), Boc 
anhydride (Aldrich, 95%), folic acid (Sigma, 99%), aluminum (lll) phthalocyanine chloride 
tetrasulfonic acid (AlPcS2a, Frontier Scientific), N-hydroxysulfosuccinimide sodium salt 
(Sulfo-NHS, Aldrich, 98%), 4,6-diamidino-2- phenylindole dihydrochloride (DAPI, ≥98%), 
Bis[N,N−bis(carboxymethyl) aminomethyl] fluorescein (calcein), Folic Acid (FA, >97 %). 
Doubly distilled water from a Millipore system (Milli-Q academie A-10) was used for all 
syntheses and purification steps. All solvents and buffer contents above were purchased from 
Sigma-Aldrich. Wheat germ agglutinin (WGA) Alexa Fluor 488 conjugate (Invitrogen), 
Atto-633 maleimide (ATTO-TEC). Unless otherwise noted, all reagents were used without 
further purification. 
 
Synthesis procedures.  
Preparation of shell-functionalized colloidal mesoporous silica nanoparticles (MSN-NH2). 
MSN nanoparticles were prepared by a delayed co-condensation approach as described earlier 
by Cauda et al.1 In detail, a two phase mixture of TEA (14.3 g) and TEOS (1.9 g, 9.12 mmol) 
was heated at 90 °C for 20 minutes without stirring. After removal of the oil bath, a preheated 
(60 °C) solution of CTAC (2.14 mL, 1.62 mmol, 25 wt% in H2O) and water (21.7 g) was added 
and stirred afterwards at 500 rpm for 30 min at room temperature. Subsequently, a mixture of 
3-aminopropyltriethoxysilane (22.5 µL, 96 µmol) and TEOS (20.5 µL, 92 µmol) was added. 
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The resulting solution was stirred overnight at room temperature at 500 rpm. Extraction of the 
organic template was achieved by heating the ethanol-suspended sample (10 mg/mL) under 
reflux at 90 °C for 1 h in a mixture of 2 g ammonium nitrate and 100 mL ethanol. Afterwards, 
the sample was centrifuged for 20 min (19000 rpm, 43146 rcf), re-dispersed in ethanol and 
heated under reflux at 90 °C in a solution of 8 mL concentrated HCl and 32 mL ethanol for 
45 minutes. After centrifugation, the particles were re-dispersed in ethanol, resulting in a 
colloidal suspension. 
Protection of NH2-PVP-COOH (Boc-PVP-COOH). To a solution of NH2-PVP-COOH 
(500 mg, 5 µmol) in  10 mL dry dichloromethane, triethylamine (15 µL, 0.11 mmol) and Boc 
anhydride (15 mg, 6.9 µmol) were added. The solution was stirred overnight and extracted 
several times with brine. The organic phase was dried over MgSO4 and the solvent removed in 
vacuo to yield the Boc protected polymer. The polymer was used without further purification. 
General procedure for the attachment of poly(2-vinyl pyridine) to MSN-NH2 
(MSN-PVP-Boc). To a colloidal solution of MSN-NH2 (50 mg), tetrahydrofuran (THF, 10 mL) 
and the Boc protected polymer (60 mg, 5.6 µmol) dissolved in 1.5 mL THF was added. The 
amidation was activated by the addition of EDC (10 µL, 57.2 µmol) and sulfo-NHS (1.3 mg, 6 
µmol). The mixture was stirred at room temperature for 12 h. Afterwards the particles were 
separated by centrifugation (19000 rpm, 43146 rcf, 20 min) and washed 3 times by repeated 
centrifugation and re-dispersion in 30 mL THF. 
Deprotection of MSN-PVP-Boc (MSN-PVP-NH2). Deprotection of the polymer was 
achieved through stirring 10 mg polymer functionalized particles in a mixture of 2 mL 
trifluoroacetic acid and 8 mL water for 24 h. After deprotection, the particles were extensively 
washed by centrifugation (19000 rpm, 43146 rcf, 20 min) and re-dispersion in a mixture of 
0.01 M HCl and EtOH. 
Conversion of MSN-PVP-NH2 to MSN-PVP-COOH. 10 mg MSN-PVP-NH2 in 2 mL EtOH 
were reacted with a large excess of oxalic acid (5 mg, 55 µmol) and EDC (9 µL, 51 µmol) for 
1 h. Afterwards, the particles were extensively washed by centrifugation (19000 rpm, 43146 rcf, 
20 min) and re-dispersion in a mixture of 0.01 M HCl and EtOH. 
PEGylation of MSN-PVP-COOH (MSN-PVP-PEG-NH2). To a colloidal solution of 
MSN-PVP-COOH (1 mg) in 500 µL EtOH, NH2-PEG-NH2 (2 mg, 100 nmol – dissolved in 
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500 µL bi-distilled water) was added, Afterwards, EDC (0.5 µL, 2.8 µmol) was added and the 
reaction was allowed to stir at ambient temperature for 1 h. The sample was purified by 
subsequent centrifugation (4 min, 14000 rpm, 16873 rcf) with a mixture of EtOH:water (1:1). 
The washing step was repeated three times with 1 mL each.  
Attachment of folic acid to MSN-PVP-PEG-NH2 (MSN-PVP-PEG-NH2-FA). The amino 
functionalities of MSN-PVP-PEG-NH2 (1 mg, in 1 mL EtOH:water 1:1) were partially reacted 
with folic acid (0.44 µg, 1 nmol).  Subsequently, EDC (0.5 µL, 2.8 µmol) and a catalytic amount 
of sulfo-NHS (~1 mg) was added. After 1 h, the sample was washed 3 time by subsequent 
centrifugation (4 min, 14000 rpm, 16873 rcf) and re-dispersion with a mixture of EtOH:water 
1:1. 
Attachment of AlPcS2a to residual amino groups of MSN-PVP-PEG-NH2-FA (MSN-PVP-
PEG-FA- AlPcS2a). To the sample MSN-PVP-PEG-NH2-FA (1 mg) in 1 mL DMSO:water 1:1 
20 µL of AlPcS2a (1 mg/mL in DMSO) were added. The resulting mixture was stirred at room 
temperature in the dark for 24 hours. The sample was washed extensively with DMSO:water 
1:1 by repeated centrifugation (4 min, 14000 rpm, 16873 rcf) and re-dispersion until no 
photosensitizer could be detected in the supernatant. 
 
Release experiments: 
Drug/dye loading. 1 mg MSN-PVP-PEG-NH2 were dispersed in 500 µL of a 1 mM drug/dye 
solution in water. To open the pores and enable the uptake, 50 µL of citrate buffer (pH 2) were 
added. The particles were stirred overnight, centrifuged, and re-dispersed in 1 mL SSC buffer 
(pH 7) to trigger closure of the polymer shell. The particles were washed extensively with SSC 
buffer until no fluorescence was detected in the supernatant.  
In vial fluorescein release: 1 mg fluorescein loaded MSN-PVP-NH2 or MSN-PVP-PEG-NH2 
were re-dispersed in 200 µL SSC buffer and transferred to the cap of the fluorescence cuvette. 
This cap was sealed with a dialysis membrane (molecular weight cutoff of 16000 g/mol) and 
placed on top of the fluorescence cuvette, which was also filled with SSC buffer. The “release” 
of fluorescein out of the closed particles was monitored for 2 h (λex = 490 nm, λem = 512 nm). 
Subsequently, the cap was removed and the particles were centrifuged and re-dispersed in 
200 µL citrate-phosphate buffer (pH 5), before being put into the cap of the release setup. The 
fluorescence cuvette was also filled with citrate-phosphate buffer (pH 5). After reassembling 
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the release setup, the release of fluorescein was continuously measured for 10 h. For comparison 
of the obtained curves, calibration curves of fluorescein in SSC buffer (pH 7) and in citrate-
phosphate buffer (pH 5) were recorded. 
Characterization. All samples were investigated with a FEI Titan 80-300 operating at 300 kV 
with a high-angle annular dark field detector. A droplet of the diluted MSN solution in absolute 
ethanol was dried on a carbon-coated copper grid. Nitrogen sorption measurements were 
performed on a Quantachrome Instruments NOVA 4000e. All samples (15 mg each) were 
heated to 60 °C for 12 h in vacuum (10 mTorr) to outgas the samples before nitrogen sorption 
was measured at 77 K. Pore size and pore volume were calculated by a NLDFT equilibrium 
model of N2 on silica, based on the desorption branch of the isotherms. In order to remove the 
contribution of the interparticle textural porosity, pore volumes were calculated only up to a 
pore size of 8 nm. A BET model was applied in the range of 0.05 – 0.20 p/p0 to evaluate the 
specific surface area of the samples. Centrifugation was performed using a Sorvall Evolution 
RC equipped with a SS-34 rotor or an Eppendorf centrifuge 5418 for small volumes. Raman 
spectra were recorded on a Jobin Yvon Horiba HR800 UV Raman microscope using a He-Ne 
laser emitting at λ = 633 nm. Dynamic light scattering (DLS) measurements were performed 
on a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser (633 nm) and an 
avalanche photodiode. The hydrodynamic radius of the particles was determined by dynamic 
light scattering in ethanolic suspension. For this purpose, 100 µL of an ethanolic suspension of 
MSN particles (ca. 10 mg/mL) was diluted with 3 mL of ethanol prior to the measurement. Zeta 
potential measurements of the samples were performed on a Malvern Zetasizer-Nano 
instrument equipped with a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. Zeta 
potential measurements were performed using the add-on Zetasizer titration system (MPT-2) 
based on diluted NaOH and HCl as titrants. For this purpose, 1 mg of the particles was diluted 
in 10 mL bi-distilled water.  IR measurements were performed on a Bruker Equinox 55 
FTIR/FTNIR Spectrometer in absorbance mode (spectra were background substracted). 
Thermogravimetric analysis was performed on a Netzsch STA 440 C TG/DSC with a heating 
rate of 10 K / min in a stream of synthetic air of about 25 mL/min. The mass was normalized 
to 100% at 150 °C for all samples. UV-VIS spectra were recorded with a NanoDrop ND 1000 
spectrometer. Usually, 2 µL of sample were used and all presented spectra are background 
corrected for water absorption.  
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Cell culture and in vitro Experiments 
Cell culture. KB cells were grown in folic acid deficient Roswell Park Memorial Institute 1640 
medium (RPMI 1640, Invitrogen) supplemented with 10% fetal bovine serum (FBS). HeLa 
cells were grown in Dulbecco’s modified Eagle’s medium (DMEM):F12 (1:1) (Invitrogen) with 
Glutamax I medium supplemented with 10 % FBS. Tubulin-GFP expressing HuH7 cells were 
grown in Dulbecco’s modified Eagle’s medium : F12 (1:1) supplemented with 10% FBS. All 
cells were cultured at 37 °C in a 5% CO2 humidified atmosphere. KB cells were seeded on 
ibidiTreat μ-Slides (IBIDI). HeLa and tubulin GFP expressing HuH7 cells were seeded on 
collagen A - coated LabTek chambered cover glass (Nunc). For live cell imaging the cells were 
seeded 48 or 24 h before measuring, at a cell density of 1x104 or 2x104 cells / cm2, respectively. 
Spinning disc confocal microscopy. Live-cell imaging was performed on a confocal setup 
based on the Zeiss Cell Observer SD, utilizing a Yokogawa spinning disc unit CSU-X1. The 
system was equipped with a 1.40 NA 100x or 63x Plan apochromat oil immersion objective 
from Zeiss. The exposure time was 0.1 s for all experiments und the frame rate varied between 
3 frames / s and 1 frame / 30 s, depending on the experiment.  Calcein, WGA 488 and GFP 
were imaged with approximately 0.39, 0.29 and 1.1 W/mm2 of 488 nm excitation light. 
Atto-633 was imaged with approximately 0.06 W/mm2 of 639 nm excitation light and DAPI 
with 0.16 W/mm2, respectively. The photosensitizer AlPcS2a was excited with approximately 
0.12 W/mm2 at 639 nm for imaging and with 1.2 W / mm2 for photoactivation. A quad-edge 
dichroic beamsplitter (FF410/504/582/669-Di01-25xx36, Semrock) was used in the excitation 
path. For the two-color detection of calcein and AlPcS2a, WGA 488 and Atto 633 or GFP and 
Atto 633, a dichroic mirror (660 nm, Semrock) and band-pass filters 525 / 50 and 690 / 60 (both 
semrock) were used in the detection path. Separate images for each fluorescence channel were 
acquired using two separate electron multiplier charge coupled device (EMCCD) cameras 
(Photometrics EvolveTM) 
Uptake studies. The functionality of the folic acid targeting ligand was evaluated in a receptor 
competition experiment. For this purpose, one part of the KB cells was preincubated with 3 mM 
folic acid (Sigma), to block the receptors, for 2 h at 37 °C under a 5% CO2 humidified 
atmosphere. Then the KB cells were incubated with particles (MSN-PVP-PEG-FA, covalently 
labeled with Atto 633; 25 µg / mL) for 2 h at 37 °C under a 5% CO2 humidified atmosphere. 
After the incubation the cells were washed three times with PBS (Invitrogen), and 4% 
paraformaldehyde (PFA, Science Service) was added for 15 min. The PFA was removed and 
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the cells were washed again three times with PBS. For staining the cell membrane, the cells 
were incubated with a final concentration of 10 μg/mL wheat germ agglutinin Alexa Fluor 488 
conjugate (WGA 488, Invitrogen) for one minute. The cells were washed once with PBS and 
imaged.  
Cargo release Experiments. To measure the photoactivated cargo release the cells were 
incubated with particles (MSN-PVP-PEG-AlPcS2a-FA, 25 μg/mL) for 16-20 h at 37 °C under 
a 5% CO2 humidified atmosphere. For imaging the medium was replaced by CO2-independent 
medium (Invitrogen), during the measurements the cells were kept on a heated microscope stage 
at 37 °C. For activation of the photosensitizer, the cells were irradiated with 1.2 W/mm2 of 
639 nm light for 1 min. The release of cell-membrane permeable cargo due to pH-dependent 
opening of the PVP-coating inside the endosomes was also measured.  
 
5.5 Appendix 
 
 
Figure 5.8: Synthesis pathway of a fully functionalized mesoporous silica nanoparticle. 
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Figure 5.9: Titration experiments showing the zeta potential of MSN-PVP (black), and dynamic light 
scattering of MSN-PVP (red) and MSN-PVP-PEG (blue), respectively. 
 
Figure 5.10: IR spectra of MSN-NH2 (black), MSN-PVP-Boc (blue), MSN-PVP-COOH (red), 
MSN-PVP-PEG (green), HOOC-PVP-NH2 (grey) and NH2-PEG-NH2 (magenta). 
5.5. Appendix  
 
148 
 
 
Figure 5.11: Raman spectra of MSN-NH2 (black), MSN-PVP-NH2 (red) and HOOC-PVP-NH2 (blue). 
In addition, Raman spectroscopy was used to monitor the attachment of HOOC-PVP-NH2 (blue 
curve) to MSN-NH2 (black curve) resulting in MSN-PVP-NH2 (red curve). Bands at 3062 cm
-1 
(*) (C-H stretching vibration of aromatic rings (pyridine)) and 1054 & 995 cm-1 (*) (ring 
stretching vibration of mono-substituted pyridines) are typical for the pyridine groups of poly-
2-vinylpryridine.  The signals from the polymer appear in the MSN sample after attachment of 
PVP to MSN and are marked with an asterisk. 
 
Experimental Setup of fluorescence release experiments. 
Fluorescence experiments were performed to show the time-dependent release of fluorescein 
from the mesopores of colloidal mesoporous silica spheres. The measurements were recorded 
on a PTI fluorescence system featuring a PTI 814 photomultiplier detector and a PTI A1010B 
Xenon arc lamp driven by a PTI LPS-220B lamp power supply. For temperature settings, a 
Quantum Northwest TC 125 sample holder was used. Fluorescein was excited with 490 nm and 
emission was detected at 512 nm (excitation slit 1.0 mm, emission slit 1.0 mm, 1 point per 
30 min). For the release experiment, a ROTH Visking Typ 8/32 dialysis membrane with a 
molecular cut-off of 14000 g/mol was used.  
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Figure 5.12: Custom made release experiment setup featuring a 200 µL Teflon tube (a) which is closed 
by a dialysis membrane (b). This setup is put onto a fluorescence cuvette filled with the desired buffer 
(c). 
For the release experiment, the particles were re-dispersed in 200 µL SSC buffer pH 7 and put 
into a container that was subsequently closed by a dialysis membrane. The closed container was 
then put onto a fluorescence cuvette, which was completely filled with SSC buffer pH 7. The 
released dye is able to pass through the applied membrane while the relatively larger particles 
are retained. After 16 h, the particles were centrifuged and re-dispersed in 200 µL Mc Ilvaine’s 
buffer pH 5, put into the container and closed by the dialysis membrane. The closed container 
was then put onto the fluorescence cuvette, which was completely filled with Mc Ilvaine’s 
buffer pH 5. The release was measured every 30 min until no further release was observed 
(Figure 5.13). 
 
 
Figure 5.13: Long term release curve (normalized fluorescence intensity). 
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As the fluorescence of fluorescein is strongly dependent on the pH, calibration curves at pH 7 
and pH 5 were recorded (Figure 5.14) to be able to compare fluorescence signals in the closed 
and open state.  
 
 
Figure 5.14: Calibration curves of fluorescein at pH 7 (red) and pH 5 (blue).  
 
 
 
Release in cells with three week old particles 
Cell experiments also revealed the good stability of the system. Even after storage of the ready-
for-use particles for four weeks at 4 °C the release behavior stays the same, as can be seen in 
Figure 5.15. This test is in good agreement with the stability tests that are described above. It 
clearly demonstrates the good shielding of the silica core by the polymer layer. 
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Figure 5.15: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA nanoparticles loaded with 
calcein inside KB cells; particles had been stored three weeks at 4 °C. a-c) Calcein (green) and AlPcS2a 
(red) are co-localized (yellow) prior to photoactivation. The red line indicates photoactivation with 1.2 
W/mm2 of red light (639 nm). d-f) after 1 min. photoactivation, h-i) 5 min. after photoactivation, j-l) 10 
min. after photoactivation. The scale bar represents 10 µm. 
 
 
Figure 5.16: Dynamic light scattering of MSN-PVP-PEG as synthesized (black curve) and after drying 
the particles followed by re-dispersion in water (red curve). There is only a small apparent size increase 
from around 142 nm to around 164 nm, which demonstrates good re-dispersability 
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Release behavior of the membrane impermeable cargo calcein. 
Even after 20 h of incubation the cargo stays co-localized with the MSN-fluorescence. In the 
absence of photosensitizer no release could be detected. 
 
Figure 5.17: Fluorescence microscopy of MSN(Atto633)-PVP-PEG (25 μg/mL) nanoparticles loaded 
with calcein inside HeLa cells after 20 h incubation. a) Merge of brightfield image and fluorescence 
image. b) Fluorescence image of calcein (green) and Atto633 (red) are co-localized (yellow), no 
spreading of calcein can be observed, thus no endosomal escape has occurred. The scale bar represents 
10 µm. 
a) 
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Figure 5.18: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA (25 μg/mL) nanoparticles 
loaded with calcein inside HeLa cells after 24 h incubation. a-c) Calcein (green) and AlPcS2a (red) are 
co-localized (yellow) prior to photoactivation. The cell was constantly monitored with a frame rate of 
1 frame/s and 0.6 W/mm2 of red light (639 nm). d-i) example images after different time points; 
spreading of calcein can be clearly seen over time, whereas AlPcS2a stays at the same location. j) 
Intensity of calcein fluorescence inside the cytosol over time in the indicated rectangle, after 
approximately 2 min an increase can be monitored. The scale bar represents 10 µm. 
In comparison to Figure 5.18, the incubation of cells with free photosensitizer and free calcein 
(Figure 5.19) does not lead to the same effect. It is possible to detect calcein in the beginning 
of the experiment, but the endocytosed amount is too low to be detected after some time and 
therefore no spreading could be observed. In contrast to the dot-like pattern of the particle-
bound photosensitizer in Figure 5.17, the spreading of the free photosensitizer can be detected 
in Figure 5.18. 
a) d) g) 
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Figure 5.19: Fluorescence microscopy of free calcein and free AlPcS2a (each 2.5 μg/mL) inside HeLa 
cells after 24h incubation. a-c) Calcein (green) and AlPcS2a (red) are co-localized (yellow) prior to 
photoactivation. The cell was constantly monitored with a frame rate of 1frame/s and 0.6 W/mm2 of red 
light (639 nm). d-i) example images after different time points, spreading of AlPcS2a can be clearly seen 
over time, whereas the calcein fluorescence is too weak to be detected after some time. j) Intensity of 
calcein fluorescence inside the cytosol over time in the indicated rectangle; no increase inside the cytosol 
can be detected. The scale bar represents 10 µm. 
 
  
 155 
 
5.6 References 
1. Brewer, E.; Coleman, J.; Lowman, A. J. Nano Mat. 2011, 1-10. 
2. Shu, J. Y.; Panganiban, B.; Xu, T. Annu. Rev. Phys. Chem. 2013, 64, 631-657. 
3. de Groot, G. W.; Santonicola, M. G.; Sugihara, K.; Zambelli, T.; Reimhult, E.; Vörös, 
J.; Vancso, G. J. ACS Appl. Mater. Interfaces 2013, 5, 1400-1407. 
4. Synytska, A.; Stamm, M.; Diez, S.; Ionov, L. Langmuir 2007, 23, 5205-5209. 
5. Hotta, J.-i.; Uji-i, H.; Hofkens, J. Opt. Express 2006, 14, 6273-6278. 
6. Meyer, M.; Dohmen, C.; Philipp, A.; Kiener, D.; Maiwald, G.; Scheu, C.; Ogris, M.; 
Wagner, E. Mol. Pharm. 2009, 6, 752-762. 
7. Vetter, A.; Virdi, K. S.; Espenlaub, S.; Rödl, W.; Wagner, E.; Holm, P. S.; Scheu, C.; 
Kreppel, F.; Spitzweg, C.; Ogris, M. Mol. Pharm. 2013, 10, 606-618. 
8. Minard-Basquin, C.; Weil, T.; Hohner, A.; Rädler, J. O.; Müllen, K. J. Am. Chem. Soc. 
2003, 125, 5832-5838. 
9. Arpicco, S.; Stella, B.; Schiavon, O.; Milla, P.; Zonari, D.; Cattel, L. Int. J. Pharm. 
2013, 454, 653-659. 
10. Cauda, V.; Argyo, C.; Bein, T. J. Mater. Chem. 2010, 20, 8693-8699. 
11. Zhou, Z.; Ma, X.; Jin, E.; Tang, J.; Sui, M.; Shen, Y.; Van Kirk, E. A.; Murdoch, W. J.; 
Radosz, M. Biomaterials 2013, 34, 5722-5735. 
12. Coti, K. K.; Belowich, M. E.; Liong, M.; Ambrogio, M. W.; Lau, Y. A.; Khatib, H. A.; 
Zink, J. I.; Khashab, N. M.; Stoddart, J. F. Nanoscale 2009, 1, 16-39. 
13. Slowing, I. I.; Trewyn, B. G.; Giri, S.; Lin, V. S. Y. Adv. Funct. Mat. 2007, 17, 1225-
1236. 
14. Mackowiak, S. A.; Schmidt, A.; Weiss, V.; Argyo, C.; von Schirnding, C.; Bein, T.; 
Bräuchle, C. Nano Lett. 2013, 13, 2576-83. 
15. Tarn, D.; Ashley, C. E.; Xue, M.; Carnes, E. C.; Zink, J. I.; Brinker, C. J. Acc. Chem. 
Res. 2013, 46, 792-801. 
16. Zhang, F.; Lees, E.; Amin, F.; Rivera-Gil, P.; Yang, F.; Mulvaney, P.; Parak, W. J. Small 
2011, 7, 3113-3127. 
17. Cauda, V.; Schlossbauer, A.; Kecht, J.; Zürner, A.; Bein, T. J. Am. Chem. Soc. 2009, 
131, 11361-11370. 
18. Schlossbauer, A.; Dohmen, C.; Schaffert, D.; Wagner, E.; Bein, T. Angew. Chem. Int. 
Ed. 2011, 50, 6828-6830. 
5.6. References  
 
156 
 
19. Strassert, C. A.; Otter, M.; Albuquerque, R. Q.; Höne, A.; Vida, Y.; Maier, B.; De Cola, 
L. Angew. Chem. Int. Ed. 2009, 48, 7928-7931. 
20. Liu, R.; Liao, P.; Liu, J.; Feng, P. Langmuir 2011, 27, 3095-3099. 
21. Tarn, D.; Xue, M.; Zink, J. I. Inorg. Chem. 2013, 52, 2044-2049. 
22. Ashley, C. E.; Carnes, E. C.; Phillips, G. K.; Padilla, D.; Durfee, P. N.; Brown, P. A.; 
Hanna, T. N.; Liu, J.; Phillips, B.; Carter, M. B.; Carroll, N. J.; Jiang, X.; Dunphy, D. 
R.; Willman, C. L.; Petsev, D. N.; Evans, D. G.; Parikh, A. N.; Chackerian, B.; Wharton, 
W.; Peabody, D. S.; Brinker, C. J. Nat. Mater. 2011, 10, 389-397. 
23. Cauda, V.; Engelke, H.; Sauer, A.; Arcizet, D.; Bräuchle, C.; Rädler, J.; Bein, T. Nano 
Lett. 2010, 10, 2484-2492. 
24. Slowing, I. I.; Vivero-Escoto, J. L.; Wu, C.-W.; Lin, V. S. Y. Adv. Drug Delivery Rev. 
2008, 60, 1278-1288. 
25. Croissant, J.; Zink, J. I. J. Am. Chem. Soc. 2012, 134, 7628-7631. 
26. Vivero-Escoto, J. L.; Slowing, I. I.; Wu, C.-W.; Lin, V. S. Y. J. Am. Chem. Soc. 2009, 
131, 3462-3463. 
27. You, Y.-Z.; Kalebaila, K. K.; Brock, S. L.; Oupický, D. Chem. Mater. 2008, 20, 3354-
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6 Fluorocarbon Surfactant-mediated Synthesis of Small 
Mesoporous Silica Nanoparticles with Ultra-large Pores 
This chapter is based on the work in collaboration with: 
Martina Lichtnecker and Kathrin Bader 
 
 
Abstract 
Colloidal mesoporous silica nanoparticles (MSNs) have attracted great attention in recent years 
as versatile vehicles for advanced drug delivery applications.1-3 In this context, MSNs are highly 
interesting due to the possibility to tailor structural and textural parameters (e.g. pore sizes and 
morphologies) while introducing a multiplicity of different functionalities within the 
mesoporous framework for selective post-synthetic modification.2-4 Recently, we have 
developed several bare and modified colloidal mesoporous silica systems, for example MSNs 
functionalized with numerous organic moieties.3-5 However, the synthesis of MSNs with large 
pores (LP_MSNs) and defined small particle sizes is still challenging since the pore size of 
conventional silica nanoparticles (around 4 nm) is inappropriate for the adsorption of larger 
biomolecules such as small interfering RNA (siRNA) or enzymes. In this chapter, the 
optimization of the pore diameter with regard to the adsorption of large biomolecules and the 
molecular functionalization of the mesopores in order to allow the facile diffusion and 
attachment of guest molecules into the host is demonstrated. An increase in pore diameter to 
values larger than 5 nm was achieved with various swelling agents that were incorporated into 
the surfactant aggregates and were used as structure-directing agents during the MSN synthesis. 
Moreover, large molecular weight surfactants (Pluronic F127) and novel fluorinated 
co-surfactants,6, 7 distinct low temperature synthesis protocols and the impact of hydrothermal 
6.1. Introduction  
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treatment steps on the pore diameter were investigated in this study. Additionally, the impact 
of different organo-silanes bearing functional groups such as amino- and thiol-moieties on the 
mesostructure and morphology of the MSNs will be discussed. 
6.1 Introduction 
Considerable effort has been made in the past decade regarding the synthesis of mesoporous 
silica nanoparticles (MSNs) with a focus on mesostructural diversity, compositional flexibility 
and morphological control.3, 4, 6-8 These multifunctional MSNs have recently been widely 
studied as promising nano-carriers for anti-cancer drugs such as doxorubicin9, 10 or paclitaxel11 
both in vitro as well as in vivo.12, 13 However, for the application of MSNs as host systems for 
larger molecules, such as enzymes, proteins and nucleic acids, larger mesopores than those 
available in conventional MSN systems are of key importance for a successful uptake into the 
host-system. An attractive application of LP_MSNs is the adsorption of small interfering RNA 
(siRNA) into their ultra-large pores. Artificially generated siRNA is a promising therapeutic 
agent in gene therapy since it can be specifically designed to knock down the targeted mRNA 
and therefore inhibit the translation of a target protein that is known to cause a certain 
disease.14-16 Hom et al. attached siRNA to the external surface of PEI-modified MSNs and 
observed an effective gene silencing of enhanced green fluorescent protein (EGFP).17 However, 
it would be advantageous to incorporate the fragile and expensive molecules within the 
mesoporous channels of the drug delivery vehicles to prevent premature degradation and 
undesired leakage. Two different studies showed a successful delivery of oligonucleotides 
(pDNA and siRNA, respectively) to cells with amino-functionalized LP_MSNs.7, 18 Gao et al. 
used post-synthesis amino-modified LP_MSNs for pDNA adsorption7, whereas Hartono et al. 
modified the outer silica shell with the cationic polymer poly-L-lysine.18. Cationic polymers 
are widely used for the generation of polyplexes for efficient gene delivery due to their 
electrostatic interaction with the negative backbone of the oligonucleotides.19-21 A 
well-established representative of mesoporous silica materials is the Santa Barbara Amorphous 
15 (SBA-15), which was introduced by Stucky and co-workers in 1998, exhibiting high 
hydrothermal stability and large, tuneable pore sizes (4.9 – 30 nm).22, 23 Kruk and co-workers 
showed that the substitution of 1,3,5-trimethylbenzene (TMB) by 1,3,5-triisopropylbenzene 
(TiPB) leads to an increase in pore size for SBA-15 particles,24, 25 and Bräuchle, Bein and 
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co-workers already showed the impact of this micellar expander on multifunctional core-shell 
MSNs, increasing their pore size by 25% to 5 nm.3 However, we note that in addition to large 
pore sizes, a distinctly small particle size (within a size range of 50 – 300 nm) of the nano-carrier 
is of great importance for cell experiments and in vivo applications such as drug delivery since 
the endosomal uptake of nanoparticles is highly size dependent.26 In addressing this issue, 
recently several strategies for the synthesis of LP_MSNs with a particle diameter of 70 – 300 nm 
and very large pores (up to 17 nm) using fluorocarbon surfactant FC-4 and triblock copolymers 
(Pluronic F127, P123 and P65) have been published by different groups.6, 7, 27 Gao et al. 
developed a novel strategy based on the publication of Han et al.6 to synthesize LP_MSNs at 
low temperatures (10 °C) applying a dual surfactant system consisting of Pluronic F127 
together with fluorocarbon surfactant FC-4 and TMB as micellar expander to generate spherical 
MSNs with large pores.7 In all published syntheses, the fluorocarbon surfactant seems to play 
a crucial role to keep the size of the LP_MSNs small, but it did not contribute to the 
mesostructure formation. One missing feature of the above-mentioned LP_MSN synthesis 
protocols is the incorporation of organo-functionalizations into the mesoporous framework, 
which is a key prerequisite for the attachment of external triggers such as targeting ligands 
and/or stimuli-responsive capping mechanisms. Organo-functionalization can be introduced 
into the LP_MSNs via post-synthesis grafting, yet this post-modification requires an additional 
synthesis step under dry conditions, and control over the exact amount of organo-silane that is 
grafted onto the silica surface is challenging. 
Here we describe the successful development of novel organo-functionalized LP_MSNs by 
employing a dual surfactant system consisting of the triblock copolymer F127 and fluorocarbon 
surfactant FC-4. Low synthesis temperatures (10 °C and 30 °C) and two different micellar 
expanders (1,3,5-trimethylbenzene and 1,3,5-triisopropylbenzene) were applied to generate 
uniform LP_MSNs. We were able to introduce multiple organo-functionalizations (thiol-, 
azide- and amino/phenyl-moieties) into the mesoporous framework by a co-condensation 
approach under mildly acidic conditions. 
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6.2 Results and Discussion 
The synthesis procedure described by Gao et al.7, carried out at low temperatures (10 °C) with 
Pluronic F127 as organic template, fluorocarbon surfactant FC-4 as co-surfactant and 
1,3,5-trimethylbenzene (TMB) as micellar expander served as a starting point for this work. 
The impact of different hydrothermal treatment steps in acidic media on the pore size of the 
synthesized nanoparticles was investigated with nitrogen adsorption measurements 
(cf. appendix 6.22) and transmission electron microscopy (cf. appendix 6.23). It was shown that 
non-hydtrothermally treated particles exhibit smaller pore sizes than those synthesized with the 
typical hydrothermal treatment. Hydrothermal treatment leads to an increase in entropy and an 
additional expansion effect on the micelles by the organic swelling agent. It proved mandatory 
to employ slightly more acidic conditions for the second hydrothermal treatment (0.2 M 
hydrochloric acid); it is assumed that the presence of the diluted hydrochloric acid leads to an 
additional ‘etching’ of the pore entrances. TEM micrographs of the unfunctionalized, 
hydrothermally treated MSNs with large pores (LP_MSN-bare) are shown in Figure 6.1. 
 
Figure 6.1: TEM micrographs of unfunctionalized LP_MSNs synthesized with TMB at 10 °C. 
The TEM micrographs show spherically shaped particles within a size range of 70 – 100 nm 
and large pores of 10 – 15 nm. The pores are regularly arranged over the entire nanoparticle. 
Besides the particles a small amount of impurities is present in the sample. Kruk and co-workers 
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reported that the pore size of SBA-15 particles can be increased by the substitution of TMB by 
1,3,5-triisopropylbenzene (TiPB)24, 25 and we had successfully shown a similar increase of the 
pore size for core-shell MSNs (cf. chapter 4).3 Therefore, the impact of TiPB as micellar 
expander on the synthesis of unfunctionalized LP_MSNs was investigated. 
6.2.1 Synthesis of unfunctionalized large pore silica nanoparticles  
Synthesis of LP_MSNs with TiPB as micellar expander at 10 °C 
In brief, a modified synthesis protocol based on the publication of Gao et al. was employed for 
the synthesis of LP_MSNs with TiPB as micellar expander.7 The mildly acidic surfactant 
solution consisting of the dual surfactant system Pluronic F127 and fluorocarbon surfactant 
FC-4, together with a distinct amount of TiPB (same molar amount previously applied for 
TMB), was allowed to stir for 2 h at 10 °C to induce micelle formation. After this time period, 
tetraethyl orthosilicate (TEOS) was introduced drop-wise into the surfactant solution as silica 
source and the reaction mixture was allowed to stir over night at 10 °C. The as-synthesized 
LP_MSNs were hydrothermally treated for one day at 150 °C in the synthesis solution. 
Subsequently they were centrifuged and re-suspended in 0.2 M hydrochloric acid. A second 
hydrothermal treatment step (140 °C, 2 d) was employed afterwards. The structure-directing 
agent was removed by solvent extraction in a mixture of ethanol, acetone and hydrochloric acid 
to maintain the colloidal behavior of the nanoparticles. In order to study the impact of TiPB on 
the mesostructure, the template-free, unfunctionalized LP_MSNs (LP_MSN-bare-TiPB) were 
compared with LP_MSNs generated with TMB (LP_MSN-bare-TMB). The hydrothermal 
treatment and template removal was identical for both samples. The resulting samples 
(LP_MSN-bare) were investigated with small angle X-ray diffraction (SAXS). The diffraction 
pattern for LP_MSN-bare-TiPB shows a reflection at 2θ = 0.55° (cf. appendix 6.24). 
Additionally, for both samples nitrogen physisorption measurements were performed 
(Figure 6.2). 
6.2. Results and Discussion  
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Figure 6.2: Nitrogen sorption data for LP_MSN-bare synthesized at 10 °C with 1,3,5-trimethylbenzene 
(LP_MSN-bare - 10 °C - TMB, black) and 1,3,5-triisopropylbenzene (LP_MSN-bare - 10 °C - TiPB, 
blue) as micellar expander. A) Nitrogen sorption isotherms and B) calculated NLDFT pore size 
distributions of template-free LP_MSNs. 
The isotherm of LP_MSN-bare-TMB (black curve) represents a type IV isotherm with an H3 
hysteresis indicating a significant degree of textural porosity in the macroporous regime. The 
isotherm of LP_MSN-bare-TiPB (blue curve) shows the same characteristic but with lower 
values of adsorbed volumes. A monolayer formation of the adsorbate can be observed between 
p/p0 = 0 and 0.02, followed by multilayer adsorption over a broad range. Both isotherms show 
a relatively flat slope during capillary condensation at p/p0 = 0.5–0.8, resulting in broad pore 
size distributions (PSD) for both samples (Figure 6.2B). In addition, the slope is notably flatter 
for LP_MSN-bare - 10 °C - TiPB resulting in an even wider PSD than was observed for 
LP_MSN-bare - 10 °C - TMB; a distinct maximum cannot be obtained for the LP_MSNs 
synthesized with TiPB. Both isotherms do not reach a saturation plateau at high p/p0 values 
indicating the presence of either impurities within the sample or textural porosity. The resulting 
BET surface areas, pore volumes and pore sizes are summarized in Table 6.1. 
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Table 6.1: Nitrogen sorption data of LP_MSN-bare synthesized with different micellar expanders.  
Sample BET surface area 
(m²/g) 
Pore volume 
(cm³/g) 
Pore size (nm) 
LP_MSN-bare – 10 °C – TMB 431 0.84 5–17 
LP_MSN-bare – 10 °C – TiPB 249 0.51 6–13 
 
Compared to conventional MSNs4, 28 and SBA-15 materials22, 24, the BET surface area is rather 
low for both obtained nanoparticles, but in the typical range of LP_MSNs generated with FC-4 
reported by Gao et al. (As = 201 – 561 m2/g, dependent on the synthesis employed).7 From the 
shape of the pore size distribution it can be concluded that the formation of the mesostructure 
is, at least partly disrupted by the TiPB at the applied synthesis conditions. The scanning 
electron microscopy image of LP_MSN-bare synthesized with TiPB shows a broad particle size 
distribution with spherical nanoparticles in the size range of 50 – 300 nm, allowing us to assume 
that the particle morphology itself is not disrupted by the micellar expander (Figure 6.3). It can 
be concluded that the synthesis approach with TiPB at low temperatures is not favorable for the 
generation of well-defined LP_MSNs without organo-functionality. 
 
 
Figure 6.3: Scanning electron micrograph of LP_MSN-bare synthesized at 10 °C with TiPB. 
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Synthesis of unfunctionalized large pore silica nanoparticles with TiPB at 30 °C 
As the synthesis approach at 10 °C with TiPB does not lead to the desired result but partly 
disrupted the mesostructure, a higher synthesis temperature was examined. The synthesis of 
unfunctionalized LP_MSN-bare at 30 °C was based on the previously described procedure 
reported by Gao et al.7 In comparison to the aforementioned synthesis we used TiPB at a distinct 
synthesis temperature of 30 °C for the synthesis of LP_MSNs. TEOS was hydrolyzed in a 
mildly acidic reaction mixture containing the tri-block copolymer Pluronic F127, fluorocarbon 
surfactant FC-4 and TiPB in an overnight reaction which yielded the LP_MSNs as white 
precipitate. For all samples the two step post-synthetic hydrothermal treatment (1 d at 150 °C, 
2 d at 140 °C) introduced by Gao et al. was applied.7  
 
Figure 6.4: Nitrogen physisorption data of unfunctionalized LP_MSN-bare synthesized at 30 °C with 
TiPB A) Nitrogen sorption isotherm and B) calculated NLDFT pore size distribution. 
The nitrogen adsorption isotherm (Figure 6.4A) reveals a type IV isotherm typical for 
mesoporous materials. The first part of the isotherm at relative pressures between 0 and 0.2 p/p0 
shows a nearly logarithmic slope that can be assigned to monolayer adsorption of nitrogen. 
Monolayer adsorption is followed by linearly increasing multilayer adsorption taking place at 
p/p0 values of 0.2–0.42. At p/p0 values between 0.42 and 0.92 the isotherm ascends steeply and 
a hysteresis occurs between the adsorption and the desorption branch resulting from capillary 
condensation. At relative pressures higher than 0.92, the isotherm almost reaches a plateau 
indicating that pore saturation occurs. NLDFT pore size distribution calculated from nitrogen 
sorption data gave an average pore diameter of 8.2 nm for the LP_MSNs with a narrow 
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distribution pattern comparable to LP_MSNs synthesized at 10 °C with TMB. The XRD 
diffraction pattern (cf. appendix 6.25) showed a (1 0 0) reflection at 2θ = 0.64°, which gave a 
calculated d-spacing of d100 = 13.8 nm. Dynamic light scattering (DLS) measurements in 
ethanolic media feature an average particle size of 145 nm with a narrow particle size 
distribution (Figure 6.5). No agglomeration of LP_MSNs occurred in ethanolic suspensions and 
the sample showed good colloidal stability. 
 
Figure 6.5: Dynamic light scattering (DLS) measurement of large pore mesoporous silica nanoparticles 
(LP_MSNs) without organo-functionalization synthesized at 30 °C with TiPB as micellar expander in 
ethanol. 
The key features of LP_MSN-bare obtained with nitrogen sorption measurements and dynamic 
light scattering are summarized in Table 6.2. The unfunctionalized LP_MSNs exhibit a high 
pore volume and a BET surface area typical for large pore silica nanoparticles. We note that the 
BET surface area for LP_MSN-bare synthesized with TiPB at 30 °C is lower than for LP_MSNs 
generated with TMB (As = 421 m
2/g). 
 
Table 6.2: Structural parameters of LP_MSN-bare synthesized with TiPB at 30 °C. 
Sample Particle sizea         
(nm) 
BET surface 
area (m²/g) 
Pore volume 
(cm³/g) 
Pore sizeb 
(nm) 
LP_MSN-bare 30 °C 145 321 0.72 8.2 
aAverage particle size refers to the peak value of the particle size distribution derived from DLS measurements in 
ethanolic solution; bDFT pore size refers to the peak value of the pore size distribution. 
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Transmission electron microscopy (TEM) was conducted in order to obtain a detailed overview 
of the morphology of the synthesized, template-extracted LP_MSNs. 
 
 
Figure 6.6: Unfunctionalized mesoporous silica nanoparticles synthesized with TiPB as micellar 
expander at 30 °C. A) TEM micrograph and B) STEM micrograph of LP_MSN-bare. The images show 
spherically shaped and uniform particles. 
The representative TEM micrograph (Figure 6.6A) shows a homogenously composed sample 
with spherically shaped particles having an average diameter of about 120 nm, which is in good 
accordance with the data obtained from dynamic light scattering. The slightly higher value 
derived from DLS can be explained by the hydrodynamic radius of the measured sample and 
weak agglomeration. The mesopores are clearly visible and evenly distributed over the entire 
nanoparticle and in good accordance with the data obtained from nitrogen physisorption. It can 
be noted that the synthesized LP_MSNs, compared to standard MSNs (cf. chapter 4 and 5) and 
unfunctionalized LP_MSNs synthesized at 10 °C, seem to exhibit an entirely different growth 
mechanism visible by transmission electron microscopy (cf. chapter 4 and Figures 6.1 and 6.6). 
TEM data of the standard MSNs suggest a typical radial growth mechanism, resulting in a 
worm-like mesoporous network. Additionally, scanning transmission electron microscopy 
(STEM) images were recorded to gain an even better contrast of the mesoporous framework of 
the LP_MSNs (Figure 6.6 B). 
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In summary, we were able to successfully synthesize spherical, homogenous LP_MSN-bare 
with TiPB as micellar expander and a synthesis temperature of 30 °C; the data show that the 
higher temperature combined with TiPB has a positive effect on the mesostructure formation 
of unfunctionalized LP_MSNs. Compared to the samples generated at 10 °C with TMB, less 
impurities were observed and the LP_MSNs exhibit a narrower pore size distribution. 
Additionally, the nanoparticles are of well-defined spherical shape and homogeneous within 
the sample. 
6.2.2 Synthesis of organo-functionalized large pore mesoporous silica nanoparticles 
One major goal of this work was the synthesis of organo-functionalized LP_MSNs synthesized 
with a direct co-condensation approach. To date, organo-modified large-pore silica 
nanoparticles are only available by applying a post-synthesis grafting step after the original 
synthesis, which has certain drawbacks (e.g., additional modification step under dry 
conditions). It is desirable to achieve good control over the amount of functional groups 
introduced and to obtain a homogenous distribution of organic moieties;4, 28 therefore we 
investigated co-condensation reactions with different organo-silanes (3-mercaptopropyl 
triethoxysilane, 3-azidopropyl triethoxysilane and 3-aminopropyl triethoxysilane : phenyl 
triethoxysilane (1:1 mixture)) with the two above-mentioned micellar expanders at different 
synthesis temperatures (10 °C and 30 °C).  
Synthesis of LP_MSN with thiol-functionality at different temperatures 
For the synthesis of mesoporous silica nanoparticles with ultra-large pores and organo-
functionalization (LP_MSN-SH) a modified sol-gel method at mildly acidic conditions with 
Pluronic F127 as structure directing agent and an increased amount of fluorocarbon surfactant 
FC-4 as co-surfactant was employed.7 We chose to introduce a low amount of 
thiol-functionalization (1 mol% of the original TEOS amount) via a co-condensation method to 
LP_MSNs in order to obtain a homogeneous distribution of the organic-moieties within the 
silica material. The silica source TEOS was mixed with the respective amount of 
3-mercaptopropyl triethoxysilane before the resulting solution was introduced drop-wise into 
an acidic template solution consisting of Pluronic F127, FC-4 and the respective micellar 
expander. The reaction mixture was stirred at the desired temperature (10 °C or 30 °C, 
respectively – dependent of the employed micellar expander) for 14 h.  Afterwards, a two-step 
hydrothermal treatment of the as-synthesized material in acidic media was carried out to yield 
6.2. Results and Discussion  
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two different samples of LP_MSN-SH (cf. experimental section).7. Small angle XRD 
measurements (cf. appendix 6.26A for LP_MSN-SH-30 °C and 6.26B for LP_MSN-SH-10 °C) 
were carried out to yield information about the structural nature of LP_MSN-SH. The sample 
LP_MSN-SH-30 °C shows a sharp reflection (2 theta = 0.65 °) whereas the sample 
LP_MSN-SH-10 °C shows a broadened reflection at 2 theta = 0.68 °. These results are in good 
accordance with the data obtained from nitrogen sorption measurements (cf. Figure 6.7B).  
The isotherm of the template-extracted sample LP_MSN-SH-30 °C (Figure 6.7A, black curve) 
exhibits a steeper slope in the range of p/p0 = 0.5–0.8 compared to LP_MSN-SH-10 °C (blue 
curve). Accordingly, the calculated pore size distribution of the sample synthesized at 30 °C is 
considerably narrower (Figure, 6.7B maximum at 9.4 nm) compared to the pore size distribution 
of LP_MSN-SH-10 °C. In the case of the 30 °C sample, pore saturation is indicated at p/p0 
values beyond 0.9, while the remaining upwards slope hints at additional textural porosity. The 
latter is more pronounced in the case of the 10 °C sample. Dynamic light scattering (DLS) 
measurements of the template-extracted silica nanoparticles after size separation centrifugation 
in ethanol yielded rather similar size distributions with maxima at 164 nm (LP_MSN-SH-30 °C, 
Figure 6.7C, black curve) and 142 nm (LP_MSN-SH-10 °C, blue curve). A narrow particle size 
distribution was observed for both samples, indicating the absence of aggregates. Zeta potential 
measurements gave information about the successful incorporation of organo-functionalization 
on the outer surface, although thiol-moieties do not show distinctly higher values than 
unfunctionalized LP_MSNs (Figure 6.7D). Thiol-groups need to be located at the outer surface 
of the silica nanoparticle to influence the zeta potential of the LP_MSNs. The zeta potential of 
both samples is negative within the pH range of 2–7, since the mercapto moieties cannot be 
protonated at low pH values. The decrease of the zeta potential with increasing pH value is a 
result of the deprotonation of the mercapto-groups. 
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Figure 6.7: Analysis of LP_MSN-SH synthesized with different synthesis procedures; synthesized with 
1,3,5-triisopropylbenzene as micellar expander at 30 °C (black) and TMB at 10 °C (blue). A) Nitrogen 
sorption isotherms of template-free LP_MSNs – the isotherm of LP_MSN-SH-10 °C was shifted by a 
value of 200 along the y-axis for clarity reasons. B) NLDFT pore size distribution. C) Dynamic light 
scattering (DLS) data of the template-extracted nanoparticles in ethanol, and D) zeta potential 
measurements of LP_MSN-SH-30 °C (black), LP_MSN-SH-10 °C (blue) and LP_MSN-bare 
(LP_MSNs without organo-functionality, red). 
The larger pore size of LP_MSN-SH-30 °C results in a lower BET surface area of 492 m2/g 
compared to 521 m2/g for the sample LP_MSN-SH-10 °C. The pore volume is not changed in 
both samples. The key features of the LP_MSN-SH obtained by dynamic light scattering and 
nitrogen adsorption are summarized in Table 6.3. 
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Table 6.3: Dynamic light scattering (DLS) results after size separation centrifugation and nitrogen 
sorption data of LP_MSN-SH synthesized at different temperatures.  
Sample Particle sizea         
(nm) 
BET surface 
area (m²/g) 
Pore volume 
(cm³/g) 
Pore sizeb 
(nm) 
LP_MSN-SH – 30 °C (TiPB) 163 492 1.2 9.4 
LP_MSN-SH – 10 °C (TMB) 142 521 1.2 7.0 
aAverage particle size refers to the peak value of the particle size distribution derived from DLS measurements in 
ethanolic solution; bDFT pore size refers to the peak value of the pore size distribution 
 
We note that despite the different pore sizes of the LP_MSN-SH, the pore volume and the BET 
surface area are similar for both samples, as are the particle sizes obtained from DLS 
measurements. Vibrational spectroscopy gives information about organic moieties within the 
sample and was thus used to obtain insights about the functionality of the samples. 
 
Figure 6.8: Raman spectrum of template-free LP_MSN-SH–10 °C. 
Distinct bands arise (marked with an asterisk in Figure 6.8) at 2725 cm-1 (-CH2-SH, stretching 
vibration) and 734 cm-1 (-C-SH, stretching vibration) indicating a successful 
organo-functionalization with thiol-moieties. Additionally, the C-H stretching vibration modes 
of the alkyl chains (including ethoxy-groups on the silica framework) are present at 2952, 2874 
and 2848 cm-1. From these data, we conclude that thiol-groups were successfully incorporated 
into the mesoporous framework of LP_MSNs via the co-condensation approach. The 
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morphology and pore structure of both LP_MSN samples was investigated with transmission 
electron microscopy after size separation centrifugation. The nanoparticles of sample 
LP_MSN-SH-30 °C (Figure 6.9A and B) are of spherical shape with particle diameters within 
a size range of 70 – 120 nm. The mesopores are visible and evenly distributed within each 
particle of the sample LP_MSN-SH. The pores appear in a size range of 8 – 10 nm (data taken 
from the micrograph), which is in good accordance with the nitrogen adsorption results for 
LP_MSN-SH-30 °C. We note that the mesoporous structure of the sample synthesized at 10 °C 
with TMB (LP_MSN-SH-10 °C, Figure 6.9C and D) appears to be slightly less ordered than 
LP_MSN-SH-30 °C. The majority of the nanoparticles in the sample after size separation 
centrifugation is of spherical shape with a particle size between 90 – 170 nm, which is in good 
accordance with the DLS measurements. 
 
 
Figure 6.9: Transmission electron micrographs after size separation centrifugation of two differently 
synthesized, template-extracted LP_MSN-SH, A) and B) synthesized with TiPB as micellar expander 
at 30 °C (sample LP_MSN-SH-30 °C). C) and D) LP_MSN-SH synthesized with the same molar 
amount of TMB and a synthesis temperature of 10 °C (sample LP_MSN-SH-10 °C). 
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From all the obtained data it can be concluded that both synthesis approaches yield 
LP_MSN-SH of a distinct small size suitable for post-synthesis modifications. 
 
Synthesis of LP_MSNs with azide-functionality at 10 °C with TMB as micellar expander 
Azide-functionalized mesoporous silica nanoparticles with ultra-large pores (LP_MSN-N3) 
were successfully synthesized employing a modified sol-gel method at mildly acidic conditions 
and low temperatures (10 °C).7These LP_MSNs are suitable for the immobilization of alkyne-
functionalized enzymes by a click chemistry approach. In brief, a co-condensation approach 
was chosen to introduce low amounts (1 mol% of the original TEOS amount) of azide-
functionality into the mesoporous framework of the LP_MSNs and to obtain a homogeneous 
distribution of organic-moieties within the silica material. For this purpose, the silica source 
TEOS was mixed with freshly synthesized 3-azidopropyl triethoxysilane (AzTES)29 before the 
resulting solution was introduced into an acidic solution consisting of the dual surfactant system 
Pluronic F127 and an increased amount of FC-4 (1.4 g), together with TMB). We applied a 
hydrothermal treatment of the as-synthesized material in acidic media developed by Gao et al. 
in order to obtain LP_MSN-N3 (cf. experimental section).
7 The key features of the newly 
generated LP_MSN-N3 are summarized below. 
Table 6.4: Dynamic light scattering (DLS) after size separation centrifugation and nitrogen sorption 
data of LP_MSN-N3.  
Sample Particle sizea         
(nm) 
BET surface 
area (m²/g) 
Pore volume 
(cm³/g) 
Pore sizeb 
(nm) 
LP_MSN-N3 220 150 0.7 11.8 
aAverage particle size refers to the peak value of the particle size distribution after size separation centrifugation 
derived from DLS measurements in ethanolic solution; bDFT pore size refers to the peak value of the pore size 
distribution. 
Transmission electron microscopy (Figure 6.10A) and scanning TEM images (Figure 6.10B) 
after size separation centrifugation show spherically shaped nanoparticles with a narrow 
particle size distribution within a size range of 80 – 150 nm. The large pores are present in each 
LP_MSN-N3 nanoparticle and evenly distributed over the entire particle. 
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Figure 6.10: A) Transmission electron micrograph of LP_MSN-N3 after size separation centrifugation 
and B) scanning transmission electron micrograph of LP_MSN-N3. 
The detailed analysis and discussion of the sample LP_MSN-N3 is given in Chapter 7, 
describing their performance as solid support for the alkyne-functionalized enzymes 
cytochrome C (sp-CytC) and alkyne-functionalized trypsin (sp-trypsin). 
 
Synthesis of LP_MSNs with amino/phenyl-functionality 
T. Lebold showed in his doctoral thesis (LMU) that co-condensed SBA-15 type particles cannot 
be synthesized exclusively as amino-functionalized derivative, as 3-aminopropyl 
triethoxysilane (APTES) disrupts the mesostructure of the silica material.30 However, a 
co-condensation approach can be successfully pursued for SBA-15 when APTES (5 mol% of 
the original TEOS amount employed for unfunctionalized SBA-15) is reacted together with 
phenyl triethoxysilane (PTES, 5 mol%) and TEOS (90 mol% of the original amount).31 To 
generate amino/phenyl functionalized LP_MSNs, the silica source TEOS was mixed with 
0.5 mol% APTES and 0.5 mol% PTES before the resulting precursor solution was introduced 
into an acidic solution consisting of the dual surfactant system Pluronic F127 and an increased 
amount of FC-4 (1.4 g), together with TMB. The as-synthesized LP_MSNs were 
hydrothermally treated according to the previously described procedure before the template was 
removed by solvent extraction in a mixture of ethanol, acetone and hydrochloric acid to retain 
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the colloidal behavior of the nanoparticles. The obtained, template-free LP_MSN-NH2/Ph 
particles were investigated with nitrogen physisorption. 
 
Figure 6.11: Nitrogen sorption data of LP_MSN-NH2/Ph with 1 mol% functionality; A) nitrogen 
adsorption isotherm, and B) calculated NLDFT pore size distribution. 
The isotherm of LP_MSN-NH2/Ph can be interpreted as a hybrid form between a type II 
isotherm combined with a certain degree of type IV. The hysteresis can be characterized as an 
H3 hysteresis loop that results from aggregation and thus from a significant degree of textural 
porosity (Figure 6.11A). A monolayer formation of the adsorbate can be observed between 
p/p0 = 0 and 0.02, followed by multilayer adsorption over a broad range. The lack of saturation 
at high p/p0 values can be explained with the large structural pore diameter of our synthesized 
LP_MSN-NH2/Ph, in combination with larger textural interparticle voids that are present 
between the dried LP_MSNs. The calculated pore size (Figure 6.11B), exhibiting a maximum 
at 13 nm, show the presence of a mesoporous MSN material, which was confirmed with 
transmission electron microscopy. The key features of the LP_MSN-NH2/Ph derived from DLS 
measurements and N2 physisorption are summarized in Table 6.5. 
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Table 6.5: Dynamic light scattering (DLS) after size separation centrifugation and nitrogen sorption 
data of LP_MSN-NH2/Ph with 1 mol% functionality.  
Sample Particle sizea         
(nm) 
BET surface 
area (m²/g) 
Pore volume 
(cm³/g) 
Pore sizeb 
(nm) 
LP_MSN-NH2/Ph  90 176 0.8 13.0 
aAverage particle size after size separation centrifugation refers to the peak value of the particle size distribution 
derived from DLS measurements in ethanolic solution; bDFT pore size refers to the peak value of the pore size 
distribution. 
 
 
Figure 6.12: A) Dynamic light scattering data of LP_MSN-NH2/Ph after size separation centrifugation 
and B) zeta potential measurements of LP_MSN-NH2/Ph (blue) and unfunctionalized LP_MSN-bare 
(black). 
Compared to unfunctionalized LP_MSNs (black curve), the sample LP_MSN-NH2/Ph (blue 
curve) shows positive zeta potential values between pH 2 and pH 5, which is typical for 
materials with amino-functionality at the outer surface. With increasing pH, the degree of 
protonation declines, resulting in a decrease of the zeta potential values. At pH values between 
5 and 7, the potential turns negative due to the deprotonation of the remaining silanol groups. 
The entire curve is typical for amino-functionalized nanoparticles and indicates the successful 
functionalization of LP_MSN by co-condensation. The isoelectric point (IEP) for the sample 
LP_MSN-NH2/Ph is about 4.9, a value that is comparably high considering only 1 mol% overall 
functionalization within the nanoparticles. The IEP is about 1.9 for LP_MSN-bare, which 
results from the silanol groups of the silica framework leading to a more negative surface upon 
deprotonation. We note that an analysis of the LP_MSNs with spectroscopic methods did not 
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yield sufficient information about the successful incorporation of functional groups within the 
mesoporous framework, as only 1 mol% overall functionality is present in the nanoparticles. 
 
 
Figure 6.13: Transmission electron microscopy analysis of LP_MSN-NH2/-Ph with 1 mol% 
amino/phenyl functionalization after size separation centrifugation. A) TEM micrograph and B) 
scanning TEM micrograph. 
6.2.3 Hollow sphere mesoporous silica nanoparticles with amino/phenyl-
functionalization 
In this section we report about the unexpected formation of hollow sphere mesoporous 
nanoparticles by using a modified synthesis of the large-pore mesoporous nanoparticles. Here, 
the original synthesis of Gao et al. was modified with respect to the amount of applied silica 
precursor, as TEOS was partly substituted through organo-silanes (5 mol% phenyl 
triethoxysilane and 5 mol% 3-aminopropyl triethoxysilane)7 to generate organo-functionalized 
LP_MSNs via a facile co-condensation approach. The respective organo-silanes were mixed 
with the 90 mol% of the original amount of TEOS at ambient temperature before the silica 
precursor solution was added drop-wise to the mildly acidic reaction mixture consisting of 
Pluronic F127, fluorocarbon surfactant FC-4 and TMB. Initially, the reaction mixture was 
stirred at 10 °C over night without the hydrothermal treatment steps as previously described, 
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but instead of the expected LP_MSNs with amino-functionality, hollow sphere nanoparticles 
(HS_MSNs) were obtained. Nitrogen adsorption revealed a hybrid-isotherm (type II with a 
certain amount of type IV) with a typical H3 hysteresis loop, indicating a certain degree of 
textural porosity, a low BET surface area of As = 182 m²/g, a low pore volume of 0.36 cm
3/g 
and a rather broad NLDFT pore size distribution between 4.8 and 15 nm (Figure 6.14). 
 
Figure 6.14: Nitrogen sorption data of hollow spheres HS_MSN-NH2/Ph with 10 mol% functionality 
synthesized over night. A) Nitrogen sorption isotherm and B) DFT pore size distribution. 
No saturation is reached at high relative pressures implying either high textural porosity or the 
presence of a large amount of unstructured material within the sample; the latter was confirmed 
by scanning electron microscopy (SEM, Figure 6.15). 
 
Figure 6.15: SEM micrographs of HS_MSN-NH2/Ph (with 10 % organo-functionality consisting of 
5 mol% PTES and 5 mol% APTES) synthesized with TMB at 10 °C overnight. 
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The micrographs show that only a small number of spherically shaped nanoparticles in a size 
range of 30 – 60 nm is present in the sample, whereas large parts of the sample consist of 
unstructured bulk material.  
The same synthesis pathway was also examined with reduced stirring time in order to reduce 
silica precursor condensation and to limit the formation of the disordered structures present in 
the above-mentioned synthesis. Indeed, completely different hollow sphere morphologies were 
obtained following this synthetic pathway. The process of hollow sphere (HS) formation within 
the reaction time was followed by dynamic light scattering (Figure 6.16A) and was stopped 6 h 
after the initial TEOS addition. The synthesis was completed by a two-step hydrothermal 
treatment (1 d at 150 °C in the original synthesis solution, 2 d at 140 °C in 0.2 M hydrochloric 
acid) and the template was removed from the mesopores via solvent extraction. DLS 
measurements of the template-extracted nanoparticles in ethanol revealed a homogeneous 
sample without agglomeration (Figure 6.16B), with a maximum at 32 nm, which corresponds 
to the initial peak obtained for the as-synthesized LP_MSNs after 2 h. 
 
Figure 6.16: Dynamic light scattering (DLS) measurements of the sample HS_MSN-NH2/Ph in ethanol. 
A) Time-dependent particle formation of HS_MSN-NH2/Ph after initial TEOS addition to the dual 
surfactant solution and B) DLS of template-extracted HS_MSN-NH2/Ph exhibiting a single peak with a 
maximum at 32 nm. 
Nitrogen adsorption measurements yield a type IV isotherm typical for mesoporous materials 
(Figure 6.17A) showing a H1 hysteresis loop. The isotherm nearly reaches saturation at high 
p/p0 values, indicating a homogeneous sample with barely any textural porosity. The isotherm 
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increases in the first part up to a relative pressure of 0.2, which can be attributed to the 
monolayer adsorption. Subsequently, multilayer adsorption takes place resulting in a linear 
slope of the isotherm at p/p0 values between 0.2 and 0.45. At relative pressures of 0.45–0.95 
capillary condensation occurs which results in a hysteresis loop between the adsorption and the 
desorption branch. Since the slope of the desorption branch at relative pressures p/p0 between 
0.5 and 0.8 is relatively constant, a broad NLDFT pore size distribution (Figure 6.17B) is 
obtained. The pore size distribution extracted from nitrogen sorption data indicates that a 
mesoporous system with bimodal pores (maxima at 6.6 nm and 19 nm) and very high pore 
volumes (Table 6.6) was synthesized. Transmission electron microscopy (TEM) shows hollow 
sphere silica particles (HS_MSNs) with an approximate diameter of 25–30 nm (Figure 6.17C 
and D). The sample is rather monodisperse and no impurities are detectable, which is also 
supported by the dynamic light scattering (DLS) results giving an average particle diameter of 
32 nm after extraction. All particles possess only one large pore (light grey) which is surrounded 
by a thin silica layer (dark grey). The mean pore diameter visible in TEM is 12 – 15 nm whereas 
the width of the silica coating is between 5 – 9 nm. We note that these results seem to differ 
from the above-mentioned bimodal pore system; we attribute the peak at 6.6 nm to textural 
porosity between the dried particles (Figure 6.17C – red lines) and additionally to the windows 
into the hollow spheres, some of which can be seen in Figure 6.17D).  
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Figure 6.17: Characterization of silica hollow spheres HS_MSN-NH2/Ph obtained after a reaction time 
of 6 h. A) Nitrogen sorption isotherm of HS_MSN-NH2/Ph, B) calculated NLDFT pore size distribution 
showing a bimodal pore system, C) Transmission electron microscopy image of amino/phenyl-
functionalized hollow sphere MSNs (red bars indicating interparticle porosity), and D) scanning 
transmission electron micrograph of the sample HS_MSN-NH2/Ph. 
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Table 6.6: Dynamic light scattering (DLS) and nitrogen sorption data of HS_MSN-NH2/Ph synthesized 
with TMB at 10 °C and a reaction time of 6 h.  
Sample Particle sizea         
(nm) 
BET surface area 
(m²/g) 
Pore volume 
(cm³/g) 
Pore sizeb 
(nm) 
HS_MSN-NH2/Ph – 6 h 32 486 1.13 6.6 & 19 
aAverage particle size refers to the peak value of the particle size distribution derived from DLS measurements in 
ethanolic solution; bDFT pore size refers to the two peak values of the pore size distribution. 
 
To prove the functionality of the hollow sphere silica nanoparticles, zeta potential 
measurements of HS_MSN-NH2/Ph and unfunctionalized LP_MSNs were recorded and 
additionally Raman spectroscopy was performed with the synthesized material. The zeta 
potential of the synthesized silica nanoparticles is highly dependent of the pH value of the 
aqueous solution (Figure 6.18A). A positive surface charge refers to protonable groups such as 
amino-moieties. The sample HS_MSN-NH2/Ph (blue curve) shows, compared to 
LP_MSN-bare (LP_MSNs without organo-functionality, black curve), highly positive zeta 
potential values over the entire acidic pH range. The isoelectric point (IEP) for the sample 
HS_MSN-NH2/Ph at a pH value of 5 is indicating amino-groups located at the outer surface of 
the hollow sphere silica nanoparticles, as the unfunctionalized LP_MSNs have an IEP = 2.0. 
As mentioned above, this is an effect of the silanol groups of the silica framework leading to a 
more negative surface upon deprotonation. The obtained zeta potential data for 
HS_MSN NH2/Ph give a first indication of the successful incorporation of amino-moieties. 
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Figure 6.18: A) Zeta potential measurements of HS_MSN-NH2/Ph (blue) and unfunctionalized 
LP_MSN-bare (black) and B) Raman spectrum of HS_MSN-NH2/Ph. 
The existence of functional groups in the sample HS_MSN-NH2/Ph can be demonstrated with 
Raman spectroscopy (Figure 6.18B) since the phenyl-moieties in the sample exhibit strong 
bands. The HS_MSN-NH2/Ph shows characteristic bands of the aromatic system at 3065 cm
-1 
(C-H stretching vibration of aromatic rings), 1598 cm-1 (-C=C- stretching vibration), 1572 cm-1 
(ring vibration) and a deformation vibration of the phenyl ring at 998 cm-1. Additionally, the 
C-H stretching vibration modes of the alkyl chains (including ethoxy-groups on the silica 
framework) are present at 2983, 2939 and 2902 cm-1. In addition to the above-mentioned 
analysis methods that already confirm the successful amino/phenyl-functionalization of the 
hollow spheres, the amino-moieties of the sample were reacted with carboxy-terminated gold 
nanoparticles (AuNPs, 3 nm diameter)32 via an EDC amidation. The sample was subsequently 
washed thoroughly to remove the excess of unbound AuNPs and was investigated with 
scanning transmission electron microscopy (STEM, Figure 6.19). The staining can be imaged 
with STEM due to the z-contrast between gold and silica, giving a better contrast than TEM 
imaging. 
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Figure 6.19: STEM micrograph of HS_MSN-NH2/Ph (5 mol% PTES, 5 mol% APTES) stained with 
covalently attached AuNPs (3 nm).  
The representative STEM image of HS_MSN-NH2/Ph with covalently attached AuNPs shows 
an increased concentration of the gold nanoparticles (small white dots) on the silica material of 
the particles (grey circle), suggesting a successful amino-functionalization of the hollow 
spheres. We conclude from the obtained data for HS_MSN-NH2/Ph the successful synthesis of 
organo-functionalized hollow sphere silica nanoparticles with a rather uniform particle size of 
around 32 nm and one single pore with an average diameter of 15 nm. 
In addition to the newly developed synthesis pathway described above, the micellar expander 
TMB was substituted by an equal molar amount of TiPB. The influence of the different swelling 
agent on the synthesis of hollow sphere silica nanoparticles was studied in detail together with 
the influence of the reaction time (6 h and overnight). We followed the previously described 
fluorocarbon surfactant-assisted synthesis pathway with Pluronic F127 as structure directing 
agent under mildly acidic conditions, but changed the reaction temperature to 30 °C and 
substituted TMB against an equal molar amount of TiPB. TEOS (90 mol% of the original 
amount) was partly substituted through phenyl triethoxysilane (5 mol%) and APTES (5 mol%). 
The two-step hydrothermal treatment approach (1 d at 150 °C, 2 d at 140 °C in 0.2 M 
hydrochloric acid) and the template removal was identical for both samples. The obtained 
amino/phenyl functionalized silica nanoparticles were characterized with regard to their particle 
size, porosity and morphology with dynamic light scattering (DLS), nitrogen physisorption and 
transmission electron microscopy, respectively. Additionally, the organo-functionalization of 
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the synthesized HS_MSNs was investigated with zeta potential measurements. The obtained 
results are summarized in Figure 6.20 (DLS, nitrogen sorption and zeta potential measurements) 
and Figure 6.21 (TEM images). 
 
Figure 6.20: Analysis of amino/phenyl functionalized hollow sphere silica nanoparticles (HS_MSNs) 
synthesized with TiPB as micellar expander during different reaction times; HS_MSN-NH2/Ph-
overnight (black) and HS_MSN-NH2/Ph-6 h (blue). A) Nitrogen sorption isotherms of template-free 
HS_MSNs, B) NLDFT pore size distributions, C) dynamic light scattering (DLS) data of the 
as-synthesized nanoparticles in ethanol, and D) zeta potential measurements of HS_MSN-NH2/Ph-
overnight (black), HS_MSN-NH2/Ph-6h (blue) and LP_MSN-bare (LP_MSN without organo-
functionality, red). The color coding (black, blue) is consistent in the different panels. 
The nitrogen adsorption isotherms (Figure 6.20A) for both samples reveal a type IV isotherm 
which is typical for mesoporous materials. The first part of the isotherm at relative pressures 
between 0 and 0.2 p/p0 can be assigned to monolayer adsorption of nitrogen. Both samples 
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show a multilayer adsorption at p/p0 values between 0.2–0.6. The capillary condensation which 
follows after the multilayer adsorption ranges between p/p0 = 0.6–0.9 for HS_MSN-NH2/Ph-
overnight and p/p0 = 0.6–0.95 for HS_MSN-NH2/Ph-6h. A slight shift to higher pressures for 
HS_MSN-NH2/Ph-6h can be noted, whereas the absolute value of adsorbed nitrogen amount is 
increased for the sample HS_MSN-NH2/Ph-overnight. At relative pressures higher than 0.92, 
both isotherms reach a plateau, indicating pore saturation followed by adsorption at the external 
surface of the nanoparticles. The particle size of the as-synthesized amino/phenyl functionalized 
nanoparticles was determined by dynamic light scattering in ethanol (Figure 6.20C); both 
samples show a nearly identical and very homogenous particle size distribution with a 
maximum at 24 nm for HS_MSN-NH2/Ph-overnight and 22 nm for HS_MSN-NH2/Ph-6h. The 
key features of the synthesized silica hollow spheres, obtained with dynamic light scattering 
and nitrogen adsorption, are summarized in Table 6.7. 
Table 6.7: Dynamic light scattering (DLS) and nitrogen sorption data of HS_MSN-NH2/Ph-overnight 
and HS_MSN-NH2/Ph-6h synthesized with TiPB at 10 °C.  
Sample Particle sizea         
(nm) 
BET surface 
area (m²/g) 
Pore volume 
(cm³/g) 
Pore sizeb 
(nm) 
HS_MSN-NH2/Ph - overnight 22 503 1.18 6.5-12.5 
HS_MSN-NH2/Ph – 6 h 24 412 0.97 5.7-12.5 
aAverage particle size after size separation centrifugation refers to the peak value of the particle size distribution 
derived from DLS measurements in ethanolic solution; bDFT pore size refers to the peak value of the pore size 
distribution 
 
The applied synthesis procedure leads to a lower BET surface area for the sample synthesized 
with a reaction time of 6 h (As = 412 m
2/g compared to As = 486 m
2/g for HS_MSNs synthesized 
at 10 °C), whereas the BET area for the sample HS_MSN-NH2/Ph-overnight is slightly higher 
compared to the previously synthesized HS_MSN-NH2/Ph, as is the pore volume (1.18 cm
3/g 
compared to 1.13 cm3/g for HS_MSNs synthesized at 10 °C). In order to prove the successful 
incorporation of organo-functionality into the mesoporous framework of the HS_MSNs, zeta 
potential measurements with the template-free samples were carried out (Figure 6.20D). Both 
amino/phenyl functionalized HS_MSNs show the typical zeta potential values for silica 
nanoparticles with amino-moieties on the outer surface. It can be noted that the zeta potential 
values for the sample HS_MSN-NH2/Ph-overnight are slightly higher than for 
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HS_MSN-NH2/Ph - 6 h at pH 2, whereas the isoelectric point is higher for 
HS_MSN-NH2/Ph-6h (IEP = 5.0 compared to 4.4 for HS_MSN-NH2/Ph-overnight). The IEP = 
5.0 is similar to that obtained for the sample synthesized at 10 °C and with TMB. From the 
results it can be concluded that extremely small hollow sphere silica nanoparticles with amino-
moieties were synthesized with this novel synthesis procedure. 
In order to investigate the homogeneity, the morphology and the shape of the synthesized 
nanoparticles, transmission electron microscopy analysis of both samples was performed 
(Figure 6.21). 
 
Figure 6.21: Transmission electron microscopy images of A) HS_MSN-NH2/Ph stirred overnight at 
30 °C and B) HS_MSN-NH2/Ph stirred for 6 h. 
Both samples, HS_MSN-NH2/Ph-overnight and HS_MSN-NH2/Ph-6 h, show small 
nanoparticles within a size range of 10 – 15 nm and display no contamination with unstructured 
silica material. The particles are constituted of a silica shell (dark grey) that surrounds one single 
large pore (light grey) with pore diameters of 5 – 10 nm, which is smaller than the value 
obtained for HS_MSNs synthesized with TMB at 10 °C. Additionally, the homogeneity is 
reduced compared to the previous sample and in both cases, the particles are partially 
fragmented. Additionally, it can be noted that a reduced reaction time leads to a strong decrease 
of particle numbers. It appears from the obtained TEM data that the employment of TiPB and 
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the higher synthesis temperature of 30 °C seem to disrupt the formation of hollow sphere silica 
nanoparticles, implying that his approach is unfavorable for the generation of amino-
functionalized silica hollow spheres. 
6.3 Conclusion 
We report for the first time the FC-4 assisted synthesis of organo-functionalized large-pore 
MSNs via a co-condensation method. Different mesoporous silica nanoparticles with ultra-large 
pores (LP_MSNs) suitable for the adsorption of biomolecules were successfully synthesized 
using a dual-surfactant mediated synthesis pathway. A fluorocarbon surfactant-mediated 
synthesis at low temperatures and mildly acidic conditions with a dual surfactant system (FC-4 
and Pluronic F127) and a micellar expander proved to be successful for the generation of 
LP_MSNs. The employment of fluorocarbon surfactant FC-4 was crucial for the synthesis 
procedure to yield nanoparticles of defined small sizes. Different silica nanoparticles with 
various pore sizes were generated throughout this work, ranging from LP_MSNs with a pore 
size of 8 nm to hollow spheres (HS_MSNs) offering a single pore of about 20 nm. Importantly, 
different functional groups (amino-, thiol- and azide-moieties) could be introduced into the 
silica framework via an one-pot co-condensation approach, which allows for the generation of 
a platform for post-synthesis modifications and immobilization of different cargo molecules, to 
be addressed in the following chapters. The impact of different molar ratios of 3-aminopropyl 
triethoxysilane (APTES) on the mesostructure formation was studied in detail together with the 
influence of temperature on the synthesis. Thus, in summary, we present the successful 
development of artificial hybrid nano-constructs based on structurally stable, mesoporous 
colloidal silica materials with defined morphologies and tuneable mesopores. These novel 
nanomaterials featuring large mesopores are suitable to act as solid support for biomolecules 
and for advanced host-guest chemistry and can be post-synthetically functionalized with 
stimuli-responsive trigger functions and cell-dependent recognition molecules. Both 
applications of these novel LP_MSNs will be discussed in the next chapter. 
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6.4 Experimental 
Chemicals: Pluronic F127 (F127, Sigma), fluorocarbon surfactant 4 (FC-4, Yick-vik 
Chemicals), tetraethyl orthosilicate (TEOS, Fluka, >99%), 1,3,5-trimethylbenzene (TMB, 
Fluka, 96%), 1,3,5-triisopropylbenzene (TiPB, Fluka, >95%), ethanol absolute (EtOH, Aldrich, 
>99.5%), conc. hydrochloric acid (Aldrich, >95%, 37 wt%), 3-mercaptopropyl triethoxysilane 
(MPTES, ABCR, >92%), 3-aminopropyl triethoxysilane (APTES, Sigma, ≥ 98%), phenyl 
triethoxysilane (PTES, Sigma, 98%), acetone (reaction grade, Acros), N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide (EDC, Sigma, 97%). 
Unless otherwise noted, all reagents were used without further purification. Bi-distilled water 
from a Millipore system (Milli-Q Academic A10) was used for all syntheses and purification 
steps. 
0.2 M HCl and 0.02 M HCl were prepared with bi-distilled water and conc. hydrochloric acid. 
 
Synthesis of unfunctionalized LP_MSNs with 1,3,5-triisopropylbenzene as micellar 
expander. The synthesis of LP_MSNs at 30 °C followed a modified synthesis protocol 
published by Gao et al..7 Pluronic F127 (0.25 g) and fluorocarbon surfactant FC-4 (0.70 g) were 
dissolved in hydrochloric acid (HCl, 30 mL, 0.02 M). 1,3,5-Triisopropylbenzene (TiPB, 0.34 g, 
1.66 mmol) was added and the solution stirred for 2 h at 30 °C. Tetraethyl orthosilicate (TEOS, 
1.5 g, 7.2 mmol) was added drop-wise and the reaction mixture was stirred vigorously 
(1250 rpm) over night at 30 °C. The resulting particle suspension was hydrothermally treated 
under static conditions (150 °C, 1 d) before the mixture was centrifuged (15 min, 20500 rpm, 
50228 rcf), re-suspended in hydrochloric acid (HCl, 30 mL, 0.2 M) and heated under static 
conditions (140 °C, 2 d). Parr autoclaves (100 mL) were used for post-synthetic hydrothermal 
treatment. After the addition of 50 mL bi-distilled H2O, the LP_MSNs were collected by 
centrifugation (15 min, 20500 rpm, 50228 rcf), re-dispersed in 50 mL EtOH and extracted 
according to the procedure described below. 
Template removal from LP_MSNs. The organic template was removed via extraction from 
LP_MSNs. For this purpose, 250 mg of the particles were refluxed for 2 h at 75 °C in a mixture 
of absolute EtOH (80 mL), acetone (40 mL) and conc. HCl (10 mL). This extraction step was 
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performed twice. The template-free LP_MSNs were separated by centrifugation (15 min, 
20500 rpm, 50228 rcf) and washed with EtOH after each extraction step. LP_MSNs were 
obtained as colloidal suspension in EtOH. This extraction procedure was carried out for all 
samples unless otherwise noted. 
Size separation centrifugation of LP_MSNs. In order to separate large agglomerates from the 
synthesized nanoparticles, a size separation centrifugation was performed (15 s, 3.000 rpm, 
775 rcf) for selected samples. The resulting supernatant containing a nanoparticle yield of 50% 
(relative to the synthesis yield) was employed for all further applications. The obtained particles 
in ethanol were stored in tightly sealed glass vials. 
Synthesis of thiol functionalized large pore mesoporous silica nanoparticles 
(LP_MSN-SH). Pluronic F127 (0.25 g) and fluorocarbon surfactant FC-4 (0.7 g) were 
dissolved in hydrochloric acid (HCl, 30 mL, 0.02 M), followed by the addition of TMB (0.20 g, 
1.66 mmol), or 1,3,5-triisopropylbenzene (TiPB, 0.34 g, 1.66 mmol) respectively. The reaction 
mixture was stirred in a 100 mL polypropylene reactor for 2 h at 10 °C (for TMB) or 30 °C (for 
TiPB) before a mixture of tetraethyl orthosilicate (TEOS, 1.5 g, 7.2 mmol, 100 mol%) and 
3-mercaptopropyl triethoxysilane (MPTES, 18.7 µL, 0.072 mmol, 1 mol%) was added 
drop-wise. The resulting suspension was stirred vigorously (1250 rpm) over night at 10 °C (or 
30 °C for TiPB). The resulting particle suspension was hydrothermally treated in a 100 mL 
autoclave under static conditions (150 °C, 1 d). The mixture was centrifuged (15 min, 
20500 rpm, 50228 rcf), re-suspended in hydrochloric acid (HCl, 30 mL, 0.2 M) and heated 
under static conditions (140 °C, 2 d). After the addition of 50 mL bi-distilled H2O, the 
LP_MSNs were collected by centrifugation (15 min, 20500 rpm, 50228 rcf), re-dispersed in 
50 mL EtOH and extracted according to the procedure described above. 
Synthesis of azide functionalized large pore mesoporous silica nanoparticles 
(LP_MSN-N3). A modified literature procedure was employed to synthesize 
LP_MSN-NH2/Ph.
7, 27 Pluronic F127 (0.25 g) and an increased amount of fluorocarbon 
surfactant FC-4 (1.40 g) was dissolved in hydrochloric acid (HCl, 30 mL, 0.02 M), followed by 
the addition TMB (0.20 g, 1.66 mmol). The reaction mixture was stirred in a 100 mL 
polypropylene reactor for 2 h at 10 °C before a mixture of tetraethyl orthosilicate (TEOS, 1.5 g, 
7.2 mmol) and (3-azidopropyl) triethoxysilane29 (0.072 mmol) was added drop-wise. The 
resulting suspension was stirred vigorously (1250 rpm) over night at 10 °C. The resulting 
particle suspension was hydrothermally treated in a 100 mL autoclave under static conditions 
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(150 °C, 1 d). The mixture was centrifuged (15 min, 20500 rpm, 50228 rcf), re-suspended in 
hydrochloric acid (HCl, 30 mL, 0.2 M) and heated under static conditions (140 °C, 2 d). After 
the addition of 50 mL bi-distilled H2O, the LP_MSNs were collected by centrifugation (15 min, 
20500 rpm, 50228 rcf), re-dispersed in 50 mL EtOH and extracted according to the procedure 
described previously. 
Synthesis of amino/phenyl functionalized large pore silica nanoparticles 
(LP_MSN-NH2/Ph) with 1 mol% functionality. A modified literature procedure was 
employed to synthesize LP_MSN-NH2/Ph.
7, 27 Pluronic F127 (0.25 g) and fluorocarbon 
surfactant FC-4 (1.4 g) were dissolved in hydrochloric acid (HCl, 30 mL, 0.02 M), followed by 
the addition of TMB (0.20 g, 1.66 mmol). The reaction mixture was stirred in a 100 mL 
polypropylene reactor for 2 h at 10 °C before a mixture of tetraethyl orthosilicate (TEOS, 1.5 g, 
7.2 mmol, 100 mol%), phenyl triethoxysilane (PTES, 8.7 μL, 0.036 mmol, 0.5 mol%) and of 
3-aminopropyl triethoxysilane (8.4 μL, 0.036 mmol, 0.5 mol%) was added drop-wise. The 
resulting suspension was stirred vigorously (1250 rpm) for 14 h at 10 °C. The resulting particle 
suspension was hydrothermally treated under static conditions (150 °C, 1 d). The mixture was 
centrifuged (15 min, 20500 rpm, 50228 rcf), re-suspended in hydrochloric acid (HCl, 30 mL, 
0.2 M) and heated under static conditions (140 °C, 2 d). After the addition of 50 mL bi-distilled 
H2O, the LP_MSN were collected by centrifugation (15 min, 20500 rpm, 50228 rcf), 
re-dispersed in 50 mL EtOH and extracted according to the procedure previously described. 
Synthesis of amino/phenyl functionalized large pore silica nanoparticles 
(LP_MSN-NH2/Ph) with 10 mol% functionality. Pluronic F127 (0.25 g) and fluorocarbon 
surfactant FC-4 (0.7 g) were dissolved in hydrochloric acid (HCl, 30 mL, 0.02 M), followed by 
the addition of TMB (0.20 g, 1.66 mmol). The reaction mixture was stirred in a 100 mL 
polypropylene reactor for 2 h at 10 °C before a mixture of TEOS (1.35 g, 6.43 mmol, 90 mol%), 
phenyl triethoxysilane (PTES, 87 μL, 0.36 mmol, 5 mol%) and of 3-aminopropyl 
triethoxysilane (84 μL, 0.36 mmol, 5 mol%) was added drop-wise. The resulting suspension 
was stirred vigorously (1250 rpm) at 10 °C overnight. The resulting particle suspension was 
hydrothermally treated under static conditions (150 °C, 1 d). The mixture was centrifuged 
(15 min, 20500 rpm, 50228 rcf), re-suspended in hydrochloric acid (HCl, 30 mL, 0.2 M) and 
heated under static conditions (140 °C, 2 d). After the addition of 50 mL bi-distilled H2O, the 
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LP_MSNs were collected by centrifugation (15 min, 20500 rpm, 50228 rcf), re-dispersed in 
50 mL EtOH and extracted according to the procedure described above. 
Synthesis of amino/phenyl functionalized hollow sphere silica nanoparticles 
(HS_MSN-NH2/Ph). A modified literature procedure was employed to synthesize 
HS_MSN-NH2/Ph.
7, 27 Pluronic F127 (0.25 g) and fluorocarbon surfactant FC-4 (0.7 g) were 
dissolved in hydrochloric acid (HCl, 30 mL, 0.02 M), followed by the addition of TMB (0.20 g, 
1.66 mmol). The reaction mixture was stirred in a 100 mL polypropylene reactor for 2 h at 
10 °C before a mixture of TEOS (1.35 g, 6.43 mmol, 90 mol%), phenyl triethoxysilane (PTES, 
87 μL, 0.36 mmol, 5 mol%) and of 3-aminopropyl triethoxysilane (84 μL, 0.36 mmol, 5 mol%) 
was added drop-wise. The resulting suspension was stirred vigorously (1250 rpm) for 6 h at 
10 °C. The resulting particle suspension was hydrothermally treated under static conditions 
(150 °C, 1 d). The mixture was centrifuged (15 min, 20500 rpm, 50228 rcf), re-suspended in 
hydrochloric acid (HCl, 30 mL, 0.2 M) and heated under static conditions (140 °C, 2 d). After 
the addition of 50 mL bi-distilled H2O, the LP_MSNs were collected by centrifugation (15 min, 
20500 rpm, 50228 rcf), re-dispersed in 50 mL EtOH and extracted according to the procedure 
described above. 
Synthesis of amino/phenyl functionalized hollow sphere silica nanoparticles 
(HS_MSN-NH2/Ph) with TiPB. The hollow sphere silica nanoparticles were synthesized 
according to the above mentioned synthesis protocol. TMB (0.20 g, 1.66 mmol) was substituted 
by the same molar amount of TiPB (0.34 g, 1.66 mmol) and a synthesis temperature of 30 °C 
was employed. 
Covalent attachment of carboxy-terminated gold nanoparticles (3 nm) to 
HS_MSN-NH2/Ph via an EDC-assisted amidation. 1 mg of template-free HS_MSN-NH2/Ph 
(111 µL of an ethanolic solution) was washed with absolute EtOH three times (1 mL for each 
washing step). Subsequently, 20 µL of a carboxy-terminated gold nanoparticle solution 
(AuNPs, 3 nm, 1 mg/mL in toluene) was added to the HS_MSN solution. EDC (1 µL, 5.7 µmol) 
was added and the reaction mixture was stirred overnight. The resulting 
AuNPs@HS_MSN-NH2/Ph were extensively washed with 1 mL absolute EtOH (five times, 
1 mL EtOH each) by centrifugation (5000 rpm, 1291 rcf, 1 min) in order to remove unbound 
AuNPs. The supernatant was discarded after each washing step and the purified 
AuNPs@HS_MSN-NH2/Ph were investigated with scanning transmission electron microscopy 
(Figure 6.19). 
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Characterization. Centrifugation was performed using a Sorvall Evolution RC equipped with 
an SS-34 rotor or an Eppendorf centrifuge 5418 for small volumes. Nitrogen sorption 
measurements were performed with a Quantachrome NOVA 4000e or on a Quantachrome 
Autosorb iQ at -196 °C. Sample out-gassing was performed at 120 °C for 12 h at a pressure of 
10 mTorr. Pore size and pore volume were calculated using a NLDFT equilibrium model for 
cylindrical pores of N2 on silica, based on the desorption branch of the isotherm. The Brunauer-
Emmett-Teller (BET) surface areas for all samples were calculated from the corresponding 
nitrogen sorption isotherms in the range of p/p0 = 0.05 – 0.2. To calculate the total pore volume 
of the LP_MSNs, the amount of adsorbed nitrogen at the apparent plateau of the isotherm at 
high p/p0 values was used. Dynamic light scattering (DLS) and zeta potential measurements 
were performed on a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser 
(633 nm) and an avalanche photodiode. DLS measurements were directly recorded on ethanolic 
colloidal suspensions at a concentration of 1 mg/mL. For the determination of the zeta potential 
profiles, three drops of the ethanolic particle suspension (ca. 3 wt%) were mixed with 1 mL of 
commercial Hydrion Buffer solution of the appropriate pH value prior to measurement. 
Hückel’s approximation was used for interpretation. Raman spectra were recorded on a Jobin 
Yvon Horiba HR800 UV Raman microscope using a He-Ne laser emitting at λ = 633 nm. For 
scanning electron microscopy (SEM), a JEOL JSM-6500F scanning electron microscope was 
employed. Transmission electron microscopy (TEM) was performed on an FEI Titan 
80-300 kV microscope operating at 300 kV or on a JEOL JEM-2011 at 200 kV. Scanning 
transmission electron microscopy (STEM) was performed on the above-mentioned Titan 
microscope. Samples were prepared by dispersing LP_MSNs (0.5 mg) in 2 mL absolute 
ethanol. A drop of the resulting diluted suspension was dried on a carbon-coated copper grid. 
Small angle X-ray scattering (SAXS) was performed on a Bruker D8 Discover diffractometer 
with Cu Kα-radiation (λ = 1.5406 Å).  
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Figure 6.22: Nitrogen sorption analysis of template-free LP_MSN-bare synthesized with TMB at 10 °C 
with two-step hydrothermal treatment (black) and without (blue). A) Nitrogen sorption isotherms and 
B) calculated NLDFT pore size distribution. 
 
 
Figure 6.23: TEM micrographs of template-free LP_MSN-bare synthesized with TMB at 10 °C A) with 
two-step hydrothermal treatment of the as-synthesized LP_MSN-bare and B) without hydrothermal 
treatment. 
6.5. Appendix  
 
196 
 
 
Figure 6.24: SAXS pattern of LP_MSN-bare synthesized with TiPB at 100 °C; (100) reflection at 0.55°. 
 
 
Figure 6.25: SAXS diffraction pattern of LP_MSN-bare synthesized with TiPB at 30 °C; (1 0 0) 
reflection at 0.63 °. 
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Figure 6.26: SAXS patterns of template-extracted LP_MSN-SH. A) synthesized at 30 °C with TMB 
and B) synthesized at 10 °C with TiPB. 
 
Figure 6.27: Scanning electron microscopy image of HS_MSN-NH2/Ph-6h synthesized with TMB at 
10 °C and a reaction time of 6 h. 
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7 Click chemistry – a versatile method for enzyme immobilization onto 
large pore colloidal mesoporous silica nanoparticles 
This chapter is based on the following publication: 
Alexandra Schmidt, Martina Lichtnecker, Stefan Niedermayer, Kathrin Bader, and Thomas 
Bein, to be submitted to ACS Nano 2014 
 
 
 
Abstract 
Various bio applications of mesoporous materials (e.g., the immobilization of enzymes or the 
delivery of biomolecules such as siRNA) require large pores for the successful adsorption of 
the rather large molecules of interest and protecting the fragile cargo from external forces such 
as degradation. We describe the facile synthesis of functionalized mesoporous silica 
nanoparticles with ultra-large pores (LP_MSNs) providing high loading capacity for the 
immobilization of two differently sized enzymes. The synthesis procedure yields homogeneous 
azide-functionalized LP_MSN-N3 of about 120 nm in size with ultra-large pores of about 10 nm 
diameter. The azide-functionalized LP_MSN-N3 were synthesized employing a fluorocarbon-
mediated pathway with a dual surfactant system (F127 and FC-4) at 10 °C. Organo-moieties 
were incorporated into the mesoporous framework of LP_MSN via a co-condensation 
approach. Due to the azide-functionality these LP_MSNs are suitable for bio-orthogonal click 
chemistry reactions within the porous network. Two different acetylene-functionalized 
7.1. Introduction  
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enzymes (sp-cytochrome C and sp-trypsin) were immobilized in the pores of the obtained 
LP_MSNs by a copper-catalyzed 1,3-dipolar cycloaddition reaction. The covalent attachment 
of the enzymes within the mesopores allowed us to investigate the catalytic performance of the 
enzyme-silica systems. The enzymes are stable after bioconjugation with the silica support and 
show extremely high catalytic activity for the colorimetric reaction of 4-aminoantipyrine 
(4-AAP) and N,N-diethylaniline (DEA) in case of LP_MSN-CytC and the hydrolysis of p-
toluene-sulfonyl-L-arginine methyl ester (TAME) by LP_MSN-Trypsin.  
 
7.1 Introduction 
Ordered mesoporous silica materials have attracted increasing attention due to the ability to 
tailor their structural and textural features including particle size, pore size, pore volume and 
surface area.1-3 With the possibility to introduce various functionalities into the mesoporous 
framework, these materials have turned into interesting candidates for various biotechnological 
applications.3-5 However, such applications often involve fairly large molecules of more than 
5 nm in size that may not fit into the pores of established silica nanoparticles (ca. 4 nm). 
Additionally, the active molecules need to be immobilized while conserving their function. 
Considerable efforts have been made in the past years regarding the control of mesostructural 
diversity, compositional flexibility and morphology during the synthesis of mesoporous silica 
nanoparticles (MSNs).2, 6-8 In recent years the synthesis of well-defined ultra-large pore 
mesoporous systems with small particle sizes (in the size-range of 100 – 200 nm) for the 
encapsulation of large biomolecules (i.e. enzymes or siRNA) has been addressed.9-11 Synthesis 
strategies for the generation of MSNs with a diameter between 70 and 300 nm and very large 
pores (up to 17 nm) using a fluorocarbon surfactant and the triblock copolymer Pluronic® F127 
have been published.9, 12 To limit the growth of the nanoparticles, Han et al. additionally applied 
the cationic fluorocarbon surfactant FC-4 and obtained small particles in the range of 
50-300 nm.9 Gao et al. developed a new strategy to synthesize mesoporous silica nanoparticles 
with large pores (LP_MSN) at low temperatures (10 °C) by applying the triblock copolymer 
F127 as template and 1,3,5-trimethylbenzene (TMB) as swelling agent.3 Based on a modified 
approach of the above-mentioned synthesis procedures, we were able to obtain LP_MSNs and 
directly functionalize them with organo-silanes during a co-condensation procedure. Due to 
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their large pores, our novel functionalized LP_MSNs can be loaded with large bioactive 
molecules and thus are promising candidates for numerous bio-applications, including 
biocatalysis. A promising way to introduce enzymes as biocatalysts in industrial applications is 
their immobilization onto inorganic mesoporous supports.1, 13, 14 Organo-functionalized 
nanostructured mesoporous silica materials have attracted great attention among the available 
inorganic host systems as they offer outstanding properties for the immobilization and 
encapsulation of biomolecules.1, 15, 16 As larger mesopores match the size of enzymes, 
mesoporous silica materials are also excellent candidates for enzyme immobilization,17 yet the 
potential of LP_MSNs in this field still needs to be explored. Previous studies on established 
mesoporous silica materials (e.g. SBA-15) revealed that enzyme confinement within such hosts 
can increase the stability and reduce denaturation by protein unfolding, one major issue in 
industrial applications of biocatalysts.18 However, as a consequence of immobilization onto the 
solid support, a decrease of the enzymatic activity relative to the free enzyme is often observed 
in such systems.19, 20 Strong interactions between enzymes and the host materials can be 
obtained by complementary organo-functionalization within the porous network of the solid 
support, resulting in different catalytic activity and loading capacities.21-23 As the 
functionalization of the mesoporous framework can be easily modified, the organo-moieties 
can be adjusted to the respective enzyme and the preferred attachment reaction. Furthermore, 
the application of mesoporous silica supports allows for the adjustment of pore- and particle 
size, structural arrangement and surface properties to optimize loading capacity and enzyme 
activity.5, 24, 25 Recently, Lee et al. have reviewed different methods of covalent enzyme 
immobilization onto mesoporous silica supports.26  
Here, we use the flexibility of silica functionalization for loading active enzymes and our newly 
developed MSNs with ultra-large pores to immobilize enzymes while retaining their activity. 
Kao et al. investigated the immobilization of the peroxidase cytochrome c in post-synthesis 
modified LP_MSN using glutaraldehyde, glutaric anhydride and 
succinimido-3-maleimidopropionate as covalent linkers.27 They show that the orientation of the 
active site of cytochrome c is controlled by specific binding and that it correlates highly with 
the catalytic activity of the immobilized enzyme.  
A modified azide-alkyne click chemistry approach established by Schlossbauer et al. was used 
to immobilize enzymes into the LP_MSNs, as this method is highly biocompatible and avoids 
unfavorable pore blocking.28, 29 Two enzymes of different sizes, namely the peroxidase 
cytochrome C and the protease trypsin, were chosen for this study and were immobilized in an 
7.2. Results and Discussion  
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efficient method in the newly developed MSNs. Low degrees of organo-functionalization were 
chosen for the LP_MSNs, as high degrees of modification can result in a reduction of the pore 
diameter, which hinders enzyme diffusion into the mesoporous channels and increases the 
probability of pore blocking. A novel co-condensation synthesis approach was developed to 
generate organo-functionalized MSNs with ultra-large pores suitable for highly biocompatible 
coupling methods. The catalytic activity of immobilized enzymes within the LP_MSNs was 
studied in detail and it was shown that the immobilized enzymes exhibit high stability and are 
highly active after covalent immobilization in the LP_MSNs.  
7.2 Results and Discussion 
Synthesis of large pore MSNs 
For the immobilization of alkyne-functionalized enzymes by a click chemistry approach, 
azide-functionalized mesoporous silica nanoparticles with ultra-large pores (LP_MSN-N3) 
were synthesized using a modified sol-gel method at mildly acidic conditions and low 
temperatures (10 °C).3 A co-condensation approach was chosen to introduce low amounts 
(1 mol% of the original TEOS amount) of azide-functionality into the mesoporous framework 
of the MSNs and to obtain a homogeneous distribution of organic-moieties within the silica 
material. Low degrees of organo-functionalization were chosen for the LP_MSNs, as high 
degrees of modification can result in a reduction of the pore diameter. This would impede the 
diffusion of enzyme molecules into the mesoporous channels and increase the likelihood of 
pore blocking. 
The silica source tetraethyl orthosilicate (TEOS) was mixed with (3-azidopropyl) 
triethoxysilane before the resulting solution was introduced into an acidic solution consisting 
of the dual surfactant system Pluronic® F127 and FC-4, together with the micellar expander 
1,3,5-trimethylbenzene (TMB). We modified a hydrothermal treatment process of the 
as-synthesized material in acidic media developed by Gao et al. in order to obtain LP_MSN-N3 
(cf. experimental section).3 This hydrothermal treatment is required for the formation of ultra-
large pores. Additionally, we found that the introduction of organo-moieties in the case of azide-
silanes has no negative effect on the formation of the mesoporous structure, whereas amine-
functionalities easily disrupt the nanoparticle formation. For all template-extracted 
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LP_MSN-N3 samples, a size separation step (by centrifugation) with an overall yield of 50% 
was employed before the nanoparticles were used for further reactions. 
 
Figure 7.1: Characterization of LP_MSN-N3. A) Scanning transmission electron microscopy (STEM) 
micrograph of template-extracted LP_MSN-N3 after size separation centrifugation, B) dynamic light 
scattering (DLS) measurement showing a narrow size distribution (after size separation centrifugation), 
C) nitrogen sorption isotherms and D) pore size distribution obtained from nitrogen sorption 
measurement for LP_MSN-N3. 
Transmission electron microscopy images after size separation centrifugation (cf. experimental 
section) show spherically shaped nanoparticles with a fairly homogenous particle size 
distribution within a size range of 80 – 150 nm (Figure 7.1A). The large pores are present in 
each LP_MSN and evenly distributed over the entire nanoparticle. The size distribution data 
are in good accordance with the values obtained by dynamic light scattering, exhibiting a 
maximum at 220 nm (Figure 7.1B). We explain the moderately increased size obtained by DLS 
measurements compared to the TEM measurements with the larger hydrodynamic radius of the 
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LP_MSN-N3 as compared to their real size - possibly weak agglomeration is also present. The 
mesoporous framework is highly regular, well-defined and clearly present in all particles 
(Figure 7.1A). The pore sizes are in a range of 9 – 13 nm (deduced from TEM measurements) 
and consistent with the maximum value of around 12 nm obtained from nitrogen sorption 
measurements (cf. 7.1D). The resulting isotherm shows a hybrid isotherm of a type II isotherm 
combined with a certain degree of type IV. The hysteresis can be characterized as an H3 
hysteresis loop that results from aggregation and thus from a significant degree of textural 
porosity, indicated by the long tail in the pore size distribution (Figure 7.1C). Monolayer 
formation of the adsorbate can be observed between p/p0 = 0 and 0.02, followed by multilayer 
adsorption over a broad range. The apparent lack of saturation (pore filling) at high p/p0 could 
be due to a broad distribution of textural porosity between the particles in the dried LP_MSN. 
The interparticle voids, which are visible in the STEM micrograph (Figure 7.1A), are within a 
size-range of 15 – 30 nm. Summarizing, we obtained LP_MSNs exhibiting a pore size in the 
range of mesoporous materials (Figure 7.1D, maximum around 12 nm), with a pore volume of 
0.8 cm3/g and a BET surface area of As = 246 m
2/g. In addition, infrared spectroscopy was 
carried out to verify the presence of azide-moieties within the framework of LP_MSN-N3 (cf. 
appendix 7.6). 
 
Immobilization of alkyne-functionalized cytochrome C and trypsin onto LP_MSN-N3 
via a click chemistry approach 
Two enzymes of different dimensions, namely cytochrome C (CytC, 12 400 Da, 2.6 x 3.2 x 
3.3 nm3) and trypsin (23 400 Da, ca. 3.8 nm spherical)17, were immobilized in the mesoporous 
nanoparticles. Specifically, a modified click chemistry approach was used to immobilize the 
enzymes within the mesoporous framework of our newly generated LP_MSNs, which required 
prior alkyne functionalization of the enzyme (cf. experimental section and Appendix 7.7).28, 30 
The latter was achieved by the EDC-activated attachment of 4-pentynoic acid to the amine 
moieties of CytC or trypsin, respectively (cf. appendix 7.7). In a second synthesis step, the 
LP_MSN-N3 particles were incubated with the alkyne-functionalized enzymes for 1–2 h to 
ensure their diffusion into the large mesopores before the catalysts were added to the reaction 
mixture, in order to avoid pore blocking (cf. experimental section). Subsequently, a click 
reaction was performed according to a slightly modified procedure published by Maier et al., 
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employing N,N-diisopropylethylamine as complexing agent to prevent the premature oxidation 
of Cu+ (Figure 7.2).31 The nanoparticles were washed several times with buffer in order to 
remove excess and unbound enzyme molecules.  
 
Figure 7.2: Scheme for enzyme immobilization in LP_MSNs using click chemistry. CuI was applied as 
catalyst and N,N-diisopropylethylamine as complexing agent. 
 
Figure 7.3: Nitrogen sorption data of LP_MSN-N3 with immobilized enzymes. A) Isotherm of 
LP_MSN-N3 (black), LP_MSN-CytC (blue) and LP_MSN-Trypsin (red). B) Pore size distribution for 
LP_MSN-N3 (black), LP_MSN-CytC (blue) and LP_MSN-Trypsin (red). C) Thermogravimetric 
analysis data of LP_MSN-N3 (black), LP_MSN-CytC (blue) and LP_MSN-Trypsin (red). All curves are 
normalized to 100% at 130 °C. 
All obtained nitrogen sorption data show isotherms that appear as hybrids between type II and 
type IV isotherms, with a narrow H3-hysteresis loop. After the attachment of sp-enzymes the 
calculated BET-surface decreased significantly (Figure 7.3A and Table 7.1). This can be 
attributed to the uptake and covalent immobilization of the enzyme molecules within the large 
mesopores of the nanoparticles and the resulting pore filling. Accordingly, the pore volume and 
pore size decreased likewise (Figure 7.3B). The shrinkage of the pore size can also be attributed 
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to partial blocking of the pore openings by attached enzyme molecules. We assume that the 
decrease in pore volume in case of the sample LP_MSN-CytC is stronger than in LP_MSN-
Trypsin, because a higher amount of sp-CytC could be incorporated into the mesoporous 
framework of our nanoparticles. These results are in good accordance with the obtained 
thermogravimetric analysis data (Figure 7.3C and Table 7.1 for relative mass loss), showing 
that more cytochrome C than trypsin was immobilized in the LP_MSNs. The higher 
functionalization degree of CytC as compared to trypsin is attributed to its relatively small 
dimension; the enzyme can easily diffuse into the mesopores without having much contact with 
the pore walls and the attached organic moieties, whereas the diffusion and subsequent 
attachment of trypsin might be sterically hindered due to repulsions with the pore walls.  
 
Table 7.1: Nitrogen physisorption and thermogravimetric analysis data of LP_MSN-N3 and 
LP_MSN-Enzyme. 
Sample 
BET surface area 
[m²/g] 
Pore sizea  
[nm] 
Relative mass lossb 
[%] 
[cm3/g] LP_MSN-N3 155 11.8 5.2 
LP_MSN-CytC 97 8.4 14.8 
LP_MSN-Trypsin 153 8.4 7.7 
aDFT pore size refers to the peak value of the pore size distribution. bRelative mass loss obtained by TGA; all 
curves are normalized to 130 °C 
From the additional mass loss of 9.6% for the sample LP_MSN-CytC, the amount of attached 
enzyme can be estimated to 9.1 µmol per g silica (cf. appendix for calculation). This indicates 
that 13% of all azide-moieties have reacted with sp-CytC, as the amount of azide-moieties was 
estimated to 0.69 mmol per g silica. From the additional mass loss of 2.5%, the amount of 
immobilized trypsin can be estimated to 1.2 µmol per g silica (cf. appendix calculation 7.1) and 
the amount of azide-moieties can be estimated to 0.69 mmol per g silica. This indicates that 
only a small amount of sp-trypsin molecules were able to diffuse into the large mesopores and 
react with 1.7% of all azide-moieties of LP_MSN-N3. A probable reason for this is the large 
molecular dimension of trypsin (ca. 3.8 nm spherical)17, resulting in partial blocking of the pore 
openings by immobilized trypsin. All nitrogen sorption data are supported by the corresponding 
thermogravimetric analysis and the calculated relative mass losses that are summarized in 
 209 
 
Table 7.1. In order to prove the successful attachment of sp-enzymes via click chemistry, 
vibrational spectroscopy was employed for the respective LP_MSN-enzyme samples 
(Figure 7.4 and cf. appendix 7.8 for LP_MSN-Trypsin). The symmetric and asymmetric CH2 
stretching vibrations of the enzyme appear in the range of 2960–2871 cm-1 in the spectrum of 
LP_MSN-CytC and of free CytC. The peak at 2106 cm-1 can be attributed to the asymmetric 
N3 stretching vibration of LP_MSN-N3 (asterisked peak) and decreases in intensity after linking 
of sp-CytC. At 1651 cm-1 (dashed line) the C=O stretching vibration appears in the spectrum of 
LP_MSN-CytC, which is attributed to the amide bonds of the attached enzyme. The vibration 
at 1539 cm-1 (second dashed line) is also only visible in the spectra of free CytC and 
LP_MSN-CytC and represents the N-H bending vibration of the peptide bonds of the enyzme. 
The peak at 1627 cm-1 in the spectrum of LP_MSN-N3 indicates the presence of traces of water 
within the sample. Below 1300 cm-1, vibrations of the silica framework appear with strong 
intensity. 
 
Figure 7.4: IR spectra of LP_MSN-N3 (black), LP_MSN-CytC (blue) and free CytC (magenta). The 
spectra were normalized to the silica peak at about 1053 cm-1 or divided by the maximum in case of 
CytC. The dashed lines at 1651 cm-1 can be attributed to the C=O stretching vibration and at 1539 cm-1 
to the N-H bending vibration of the peptide bonds in sample LP_MSN-CytC. The spectra are offset on 
the y-axis by 0.25 units for clarity. 
The results obtained by nitrogen sorption, thermogravimetric analysis and vibrational 
spectroscopy indicate the successful immobilization of CytC and trypsin within the porous 
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network of LP_MSN-N3. In the following we address the catalytic properties of the 
immobilized enzymes. 
 
Catalytic activity determination of immobilized enzymes 
To characterize the properties of immobilized CytC, the catalysis of the colorimetric reaction 
of 4-aminoantipyrine (4-AAP) and N,N-diethylaniline (DEA) was studied by measuring the 
absorbance of the released quinoid dye at 550 nm (Figure 7.5A and cf. appendix 7.9). Different 
substrate concentrations were applied to improve the reaction conditions. The concentrations 
given in Table 7.3 (cf. experimental section) correspond to 4-AAP as the molar ratio of 4-AAP 
to DEA was kept constant (0.61). For determination of the reaction rate, the slopes in the linear 
region of the graphs (outlined square in Figure 7.5A) were applied as they represent the change 
of absorbance per time. The catalytic activity of the different samples was then determined by 
using Lambert-Beer’s law (with ε = 16500 Lmol-1cm-1 from Lit.32, Table 7.2). 
 
 
Figure 7.5: A) UV-Vis absorption measurement of LP_MSN-CytC_A–D and free CytC within a period 
of 800 s (13.3 min) at 550 nm, the slope in the linear region of the graphs (black box) was used to 
calculate the enzyme activities, the given concentrations correspond to 4-AAP. B) Activity 
determination of LP_MSN-trypsin by measuring the absorbance at 247 nm in a time range of 11 min 
and intervals of 1 min. The enzyme activity was determined from the slope of the obtained linear 
regression. 
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Table 7.2: Catalytic activity of LP_MSN-CytC and applied 4-AAP substrate concentration. 
Sample 
BE4-AAP concentration 
[µmol*mL-1] 
Catalytic activity 
[10-5 mol*L-1 min-1] 
LP_MSN-CytC_A 0.563 2.47 
LP_MSN-CytC_B 0.825 2.57 
LP_MSN-CytC_C 1.125 2.62 
LP_MSN-CytC_D 1.425 2.80 
Free CytC 1.425 0.96 
 
With increasing substrate concentration, the catalytic activity of CytC increases likewise 
(cf. Table 7.2 ). This indicates that the substrate saturation of the enzyme was not reached in 
these experiments. Therefore, the highest applied amount of substrate was used to verify 
enzyme activity differences between immobilized and free CytC. The data revealed a 2.9 times 
higher activity of CytC immobilized in LP_MSNs (2.80 molL-1min-1) compared to an equal 
amount of free CytC (0.96 molL-1min-1). It can be assumed that the enzyme confinement within 
the large mesopores increases the stability of CytC, as shown in previous studies.17, 33, 34 Aside 
from that, it further indicates a good pore size adjustment of the large pores of MSN to the 
molecular dimensions of CytC. The enzymatic activity in the MSN host is extremely high 
compared to values previously reported in the literature. 
Trypsin activity determination 
In order to determine the catalytic activity of the attached trypsin molecules, an 
Nα-p-tosyl-L-arginine methyl ester hydrochloride (TAME) assay was performed.
28 Thereby, 
the catalyzed hydrolysis of (TAME) was measured by recording the absorption of the produced 
Nα-p-tosyl-L-arginine at 247 nm with UV-Vis spectroscopy (Figure 7.5B, cf. experimental 
section). The enzyme activity was determined from the slope of the obtained linear regression 
after the parameters were adjusted in several experiments. As the slope of the linear regression 
is 0.0068 min-1 and Ew is 1.847∙10-4 mg trypsin / 0.1 mL solution (calculated from TGA data, 
cf. Figure 7.3C), the activity can be calculated to 102 units/mg (enzyme). Here, one unit is 
defined as the amount of enzyme releasing 1 µmol Nα-p-tosyl-L-arginine per minute under 
denoted conditions. For comparison, previous studies of Schlossbauer et al. obtained an activity 
of 346.3 units/mg for native trypsin and an activity of 65.6 units/mg for trypsin immobilized in 
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SBA-15 with a pore size of 8 nm.28 This indicates that immobilized trypsin suffers from a 
certain loss of activity. The higher catalytic activity within LP_MSNs compared to SBA-15 
with smaller pores might be associated (i) with the nanoscale size of the host and (ii) with the 
larger pore diameter involved in our present study. The catalytic activity within the pores might 
even be further improved by additional functionalization of LP_MSN-N3 with amine moieties, 
since trypsin has an optimal operating pH of about 8.35 These effects will have to be investigated 
in future studies. 
 
7.3 Conclusion 
We report for the first time the FC-4 assisted synthesis of organo-functionalized LP_MSNs via 
a co-condensation method. This direct approach to introduce organo-moieties into the 
mesoporous network is highly beneficial since different functionalities can be efficiently 
introduced at controlled concentrations. This method further avoids additional grafting steps 
that may be difficult with colloidal systems. Our low temperature synthesis yields mesoporous 
silica nanoparticles within a size range of about 100 nm that exhibit ultra-large pore sizes of 11 
nm and bear an azide-functionality. This organo-functionalization makes the LP_MSNs 
suitable for a biocompatible click chemistry approach. We chose to immobilize two enzymes 
of different molecular dimensions, namely cytochrome C and trypsin, covalently to the 
LP_MSN-N3 host. The peroxidase cytochrome C (2.6 x 3.2 x 3.3 nm
3) and the protease trypsin 
(3.8 nm spherical)17 were successfully modified with an alkyne-linker to allow for a Cu(I)-
catalyzed click reaction. The enzymes were allowed to diffuse into the mesopores before the 
catalysts were added to the reaction mixture, thus avoiding unfavorable pore blocking and low 
catalytic activity. Compared to the small amount of azide-functionalization in the LP_MSNs, a 
high-density enzyme immobilization in the LP_MSN-N3 host could be achieved. We could 
demonstrate in this study that both enzymes are still highly active in their immobilized state. 
Strikingly, for the case of LP_MSN-CytC we observed a 2.9 times higher activity of the 
immobilized enzyme compared to free cytochrome C. Thus, we conclude that the confined 
attachment of sp-CytC within the framework leads to a favorable confined state of the enzyme, 
resulting in high activity. In the case of trypsin we could also prove a high and persisting activity 
after attachment to the solid support. We propose that the high activity of the enzymes 
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immobilized in large-pore MSNs is at least partially caused by the extremely short diffusion 
distances in the nanoscale host systems. Overall, we present a highly promising colloidal MSN-
system with ultra-large pores for the immobilization of biomolecules that can be further 
exploited in numerous ways. 
 
 
 
7.4 Experimental 
Materials. Pluronic F127 (F127, Sigma), fluorocarbon surfactant 4 (FC-4, Yick-vik 
Chemicals), tetraethylorthosilicate (TEOS, Fluka, >99%), 1,3,5-trimethylbenzene (TMB, 
Fluka, 96%), N-ethylcarbodiimide hydrochloride  (EDC, Fluka, 97%), trypsin from bovine 
pancreas (Sigma, lyophilized, essentially salt-free, TPCK treated), ethanol (EtOH, Aldrich, 
>99.5%), conc. hydrochloric acid (Aldrich, >95%, 37 wt%), 4-pentynoic acid (Fluka, 97%,) 
Nα-p-tosyl-L-arginine methyl ester hydrochloride (TAME, Sigma), phosphate buffer solution 
(Sigma), tris(hydroxymethyl) aminomethane (TRIS, Sigma, 99.8 %), 2-(N-
morpholino)ethanesulfonic acid (MES, Sigma, 99.5 %), disodium hydrogen phosphate 
(Na2HPO4, Sigma, >99%), monosodium hydrogen phosphate (NaH2PO4, Sigma, >99%), 
sodium hydroxide (1 M, Sigma), cytochrome C from bovine heart (Fluka, >95%), (3-
chloropropyl) triethoxysilane (CPTES, Fluka, 95%), diethyl ether (Et2O, Sigma, >98%), 
sodium azide (Fluka, 99%), N,N-diisopropylethylamine (Sigma, 99%), Cu(I)I (Sigma, 98%), 
4-aminoantipyrine (4-AAP, Sigma, >98%), N,N-diethylaniline (DEA, Sigma, >99%) hydrogen 
peroxide (Sigma, 30 wt%). 
 
Unless otherwise noted, all reagents were used without further purification.  Bi-distilled water 
from a Millipore system (Milli-Q Academic A10) was used for all syntheses and purification 
steps.  
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Preparation of Buffer Solutions 
MES buffer. 2-(N-morpholino)ethanesulfonic acid (MES, 1.95 g) was dissolved in water 
(500 mL). The pH was adjusted to 5.5 using sodium hydroxide (1 M). The volume was adjusted 
to 1 L by addition of bidistilled water. 
 
Citric acid phosphate buffer (McIlvaine buffer). An aqueous solution (250 mL) of citric acid 
(9.61 g, 0.05 mol) and an aqueous solution (250 mL) of disodium hydrogen phosphate 
(Na2HPO4, 7.10 g, 0.05 mol) were prepared. The two solutions were mixed under pH-control 
with a pH meter to obtain a pH value of 5.5. 
Sodium phosphate buffer (10 mM, pH 7.2). Monosodium hydrogen phosphate (5.84 g, 
48.7 mmol) and disodium hydrogen phosphate (15.47 g, 109.0 mmol) were dissolved in 10 L 
of water (10 mM). The pH was adjusted to 7.2 using a pH-meter. 
 
TRIS buffer (pH 8.1). Tris(hydroxymethyl)aminomethane (TRIS, 5.57 g) and calcium 
chloride dihydrate (CaCl2 ∙ 2 H2O, 169 mg) were dissolved in water (60 mL). The pH was 
adjusted to 8.1 using HCl (1 M). The volume was adjusted to 100 mL by addition of distilled 
water. 
 
Synthesis of alkyne-modified enzymes (sp-enzymes) 
Cytochrome C (sp-CytC). To a freshly prepared, cooled solution (4 °C) of cytochrome c (15 mg, 
1.21 µmol) in MES buffer (pH 5.5, 15 mL, 10 mM), an aqueous solution (750 µL) of 
4-pentynoic acid (0.1 M, 7.36 mg, 0.08 mmol) was added. The resulting mixture was vortexed 
for 2 min and then stored at 4 °C for 15 min. Subsequently, EDC (14.9 mg, 0.08 mmol) was 
added to the solution. The reaction was vortexed again for 2 min and then kept at 4 °C for 4 h 
without stirring. Afterwards, the obtained solution was dialyzed in a cold room at 4 °C against 
sodium phosphate buffer (10 mM, pH 7.2, 10 L) for a period of 24 h. The concentration of 
sp-CytC (0.48 mg/mL) was determined with UV-Vis spectroscopy (proteinA280). The alkyne-
functionalized CytC was used for click reactions without further purification.  
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Trypsin (sp-Tryp). Alkyne-functionalized trypsin was synthesized according to Gole et al. as 
described above.3 The concentration of sp-Trypsin (1.03 mg/mL) was determined with UV-Vis 
spectroscopy (proteinA280). 
Synthesis of (3-azidopropyl) triethoxysilane 
(3-azidopropyl)triethoxysilane was synthesized according to a procedure published by 
Nazakawa et al..4 (3-chloropropyl) triethoxysilane (10 g, 41.7 mmol) and sodium azide (10 g, 
154 mmol) were heated in anhydrous DMF (100 mL) under inert gas conditions to 90 °C for 
4 h. Low boiling materials were removed from the mixture under reduced pressure. The crude 
oily product was dissolved in diethyl ether, resulting in precipitation of salts, which were 
removed by filtration. Et2O was removed in vacuo and the residual oil was distilled (95 °C).  
(3-azidopropyl)triethoxysilane was obtained as colorless liquid and used without further 
purification.  
Synthesis of azide functionalized large pore mesoporous silica nanoparticles 
(LP_MSN-N3). A modified literature procedure was employed to synthesize LP_MSN-N3.
5, 6 
Pluronic F127 (0.25 g) and fluorocarbon surfactant FC-4 (1.40 g) was dissolved in hydrochloric 
acid (HCl, 30 mL, 0.02 M), followed by the addition of TMB (0.20 g, 1.66 mmol). The reaction 
mixture was stirred in a 100 mL polypropylene reactor for 2 h at 10 °C before a mixture of 
tetraethyl orthosilicate (TEOS, 1.5 g, 7.2 mmol) and (3-azidopropyl) triethoxysilane was added 
drop-wise. The resulting suspension was stirred vigorously (1250 rpm) over night at 10 °C. The 
resulting particle suspension was hydrothermally treated under static conditions (150 °C, 1d). 
The mixture was centrifuged (15 min, 20500 rpm, 50228 rcf), re-suspended in hydrochloric 
acid (HCl, 30 mL, 0.2 M) and heated under static conditions (140 °C, 2d). Parr autoclaves 
(100 mL) were used for post-synthetic hydrothermal treatment. 
After the addition of 50 mL bi-distilled H2O, the LP_MSN were collected by centrifugation (15 
min, 20500 rpm, 50228 rcf), re-dispersed in 50 mL EtOH and extracted according to the 
procedure described below. 
Template removal from LP_MSN-N3. The organic template was removed via extraction from 
LP_MSN-N3. Thus, 250 mg of the particles were refluxed for 2 h at 75 °C in a mixture of 
absolute EtOH (120 mL), acetone (80 mL) and conc. HCl (10 mL). This extraction step was 
performed twice. The template-free LP_MSNs were separated by centrifugation (15 min, 
20500 rpm, 50228 rcf) and washed with EtOH after each extraction step. LP_MSN-N3 were 
obtained as colloidal suspension in EtOH.  
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Size separation centrifugation of LP_MSN-N3. In order to separate large agglomerates from 
the synthesized nanoparticles, a size separation centrifugation was performed (15 sec, 
3.000 rpm, 775 rcf). The resulting supernatant comprising a nanoparticle yield of 50% (relative 
to the synthesis yield) was employed for all further applications. The obtained particles in 
ethanol were stored in tightly sealed glass vials. 
 
Immobilization of sp-enzymes in large pore mesoporous silica nanoparticles (LP_MSN-
Enzyme) 
Immobilization of alkyne-functionalized cytochrome C (LP_MSN-CytC) 
An ethanolic suspension containing 50 mg LP_MSN-N3 was centrifuged (15 min, 20500 rpm, 
50228 rcf) and re-dispersed in 10 mL of water. This washing step was repeated twice. 
Subsequently, the LP_MSN-N3 was re-dispersed in 3.5 mL of water and 3.5 mL of the buffered 
sp-CytC solution (containing 1.67 mg, 0.14 µmol sp-CytC). The resulting mixture was stirred 
at 4 °C for 2 h. In the meantime, N,N’-diisopropylethylamine (1.33 µL, 7.63 µmol) was added 
to a solution of Cu(I)I (1 mg, 5.25 µmol) dissolved in 5 mL DMSO and stirred for 30 min at 
ambient temperature. 50 µL of this freshly prepared solution was added to the reaction mixture 
containing LP_MSN-N3 and sp-CytC to catalyze the covalent attachment of the enzyme via 
click chemistry. The resulting suspension was stirred for 48 h at 4 °C. Subsequently, the 
particles were collected by centrifugation (15 min, 20500 rpm, 50228 rcf) and re-dispersed in 
30 mL of water. This washing procedure was repeated three times. LP_MSN-CytC were 
obtained as colloidal solution in water and were stored at -20 °C until further use.  
Trypsin (LP_MSN-Tryp). sp-Trypsin was immobilized onto LP_MSN-N3 via a click chemistry 
approach accordingly the synthesis procedure described above for sp-CytC. An ethanolic 
suspension containing 50 mg LP_MSN-N3 was centrifuged (15 min, 20500 rpm, 50228 rcf) and 
re-dispersed in 10 mL water. This washing step was repeated twice. The obtained pellet of 
LP_MSN-N3 was re-dispersed in a mixture of sp-trypsin (3.50 mL, 3.6 mg, 0.15 µmol, 1 eq) 
and water (3.50 mL) for one hour before the freshly prepared ligand solution was added. 
LP_MSN-Trypsin was obtained as colloidal solution in water after several washing steps.  
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Catalytic activity determination of LP_MSN-CytC. The catalytic activity of LP_MSN-CytC 
was determined by a method published by Saito et al. 7 Fresh solutions of 4-aminoantipyrine 
(4-AAP, 7.5 mM 15.2 mg, 75 µmol in 10 mL water) and N,N-diethylaniline (DEA, 7.5 mM 
12 µL, 75 µmol  in 10 mL of a 1:1 wt% mixture of water and ethanol) were prepared shortly 
before the experiment. 100 µl of an aqueous suspension of LP_MSN-CytC (containing 15.6 µg 
(1.26 nmol) cytochrome c, calculated from TGA-data) were mixed in Hellma Suprasil precision 
cells with different volumes of the prepared DEA- and 4-AAP-solution and with distinct 
amounts of McIlvaine buffer (pH 5.5). Detailed information on the volumes is given in Table 
T1.  Subsequently, 50 µl H2O2 were added to the solution and a total volume of 1 mL was 
obtained (see Table 7.3). The time-dependent formation of the dye was determined by 
measuring the absorbance (550 nm, 800 s and intervals of 1 s). All spectra were background 
corrected. 
Table 7.3: Applied volumes of enzyme solution, DEA, 4-AAP, McIlvaine buffer and H2O2. 
Experiment 
name 
Volume of enzyme 
solution 
Volume of 
DEA 
solution[µL] 
Volume of 
4-AAP 
solution 
[µL] 
Volume of 
McIlvaine-buffer  
(pH 5.5) [µL] 
Volume 
of H2O2 
(1 wt%) 
Total 
volume 
[µL] 
LP_MSN-
CytC_A 
100 µL 
LP_MSN-CytC 
125 75 650 50 1000 
LP_MSN-
CytC_B 
100 µL 
LP_MSN- CytC 
190 110 550 50 1000 
LP_MSN-
CytC_C 
100 µL 
LP_MSN- CytC 
250 150 450 50 1000 
LP_MSN-
CytC_D 
100 µL 
LP_MSN- CytC 
310 190 350 50 1000 
free CytC 100 µL 
CytC -solution 
310 190 350 50 1000 
 
Catalytic activity determination of LP_MSN-Tryp via TAME assay. Schwert and Takenaka 
have developed a sensitive spectrophotometric assay for trypsin and chymotrypsin using 
synthetic substrates,8 which was modified by Hummel et al. utilizing N-p-tosyl-L-arginine 
methyl ester hydrochloride as substrate.9 Based on the procedure published by Schlossbauer 
et al.28 the TAME assay was carried out employing a 0.01 M TAME stock solution (7.56 mg 
TAME dissolved in 2 mL H2O) and an aqueous suspension of LP_MSN-Tryp particles 
(containing 37.0 µg trypsin/mL - calculated from TGA-data). 200 µL TAME stock solution 
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(2 µmol TAME) and 1.23 µL TRIS buffer (pH 8.1) were mixed in a precision cell shortly before 
LP_MSN-Trypsin (75 µL - containing 2.77 µg, 0.12 nmol trypsin) was added. Subsequently, 
the time-dependent formation of the colored product was determined by UV-VIS spectroscopy 
(247 nm, 660 s, intervals of 1 min) under continuous stirring of the mixture. All spectra were 
background corrected. 
 
Characterization. Centrifugation was performed using a Sorvall Evolution RC equipped with 
an SS-34 rotor or an Eppendorf centrifuge 5418 for small volumes. Nitrogen sorption 
measurements were performed with a Quantachrome NOVA 4000e or on a Quantachrome 
Autosorb iQ at -196 °C. Sample out-gassing was performed at 22 °C for 12 h at a pressure of 
10 mTorr. Pore size and pore volume were calculated using a NLDFT equilibrium model for 
cylindrical pores of N2 on silica, based on the desorption branch of the isotherm. The Brunauer-
Emmett-Teller (BET) surface areas for all samples were calculated from the corresponding 
nitrogen sorption isotherms in the range of p/p0 = 0.05 – 0.2. To calculate the total pore volume 
of the LP_MSNs, the amount of adsorbed nitrogen at the apparent plateau of the isotherm at 
high p/p0 values is used. Dynamic light scattering (DLS) and zeta potential measurements were 
performed on a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser 
(633 nm) and an avalanche photodiode. DLS measurements were directly recorded with 
ethanolic colloidal suspensions at a concentration of 1 mg/mL. Transmission electron 
microscopy (TEM) was performed on a FEI Titan 80-300 kV microscope operating at 300 kV. 
Scanning transmission electron microscopy (STEM) was also performed on the Titan 
microscope. Samples were prepared by dispersing LP_MSNs (0.5 mg) in 2 mL absolute 
ethanol. A drop of the resulting diluted suspension was dried on a carbon-coated copper grid. 
Thermogravimetric analysis was performed on a Netzsch STA 440 C TG/DSC with a heating 
rate of 10 K/min in a stream of synthetic air of about 25 mL/min. All IR measurements were 
performed on a Thermo Scientific Nicolet iN10 IR Microscope in reflexion-absorption mode 
with a liquid nitrogen-cooled MCT-A detector. All spectra are background corrected. The 
signals were normalized to the most intensive silica band. UV-VIS measurements were 
performed on a Perkin Elmer Lambda 1050 spectrophotometer with a deuterium arc lamp (UV 
region) and a tungsten filament (visible region). The detector was an InGaAs integrating sphere 
detector. Time-based enzyme activity assays were performed in Hellma Suprasil precision cells 
(path length 10 mm). For small sample amounts (2 µL of the sample) a NanoDrop 2000c 
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spectrometer from Thermo Scientific Fisher was employed for UV-Vis measurements.  The 
absorbance at 280 nm (mode A280) was used to determine enzyme concentrations. For 
enzymatic color reactions with the NanoDrop 2000c spectrometer, the samples were measured 
in a Brand UV- micro cuvette (light path 10 mm).  
7.5 Appendix 
 
Figure 7.6:  IR spectra of LP_MSN-N3. The dashed lines indicate the typical vibrations arising from 
the azide-functionality. 
IR spectroscopy was carried out to verify the presence of azide moieties in LP_MSN-N3 
(Figure 7.6). The asymmetric CH2 stretching vibrations of the azidopropyl-moieties are visible 
between 2985 cm-1 and 2935 cm-1. Furthermore, the CH2 bending vibration appears at 
1461 cm-1. The vibrations at 2105 cm-1 and 1376 cm-1 exhibit very small intensities and can be 
attributed to the symmetric and asymmetric stretching vibration of the N3-groups (outlined by 
dashed lines). The vibration at 1678 cm-1 appears with medium intensity and can be attributed 
to the vibrations of residual amounts of water in the sample. Vibrations of the silica framework 
are visible below 1300 cm-1 with strong intensities. 
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Alkyne-functionalization of enzymes 
 
Figure 7.7: EDC activated attachment of 4-pentynoic acid to the respective enzyme (CytC or trypsin). 
The reaction was carried out in MES buffer (pH 5.5) at 4 °C. 
 
Figure 7.8: IR spectra of LP_MSN-N3 (black), LP_MSN-trypsin (red) and free trypsin (grey). The 
spectra were normalized to the silica peak or divided by the maximum in case of trypsin. The spectra 
are offset by a value of 0.2 for clarity reasons. The modes at 1656 cm-1 (dashed lines) can be attributed 
to the C=O stretching vibration and those at 1531 cm-1 to the N-H bending vibration of the peptide bonds 
in sample LP_MSN-Trypsin. 
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Figure 7.9: Color reaction of 4-aminoantipyrine (4-AAP) and N,N-diethylaniline (DEA) with H2O2, 
catalyzed by LP_MSN-CytC particles.  
 
Figure 7.10: Image of the sample LP_MSN-CytC at the time points t = 0 sec and t = 800 sec after the 
start of the reaction of 4-aminoantipyrine (4-AAP) and N,N-diethylaniline (DEA) with H2O2. 
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Calculation 7.1: Example for the calculation for thermogravimetric analysis (TGA) of sample 
LP_MSN-N3 and LP_MSN-CytC. 
 
1 g sample LP_MSN-N3 contains 53 mg azide-residues (mass loss 5.3%, Mw(C3H6N3)=81.05 g*mol-1) 
 
53 𝑚𝑔
(100% − 5.3%) 𝑔
= 56 𝑚𝑔 𝑎𝑧𝑖𝑑𝑒 − 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 / 𝑔 𝑠𝑖𝑙𝑖𝑐𝑎 
0.056 𝑔 
81.05 
𝑔
𝑚𝑜𝑙
= 0.69 𝑚𝑚𝑜𝑙 𝑎𝑧𝑖𝑑𝑒 − 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 / 𝑔 𝑠𝑖𝑙𝑖𝑐𝑎 
1 g sample LP_MSN-CytC contains 96 mg CytC (additional mass loss 9.6%, Mw(CytC) = 
12400 gmol-1) 
 
96 𝑚𝑔
(100% − 5.3% − 9.6%) 𝑔
= 113 𝑚𝑔 𝐶𝑦𝑡𝐶 / 𝑔 𝑠𝑖𝑙𝑖𝑐𝑎 
0.113 𝑔 
12400 
𝑔
𝑚𝑜𝑙
= 9.1 µ𝑚𝑜𝑙 𝐶𝑦𝑡𝐶 / 𝑔 𝑠𝑖𝑙𝑖𝑐𝑎 
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8 Post-synthesis modification of mesoporous silica nanoparticle with large 
pores and their investigation on a cellular level  
This chapter is based on a collaboration with: 
Veronika Weiss, Martina Lichtnecker, Katharina Braunger and Christoph Bräuchle 
 
 
Abstract 
The successful synthesis of mesoporous silica nanoparticles with ultra-large pores (LP_MSNs) 
bearing different organo-functionalities and their application as solid support for enzymes has 
been discussed in previous chapters of this work. In brief, a fluorocarbon-mediated synthesis 
pathway at low temperatures (10 °C) was employed to generate LP_MSNs with pore sizes up 
to 15 nm, which are necessary for the delivery of large biomolecules (e.g. siRNA). The 
organo-functionalities were introduced via a co-condensation approach to obtain a 
homogeneous distribution of amino/phenyl-moieties within the nanoparticle. This chapter 
focuses on the post-synthesis modification of the novel LP_MSNs with amino/phenyl-moieties 
to design a multi-functional carrier-system with high loading capacities and stimuli-responsive 
release mechanisms. Specifically, we present a system based on colloidal large pore 
mesoporous silica nanoparticles equipped with an on-board red-light photosensitizer and 
capped by a supported lipid bilayer (SLB) to prevent premature release from the mesopores. 
The functionality of the organo-modified drug delivery vehicles was studied in detail on a 
cellular level with fluorescence imaging in close collaboration with the group of Prof. C. 
Bräuchle. 
8.1. Introduction  
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8.1 Introduction 
Mesoporous silica nanoparticles (MSNs) with pore sizes of around 4 nm have been widely 
studied in the past years as promising drug delivery vehicles based on the possibility to fine-
tune their functional properties for biocompatibility and the specific functionalization of the 
nano-carrier (e.g., attachment of targeting ligands).1-5 Release on-demand drug delivery 
systems with stimuli-responsive capping and endosomal escape systems have recently attracted 
high interest as they allow for precise control over the endosomal escape of nano-vehicles.2, 6 
Spatial and temporal control over cargo release was achieved with intracellular triggers such as 
change in pH7, 8, redox reactions6, 9, 10 or the presence of certain enzymes within the cell 
compartments.11 Additionally, external triggers including light2, 3 or heat12-14 can stimulate the 
controlled release of the adsorbed cargo. However, most of the above-mentioned stimuli-
responsive nano-carrier systems are based on standard MSNs (pore sizes of 2 – 4 nm), which 
limits their applications as host-system to relatively small molecules (e.g. chemotherapeutics 
like doxorubicin and paclitaxel).4, 15, 16 A few studies have reported the successful delivery of 
larger molecules such as nucleic acids with conventional MSNs.1, 17 Li et al. demonstrated the 
packing of siRNA into the mesopores of magnetic MSNs containing a Fe3O4-core by using a 
chaotropic salt solution during the adsorption process.17 However, the generation of silica 
nanoparticles with ultra-large pores and well-defined small particle sizes (LP_MSNs) is highly 
desirable for the intracellular delivery of large biomolecules. Therefore the synthesis of 
mesoporous silica nanoparticles with ultra-large pores (7 - 20 nm) has recently attracted much 
attention and several different synthesis approaches are known today.18-20 Gao et al. reported 
the successful modification of LP_MSNs, generated by employing a fluorocarbon-surfactant 
mediated synthesis pathway, with aminopropyl-moieties to enable sufficient uptake of plasmid 
DNA.19 Hartono et al. also used a fluorocarbon-mediated synthesis pathway and functionalized 
the obtained LP_MSNs with poly-L-lysine for efficient gene delivery with siRNA.21 Although 
the alternative synthesis pathway of Ryoo and co-workers is not based on a fluorocarbon-
mediated synthesis approach, LP_MSNs with pore sizes of up to 23 nm were obtained 
employing a distinct hydrothermal treatment; the resulting system with siRNA cargo molecules 
was studied in vitro and in vivo without observing a notable cytotoxicity.20 All above-mentioned 
systems have in common that the respective organo-functionality was introduced via a post-
synthesis grafting approach.  We have already reported the successful synthesis of organo-
modified LP_MSNs based on a fluorocarbon surfactant mediated synthesis approach using 
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co-condensation (cf. chapter 6), and first applications as host-system for two different enzymes 
(cf. chapter 7). Here we will focus on the successful modification of LP_MSNs with stimuli-
responsive triggers, the adsorption of differently sized cargo molecules and the sealing of the 
mesopores with a biocompatible supported lipid bilayer (SLB), which can be opened through 
red-light activation of an attached photosensitizer.  Moreover, the interactions of these newly 
generated LP_MSNs with live cells were studied in close collaboration with the group of Prof. 
C. Bräuchle.  
 
8.2 Results and Discussion 
We have successfully synthesized amino/phenyl-functionalized mesoporous silica 
nanoparticles with ultra-large pores (LP_MSN-NH2/Ph) employing a modified sol-gel method 
at mildly acidic conditions and low temperatures (10 °C).19 For this purpose, the silica source 
tetraethyl orthosilicate (TEOS) was mixed with 3-aminopropyl triethoxysilane (APTES, 0.5 
mol% of the original TEOS amount) and phenyl triethoxysilane (PTES, 0.5 mol%) before the 
silica precursor mixture was introduced into an acidic solution consisting of the dual surfactant 
system Pluronic F127 and FC-4, together with the micellar expander 1,3,5-trimethylbenzene 
(TMB). We applied a hydrothermal treatment of the as-synthesized material in acidic media 
developed by Gao et al. in order to obtain LP_MSN-NH2/Ph (cf. experimental section).
19 The 
template-extracted LP_MSNs were thoroughly characterized with regard to their size and 
functionality by nitrogen sorption, dynamic light scattering, transmission electron microscopy 
and IR-spectroscopy (cf. chapter 6). 
 
Figure 8.1: Characteristic data of the template-free LP_MSN-NH2/Ph A) Calculated NLDFT pore size 
distribution, B) dynamic light scattering measurement in ethanolic solution and C) transmission electron 
micrograph after size separation centrifugation. 
8.2. Results and Discussion  
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In brief, the isotherm of LP_MSN-NH2/Ph can be interpreted as a hybrid form between a type II 
isotherm combined with a certain degree of type IV behavior, exhibiting an H3 hysteresis. An 
average pore size of 13 nm was calculated from nitrogen physisorption data (Figure 8.1A). The 
size separated LP_MSNs show a narrow size distribution with a maximum at 90 nm in dynamic 
light scattering measurements, which was confirmed by transmission electron microscopy. A 
detailed characterization of the sample LP_MSN-NH2/Ph is given in Chapter 6. 
As the generated LP_MSN-NH2/Ph particles are of a similar size and exhibit similar surface 
properties as standard MSNs, it was investigated whether a supported lipid bilayer (SLB) is 
suitable to cap the mesopores of the LP_MSNs. We have previously reported that SLB-capped 
MSNs are highly promising candidates for drug delivery applications (cf. chapter 4) due to their 
excellent biocompatibility2, 22 and prospects for post-synthesis modification including 
functionalities such as targeting ligands.3 In brief, a fluorescent cargo (calcein and 
FITC-dextrans of different sizes) was adsorbed into the MSN pores in an overnight reaction 
under continuous stirring (Figure 8.2–1) before the LP_MSNs were enclosed by a supported 
lipid bilayer (SLB) to prevent premature release of the cargo from the MSN core (Figure 8.2–
2). The SLB was generated around the nanoparticle via a solvent exchange method published 
by Cauda et al.22 consisting of a lipid mixture of 70 v% of 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) and 30 v% of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP). 
 
Figure 8.2: Schematic synthesis pathway of 1) cargo adsorption (e.g. calcein) or covalent labeling with 
fluorescent dyes, and 2) generation of a Supported DOPC-DOTAP Lipid Bilayer (SLB) around the 
LP_MSNs. 
To prove the integrity of the enclosure mechanism, time-dependent fluorescence release 
experiments were carried out with the obtained SLB@LP_MSN-NH2/Ph-Cargo samples. As 
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the LP_MSNs offer larger pores than conventional MSNs, FITC-dextrans of different sizes 
(3 – 5 kDa and 10 kDa) were employed as non-membrane permeable model drugs in addition 
to the standard dye calcein (cf. appendix 8.15). All time-based fluorescence release experiments 
were measured with our custom-made release setup consisting of a reservoir cap which is sealed 
by a dialysis membrane (MWCO = 14000 g/mol), allowing only the smaller dye molecules to 
diffuse into the water-filled cuvette.11 All three samples were measured in the closed state 
applying the respective excitation/emission wavelengths of the cargo molecules at 37 °C, 
mimicking physiological temperatures. In comparison to the time-based release experiment 
with calcein, a slight premature release of dye molecules was observed (for both FITC-dextran 
sizes; Figure 8.3A for 5 kDa FITC-Dextran, Figure 8.3B for FITC-Dextran (10 kDa)). We 
assume that small amounts of the large sugar molecules are interacting with the lipids at the 
outer surface of the SLB around the LP_MSNs and therefore are able to diffuse into the cuvette. 
A leaky SLB can be excluded as both samples reach a saturation plateau after 2.5 h at a 
fluorescence intensity of an order of magnitude lower than the intensity of the cargo that can 
ultimately be released. After a defined elapsed time (3 h for each sample) the membrane was 
disrupted by the addition of a detergent (Triton-X); a strong increase of released FITC-dextran 
(5 kDa and 10 kDa, respectively) could be observed and a second saturation plateau was reached 
after an additional 9 h (Figure 8.3B). These results indicate that the larger FITC-dextran 
molecules were successfully encapsulated in the pores of LP_MSNs and released after 
disintegration of the SLB-membrane. The later drop in fluorescence intensity could be 
explained by bleaching of the dye. 
 
8.2. Results and Discussion  
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Figure 8.3: Dye release kinetics of SLB@LP_MSN-NH2/Ph-Cargo as a function of time. After a three-
hour incubation experiment (37 °C) with SLB-sealed LP_MSNs, Triton-X was added. A) FITC-Dextran 
(3 – 5  kDa). The inflection of the curve after 11 h presumably is a result of photobleaching of FITC. 
The curve was normalized to 100% for the amount released after 11 h. B) FITC-Dextran (10 kDa). 
Saturation of released FITC-dextran was reached after about 9 h. The curve was normalized to 100% 
for the amount released after about 9 h. 
The above results show a successful enclosure of our LP_MSNs with a supported lipid bilayer, 
which demonstrates that the system is suitable for the adsorption of differently-sized cargo 
molecules. As additional proof for the integrity of the SLB@LP_MSNs, fluorescence 
microscopy was employed. For this purpose, the fluorescent dye Atto633 was covalently 
attached to the LP_MSN-NH2/Ph through maleimide coupling (after size separation 
centrifugation) in an overnight reaction followed by subsequent washing steps to ensure that no 
free dye remains in the mesopores of the nanoparticles. This is also an additional proof for the 
successful functionalization of the LP_MSNs with organo-moieties. Note that additionally a 
defined amount of DOPC was substituted by the fluorescent lipid DOPC-Bodipy (DOPC : 
DOTAP : DOPC-Bodipy 65 : 30 : 5 v%) to enable fluorescence co-localization experiments 
(cf. experimental section). LP_MSN-NH2/Ph-Atto633 were surrounded by the above-
mentioned labeled SLB and investigated thoroughly with fluorescence imaging on a coverslip. 
For this purpose, a defined amount of nanoparticle solution in water was placed on a coverslip 
and subsequently imaged (Figure 8.4). The LP_MSNs are evenly distributed throughout the 
sample and show a perfect co-localization of the fluorescently labeled compounds (yellow; 
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merged image of green (DOPC-Bodipy) and red (Atto633)) indicating a successful generation 
of the SLB around the LP_MSNs. Additionally it can be noted that almost no large aggregates 
of nanoparticles are present within the sample, which is important for further applications. 
 
Figure 8.4: Co-localization experiments of SLB@LP_MSN-NH2/Ph at different concentrations. The 
LP_MSNs are labeled with Atto633-maleimide (red), the SLB contains a certain amount of 
DOPC-Bodipy (green), merged image of both channels (yellow). Scalebar: 10 µm. 
The above experiments demonstrate the successful generation of a biocompatible supported 
lipid bilayer around the LP_MSN-NH2/Ph particles, and effective uptake of large cargo 
molecules. These results served as starting point for the development of a stimuli-responsive 
nano-carrier system based on LP_MSNs. 
As already mentioned above, it is important to gain control over the nano-carriers via external 
triggers in order to enable a release on-demand of the incorporated cargo molecules from the 
mesopores of the silica nanoparticles. For this purpose, a red-light sensitive photosensitizer, 
Al(III) phthalocyanine chloride disulfonic acid (AlPcS2a), was covalently attached to the outer 
surface of the LP_MSN-NH2/Ph via a sulfonamide bond (Figure 8.5); an excess of AlPcS2a was 
employed for the reaction in order to avoid cross-linking of the nanoparticles as the 
photosensitizer bears two sulfonic acid groups that are available for the reaction. We note that 
no additional PEG-spacer was needed for this system in comparison to the previously described 
MSNs, as the pores of the LP_MSN-NH2/Ph are larger than AlPcS2a and thus cannot be blocked. 
8.2. Results and Discussion  
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The sample was thoroughly washed after the reaction by subsequent centrifugation until the 
supernatants were free of AlPcS2a (cf. appendix 8.16) 
 
Figure 8.5: Covalent attachment of the red-light sensitive photosensitizer AlPcS2a to the 
amino-modified silica surface. 
The functionalized inorganic-organic hybrid nanoparticles were characterized regarding 
porosity and successful post-synthesis modification by nitrogen physisorption, 
thermogravimetric analysis and IR spectroscopy. Figure 8.6A compares the nitrogen sorption 
isotherms obtained before and after organo-functionalization with the photosensitizer. Both 
isotherms can be interpreted as hybrid forms between a type II isotherm combined with a certain 
fraction of type IV isotherm. The hysteresis can be characterized as an H3 hysteresis loop that 
results from aggregation and thus from a significant degree of textural porosity in the dried 
powder sample (Figure 8.6A). The monolayer formation of the adsorbate can be observed 
between p/p0 = 0 and 0.02, followed by multilayer adsorption over a broad range. The lack of 
saturation at high p/p0 values can be explained with the large pore diameter of the 
LP_MSN-NH2/Ph sample combined with a broad distribution of textural porosity between the 
dried LP_MSNs. The isotherm of LP_MSN-NH2/Ph-AlPcS2a is slightly shifted to a higher 
adsorbed volume and thus results in a higher BET surface area (As = 176 m
2/g for 
LP_MSN-NH2/Ph and As = 246 m
2/g for LP_MSN-NH2/Ph-AlPcS2a), the origin of which is not 
clear. The calculated pore size maximum remains the same after the reaction (13 nm, Figure 
8.6B), indicating that AlPcS2a was predominantly attached on the outer surface of the 
LP_MSNs, which is supported by the calculated values (cf. appendix calculation 8.1). 
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Figure 8.6 Nitrogen physisorption data of LP_MSN-NH2/Ph (black) and LP_MSN-NH2/Ph-AlPcS2a 
(blue) A) Sorption isotherms, B) calculated NLDFT pore size distributions. 
The successful attachment of AlPcS2a was demonstrated with thermogravimetric analysis 
(TGA, Figure 8.7A) and a detailed comparison of the IR spectra of LP_MSN-NH2/Ph and 
LP_MSN-NH2/Ph-AlPcS2a (8.7B). The additional mass loss of 4.5% for LP_MSN- NH2/Ph-
AlPcS2a is quite high considering the low level of organo-functionality present within the 
sample and available for post-synthesis modification (only 0.5 mol% of the silica precursor 
consists of 3-aminopropyl triethoxysilane). This can be explained by the relatively large mass 
of the attached PS. The amount of attached AlPcS2a was calculated to be 67 µmol per gram 
LP_MSN-NH2/Ph (cf. appendix calculation 8.1), which implies that 25% of the amino-groups 
have reacted with AlPcS2a.  
 
8.2. Results and Discussion  
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Figure 8.7: A) Thermogravimetric analysis of the samples LP_MSN-NH2/Ph (black) and 
LP_MSN-NH2/Ph-AlPcS2a (blue). The curves are normalized at 130 °C. B) Infrared spectra of 
LP_MSN-NH2/Ph (black) and LP- MSN-NH2/Ph-AlPcS2a (blue), normalized to the silica peak at 
1087 cm-1 and AlPcS2a (red, normalized to the strongest peak). The spectra of LP- MSN-NH2/Ph-AlPcS2a 
and AlPcS2a are shifted along the y-axis by a value of 0.25 for clarity. 
Data derived from IR spectroscopy yield information about the organo-functionality of the 
LP_MSN samples. Both spectra show typical bands of the silica framework appearing below 
1300 cm-1 with strong intensities. Additionally, the C-H stretching vibration modes of the alkyl 
chains (including ethoxy-groups on the silica framework) are present between 2940 and 
2840 cm-1. The marked peak at 1456 cm-1 (dashed line) represents aromatic stretching 
vibrations of AlPcS2a and can be found in the spectra of LP_MSN-AlPcS2a and AlPcS2a. The 
asymmetric SO2 stretching vibration of the newly formed sulfonamide bond arises at 1377 cm
-1 
(second dashed line) and is only visible in the spectrum of LP_MSN-NH2/Ph-AlPcS2a. The key 
features of the post-synthesis modified materials are summarized in table 8.1. 
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Table 8.1: Nitrogen physisorption and thermogravimetric analysis (TGA) data of   LP_MSN-NH2/Ph 
and LP- MSN-NH2/Ph-AlPcS2a. 
Sample BET surface 
area (m²/g) 
Pore volume 
(cm³/g) 
Pore sizea 
(nm) 
Relative massb 
loss (%) 
LP_MSN-NH2/Ph  176 0.8 13 4.4 
LP_MSN-NH2/Ph-AlPcS2a 246 0.9 13 8.9 
a DFT pore size refers to the peak value of the pore size distribution; bTaken from the values at 900 °C; the curves 
are normalized to 130 °C 
 
Since the results shown above suggest a successful post-synthesis functionalization of the 
LP_MSNs with the red-light sensitive photosensitizer, the next aim was to generate a 
biocompatible supported lipid bilayer as capping system for non-membrane permeable cargos 
around the LP_MSN-NH2/Ph-AlPcS2a. A size separation centrifugation step was employed to 
remove larger aggregates from the particle suspension before the PS was attached to the outer 
surface of the nanoparticles. Figure 8.8 depicts the synthesis approach: In a first step, cargo 
molecules of different sizes (calcein, propidium iodide and Alexa-Fluor-Dextran 10 kDa) were 
adsorbed into the mesopores of the LP_MSNs. After adsorption of the model drugs into 
LP_MSN-NH2/Ph-AlPcS2a, the outer surface was sealed by a supported lipid bilayer consisting 
of DOPC and DOTAP (70 : 30 v%) by a solvent induced self-assembly (Figure 8.8).  
 
 
Figure 8.8: 1) Cargo adsorption into the mesopores of photosensitizer-modified sample LP_MSN-
NH2/Ph-AlPcS2a. 2) Generation of a supported lipid bilayer (SLB) consisting of DOPC and DOTAP 
around the LP_MSN-NH2/Ph-AlPcS2a. 
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The permeability of the SLB and the stimuli-responsive opening of the SLB by photoactivation 
with red light were examined in a cuvette release experiment (cf. experimental section) with 
calcein as fluorescent cargo. We note that only after photoactivation with red light (639 nm, 
1 min, 5.4 W/cm2) a significant amount of cargo is released, demonstrating the impermeability 
of the SLB for calcein before photoactivation. The amount of released cargo over a 3 h time 
period before opening the SLB is minimal; we assume that a small amount of calcein is trapped 
in the lipid bilayer and is therefore able to diffuse out of the reservoir. A saturation plateau was 
reached 9 hours after the SLB was disrupted by singlet oxygen. 
 
Figure 8.9: Dye release kinetics from SLB@LP_MSN-NH2/Ph-AlPcS2a-Calcein as a function of time 
at 37 °C. 1) SLB capped LP_MSN-NH2/Ph-AlPcS2a-Calcein before photoactivation (0-3 h) and 2) time-
based release of calcein after activation of the photosensitizer (639 nm, 1 min, 5.4 W/cm2) at 37 °C. The 
release curve was normalized to the value obtained after 12 h. 
The in vial release experiment with LP_MSNs modified with an on-board photosensitizer 
showed successful cargo release upon activation with red light at moderate intensities and the 
resulting membrane rupture by singlet oxygen. As these results imply the successful generation 
of a nano-carrier based on LP_MSNs, the modified particles were investigated on a cellular 
level. HeLa cells were incubated for a total time period of 21 h with the dye-loaded 
LP_MSN-system to enable a significant uptake of the SLB-capped LP_MSNs via endocytosis. 
After this period, substantial co-localization exhibiting a dot-like pattern of the particles was 
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observed for AlPcS2a (red) and calcein (green) in optical microscopy, indicating that no 
premature release of calcein had occurred upon endosomal uptake of the nanoparticles. A small 
amount of spread photosensitizer appears to be visible in the cytosol; out-of-focus fluorescence 
could be a possible explanation for this. The activation of the photosensitizer (639 nm, 
0.6 W/mm2) leads to a cascaded membrane rupture induced by singlet oxygen. In a first step 
the integrity of the SLB on the SLB@LP_MSNs is destroyed, resulting in pore opening and 
thus cargo release from the mesopores. This step is followed by the rupture of the endosomal 
membrane thus allowing the fluorescent dye to be released into the cytoplasm of the cell. These 
events were monitored with fluorescence imaging at defined time points after photosensitizer 
activation (t = -1 ; t = 1 and t = 6 min). 
 
Figure 8.10: Fluorescence microscopy of SLB@LP_MSN-NH2/Ph-AlPcS2a-Calcein inside HeLa cells 
after an incubation time of 21 h. (a-c) AlPcS2a (red) and calcein (green) are mainly co-localized (yellow) 
prior to photoactivation. The red line indicates photoactivation with 0.6 W/mm2 of red light (639 nm). 
(d-f) 1 min after photoactivation, (g-i) 6 min after photoactivation. Scalebar: 10 μm. 
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Intensity profiles for AlPcS2a (red curve) and calcein (green curve) were determined along the 
dashed white lines (Figure 8.10c-i) and are summarized in Figure 8.11. These profiles indicate 
an increased calcein release over a distinct time-frame as calcein de-quenches by dilution within 
the cell compartments. Additionally, we also note that a comparably weak increase in the 
intensity of the photosensitizer was observed. As the particles where washed thoroughly until 
no free photosensitizer could be observed by UV-VIS spectroscopy (cf. appendix 8.16) before 
cargo adsorption and subsequent cell experiments, it is highly unlikely that free PS was present 
in the sample. It could be possible that the sulfonamide bond is cleaved upon laser activation 
enabling some of the PS to diffuse into the cytoplasm and leading to the observed signal. 
However, this effect did not occur with AlPcS2a-modified standard MSNs.
3 Another possible 
explanation could be the existence of a small amount of LP_MSNs in lysosomes due to the 
prolonged uptake time of the non-targeted LP_MSNs. The more acidic environment within 
lysosomes (pH = 4) might cause a hydrolysis of the sulfonamide.  
 
 
Figure 8.11: Intensity profiles of calcein (green) and red-light photosensitizer AlPcS2a (red) 
fluorescence along the white dashed lines (Figure 8.10) in the activation series of SLB@LP_MSN-
NH2/Ph-AlPcS2a-Calcein for A) t = -1 min B) t = 1 min and C) t = 6 min with t = 0 min denoting the 
point of photosensitizer activation. 
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In a second study, the membrane-impermeable cargo propidium iodide (PI, 668 g/mol) was 
delivered to HeLa cells with SLB@LP_MSN-NH2/Ph-AlPcS2a. PI interacts with the nucleic 
acids of ribosomal RNA, thus an accumulation in the nucleoli of the cells can be observed upon 
successful release from the mesopores. In brief, PI was adsorbed into the mesopores of 
LP_MSN-NH2/Ph-AlPcS2a and a DOPC/DOTAP-SLB was subsequently generated to cap the 
mesopores and to prevent premature cargo release. The HeLa cells were incubated for 21 h with 
SLB@LP_MSN-NH2/Ph-AlPcS2a-PI to allow for a sufficient uptake by the cells before the 
samples were imaged by fluorescence microscopy. We note that the images do not show single 
confocal planes but an average of the intensity over multiple slices to improve the signal-to-
noise ratio. Significant co-localization between propidium iodide (green channel) and AlPcS2a 
(red channel) can be seen in the merged signal (yellow), however, different slices were recorded 
and an evaluation of the data is complicated by the abundance of nanoparticles. Importantly, no 
staining of the nucleoli can be observed before photoactivation (Figure 8.12 a/c) implying a 
successful capping of the LP_MSNs. After activation with red light (639 nm, 1.2 W/mm2, 
1 min) and subsequent rupture of the membranes, PI is able to diffuse out of the mesopores. 
Due to photobleaching events upon photoactivation, a strong decrease in fluorescence was 
observed (Figure 8.12 d/f), but after 10 min an accumulation of PI in the nucleoli of the cells is 
visible (Figure 8.12 j/l) indicating a successful membrane rupture and subsequent delivery of 
PI to the cytosol. Reference experiments with the sample supernatant after particle separation 
(subsequent centrifugation) showed no significant nucleoli staining. Again, a slight spreading 
of free photosensitizer did occur in this experiment. 
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Figure 8.12: Fluorescence microscopy of propidium iodide-loaded SLB@LP_MSN-NH2/Ph-AlPcS2a 
particles inside HeLa cells after an incubation time of 21 h. Several z-planes (34) were averaged in order 
to improve the signal-to-noise ratio (a-c) Propidium iodide (green) and AlPcS2a (red) before 
photoactivation. The red line indicates photoactivation with 1.2 W/mm2 of red light (639 nm). (d-f) after 
photoactivation, (g-i) 5 min and (j-k) 10 min after photoactivation. Fluorescence intensity for the 
nucleoli indicated with white squares was measured; after photoactivation strong photobleaching effects 
were observed. Scale bar: 10 μm. 
The fluorescence intensity was measured in the region of six clearly visible nucleoli (white 
squares in Figure 8.12 a/d/g/j) and plotted, setting the intensity at t = -1 to 100% (Figure 8.13). 
The intensities in the region of interest (ROI) are increasing as a function of time, after strong 
photobleaching first led to fluorescence decrease directly after activation. 
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Figure 8.13: Propidium iodide intensities for the time points t = -1 min, t = 0 min, t = 5 min and t = 10 
min after photoactivation for the six different nucleoli. The data are derived from the region of the 
nucleoli (within the outlined squares in Figure 8.12). The intensity at time point t = -1 min was 
normalized to 100%. The decrease in intensity at 0 min is caused by photobleaching due to 
photoactivation with 639 nm. 
 
To conclude, we successfully synthesized a release on-demand system based on 
LP_MSN-NH2/Ph with an on-board red light sensitive photosensitizer and were able to 
incorporate small fluorescent cargo molecules into the mesopores. Additionally, tight capping 
by a supported lipid bilayer around the nanoparticles was proven by cuvette and cell 
experiments.  
 
As LP_MSNs also offer the possibility to adsorb larger cargo molecules in their mesopores, 
Alexa-Fluor-Dextran (AFD488, 10 kDa, radius ~2.3 nm) was chosen as fluorescent model drug 
for larger molecules. Previously described cuvette release experiments already suggested a 
successful adsorption into LP_MSN-NH2/Ph without an external trigger attached. In order to 
investigate the stimuli-responsive nano-carrier system with AFD488, a defined amount of the 
dye-labeled sugar molecules was adsorbed into the mesopores (cf. experimental section) of the 
LP_MSN-NH2/Ph-AlPcS2a particles, which were subsequently sealed by a singlet oxygen-
responsive DOPC/DOTAP-SLB. To prove the functionality of the newly developed system, 
HeLa cells were incubated with the sample SLB@LP_MSN-NH2/Ph-AlPcS2a-AFD488 for 23 h 
prior to the measurement. As mentioned above for the measurement of PI-loaded LP_MSNs, 
z-projections from confocal cuts covering the entire height of the cells were analyzed instead 
of confocal cuts. The co-localization study shows that the tightly capped LP_MSNs contain 
AFD-488 (green) as cargo molecule and AlPcS2a (red); no premature release into the cytosol 
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was observed before PS activation (639 nm, 1.2 W/mm2, 1 min), whereas typical release kinetics 
were visible after photoactivation, similar to the results obtained for calcein and propidium 
iodide. The given scaling was chosen to visualize the spreading of AFD-488 in the cytoplasm 
region without particles and therefore the particle fluorescence appears to be overexposed.  
Only a slight increase of AFD-488 fluorescence could be detected in the cells (illustrated by the 
intensity profiles plotted along the dashed white lines), whereas most of the dye remains inside 
the nanoparticles. We assume that the diffusion of the large dextran cargo was hindered due to 
steric or charge effects and might need a longer time frame to diffuse out. Additionally, it has 
to be mentioned that fluorescence labeled dextrans, in comparison with other dyes used in this 
thesis (calcein and PI) are more difficult to visualize as they lack self-quenching or other 
fluorescence enhancing effects. Successful in vial (for LP_MSN-NH2/Ph loaded with 
FITC-Dextran 10 kDa) and in vitro cargo release experiments (for different cargoes, including 
Alexa-Fluor-Dextran 10 kDa) showed successful adsorption and subsequent release of the large 
molecular weight cargo molecules serving as model drugs for siRNA. Additionally, the 
LP_MSNs were successfully modified with the red-light sensitive photosensitizer AlPcS2a, 
which allows for on-demand endosomal escape upon light activation and thus cargo release 
from the mesopores into the cytosol.  
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Figure 8.14: Bottom: Fluorescence microscopy of Alexa-Fluor-dextran-488 (AFD) loaded 
SLB@LP_MSN-NH2/Ph-AlPcS2a after 23 h incubation of HeLa cells. The channels represent 
z-projections of the entire height of the cells from the confocal cuts. The signals of AF488-dextran 
(green), AlPcS2a (red) and the merged signal are displayed, respectively. (a-c) AFD488 (green) and 
AlPcS2a (red) are in the same regions (yellow) prior to photoactivation. The red line indicates the 
photoactivation with 1.2 W/mm2 of red light (639 nm) leading to a rupture of the SLB. (d-f) after 
photoactivation, (g-i) 5 min and (j-l) 10 min after photoactivation. Intensity profiles were measured 
along the white lines. The scale bar represents 10 µm. Top: fluorescence intensity of AFD along the 
white line at the time points t = -1, 0, 5, and 10 min with t = 0 min denoting the point of photosensitizer 
activation (639 nm, 1.2 W/mm2, 1 min). 
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8.3 Conclusions 
In this work, amino/phenyl-functionalized mesoporous silica nanoparticles with ultra-large 
pores (LP_MSNs) generated by a co-condensation approach were successfully modified with 
an on-board photosensitizer and a biocompatible supported lipid bilayer (SLB) for pore 
capping. This system provides an on-demand release mechanism proven by in vial and in vitro 
cargo release experiments with model drugs of different sizes (calcein, propidium iodide, and 
fluorescently-labeled dextran 10 kDa). Significant uptake into HeLa cells was achieved 
throughout this study and endosomal entrapment, a major bottle-neck in drug delivery, was 
overcome by photoactivation. Upon activation with red light the photosensitizer generates 
singlet oxygen, resulting in a cascaded membrane rupture and thus, cargo release into the 
cytosol of living cells. We were able to demonstrate the efficient delivery and release of small 
and large molecular weight cargo such as fluorescently-labeled dextrans (up to 10 kDa), making 
the new system a promising candidate for the delivery of bioactive peptides or nucleic acids 
(siRNA) for advanced drug delivery applications. 
8.4 Experimental 
Chemicals. Pluronic F127 (F127, Sigma), fluorocarbon surfactant 4 (FC-4, Yick-vik 
Chemicals), tetraethyl orthosilicate (TEOS, Fluka, >99%), 1,3,5-trimethylbenzene (TMB, 
Fluka, 96%), 3-aminopropyl triethoxysilane (APTES, Sigma, ≥ 98%), phenyl triethoxysilane 
(PTES, Sigma, 98%), ethanol absolute (EtOH, Aldrich, >99.5%), conc. hydrochloric acid 
(Aldrich, >95%, 37 wt%), acetone (reaction grade, Acros), Atto633-maleimide (Atto633-Mal, 
Atto-Tec), N,N-dimethylformamide (DMF, anhydrous, Aldrich), Al(III) phthalocyanine 
chloride disulfonic acid (AlPcS2a, Frontier Scientific), dimethyl sulfoxide (DMSO, Sigma, 
>99.5%), calcein (Sigma), propidium iodide (PI, Sigma, ≥ 98%), FITC-dextran (3000–5000 
Da, Sigma), FITC-dextran (10 kDa, Sigma), Alexa-Fluor-488-dextran (AFD488, Invitrogen) 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC, Avanti Polar Lipids), 1,2-dioleoyl-3-
trimethylammonium-propane (chloride salt) (DOTAP, Avanti Polar Lipids), Bodipy-labeled 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC-Bodipy, Invitrogen). 
All chemicals were used as received without further purification. Doubly distilled water from a 
Millipore system (Milli-Q Academic A10) was used for all synthesis and purification steps.  
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Synthesis of amino/phenyl functionalized large pore silica nanoparticles 
(LP_MSN-NH2/Ph) with 1 mol% functionality. A modified literature procedure was 
employed to synthesize LP_MSN-NH2/Ph.
18, 19 Pluronic F127 (0.25 g) and fluorocarbon 
surfactant FC-4 (1.4 g) were dissolved in hydrochloric acid (HCl, 30 mL, 0.02 M), followed by 
the addition of TMB (0.20 g, 1.66 mmol). The reaction mixture was stirred in a 100 mL 
polypropylene reactor for 2 h at 10 °C before a mixture of tetraethyl orthosilicate (TEOS, 1.5 g, 
7.2 mmol, 100 mol%), phenyl triethoxysilane (PTES, 8.7 μL, 0.036 mmol, 0.5 mol%) and of 
3-aminopropyl triethoxysilane (8.4 μL, 0.036 mmol, 0.5 mol%) was added drop-wise. The 
resulting suspension was stirred vigorously (1250 rpm) for 14 h at 10 °C. The resulting particle 
suspension was hydrothermally treated in a 100 mL Parr reactor under static conditions (150 
°C, 1d). The mixture was centrifuged (15 min, 20500 rpm, 50228 rcf), re-suspended in 
hydrochloric acid (HCl, 30 mL, 0.2 M) and heated under static conditions (140 °C, 2d). After 
the addition of 50 mL bi-distilled H2O, the LP_MSNs were collected by centrifugation (15 min, 
20500 rpm, 50228 rcf), re-dispersed in 50 mL EtOH and extracted according to the procedure 
described below. 
 
Template removal from LP_MSN. The organic template was removed via extraction from 
LP_MSNs. For this purpose, 250 mg of the particles were refluxed for 2 h at 75 °C in a mixture 
of absolute EtOH (80 mL), acetone (40 mL) and conc. HCl (10 mL). This extraction step was 
performed twice. The template-free LP_MSNs were separated by centrifugation (15 min, 20500 
rpm, 50228 rcf) and washed with EtOH after each extraction step. LP_MSNs were obtained as 
colloidal suspension in EtOH. This extraction procedure was carried out for all samples unless 
otherwise noted. 
 
Size separation centrifugation of LP_MSNs. In order to separate larger agglomerates and 
impurities from the synthesized nanoparticles, a size separation centrifugation was performed 
(15 sec, 3.000 rpm, 775 rcf). The resulting supernatant comprising a nanoparticle yield of 50% 
(relative to the synthesis yield) was employed for all further applications. The obtained particles 
in ethanol were stored in tightly sealed glass vials. 
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Adsorption of fluorescent cargos into the mesopores of LP_MSN-NH2/Ph. 0.5 mg of the 
sample LP_MSN-NH2/Ph in ethanol were centrifuged and re-dispersed in 1 mL water. This 
washing step was repeated twice with 1 mL water each. Then, the suspension was centrifuged 
again and re-dispersed in: 
 500 µL calcein (1 mM stock solution in water),  
 375 µL water and 125 µl FITC-Dextran (3 – 5 kD, 1 mg/mL stock solution in water), 
 250 µL water and 250 µL FITC-Dextran (10 kD; 5 mg/mL stock solution in water) 
The respective reaction mixtures were stirred overnight in the dark yielding the sample 
LP_MSN-NH2/Ph-Cargo.  
 
Supported DOPC/DOTAP lipid bilayer (SLB) around LP_MSN-NH2/Ph-Cargo  
The amount of 0.5 mg of LP_MSN-NH2/Ph-Cargo was separated by centrifugation (4 min, 
14000 rpm, 16873 rcf).  A mixture of 70 µL DOPC and 30 µL DOTAP (each 2.5 mg/mL in 60 
: 40 H2O : EtOH) were added to the resulting pellet, mixed extensively, and sonicated for 10 s. 
To form the supported lipid bilayer around the MSN via the solvent exchange method, 700 µL 
of water were added. The resulting suspension was mixed and sonicated for 10 s, yielding 
DOPC/DOTAP-SLB@LP_MSN-NH2/Ph-Cargo.  
 
Time-based fluorescence release experiments of the sample DOPC/DOTAP@ 
LP_MSN-NH2/Ph-Cargo. Time-based fluorescence release experiments were recorded on a 
PTI fluorescence system equipped with a PTI 814 photomultiplier detector and a PTI A1010B 
Xenon arclamp driven by a PTI LPS-220B lamp power supply. For temperature settings, a 
Quantum Northwest TC 125 sample holder was used. Our previously described custom-made 
release cuvette system was employed for all experiments. All samples were measured at a 
temperature of 37 °C with slits of 1-1.2-1-1-1 (2-2.2-2-2-2 for FITC-Dextran 10 kDa). For 
calcein an excitation wavelength of 495 nm was used (emission maximum at 516 nm), whereas 
FITC-dextran with an emission maximum at 520 nm was excited with 490 nm. 
0.5 mg of the respective DOPC/DOTAP@ LP_MSN-NH2/Ph-Cargo (Cargo = Calcein, 
FITC-Dextran 5 kDa or FITC-Dextran 10 kDa) sample was used for the experiment. 200 µL of 
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the particle suspension was filled into the reservoir cap sealed with a dialysis membrane 
(Molecular weight cut-off 14000 g/mol) allowing released dye molecules to pass into the 
fluorescence cuvette. Each sample was measured for 3 h in the closed state before the SLB was 
disrupted by added detergent. For this purpose, the LP_MSNs were transferred to an Eppendorf 
cup and mixed with 5 µL of a 1 mM stock solution of TritonX100 to disrupt the membrane. 
Afterwards, the sample was measured again for defined time periods. 
 
Dye-labeling of LP_MSN-NH2/Ph with Atto633-maleimide. The amount of 1 mg of 
LP_MSN-NH2/Ph was washed three times with absolute ethanol (1 mL each) by repeated 
centrifugation (4 min, 14000 rpm, 16873 rcf) and re-dispersion, before 5 µL Atto633-maleimide 
(13.4 nmol, 1 mg Atto633-Mal dissolved in 500 µL anhydrous DMF) was added to the 
LP_MSN solution. The reaction mixture was allowed to stir at ambient temperature for 14 hours 
in the dark. The sample was washed four times with 1 mL absolute ethanol by successive 
centrifugation (4 min, 14000 rpm, 16873 rcf) and re-dispersion to remove unbound dye. 
Generation of supported dye-labeled DOPC/DOTAP lipid bilayer (SLB) around 
LP_MSN-NH2/Ph-Atto633. The amount of 0.5 mg of LP_MSN-NH2/Ph-Atto633 was washed 
thoroughly with water (five times, 1 mL each) by successive centrifugation (4 min, 14000 rpm, 
16873 rcf). Afterwards, a mixture of 65 µL DOPC, 5 µl DOPC-Bodipy and 30 µL DOTAP 
(each 2.5 mg/mL in 60:40 H2O : EtOH) were added to the resulting pellet, mixed extensively, 
and sonicated for 10 s. To form the supported lipid bilayer around the MSN via the solvent 
exchange method, 700 µL of water were added. The resulting suspension was mixed and 
sonicated for 10 s, yielding SLB_bodipy@LP_MSN-NH2/Ph-Atto633.  
Attachment of the photosensitizer AlPcS2a to LP_MSN-NH2/Ph. 1 mg of LP_MSN-NH2/Ph 
in ethanolic solution was centrifuged (4 min, 14000 rpm, 16873 rcf) and re-suspended in a 
500 µL water/DMSO mixture (2:1). Subsequently, 20 µL of an AlPCS2a stock solution (2 mg 
in 1 mL DMSO) were added to the MSNs. The reaction mixture was stirred in the dark at room 
temperature for 72 h. The resulting LP_MSN-NH2/Ph-AlPcS2a was extensively washed by 
centrifugation (4 min, 14000 rpm, 16873 rcf) with a water/DMSO mixture (1:1) in order to 
remove excess photosensitizer. All supernatants were investigated with a Nanodrop UV-VIS in 
order to monitor the content of free photosensitizer. Results of these measurements are given 
in the Appendix. In order to remove DMSO from the mesopores, the sample was washed three 
times with bi-destilled water after no free PS could be detected. The colloidal solution of sample 
LP_MSN-NH2/Ph-AlPcS2a was immediately used for further experiments.   
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Adsorption of fluorescent cargo molecules into the mesopores of LP_MSN-NH2/Ph-
AlPcS2a  
The amount of 0.5 mg of the sample LP_MSN-NH2/Ph-AlPcS2a in ethanol was centrifuged and 
re-dispersed in 1 mL water. This washing step was repeated twice with 1 mL water each. Then, 
the suspension was centrifuged again and re-dispersed in: 
 500 µL calcein (1 mM stock solution in water),  
 250 µL water and 250 µl propidium iodide (1 mM stock solution in water), 
 100 µL water and 10 µL Alexa-Fluor-488-Dextran (10 kD; 2 mg/mL in PBS) 
The respective reaction mixtures were stirred overnight in the dark yielding the sample 
LP_MSN-NH2/Ph-AlPcS2a-Cargo. A supported lipid bilayer consisting of DOPC and DOTAP 
was built around the LP_MSNs prior to measurements (see detailed synthesis procedure above). 
Time-based fluorescence release experiments of the sample 
DOPC/DOTAP@LP_MSN-NH2/Ph-AlPcS2a-Calcein. Fluorescence time-based release 
experiments were recorded on a PTI fluorescence system equipped with a PTI 814 
photomultiplier detector and a PTI A1010B Xenon arclamp driven by a PTI LPS-220B lamp 
power supply. For temperature settings, a Quantum Northwest TC 125 sample holder was used. 
Our previously described custom-made release cuvette system was employed for all 
experiments. All samples were measured at a temperature of 37 °C with slit positions 1-1.2-1-
1-1. An excitation wavelength of 495 nm was employed (emission maximum at 516 nm). 
The amount of 0.5 mg of DOPC/DOTAP@ LP_MSN-NH2/Ph-AlPcS2a-Calcein was used for 
the experiment. 200 µL of the particle suspension was filled into the reservoir cap sealed with 
a dialysis membrane (molecular weight cut-off 14000 g/mol) allowing released dye molecules 
to pass into the fluorescence cuvette. In order to monitor the release of adsorbed dyes upon 
membrane rupture with singlet oxygen, the sample was excited with 0.56 W / mm2 of 633 nm 
light for 1 minute prior the measurement.   
 
Cell culture. HeLa cells were cultivated in Dulbecco’s modified Eagle’s medium 
(DMEM):F12 (1:1) (Invitrogen) with Glutamax I medium supplemented with 10 % fetal bovine 
serum (FBS) at 37 °C in a 5% CO2 humidified atmosphere. The cells were seeded on collagen 
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A-coated LabTek chambered cover glass (Nunc). For live cell imaging the cells were seeded 
24 or 48 h before measuring, at a cell density of 2x104 or 1x104 cells/cm2.  
 
Spinning disc confocal microscopy. Confocal microscopy for live-cell imaging was 
performed on a setup based on the Zeiss Cell Observer SD utilizing a Yokogawa spinning disk 
unit CSU-X1. The system was equipped with a 1.40 NA 100x Plan apochromat oil immersion 
objective from Zeiss. For all experiments the exposure time was 0.1 s and the frame rate varied 
between 3 frames/s and 1 frame/30s, depending on the specific requirements of the experiment.  
Cells were incubated with the corresponding particles 21 - 23 h prior to the measurements at 
37 °C under a 5% CO2 humidified atmosphere. Shortly before imaging, the medium was 
replaced by CO2-independent medium (Invitrogen). During the measurements all cells were 
kept on a heated microscope stage at 37 °C. 
Calcein and Alexa-Fluor derivatives were imaged with approximately 0.4 W/mm2 of 488 nm 
excitation light. PI was excited with 0.39 W/mm2 and Bodipy with 0,72 W/mm2 of 561 nm; 
AlPcS2a was excited with 0.12 W/mm
2 of 639 nm for imaging and for photoactivation with 0.6 
or 1.2 W/mm2. In the excitation path a quad-edge dichroic beamsplitter (FF410/504/582/669-
Di01-25x36, Semrock) was used. For two color detection of calcein, Alexa-Fluor derivatives 
and AlPcS2a a dichroic mirror (560 nm, Semrock) and band-pass filters 525/50 and 690/60 (both 
Semrock) were used in the detection path. For detection of PI or Bodipy and AlPcS2a a dichroic 
mirror with 660 nm (Semrock) and band-pass filters 629/60 (both Semrock) were used. Separate 
images for each fluorescence channel were acquired using two separate electron multiplier 
charge coupled devices (EMCCD) cameras (Photometrics EvolveTM).   
 
Characterization. Centrifugation was performed using a Sorvall Evolution RC equipped with 
a SS-34 rotor or an Eppendorf centrifuge 5418 for small volumes (1.5 mL maximum). Dynamic 
light scattering (DLS) and zeta potential measurements were performed on a Malvern Zetasizer-
Nano instrument equipped with a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. 
DLS measurements were directly recorded on ethanolic colloidal suspension at a constant 
concentration of 1 mg/mL. Transmission electron microscopy (TEM) and Scanning TEM were 
performed on a FEI Titan 80-300 kV microscope operating at 300 kV. UV-VIS spectra were 
recorded with a NanoDrop ND 1000 spectrometer. Amounts of 2 µL of sample were used and 
all presented spectra are background corrected for the respective solvent. 
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8.5 Appendix 
 
Figure 8.15: Dye release kinetics from SLB@LP_MSN-NH2/Ph-Calcein as a function of time. After a 
3 h release experiment at 37 °C with supported lipid bilayer capped LP_MSN-NH2/Ph-Calcein, Triton-
X was added to disrupt the SLB, resulting in a burst of dye release. 100% was set for the amount released 
after 8 h. 
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Figure 8.16: UV-Vis spectra of the supernatants resulting from the washing procedure of 
LP_MSN-NH2/Ph-AlPcS2a.  No free photosensitizer could be detected in supernatants 8, 9 and 10. 
Calculation 8.1: Calculation of the surface functionalization based on thermogravimetric analysis 
(TGA) of sample LP_MSN-NH2/Ph 
 
1 g sample LP_MSN-NH2/Ph contains 44 mg NH2/Ph-residues (mass loss 4.4%, 
Mw(C3H6Ph/C3H6NH2 50:50)=88.5 g*mol
-1) 
 
44 𝑚𝑔
(100% − 4.4%) 𝑔
= 46 𝑚𝑔 𝑁𝐻2/𝑃ℎ − 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 / 𝑔 𝑠𝑖𝑙𝑖𝑐𝑎 
0.046 𝑔 
88.5 
𝑔
𝑚𝑜𝑙
= 0.52 𝑚𝑚𝑜𝑙 𝑁𝐻2/𝑃ℎ − 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠/𝑔 𝑠𝑖𝑙𝑖𝑐𝑎 => 0,26 𝑚𝑚𝑜𝑙 𝑁𝐻2/𝑔 𝑠𝑖𝑙𝑖𝑎 
1 g sample LP_MSN-AlPcS2a contains 45 mg AlPcS2a (additional mass loss 4.5%, 
Mw(AlPcS2a) = 735,1 gmol
-1) 
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45 𝑚𝑔
(100% − 4.4% − 4.5%) 𝑔
= 49 𝑚𝑔 𝐴𝑙𝑃𝑐𝑆2𝑎 / 𝑔 𝑠𝑖𝑙𝑖𝑐𝑎 
0.049 𝑔 
735,1 
𝑔
𝑚𝑜𝑙
= 0,067 𝑚𝑚𝑜𝑙 𝐴𝑙𝑃𝑐𝑆2𝑎 − 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 / 𝑔 𝑠𝑖𝑙𝑖𝑐𝑎 
Amount of NH2 moieties that have reacted with AlPcS2a: 
0,067 𝑚𝑚𝑜𝑙
0,26 𝑚𝑚𝑜𝑙
= 25,8% of NH2 moieties 
BET surface of LP_MSN-NH2/Ph = 176 m
2/g 
BET surface of non-porous silica spheres of the same size = 45 m2/g 
45 𝑚2/𝑔
176 𝑚2/𝑔
= 25,6% of NH2 moieties on the particle surface LP_MSN-NH2/Ph. 
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9 Functionalization with organo-lithium reagents and post-synthesis 
modification of mesoporous MCM-41 
This chapter is based on the following publication: 
Alexandra Schmidt, Pia Köstler, Frank Tambornino, Stefan Steinlein and Thomas Bein, to be 
submitted to Chemistry of Materials 2014. 
 
Abstract 
The mesoporous framework of MCM-41 can be modified with numerous metal-organic 
reagents, enabling the introduction of functional groups to the surface of the silica material. We 
demonstrate the direct organic functionalization of mesoporous silica with easily accessible 
lithiated aromatic compounds. For this purpose, several bromine-containing aromatic 
compounds were lithiated and the products were used for the in situ functionalization of MCM-
41. In combination with the remarkably reduced cost for the synthesis and the unique features 
of these novel functionalized inorganic-organic hybrid materials, lithiated aromatic compounds 
are promising candidates for the post-synthesis modification of mesoporous silica materials. 
Here we focus on heteroatom-bearing compounds such as esters, ethers and other 
heteroaromatics (e.g., 4-bromoanisole, 4-bromobenzaldehyde dimethylacetal and 
2-bromothiophene). The resulting inorganic-organic hybrid materials offer the possibility for 
further functionalization, depending on the application of the respective material. The high 
specific surface areas, the well-defined pore size distribution and the typical 2D hexagonal array 
of the porous channels were retained during the synthesis of the inorganic-organic hybrid 
materials. Additionally, we achieved high loading capacities for our novel organic-inorganic 
hybrid materials. 
 
 
9.1. Introduction  
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9.1 Introduction 
Ever since the development of MCM-41 by Beck et al.1, 2 in 1992 there has been an increasing 
interest in the field of mesoporous silica materials. Their scope of applications has grown in the 
last two decades, ranging from solid supports for catalysts3, 4 and gas sensors5  to nano-carriers 
for advanced drug delivery applications.6-8 Mesoporous materials offer the possibility to tune 
particle morphology, pore size and pore topology according to the needs of the application, and 
it is possible to modify their internal and external surface via molecular functionalization. 
Among the numerous mesoporous silica materials that are known today, MCM-41 has been 
widely used as a promising solid support for organic catalysts: For example, Das et al.9 attached 
a Jacobsen catalyst onto MCM-41 and Yang et al. immobilized dicyano functionalized arenes 
together with palladium(0) for Heck-Reactions in the mesoporous network.10 Various pathways 
enabling the introduction of molecular functionalities into mesoporous frameworks are 
known.11 Specifically, post-synthesis grafting and co-condensation represent two important 
approaches for introducing molecular functionality. Both of these methods rely on the use of 
organo-silanes such as 3-aminopropyl triethoxysilane (APTES), but only a limited number of 
such silanes is commercially available. However, it is of interest to incorporate complex 
structures and a broad variety of functionalities into the mesoporous framework of silica 
materials at affordable costs. Whereas the availability of appropriate organo-silane reagents is 
limited, numerous bromo-functionalized aliphatic and aromatic compounds are readily 
available or can be easily synthesized with standard organic methods.  
If a pathway could be opened that would ultimately replace the bromine atom in brominated 
organic molecules with a surface silicon atom in mesoporous silica, a wealth of organic moieties 
could be immobilized in these hosts. This would offer the unique possibility to design promising 
catalysts directly and to incorporate them into the mesoporous framework of the solid support. 
The approach of employing metal-organic compounds for the direct organic modification of 
mesoporous silica materials was developed independently by Lim et al. and by some of us.12, 13 
We found a synthetic method that offers a broad spectrum of functionalities for the modification 
of the solid support.13 Initially the synthesis was based on Grignard reactants, followed by the 
reaction of lithiated arene compounds with the silica framework.14 Very low temperatures are 
employed during the synthesis, which can be an advantage when grafting sensitive organic 
moieties. The functionalization with metal-organic reagents offers the possibility to introduce 
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multiple functionalities into the mesoporous framework of silica materials. The procedure 
developed by Angloher et al. has already been employed to generate promising catalysts for 
Michael-additions.15, 16 In the above publication, nitrogen-containing arene compounds were 
immobilized on the solid support. Here we focus on the immobilization of oxygen- and sulfur-
containing molecules that offer interesting possibilities for further functionalization. Moreover, 
we further improved the synthesis procedure by using tert-butyllithium (tBuLi) as lithiating 
agent instead of n-butyllithium (nBuLi) to prevent unwanted by-products.  
9.2 Results and Discussion 
MCM-41 was synthesized according to a procedure published by Kumar et al..17 The organic 
template was removed by calcination in air, yielding template-free mesoporous MCM-41 as 
white powder, which was characterized before further reactions were conducted (resulting data 
are shown together with those of modified materials). Since reactions with metal-organic 
reagents require a moisture- and oxygen free environment, template-free MCM-41 was 
outgassed in vacuo at 150 °C for 6 h und kept under nitrogen atmosphere before the actual 
synthesis of the inorganic-organic hybrid materials was started.  
We followed different protocols in order to synthesize organo-functionalized MCM-41 (details 
see experimental section). In a first approach, several 4-bromo-arenes were lithiated with 0.8 
equivalents of n-butyllithium (nBuLi) in anhydrous hexane. The molar ratio of 0.8 equivalents 
nBuLi and 1 equivalent aromatic compound was employed to avoid the coupling of unreacted 
nBuLi with the surface of the mesoporous material. The resulting 4-lithioarenes were 
subsequently reacted with MCM-41. This post-synthesis functionalization of MCM-41 was 
carried out for 4 h at a specified temperature and was quenched with water afterwards. All 
samples were purified via soxhlet extraction in dichloromethane to remove unreacted reagents 
from the mesopores. The incorporation of the lithiated arenes (Ar-Li) proved to be successful 
and was verified with 13C and 29Si magic angle spinning (MAS) solid state NMR (ssNMR) 
(Figure 9.3B for 13C ssNMR of the reaction of 4-lithiobenzaldehyde dimethylacetal with 
MCM-41 and Figure 9.11 (cf. appendix) for 13C ssNMR of the reaction of 4-lithioanisole with 
MCM-41). However, the 13C ssNMR spectrum of MCM-41_ArOMe (reaction with 
4-lithioanisole) and MCM-41_BDMA (reaction with 4-lithiobenzaldehyde dimethylacetal) 
showed that in addition to the aromatic peaks, butyl-moieties are present in the synthesized 
materials as well. We found these butyl-residues attached to the mesoporous framework in each 
spectrum. As it is possible that nBuLi itself reacts with the silicon atoms of MCM-41 forming 
9.2. Results and Discussion  
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a Si-butyl bond, this reation was studied in more detail. For this purpose, template-free 
MCM-41 was reacted with the same molar amount of nBuLi (2.5 mmol) that had been used for 
the conversion of 4-bromoanisole to 4-lithioanisole at different temperatures (-78 °C, -20 °C 
and ambient temperature). The obtained materials were characterized with 13C and 29Si ssNMR, 
and additionally thermogravimetric analysis was performed (cf. appendix 9.9). The synthesis 
temperature strongly affects the degree of functionalization of the silica atoms, as demonstrated 
in the 29Si ssNMR spectrum (cf. appendix 9.8). When MCM-41 is reacted with nBuLi at -78 °C, 
only mono-functionalization of the silica framework occurs, indicated by the appearance of 
T2/T3 peaks in Figure 9.8 (black curve, cf. appendix). Higher temperatures (-20 °C and ambient 
temperature) lead to additional bi-functionalization of the silica atoms as indicated by the newly 
appearing D2 peak (green and red curve in Figure 9.8, appendix). However, a detailed analysis 
of the obtained 13C ssNMR spectra of MCM-41_nBuLi (Figure 9.1A) revealed that the peaks 
do not match the pattern resulting from MCM-41_ArOMe (Figure 9.1B). One peak is shifted 
to higher magnetic fields ( = 48 ppm) in the case of MCM-41_ArOMe, which does not 
correspond to an n-butyl-chain linked directly to the silica framework.  
 
Figure 9.1: 13C magic angle spinning solid state NMR (MAS ssNMR) spectra A) of the reaction of 
n-butyllithium with MCM-41 at different temperatures, and B) reaction of MCM-41 with 4-lithioanisole 
at -78 °C.  
Given the above insights, we ask about the nature and origin of the butyl groups in the pores. 
Butylbromide is a by-product of the bromine-lithium-exchange reaction with 4-bromoanisole 
(or 4-bromobenzaldehyde dimethylacetal (BDMA)), which is able to react with the siloxane 
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groups of the silica framework (cf. appendix Figure 9.7). The change of the chemical shift to 
higher magnetic fields ( = 48 ppm instead of 25 ppm) indicates that the butyl-chain is bound 
to an electron-withdrawing heteroatom, which is oxygen in this case. A variation of the reaction 
temperature for the reaction of 4-lithioanisole with MCM-41 did not result in an elimination of 
the peak at  = 48 ppm.  
Since the butoxy signal together with the distinct aromatic peaks was present in all obtained 
13C ssNMR spectra of MCM-41_Arene (MCM-41_ArOMe, MCM41_BDMA, 
MCM-41_Thiophene and MCM-41_ArNMe2) the synthesis protocol was modified. Instead of 
0.8 equivalents (2.5 mmol) nBuLi, 2 equivalents tert-butyllithium (tBuLi, 5 mmol) and 
anhydrous diethyl ether were employed for the lithiation of the bromo-containing aromatic 
compounds. The synthesis pathway is given in appendix Figure 9.7 (cf. experimental section). 
In a first reaction, 4-Br-BDMA was lithiated with tBuLi in anhydrous Et2O, yielding 
4-Li-BDMA as reactive intermediate that was subsequently reacted with template-free 
MCM-41 at low temperatures. 
 
Figure 9.2: Reaction of 4-bromobenzaldehyde dimethylacetal (Br-BDMA) with 2 eq tBuLi at low 
temperatures and subsequent reaction with MCM-41. 
It is known that the use of 2 equivalents of tBuLi eliminates butylbromide from the reaction 
itself;18 one equivalent tBuLi lithiates the arene whereas the second equivalent reacts with the 
in situ generated tert-butylbromide, yielding only gaseous by-products (isobutene and 
isobutane) and LiBr.   
 
This novel synthesis approach was studied with 4-bromoanisole and 4-bromobenzaldehyde 
dimethylacetal as model systems with the reaction parameters given in Figure 9.2. The resulting 
inorganic-organic hybrid materials were purified via soxhlet extraction for 3 h in 
dichloromethane to ensure that no unreacted precursor is present in the mesopores 
9.2. Results and Discussion  
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(cf. experimental section). The materials were analyzed with ssNMR and the results were 
compared with the data for the reaction with 0.8 eq nBuLi. The data are summarized in Figure 
9.3A, B and D (for MCM-41_BDMA) and Figure 9.11 and 9.12 (for MCM-41_ArOMe, cf. 
appendix). 
 
Figure 9.3: Organo-functionalization of MCM-41 with 4-bromobenzaldehyde dimethylacetal. A) 13C 
ssNMR of MCM-41_BDMA – halogen-lithium-exchange carried out with 2 eq tBuLi, B) 13C ssNMR 
of MCM-41_BDMA, lithiation with n-BuLi, C) 29Si ssNMR of template-free, unfunctionalized 
MCM-41, D) 29Si ssNMR of MCM-41_BDMA with tBuLi. 
As discussed previously for MCM-41_ArOMe, the lithiation of the bromo-containing 
compound with nBuLi and subsequent reaction of the Ar-Li species with MCM-41 results in 
the attachment of butyl-fragments to the mesoporous framework, which is also the case for 
MCM-41_BDMA. The 13C ssNMR of these reactions (Figure 9.3B) shows the distinct peaks at 
 = 11, 14, 25 and 48 ppm whereas no alkyl peaks are visible in the spectrum when 4-Li-BDMA 
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was generated with tBuLi. Despite the different reactivity of 4-bromoanisole, the same result 
was obtained for MCM-41_ArOMe (cf. appendix 9.11). Figure 3D shows the 29Si ssNMR 
spectrum of MCM-41_BDMA, indicating the successful attachment of 4-Li-BDMA to the 
mesoporous framework of MCM-41. Both species, Q3/Q4 ( = -101 and -110 ppm – 
corresponding to the silica species A in Figure 9.7) and T2/T3 ( = -55 and -65 ppm - 
corresponding to silica species B in Figure 9.7) were observed in the 29Si ssNMR spectra of 
MCM-41_BDMA, indicating mono-functionalization of the silica atoms in MCM-41. 
Bi-functionalized silica species that are indicated by the D2 peak (species C in Figure 9.7, 
cf. appendix) are not present.  
In order to analyze the mesostructure of the inorganic-organic hybrid material, nitrogen sorption 
measurements were carried out for template-free MCM-41 and MCM-41_BDMA. The organo-
functionalized sample exhibits a type IV isotherm (Figure 9.4A, empty squares) typical for a 
mesoporous material with a high surface area of 763 m2g-1 and a pore size of 2.9 nm 
(Figure 9.4B). Compared to MCM-41 (filled squares) the BET area is reduced by a value of 
250 m2g-1 and the pore size is smaller, which confirms the successful incorporation of the 
aromatic system into the mesoporous framework.  
 
Figure 9.4: Nitrogen sorption data of MCM-41 and MCM-41_BDMA. A) Nitrogen sorption isotherms 
of calcined MCM-41 (filled squares) and MCM-41_BDMA (empty squares), and B) pore size 
distribution of calcined MCM-41 (filled squares) and MCM-41_BDMA (empty squares).  
Additional analysis of MCM-41_BDMA and MCM-41_ArOMe (Ar-Li generated with tBuLi) 
with transmission electron microscopy (TEM) shows that the typical hexagonal 2D 
9.2. Results and Discussion  
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mesostructure of MCM-41 was retained under the given reaction conditions (cf. appendix 
Figures 9.19 for MCM-41, 9.20 for MCM-41_BDMA and 9.21 for MCM-41_ArOMe).  
As the lithiation with tBuLi proved to be successful for 4-bromoanisole and 4-benzaldehyde 
dimethylacetal, the novel synthesis procedure was extended to several additional aromatic 
compounds, shown as precursor 4-bromo arenes in Figure 5.  
 
Figure 9.5: Overview of the aromatic compounds that were successfully bound to MCM-41 in this 
work. 
All chosen aromatic compounds feature the possibility to be modified in a second post-synthesis 
reaction via various reaction pathways. MCM-41_BDMA, for example, can be converted to the 
corresponding aldehyde, which offers numerous options for further modifications. 
For all synthesized inorganic-organic hybrid materials (MCM-41_Arene), 13C and 29Si ssNMR 
studies were performed to confirm the covalent attachment of the respective aromatic 
compounds. All modified materials show T2/T3 species in the 
29Si ssNMR spectra 
corresponding to mono-functionalized silica atoms within the framework. The attachment of 
tert-butyl fragments to the mesoporous material can be excluded for all compounds, as none of 
the 13C ssNMR spectra (cf. appendix, Figure 9.13 for MCM-41_ArNMe2, Figure 9.14 for 
MCM-41_Thiophene and Figure 9.15 for MCM-41_ArCH2Cl) show the typical signals of the 
tert-butyl group. This is a significant improvement compared to the previously described 
method, as solely the aromatic system reacts with the framework. All materials were 
characterized with nitrogen sorption and thermogravimetric analysis. The key features of the 
resulting inorganic-organic hybrid materials obtained with these methods are summarized in 
Table 9.1. All functionalized materials exhibit a type IV isotherm typical for mesoporous 
materials (cf. appendix 9.16) and possess high specific surface areas and a well-defined pore 
size distribution (cf. appendix 9.17).  
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Table 9.1: Key features of organically functionalized mesoporous MCM-41 obtained by nitrogen 
adsorption measurements and thermogravimetric analysis.  
Sample 
BET surface area 
[m²/g] 
Pore sizea  
[nm] 
Relative mass lossb 
[%] 
MCM-41 962 3.4 3 
MCM-41_ArOMe 670 2.8 20 
MCM-41_BDMA 763 2.9 21 
MCM-41_Thiophene 730 3.0 14 
MCM-41_ArNMe2 565 2.9 12 
MCM-41_ArCH2Cl 724 3.0 18 
aDFT pore size refers to the peak value of the pore size distribution. bRelative mass loss obtained from TGA 
analysis. All samples were normalized to 100% at 75 °C (cf. appendix 9.18). 
The expected decrease of the specific surface area and the pore size after the post-synthesis 
modification can be explained with the steric requirements of the organic moieties attached 
within the mesopores. We note that the decrease of the BET area is more prominent for 
MCM-41_ArNMe2.  
The typical 2D hexagonal array of the pore channels of the MCM-41 material was retained 
under the applied synthesis conditions. This was demonstrated by TEM measurements 
(cf. appendix 9.19 for template-free MCM-41, 9.20 for MCM-41_ArOMe and 9.21 for 
MCM-41_BDMA). Moreover, all small angle diffractograms of the organo-functionalized 
MCM-41 compounds show the typical 100 reflection at 2.3° 2 (cf. appendix 9.22), suggesting 
that the mesostructure is preserved.  
9.3 Conclusion 
In this study, the nature of the lithiating agent used for the generation of reactive arene 
intermediates for the functionalization of mesoporous silica was optimized in order to eliminate 
undesired alkylation of the pore surface. We show that the lithiation of para-bromo arenes with 
tert-butyllithium is highly favorable compared to the lithiation with n-butyllithium. As a result, 
alkyl signals resulting from attached n-butyl groups disappear entirely from the corresponding 
13C MAS ssNMR spectra in all reactions, and only the characteristic peaks of the employed 
aromatic moieties are visible. Following this route, we were able to introduce several different 
9.4. Experimental  
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functionalities into the mesoporous framework of MCM-41, showing the generality of the 
approach. All functionalities are directly attached to the surface silicon atoms through an 
aromatic ring system (in contrast to classical organo-silane grafting reagents bearing the 
functional groups). All the aromatic systems presented here offer the possibility for further 
chemical modifications, thus opening up numerous possibilities for chemical functionalization. 
In addition, the mild reaction conditions at low temperatures and the short reaction times of the 
organo-functionalizations are of great advantage as they prevent degradation of most organic 
compounds. Moreover, this functionalization strategy can be generalized to other mesoporous 
host systems such as SBA-15 or even colloidal mesoporous silica nanoparticles with different 
pore sizes. In conclusion, the direct modification of mesoporous hosts with various aromatic 
molecules was demonstrated to be fast and highly efficient, offering an attractive variety of 
post-synthesis modifications for mesoporous materials for future applications. 
9.4 Experimental 
Materials. Tetraethyl orthosilicate (TEOS, Fluka, >98%), cetyltrimethylammonium bromide 
(CTAB, Aldrich, 95%), aqueous ammonia (25 w%, Fluka), n-butyllithium (nBuLi, Aldrich, 
obtained as 1.7 M solution in pentane), tert-butyllithium (tBuLi, Aldrich, obtained as 1.7 M 
solution in pentane), 1-bromo-4-(chloromethyl)benzene (Br-ArCH2Cl, Aldrich, >97%), 
4-bromobenzaldehyde dimethylacetal (Br-BDMA, Aldrich, 98%), 2-bromothiophene (Aldrich, 
98%), 4-bromoanisole (Br-ArOMe, Aldrich, >99%), 4-bromo-N,N-dimethylaniline 
(Br-ArNMe2, Aldrich, 97%), sodium azide (Aldrich, 99%), methanol (MeOH, Fluka, >99%), 
diethyl ether (Et2O, ), dichloromethane (Acros, >99%), absolute ethanol (EtOH, Aldrich, 
>99.5%),  n-hexane (anhydrous, Sigma, >95% ). 
Unless otherwise noted, all reagents were used without further purification.  Bi-distilled water 
from a Millipore system (Milli-Q Academic A10) was used for syntheses and purification steps.  
 
 
Experimental procedures  
Synthesis of mesoporous MCM-41. MCM-41 was synthesized according to a procedure 
published by Kumar et al.1 We employed the four-fold reaction scale of the original recipe, 
which is easily scalable. Absolute EtOH (50 g), aqueous ammonia (25 w%, 40 mL) and CTAB 
 265 
 
(9.56 g, 26.3 mmol) were dissolved in water (450 mL) in a 500 mL polypropylene reactor under 
continuous stirring. Subsequently, tetraethyl orthosilicate (40 g, 192 mmol) was added 
drop-wise to the stirred template solution. Afterwards, the reaction mixture was stirred at room 
temperature for 2 h at 500 rpm. The white precipitate was filtered off, washed with EtOH until 
the filtrate was ammonia free (neutral pH-value). The obtained colorless powder was dried at 
60 °C in air for 16 h. The template was removed via calcination in air, using a ramping profile 
with a heating rate of 1 °C min-1 up to a temperature of 550 °C. The temperature was kept for 
5 h.  
 
Preparation of MCM-41 for post-synthesis functionalization with lithiated organo 
compounds. For each reaction, 500 mg template-free MCM-41 in a 50 mL Schlenk-flask was 
dried at 150 °C in vacuo for 6 h. Afterwards, the mesoporous material was allowed to cool to 
ambient temperature before Et2O (anhydrous, 20 mL) was added. The suspension was cooled 
to -78 °C under continuous stirring.   
 
Temperature dependent reaction of nBuLi with MCM-41. Three batches of 500 mg dried 
MCM-41 each were suspended in anhydrous n-hexane (20 mL) cooled to the desired 
temperature under continuous stirring (-78 °C, -20 °C and ambient temperature). nBuLi 
(1.6 mL, 2.5 mmol) was added drop-wise to the suspension and the reaction mixture was stirred 
for 4 h at the given temperature in a 50 mL Schlenk-flask. Afterwards, the reaction mixture was 
quenched with EtOH and water (10 mL each) and filtered off. The obtained white powders were 
subsequently washed with methanol (30 mL), water (50 mL) and methanol (30 mL) and dried 
at 60 °C in air.  
 
Lithiation of 4-bromoanisole (or 4-bromobenzaldehyde dimethylacetal, respectively) with 
nBuLi and subsequent reaction with MCM-41 (yielding sample MCM-41_ArOMe or 
MCM-41_BDMA respectively) 
The respective 4-bromoarene (4-bromoanisole or 4-bromobenzaldehyde dimethylacetal, 
respectively) was dissolved in anhydrous Et2O (10 mL) and cooled to -78 °C under continuous 
stirring. nBuLi (2.5 mmol, 0.8 eq) was added drop-wise and the reaction mixture was stirred 
for 30 min at -78 °C, before it was transferred to the Schlenk-flask (50 mL) containing 
MCM-41. The in situ generated Ar-Li compound was added drop-wise to the stirred suspension 
of MCM-41 at -78 °C. The resulting reaction mixture was stirred at -78 °C for 10 minutes and 
was then allowed to warm to ambient temperature and was stirred for another 4 h. Afterwards 
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the reaction mixture was quenched with water (10 mL) and filtered off. The obtained yellowish 
powder was subsequently washed with methanol (30 mL), water (50 mL) and methanol (30 mL) 
and dried at 60 °C in air.  
 
Lithiation of different 4-bromoarenes with tBuLi (yielding samples MCM-41_Arene) 
All reactions were performed according to this synthesis protocol unless otherwise noted.  
The respective 4-bromo compound (2.5 mmol, 1 eq) was dissolved in anhydrous Et2O (10 mL) 
and cooled to -78 °C under continuous stirring. tBuLi (5 mmol, 2 eq) was added drop-wise and 
the reaction mixture was stirred for 10 min at -78 °C before the cryo-bath was removed. The 
reaction mixture was allowed to warm up for a period of 20 min before it was transferred to the 
flask containing MCM-41.  
 
Reaction of lithiated arenes (Ar-Li) with MCM-41. The in situ generated Ar-Li compound 
was added drop-wise to the stirred suspension of MCM-41 at -78 °C. The resulting reaction 
mixture was stirred at -78 °C for 10 minutes and was then allowed to warm to ambient 
temperature and was stirred for another 4 h. Afterwards the reaction mixture was quenched with 
water (10 mL) and filtered off. The obtained yellowish powder was subsequently washed with 
methanol (30 mL), water (50 mL) and methanol (30 mL) and dried at 60 °C in air.  
 
Purification of the MCM-41_Arene compounds. The obtained MCM-41_Arene samples 
were extracted with dichloromethane (70 mL) employing a soxhlet apparatus (50 °C, 3 h), under 
reflux conditions. After purification, the powder was dried at 60 °C over night and was used for 
subsequent characterization.  
 
Characterization. Nitrogen sorption measurements were performed with a Quantachrome 
NOVA 4000e. Sample out-gassing was performed at 120 °C for 12 h at a pressure of 10 mTorr. 
Pore size and pore volume were calculated using a NLDFT equilibrium model for cylindrical 
pores of N2 on silica, based on the desorption branch of the isotherm. The Brunauer-Emmett-
Teller (BET) surface areas for all samples were calculated from the corresponding nitrogen 
sorption isotherms in the range of p/p0 = 0.05 – 0.2. To calculate the total pore volume, the 
amount of adsorbed nitrogen at the apparent plateau of the isotherm at high p/p0 values was 
used. Transmission electron microscopy (TEM) was performed on a FEI Titan 80-300 kV 
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microscope operating at 300 kV. Samples were prepared by dispersing 0.5 mg sample in 2 mL 
absolute ethanol. A drop of the resulting diluted suspension was dried on a carbon-coated 
copper grid. Thermogravimetric analysis was performed on a Netzsch STA 440 C TG/DSC 
instrument with a heating rate of 10 K/min in a stream of synthetic air of about 25 mL/min.  
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Figure 9.6: Possible generation of butylbromide (BuBr) from 4-bromoanisole upon lithiation. This 
reaction is possible for all arenes employed in this work. 
 
Figure 9.7: Possible degrees of organo-functionalization of the silica framework (fragment, schematic). 
A) Mesoporous silica framework without functionalization, B) monofunctionalized silica species, and 
C) mono and bi-functionalized silica framework.  
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Figure 9.8: 29Si ssNMR of the temperature dependent reaction of MCM-41 with nBuLi at -78 °C 
(black), -20 °C (red) and at ambient temperature (green).  
Figure 9.8 shows the effect of different synthesis temperatures on the reaction of MCM-41 with 
n-butyllithium (nBuLi). When MCM-41 is reacted with nBuLi at -78 °C, only mono-
functionalization of the silica framework is observed (T2/T3 peaks in Figure 9.8). Higher 
temperatures (-20 °C and ambient temperature) lead to additional bi-functionalization of the 
silicon atoms, which is indicated by the increasing D2 peak. The patterns visible in Figure 9.8 
correspond to the above-mentioned silica species A, B, C shown in Figure 9.7. The Q3/Q4 
( = -101 and -110 ppm) peaks are typical for non-functionalized, highly condensed silica 
material, whereas T2/T3 ( = - 5 and -65 ppm) correspond to silica species B, and the D2 peak 
( = -18 ppm) to species C. The 29Si ssNMR spectra demonstrate the importance of the reaction 
temperature for the synthesis of the inorganic-organic hybrid materials.  
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Figure 9.9: Thermogravimetric analysis data of MCM-41 (black line), MCM-41_nBuLi synthesized at 
-78 °C (dashed line) and MCM-41_nBuLi synthesized at 25 °C (dotted line). The mass was normalized 
to 100% at 75 °C for all three samples.  
The above 29Si ssNMR results are in agreement the thermogravimetric analysis data (Figure 
9.9), showing a distinctly higher mass loss for the sample reacted at ambient temperature (dotted 
curve, mass loss 19%), indicating a much higher degree of organic functionalization. The 
reaction at -78 °C (solid black curve, mass loss 4%) shows no D2 peak in the NMR spectrum. 
 
 
Reaction of lithiated 4-bromoarenes (Ar-Li species generated with tBuLi) with MCM-41 
 
Figure 9.10: Reaction of 4-bromoanisole with 2 eq tBuLi and subsequent reaction of the lithiated 
compound with MCM-41.  
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The above reaction parameters were employed for all 4-bromo arenes investigated in this work. 
The detailed synthesis procedure for the reactions is given in the experimental section. 
 
13C and 29Si solid state NMR (ssNMR) data of organo-functionalized MCM-41 materials 
 
Figure 9.11: Comparison of 13C ssNMR data of MCM-41_ArOMe generated by different lithiation 
approaches for 4-bromoanisole. A) Reaction of MCM-41 with 4-lithioanisole, (Ar-Li generated by 
nBuLi), and B) reaction of MCM-41 with 4-lithioanisole, generated with 2 eq tBuLi according to 
Figure  9.10. The peak at 60 ppm can be attributed to dichloromethane from Soxhlet extraction.  
 
When 4-bromoansiole is lithiated with nBuLi and subsequently reacted with template-free 
MCM-41, the surface-bound butyl-fragments are clearly visible with high intensity in the 
obtained 13C ssNMR (Figure 9.11A,  = 11, 15, 25 ppm). Additionally, we note that the intensity 
at  = 48 ppm (derived from the reaction of butylbromide with the silanol oxygen of MCM-41 
in a nucleophilic substitution, SN2) is significantly lower than in the case of MCM-41_BDMA 
(Figure 9.3B) suggesting that less butylbromide was generated during the reaction.  
Nonetheless, surface-bound butyl-moieties were present in all synthesized samples when the 
arene was lithiated with nBuLi. In comparison, the reaction of 4-bromoanisole with 2 eq tBuLi 
does not show the above-mentioned butyl-based peaks. Only the signals of the aromatic 
compounds are visible in the spectrum (Figure 9.11B), confirming that only the arene was 
successfully attached to MCM-41. 
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Figure 9.12: 29Si ssNMR of MCM-41_ArOMe, Ar-Li generated by lithiation of 4-bromoanisole with 
tBuLi. 
Both silica-based species – Q3/Q4 ( = -101 and -110 ppm – corresponding to the silica species 
A in Figure 9.7) and T2/T3 ( = -55 and -65 ppm - corresponding to silica species B in Figure 
9.7) were observed in the 29Si ssNMR spectra of the inorganic-organic hybrid materials 
(Figure 9.3D for MCM-41_BDMA and Figure 9.12 for MCM-41_ArOMe). Bi-functional silica 
species indicated by D2 (species C in Figure 9.7) are not present in any of the synthesized 
MCM-41_Aryl samples. 
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Figure 9.13: 13C  ssNMR of MCM-41_ArNMe2, Ar-Li species generated with tBuLi. 
 
 
 
Figure 9.14: 13C  ssNMR of MCM-41_Thiophene, Ar-Li species generated with tBuLi. 
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Figure 9.15: 13C  ssNMR of MCM-41_ArCH2Cl generated with tBuLi. 
 
Nitrogen sorption measurements 
Nitrogen sorption measurements were performed on a Quantachrome Instruments NOVA 
4000e. All six samples (15 mg each) were heated to 120 °C for 12 h in vacuo (10 mTorr) to 
outgas the samples before nitrogen sorption was measured at liquid nitrogen temperature. For 
the calculation of pore sizes and pore volumes, a non-local density functional theory (NLDFT) 
equilibrium model of nitrogen on silica was used. A summary of the obtained values for BET 
area and pore size distribution of the synthesized materials is given in Table 9.1. All organo-
functionalized MCM-41 samples exhibit a type IV isotherm typical for mesoporous materials 
with high surface areas, which are summarized in Table 9.1 of the main text.  
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Figure 9.16: Nitrogen sorption isotherms of the samples MCM-41 (I, filled squares), MCM-41_ArOMe 
(II, empty squares), MCM-41_BDMA (III, filled triangles), MCM-41_ArNMe2 (IV, empty triangles), 
MCM-41_Thiophene (V, filled circles) and MCM-41_ArCH2Cl (VI, empty circles). 
 
Pore size distributions calculated from the nitrogen sorption data of the organic-inorganic 
hybrid materials (Figure 9.17). All MCM-41_Arene samples exhibit a narrow pore size 
distribution with an average pore size of around 2.9 nm depending on the immobilized aromatic 
system. The exact values are given in Table 9.1 of the main text.  
 
 275 
 
 
Figure 9.17: Pore size distributions of the samples MCM-41 (I, filled squares), MCM-41_ArOMe (II, 
empty squares), MCM-41_BDMA (III, filled up triangles), MCM-41_ArNMe2 (IV, empty up 
triangles), MCM-41_Thiophene (V, filled circles) and MCM-41_ArCH2Cl (VI, empty circles). For 
clarity reasons, all curves are shifted along the y-axis by a value of 0.4 each. MCM-41 was scaled by 
multiplying the data with a value of 0.5.  
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Figure 9.18: Thermogravimetric analysis data of the samples MCM-41 (I, black curve) 
MCM-41_ArOMe (II, blue curve), MCM-41_BDMA (III, red curve), MCM-41_ArNMe2 (IV, green 
curve), MCM-41_Thiophene (V, pink curve) and MCM-41_ArCH2Cl (VI, grey curve). The mass was 
normalized to 100% at 75 °C for all six samples. 
 
Transmission electron microscopy of the synthesized materials 
All samples were investigated with an FEI Titan 80-300 transmission electron microscope 
operating at 300 kV with a high-angle annular dark field detector. A droplet of the diluted 
MCM-41 suspension in absolute ethanol was dried on a carbon-coated copper grid. 
The TEM micrograph in Figure 9.19 shows template-extracted mesporous MCM-41, whereas 
the images in Figure 9.20 and 9.21 show examples of organo-functionalized MCM-41 
synthesized with 2 eq tBuLi (MCM-41_BDMA and MCM-41_ArOMe, respectively). The 
images indicate that the mesostructure was not significantly affected by the post-synthesis 
modification.  
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Figure 9.19: TEM micrograph of template-free MCM-41. 
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Figure 9.20: TEM micrograph of MCM-41_BDMA synthesized with 2 eq tBuLi. 
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Figure 9.21: TEM micrograph of MCM-41_ArOMe synthesized with 2 eq tBuLi. 
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Figure 9.22: SAXS data of the samples MCM-41 (I, black curve) MCM-41_ArOMe (II, blue curve), 
MCM-41_BDMA (III, red curve), MCM-41_ArNMe2 (IV, green curve), MCM-41_Thiophene (V, pink 
curve) and MCM-41_ArCH2Cl (VI, grey curve). The curves are shifted by a value of 9.000 along the 
y-axis.. 
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10 Conclusion and Outlook 
The focus of the present work was the synthesis and characterization of custom-made colloidal 
multifunctional mesoporous silica nanoparticles (MSNs) for advanced drug delivery 
applications and the generation of novel silica materials. The functionalized, stimuli-responsive 
nano-carriers developed in this work meet various requirements for controlled cargo delivery 
in targeted cancer diagnosis and therapy. 
In a first project (chapter 3), a fluorimetric reporter system based on colloidal mesoporous silica 
nanoparticles (MSNs) was developed. The MSNs were modified with a blue-light sensitive 
photosensitizer, protoporphyrin IX (PpIX) and capped with a DOPC-based supported lipid 
bilayer (SLB). In this study, photochemical internalization (PCI) with an on-board 
photosensitizer and the redox-labile disulfide-bridge approach (of a corresponding dye-
quencher system) was combined to create highly potent multifunctional MSNs acting as 
fluorimetric reporters. The photosensitizer allows escaping the endosomal entrapment through 
the formation of highly reactive singlet oxygen, which is followed by the subsequent 
disintegration of both membranes in a cascaded manner. Endosomal uptake of the SLB-capped 
MSNs and individual endosome lysis events were studied in three different cell lines (fibroblast, 
normal and carcinoma cell lines). The release-on-demand system resulted in more broadly 
distributed lysis times than expected, particularly for Renca, a renal carcinoma cell line. An 
analysis of the nanoparticle load per endosome, endosome size and uptake characteristics 
indicated that Renca cells not only take up a lower amount of MSNs in comparison with the 
fibroblast cells, but also have larger endosomes, and a lower nanoparticle load per endosome. 
An existing stochastic pi calculus model for intracellular gold nanoparticle distribution was 
extended to our reporter-system, enabling one to understand how different factors (e.g., PpIX 
load per NP) affect the distributions. Model results indicated that the lysis time distribution is 
primarily determined by the minimum net PpIX required to burst an endosome, a factor 
influenced by the NP load per endosome, as well as the endosome size. Future work could 
involve the subsequent modification of the SLB@MSN system with different lipid 
compositions or the insertion of pH-sensitive membrane destabilization proteins. 
In chapter 4, the synthesis of uniform spherical multifunctional core-shell MSNs with sizes of 
70 nm and pores of 5 nm (25% higher value compared to more standard MSNs) is described. 
In order to further improve the drug delivery system based on mesoporous silica nanoparticles, 
PEGylated MSNs with an on-board phthalocyanine-based photosensitizer (AlPcS2a) were 
synthesized, the latter being excitable with red light near the therapeutic window. The 
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photosensitizer triggers endosomal release and enables efficient intracellular drug delivery. The 
use of red light provides good biocompatibility and allows for a deeper penetration into tissues, 
which is highly favorable in comparison to other approaches. Supported lipid bilayers 
(consisting of DOPC and DOTAP) coating the MSNs (SLB@MSNs) were obtained by solvent-
induced self-assembly. Additionally, two different targeting ligands, folic acid (FA) and 
epidermal growth factor (EGF), were inserted via diffusion into the SLB@MSNs. These 
targeting ligands were chosen because their receptors are commonly overexpressed throughout 
a wide range of cancer cells. Cellular uptake of targeted MSNs into KB and HeLa cells and 
endosomal escape events were monitored with fluorescence live-cell-imaging. We aim to 
further develop the light-responsive opening mechanism by employing newly designed photo-
switchable supported lipid membranes as capping systems around MSNs, thus avoiding the 
generation of singlet oxygen with this approach. 
In chapter 5 the synthesis of a novel pH-responsive multifunctional drug delivery vehicle based 
on polymer-functionalized colloidal mesoporous silica nanoparticles (MSNs) is presented. The 
outer surface of core-shell MSNs is covalently modified with the bi-functional pH-responsive 
polymer poly(2-vinylpyridine) (PVP), which permits subsequent attachment of polyethylene 
glycol (PEG), targeting ligands (folate) and external triggers (red-light sensitive 
photosensitizer). The integrity of the polymer shell at different pH-values was investigated in 
detail with in vial and in vitro techniques. Additionally, stability tests in cell medium revealed 
an extraordinary shielding behavior towards inorganic components, implying a tight capping of 
the polymer shell and thus a long-term stability of the nano-vehicles, which is highly favorable 
for drug delivery applications. The system was successfully employed for the delivery of 
membrane-permeable and membrane-impermeable cargo molecules (DAPI and calcein, 
respectively) to different cell lines, and investigated with fluorescence live-cell imaging. First 
in vivo experiments in mouse models (not discussed in this thesis) were successfully carried out 
and yielded promising results. Therefore, future work with the newly developed pH-responsive 
nano-carriers will focus on the successful, targeted delivery of chemotherapeutics (e.g. 
doxorubicin) in vivo. 
A major interest of this work was the development of organo-modified mesoporous silica 
nanoparticles with ultra-large pores (7 – 15 nm) and defined small sizes (≤ 200 nm, LP_MSNs), 
allowing multiple molecular functionalization (chapter 6). Both the successful optimization of 
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the pore diameter and the molecular functionalization of the mesopores in order to allow the 
facile control of diffusion and attachment of larger guest molecules into the host were 
demonstrated. An increase in pore diameter to values between 7 and 13 nm was achieved with 
different micellar expanders (TMB and TiPB) that partition into the surfactant aggregates. 
Moreover, high molecular weight surfactants (Pluronic F127) and a novel fluorinated co-
surfactant (fluorocarbon surfactant FC-4) were employed at low synthesis temperatures (10 °C 
and 30 °C). The impact of specific hydrothermal treatment steps on the pore diameter was 
investigated in detail. Importantly, we reported for the first time the successful synthesis of 
organo-functionalized LP_MSNs (LP_MSN-SH, LP_MSN-NH2/Ph and LP_MSN-N3) via a 
co-condensation approach, allowing multiple prospective applications of the newly synthesized 
nanoparticles. Future work could address the fine-tuning of the developed hybrid nano-vehicles 
with ultra-large pores modified with recognition and trigger functions, ultimately allowing the 
control of various cell functions (e.g., endosomal escape events or the disruption of the 
cytoskeleton by cell-active cargo molecules).  
Based on the newly generated LP_MSNs bearing azide-moieties (LP_ MSN-N3), we also 
developed a colloidal nano-carrier system suitable for bioorthogonal click chemistry reactions 
(chapter 7). Enabling the immobilization/adsorption of larger biomolecules a basis for the great 
interest in LP_MSNs. We chose to immobilize two enzymes of different molecular dimensions, 
namely cytochrome C (CytC) and trypsin, in our LP_MSN-N3. The peroxidase CytC (2.6 x 3.2 
x 3.3 nm3) and the protease trypsin (3.8 nm, spherical) were successfully modified with an 
alkyne-linker to allow for a click reaction under mild reaction conditions. Compared to the 
small amount of azide-functionalization present in the LP_MSNs, a high-density cargo 
immobilization was achieved in the LP_MSN-N3. The activity of CytC immobilized within the 
large mesopores shows extraordinary high values, 2.9 times higher than the native enzyme in 
solution. We assume that the wall functionalities stabilize the conformational state of the 
enzyme. For immobilized trypsin, we also observed higher activity than reported in the 
literature. A promising future application of the successfully synthesized LP_MSN-CytC 
particles could be their use in antigen-detection tests in co-operation with Dr. S. Thalhammer 
from the Helmholtz Zentrum München. 
In chapter 8, the successful synthesis of colloidal amino/phenyl-functionalized mesoporous 
silica nanoparticles with ultra-large pores (LP_MSNs), suitable for the post-synthesis 
modification with a red-light sensitive on-board photosensitizer and a DOPC-DOTAP 
supported lipid bilayer (SLB) for efficient pore capping was reported. This system provides an 
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on-demand release mechanism proven by in vial and in vitro cargo release experiments with 
model drugs of different sizes (calcein, propidium iodide, fluorescently-labeled dextran 
10 kDa). Endosomal entrapment, a major bottle-neck in drug delivery applications, was 
successfully overcome upon activation of the photosensitizer with red-light after significant 
uptake into HeLa cells. We were able to successfully demonstrate the efficient delivery and 
release of small to large molecular weight cargos (up to 10 kD) from our 
SLB@LP_MSN-NH2/Ph-AlPcS2a. Future work based on this system could aim at the use of 
near-infrared or two-photon excitation for externally triggered cargo release, and the adsorption 
and intracellular release of oligonucleotides (e.g., siRNA). Additionally, other release 
mechanisms such as pH- or redox-triggered opening of gates together with the attachment of 
different targeting ligands (e.g. aptamers, antibodies) onto the outer surface of the nano-carriers 
for enhanced cell uptake should be addressed in future work.  
Another project of this work was the organo-functionalization of MCM-41 with lithiated 
aromatic compounds, which was discussed in detail in chapter 9. Different 4-bromo arenes were 
reacted with tert-butyllithium (tBuLi) and subsequently with MCM-41 under mild reaction 
conditions. In detailed 13C MAS ssNMR studies it was shown that this approach (halogen-
lithium exchange with 2 equivalents of tBuLi instead of lithiation with nBuLi) is highly 
favorable compared to previously described procedures, since only gaseous by-products are 
generated showing no side-reactions with the silica framework. Different functionalities were 
introduced into the mesoporous framework of MCM-41. The immobilized aromatic systems 
offer the possibility for further post-synthesis modification, yielding a flexible platform for 
custom-made modifications (e.g., for the synthesis of heterogeneous catalysts). We emphasize 
that the above procedure is not limited to MCM-41 but can also be employed with other 
mesoporous silica host systems such as SBA-15 or mesoporous silica nanoparticles. 
Summarizing, the direct modification of mesoporous hosts with aromatic molecules through 
silicon-carbon bonds was demonstrated to be a fast and highly efficient method offering a 
variety of possible post-synthesis modifications for mesoporous materials with potential for 
future applications. 
In conclusion, the successful synthesis and characterization of tailor-made multifunctional 
mesoporous silica nanoparticles (MSNs) for advanced drug delivery applications was 
demonstrated in this work. MSNs with different pore sizes, particle morphologies and post-
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synthesis functionalization were created, enabling the generation of stimuli-responsive release 
on-demand nano-carriers for controlled cargo delivery to meet the demands of targeted cancer 
therapy and diagnosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
